[
  {
    "text": "1. Recent Adv Inflamm Allergy Drug Discov. 2025;19(2):259-268. doi:",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      },
      {
        "text": "2025;19(2):259-268",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "A Comparative Study of Dexamethasone and Methylprednisolone in COVID-19",
    "entities": [
      {
        "text": "COVID-19",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Patients: Clinical Outcomes and Inflammatory Markers.",
    "entities": []
  },
  {
    "text": "Author information:",
    "entities": []
  },
  {
    "text": "(1)Student Research Committee, Faculty of Medicine, Mashhad University of",
    "entities": [
      {
        "text": "Research Committee",
        "label": "ORG"
      },
      {
        "text": "Faculty of Medicine, Mashhad University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medical Sciences, Mashhad, Iran.",
    "entities": [
      {
        "text": "Medical Sciences",
        "label": "ORG"
      },
      {
        "text": "Mashhad",
        "label": "GPE"
      },
      {
        "text": "Iran",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Internal Medicine, Faculty of Medicine, Mashhad University of",
    "entities": [
      {
        "text": "Internal Medicine, Faculty of Medicine, Mashhad University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.",
    "entities": [
      {
        "text": "Pharmacy, Mashhad University of Medical Sciences",
        "label": "ORG"
      },
      {
        "text": "Mashhad",
        "label": "GPE"
      },
      {
        "text": "Iran",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Lung Diseases Research Center, Faculty of Medicine, Mashhad University of",
    "entities": [
      {
        "text": "Diseases Research Center, Faculty of Medicine, Mashhad University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)Department of Pharmaceutical Nanotechnology, School of Pharmacy, Mashhad",
    "entities": [
      {
        "text": "Pharmaceutical Nanotechnology",
        "label": "ORG"
      },
      {
        "text": "School of Pharmacy",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University of Medical Sciences, Mashhad, Iran.",
    "entities": [
      {
        "text": "University of Medical Sciences",
        "label": "ORG"
      },
      {
        "text": "Mashhad",
        "label": "GPE"
      },
      {
        "text": "Iran",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Clinical Research Development Unit, Ghaem Hospital, Mashhad University of",
    "entities": [
      {
        "text": "Research Development Unit",
        "label": "ORG"
      },
      {
        "text": "Ghaem Hospital",
        "label": "ORG"
      },
      {
        "text": "Mashhad University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "BACKGROUND: The Coronavirus disease 2019 (COVID-19) pandemic, prompted by",
    "entities": [
      {
        "text": "Coronavirus",
        "label": "LOC"
      },
      {
        "text": "2019",
        "label": "DATE"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "SARS-CoV-2, has created complicated health crises. An excessive inflammatory",
    "entities": []
  },
  {
    "text": "response and cytokine storm characterize severe COVID-19. Corticosteroids like",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "dexamethasone and methylprednisolone are used for their anti-inflammatory",
    "entities": []
  },
  {
    "text": "effects, but comparisons of their efficacy are lacking.",
    "entities": []
  },
  {
    "text": "OBJECTIVE: This study seeks to rigorously assess and contrast the effectiveness",
    "entities": []
  },
  {
    "text": "of dexamethasone and methylprednisolone in combating COVID-19 infections.",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "METHODS: This retrospective clinical study evaluates the effects of these two",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "corticosteroids by reviewing the files of 500 hospitalized COVID-19 patients.",
    "entities": [
      {
        "text": "500",
        "label": "CARDINAL"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "The baseline characteristics of the patients, chest CT severity score, type of",
    "entities": [
      {
        "text": "CT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "steroid prescription, duration of hospitalization and steroid prescription,",
    "entities": []
  },
  {
    "text": "dosage of corticosteroid therapy, their recovery status, hospital mortality, and",
    "entities": []
  },
  {
    "text": "specific disease severity-associated markers, such as lactate dehydrogenase",
    "entities": []
  },
  {
    "text": "(LDH), complete blood count (CBC), C-reactive protein (CRP), and Erythrocyte",
    "entities": [
      {
        "text": "CRP",
        "label": "ORG"
      },
      {
        "text": "Erythrocyte",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "sedimentation rate (ESR) were collected and compared.",
    "entities": [
      {
        "text": "ESR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "RESULTS: The study found no significant difference in most disease",
    "entities": []
  },
  {
    "text": "severity-associated markers between the two corticosteroid groups. However,",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "lower mortality rates and shortened hospital stays were significantly associated",
    "entities": []
  },
  {
    "text": "with dexamethasone, especially in critical patient groups. A detailed analysis",
    "entities": []
  },
  {
    "text": "of inflammatory markers suggested minimal differences based on the type of",
    "entities": []
  },
  {
    "text": "CONCLUSION: The study indicates that dexamethasone may have some advantages in",
    "entities": []
  },
  {
    "text": "specific clinical outcomes. Further research needs to explore the mechanisms",
    "entities": []
  },
  {
    "text": "Copyright\u00a9 Bentham Science Publishers; For any queries, please email at",
    "entities": [
      {
        "text": "Bentham Science Publishers",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "An effective short form of the 20-item University of California Los Angeles",
    "entities": [
      {
        "text": "20",
        "label": "CARDINAL"
      },
      {
        "text": "University of California Los Angeles",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Loneliness Scale version 3: item response theory and network psychometrics.",
    "entities": [
      {
        "text": "3",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(1)Department of Biostatistics, Vanderbilt University, Nashville, Tennessee,",
    "entities": [
      {
        "text": "Biostatistics, Vanderbilt University",
        "label": "ORG"
      },
      {
        "text": "Nashville",
        "label": "GPE"
      },
      {
        "text": "Tennessee",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)University of Wisconsin-Madison, Madison, Wisconsin, USA.",
    "entities": [
      {
        "text": "2)University",
        "label": "CARDINAL"
      },
      {
        "text": "Wisconsin",
        "label": "GPE"
      },
      {
        "text": "Madison",
        "label": "PERSON"
      },
      {
        "text": "Wisconsin",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Division of Biostatistics and Bioinformatics, Herbert Wertheim School of",
    "entities": [
      {
        "text": "Biostatistics and Bioinformatics",
        "label": "ORG"
      },
      {
        "text": "Herbert Wertheim School",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Public Health and Human Longevity Science, UC San Diego, San Diego, California,",
    "entities": [
      {
        "text": "UC",
        "label": "GPE"
      },
      {
        "text": "San Diego",
        "label": "GPE"
      },
      {
        "text": "San Diego",
        "label": "GPE"
      },
      {
        "text": "California",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Division of Geriatric Psychiatry, UC San Diego, San Diego, California, USA.",
    "entities": [
      {
        "text": "Geriatric Psychiatry",
        "label": "ORG"
      },
      {
        "text": "UC",
        "label": "GPE"
      },
      {
        "text": "San Diego",
        "label": "GPE"
      },
      {
        "text": "San Diego",
        "label": "GPE"
      },
      {
        "text": "California",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Loneliness is a complex and usually unpleasant emotional response to isolation,",
    "entities": []
  },
  {
    "text": "which has been considered the latest global health epidemic exacerbated by the",
    "entities": []
  },
  {
    "text": "coronavirus disease 2019 pandemic, affecting nearly two-thirds of older adults.",
    "entities": [
      {
        "text": "2019",
        "label": "DATE"
      },
      {
        "text": "nearly two-thirds",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Some profound health implications carried by loneliness include depression,",
    "entities": []
  },
  {
    "text": "cognitive impairment, hypertension and frailty. Across the world, there is no",
    "entities": []
  },
  {
    "text": "consensus definition of loneliness, and its measure is based on the",
    "entities": []
  },
  {
    "text": "phenomenological perspective of the individual. The 20-item University of",
    "entities": [
      {
        "text": "20",
        "label": "CARDINAL"
      },
      {
        "text": "University of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "California Los Angeles Loneliness Scale version 3 (UCLA-20) is the most common",
    "entities": [
      {
        "text": "California",
        "label": "GPE"
      },
      {
        "text": "Los Angeles Loneliness Scale",
        "label": "ORG"
      },
      {
        "text": "3",
        "label": "CARDINAL"
      },
      {
        "text": "UCLA-20",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "measure. This scale demonstrates acceptable psychometric properties but is too",
    "entities": []
  },
  {
    "text": "long and complex for a phone interview. This paper addresses the increasing need",
    "entities": []
  },
  {
    "text": "to shorten this scale by adopting classical item response theory and network",
    "entities": []
  },
  {
    "text": "psychometrics to advance scale development. Through an item reduction analysis,",
    "entities": []
  },
  {
    "text": "we trimmed the original scale into an effective short form, which is as valid as",
    "entities": []
  },
  {
    "text": "the original one. With respondents' time at a premium in most research nowadays,",
    "entities": []
  },
  {
    "text": "this short-form scale is an efficient and practical alternative to the original",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 Author(s) (or their employer(s)) 2025. Re-use permitted under CC",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "CC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.",
    "entities": [
      {
        "text": "NC",
        "label": "GPE"
      },
      {
        "text": "BMJ Group",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: None declared.",
    "entities": []
  },
  {
    "text": "A data-mining analysis of host solute carrier family proteins in SARS-CoV-2",
    "entities": []
  },
  {
    "text": "infection with reference to brain endothelial cells and the blood-brain barrier",
    "entities": []
  },
  {
    "text": "in COVID-19.",
    "entities": [
      {
        "text": "COVID-19",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(1)Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL,",
    "entities": [
      {
        "text": "College of Medicine",
        "label": "ORG"
      },
      {
        "text": "Florida Atlantic University",
        "label": "ORG"
      },
      {
        "text": "Boca Raton",
        "label": "GPE"
      },
      {
        "text": "FL",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "United States.",
    "entities": [
      {
        "text": "United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: The brain vasculature is a key player in neurological manifestations",
    "entities": []
  },
  {
    "text": "of COVID-19. Infection of brain endothelial cells with SARS-CoV-2 along with",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "circulating cytokines may cause dysfunction of the blood-brain barrier (BBB).",
    "entities": [
      {
        "text": "BBB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Solute carrier transporters (SLCs) in brain endothelial cells regulate substrate",
    "entities": []
  },
  {
    "text": "transport across the BBB. Here, it was hypothesized that transport functions of",
    "entities": [
      {
        "text": "BBB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "SLCs will be impaired by interactions with viral proteins, and subsequently,",
    "entities": []
  },
  {
    "text": "METHODS: Virus-host protein-protein interaction data for SARS-CoV-2 infection",
    "entities": []
  },
  {
    "text": "were retrieved from the BioGRID database, filtered for SLCs, and then annotated",
    "entities": []
  },
  {
    "text": "for relevant expression in brain endothelial cells using a mouse brain",
    "entities": []
  },
  {
    "text": "transcriptomics database. Host SLCs expressed in brain endothelial cells were",
    "entities": []
  },
  {
    "text": "further explored using publicly available databases and information in the",
    "entities": []
  },
  {
    "text": "literature. Functional Annotation Clustering was performed using DAVID, and",
    "entities": [
      {
        "text": "Functional Annotation Clustering",
        "label": "ORG"
      },
      {
        "text": "DAVID",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Enrichr served for pathway analysis. Substrates were retrieved from NCBI Gene.",
    "entities": [
      {
        "text": "Enrichr",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Links to monogenic disorders were retrieved from Online Mendelian Inheritance in",
    "entities": [
      {
        "text": "Online Mendelian Inheritance",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Man\u2122 and screened for disorders of the nervous system. Interactome data for",
    "entities": []
  },
  {
    "text": "viral proteins of SARS-CoV-2 were retrieved from BioGRID. Reports for host SLCs",
    "entities": []
  },
  {
    "text": "in viral receptor functions, viral entry mechanisms, and other major roles in",
    "entities": []
  },
  {
    "text": "the viral cycle were explored in databases (VThunter) and literature.",
    "entities": []
  },
  {
    "text": "ATP-binding cassette transporters (ABCs) were studied in parallel.",
    "entities": []
  },
  {
    "text": "RESULTS: N = 80 host SLCs showed relevant expression in brain endothelial cells",
    "entities": [
      {
        "text": "80",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "whereby amino acid transporter stood out. N = 24/80 host SLCs were linked to",
    "entities": [
      {
        "text": "24/80",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "monogenic disorders of the nervous system. N = 9/29 SARS-CoV-2 viral proteins",
    "entities": [
      {
        "text": "9/29",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "had strong links to SLCs and key functions in viral infection (e.g., interferon",
    "entities": [
      {
        "text": "interferon\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "response). SLCs serving as viral receptors and with closely associated functions",
    "entities": []
  },
  {
    "text": "were significantly enriched among all known listed viral receptors (chi-square",
    "entities": []
  },
  {
    "text": "test, p = 0.001). Literature searches for host SLCs revealed involvement of a",
    "entities": [
      {
        "text": "0.001",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "subset of SLCs in infection mechanisms for SARS-CoV-2 and more broadly for other",
    "entities": []
  },
  {
    "text": "viruses. N = 17 host ABCs were found in brain endothelial cells where they may",
    "entities": [
      {
        "text": "17",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "DISCUSSION: This hypothesis-generating work proposes a set of N = 80 host SLCs",
    "entities": [
      {
        "text": "N",
        "label": "ORG"
      },
      {
        "text": "80",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "expressed in endothelial cells as contributors to BBB impairment after",
    "entities": [
      {
        "text": "BBB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "SARS-CoV-2 infection. Theoretically, persistent dysfunction of SLCs at the BBB,",
    "entities": [
      {
        "text": "BBB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "in particular insufficient transport of amino acids, could be one of many",
    "entities": [
      {
        "text": "one",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "reasons for cognitive changes in long-COVID. Functions of SLCs in viral entry",
    "entities": []
  },
  {
    "text": "and associated roles deserve close attention.",
    "entities": []
  },
  {
    "text": "Conflict of interest statement: The authors declare that the research was",
    "entities": []
  },
  {
    "text": "conducted in the absence of any commercial or financial relationships that could",
    "entities": []
  },
  {
    "text": "be construed as a potential conflict of interest.",
    "entities": []
  },
  {
    "text": "School-informed risk calculator tool for reducing the spread of respiratory",
    "entities": []
  },
  {
    "text": "viral infection among school-aged children.",
    "entities": []
  },
  {
    "text": "Wilson AM(1), Lowe AA(2)(3), Amoh-Asante NAA(1), Zhan Y(1), Ashraf A(1), Gerald",
    "entities": [
      {
        "text": "Wilson",
        "label": "ORG"
      },
      {
        "text": "Lowe AA(2)(3",
        "label": "ORG"
      },
      {
        "text": "Amoh-Asante NAA(1",
        "label": "ORG"
      },
      {
        "text": "Zhan",
        "label": "PERSON"
      },
      {
        "text": "Gerald\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Department of Community, Environment & Policy, Mel and Enid Zuckerman College",
    "entities": [
      {
        "text": "Community, Environment & Policy",
        "label": "ORG"
      },
      {
        "text": "Mel",
        "label": "PERSON"
      },
      {
        "text": "Enid Zuckerman College",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "of Public Health, University of Arizona, Tucson, AZ, USA.",
    "entities": [
      {
        "text": "Public Health",
        "label": "ORG"
      },
      {
        "text": "University of Arizona",
        "label": "ORG"
      },
      {
        "text": "Tucson",
        "label": "GPE"
      },
      {
        "text": "AZ",
        "label": "ORG"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Nursing & Health Sciences Division, College of Nursing, University of",
    "entities": [
      {
        "text": "2)Nursing & Health Sciences Division",
        "label": "ORG"
      },
      {
        "text": "University of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Asthma & Airway Disease Research Center, Tucson, AZ, USA.",
    "entities": [
      {
        "text": "3)Asthma & Airway Disease Research Center",
        "label": "ORG"
      },
      {
        "text": "Tucson",
        "label": "GPE"
      },
      {
        "text": "AZ",
        "label": "ORG"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Office of Population Health Sciences, Office of the Vice Chancellor for",
    "entities": [
      {
        "text": "Population Health Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Health Affairs, University of Illinois Chicago, Chicago, IL, USA.",
    "entities": [
      {
        "text": "Health Affairs",
        "label": "ORG"
      },
      {
        "text": "University of Illinois Chicago",
        "label": "ORG"
      },
      {
        "text": "Chicago",
        "label": "GPE"
      },
      {
        "text": "IL",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Breathe Chicago Center, University of Illinois Chicago, Chicago, IL, USA.",
    "entities": [
      {
        "text": "5)Breathe Chicago Center, University of Illinois Chicago",
        "label": "ORG"
      },
      {
        "text": "Chicago",
        "label": "GPE"
      },
      {
        "text": "IL",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "School health staff need decision support for responding to respiratory viral",
    "entities": []
  },
  {
    "text": "outbreaks. Quantitative microbial risk assessment (QMRA) tools are an",
    "entities": []
  },
  {
    "text": "inexpensive and fast resource. Our objectives were to engage school districts to",
    "entities": []
  },
  {
    "text": "inform the development of a risk-based calculator tool, test the tool across",
    "entities": []
  },
  {
    "text": "hypothetical cases, and elicit feedback among school health staff. We",
    "entities": []
  },
  {
    "text": "administered an online survey for Kindergarten (K) - Grade 5 teachers, school",
    "entities": [
      {
        "text": "Kindergarten",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "health professionals, and other school staff to gather data about respiratory",
    "entities": []
  },
  {
    "text": "viral disease interventions and model parameters. A risk calculator tool was",
    "entities": []
  },
  {
    "text": "developed in which users choose hypothetical scenarios to estimate infection",
    "entities": []
  },
  {
    "text": "risk per individual and compare interventions. Three case studies (CS) were",
    "entities": [
      {
        "text": "Three",
        "label": "CARDINAL"
      },
      {
        "text": "CS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "explored: CS1 - Rhinovirus transmission in a general education classroom with",
    "entities": []
  },
  {
    "text": "\"poor\" vs. \"great\" air quality, CS2 - Influenza A virus transmission in a music",
    "entities": []
  },
  {
    "text": "classroom with vs. without a portable air purifier, CS3 - SARS-CoV-2",
    "entities": []
  },
  {
    "text": "transmission in a special education classroom with vs. without open",
    "entities": []
  },
  {
    "text": "doors/windows. The prototype tool was presented at a national school nursing",
    "entities": []
  },
  {
    "text": "meeting, and attendees were surveyed on (dis)likes and anticipated tool uses.",
    "entities": [
      {
        "text": "dis)likes",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "For the initial survey of Arizona school personnel (n = 132), the top",
    "entities": [
      {
        "text": "Arizona",
        "label": "GPE"
      },
      {
        "text": "132",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "respiratory viral outbreak strategies reported by teachers were hand (94 %) and",
    "entities": [
      {
        "text": "94 %",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "surface hygiene (85.1 %). For all case studies, infection risks were above",
    "entities": [
      {
        "text": "85.1 %",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "thresholds used in other contexts but were comparable to published student",
    "entities": []
  },
  {
    "text": "respiratory illness incidence data. At the national meeting, school nurses (n =",
    "entities": []
  },
  {
    "text": "12) identified potential uses including advocating for interventions to",
    "entities": [
      {
        "text": "12",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "administrators. This work reflects a unique application of community partnership",
    "entities": []
  },
  {
    "text": "and QMRA to address school health decision support.",
    "entities": []
  },
  {
    "text": "Identifying Key Hub Genes that Attribute Varying Host Responses: A Longitudinal",
    "entities": []
  },
  {
    "text": "RNA-seq Analysis of SARS-CoV-2 Delta and Omicron Infections.",
    "entities": [
      {
        "text": "Omicron Infections",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Bajracharya D, Jansen RJ, Yan C, Ramamoorthy S.",
    "entities": [
      {
        "text": "Bajracharya D",
        "label": "PERSON"
      },
      {
        "text": "Jansen RJ",
        "label": "PERSON"
      },
      {
        "text": "Ramamoorthy S.\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, has severely impacted",
    "entities": [
      {
        "text": "Coronavirus",
        "label": "GPE"
      },
      {
        "text": "2019",
        "label": "DATE"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "global health, with different Variants of Concern (VOCs) resulting in varied",
    "entities": [
      {
        "text": "Variants of Concern",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "clinical outcomes. Among these, the Delta and Omicron variants have drawn",
    "entities": [
      {
        "text": "Delta",
        "label": "LOC"
      },
      {
        "text": "Omicron",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "significant attention due to their distinct characteristics-Delta is associated",
    "entities": [
      {
        "text": "Delta",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "with higher virulence and Omicron has greater transmissibility but reduced",
    "entities": [
      {
        "text": "Omicron",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "severity. This study compares host immune responses to the Delta and Omicron",
    "entities": [
      {
        "text": "Delta",
        "label": "LOC"
      },
      {
        "text": "Omicron",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "variants using RNA-seq data from infected primary human airway epithelial cells.",
    "entities": []
  },
  {
    "text": "Both variants triggered a robust antiviral innate immune response by 2 days",
    "entities": [
      {
        "text": "2 days",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "post-infection (dpi). However, Omicron was found to elicit a more rapid immune",
    "entities": [
      {
        "text": "Omicron",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "response, showing pathway enrichment at 1 dpi. In contrast, Delta displayed no",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      },
      {
        "text": "Delta",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "immune-related pathway activation within the first 24 hours, suggesting it may",
    "entities": [
      {
        "text": "the first 24 hours",
        "label": "TIME"
      }
    ]
  },
  {
    "text": "evade early immune detection, promoting increased viral replication. By 3 dpi,",
    "entities": [
      {
        "text": "3",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Delta induced a more aggressive immune response, particularly in pathways",
    "entities": [
      {
        "text": "Delta",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "related to cell death and pro-inflammatory signaling, such as \"programmed cell",
    "entities": []
  },
  {
    "text": "death\" and \"regulation of cell death.\" Weighted gene co-expression network",
    "entities": []
  },
  {
    "text": "analysis revealed distinct immune-related genes: Delta infections were",
    "entities": []
  },
  {
    "text": "characterized by hub genes like MYD88 and IL1R1 involved in pro-inflammatory",
    "entities": []
  },
  {
    "text": "responses, HLA-A & B, NLRC5 and PSMB9 involved in antigen presentation and",
    "entities": [
      {
        "text": "HLA-A & B",
        "label": "ORG"
      },
      {
        "text": "NLRC5",
        "label": "PRODUCT"
      },
      {
        "text": "PSMB9",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "TNSF10 and IFR1 involved in pro-apoptotic processes. Conversely, Omicron",
    "entities": [
      {
        "text": "IFR1",
        "label": "ORG"
      },
      {
        "text": "Omicron",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "infections were marked by hub genes such as CXCL1 and CXCL8 involved in immune",
    "entities": [
      {
        "text": "CXCL1",
        "label": "ORG"
      },
      {
        "text": "CXCL8",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "cells recruitment, MET and LYN involved in reducing hyperinflammatory responses",
    "entities": [
      {
        "text": "MET",
        "label": "ORG"
      },
      {
        "text": "LYN",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and maintaining immune balance, and IFI44, EIF2AK2 and IFIT5 responsible for the",
    "entities": [
      {
        "text": "IFI44",
        "label": "GPE"
      },
      {
        "text": "IFIT5",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "sensing of viral RNA among others.",
    "entities": [
      {
        "text": "RNA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Open-science discovery of DNDI-6510, a compound that addresses genotoxic and",
    "entities": []
  },
  {
    "text": "metabolic liabilities of the COVID Moonshot SARS-CoV-2 Mpro lead inhibitor.",
    "entities": []
  },
  {
    "text": "Robinson RP, Lefker BA, Duberstein S, Lahav N; COVID Moonshot Consortium;",
    "entities": [
      {
        "text": "Lefker BA",
        "label": "ORG"
      },
      {
        "text": "Duberstein S",
        "label": "PERSON"
      },
      {
        "text": "Lahav N",
        "label": "GPE"
      },
      {
        "text": "COVID Moonshot Consortium",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Braillard S, Vangeel L, Laporte M, Charvillon FB, MacLeod AK, Wells A, Garner P,",
    "entities": [
      {
        "text": "Braillard S",
        "label": "PERSON"
      },
      {
        "text": "Vangeel L",
        "label": "ORG"
      },
      {
        "text": "Laporte M",
        "label": "ORG"
      },
      {
        "text": "Charvillon FB",
        "label": "ORG"
      },
      {
        "text": "MacLeod AK",
        "label": "ORG"
      },
      {
        "text": "Wells A",
        "label": "ORG"
      },
      {
        "text": "Garner P",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Knight R, Rees P, Simon A, Jochmans D, Neyts J, Read KD, Barr H, Robinson M, Lee",
    "entities": [
      {
        "text": "Knight R",
        "label": "PERSON"
      },
      {
        "text": "Simon A",
        "label": "PERSON"
      },
      {
        "text": "Jochmans",
        "label": "NORP"
      },
      {
        "text": "Neyts",
        "label": "PERSON"
      },
      {
        "text": "Read KD",
        "label": "PERSON"
      },
      {
        "text": "Barr H",
        "label": "PERSON"
      },
      {
        "text": "Lee\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "The 2020 SARS-CoV-2 coronavirus pandemic highlighted the urgent need for novel",
    "entities": [
      {
        "text": "2020",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "small molecule antiviral drugs. (S)- x38 DNDI-6510 is a non-covalent SARS-CoV-2",
    "entities": [
      {
        "text": "x38",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "main protease inhibitor developed by the open science collaboration COVID",
    "entities": []
  },
  {
    "text": "Moonshot. Here, we report on the metabolic and toxicologic optimization of the",
    "entities": []
  },
  {
    "text": "lead series previously disclosed by the COVID Moonshot Initiative, leading up to",
    "entities": [
      {
        "text": "the COVID Moonshot Initiative",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "the selection of (S)- x38 DNDI-6510 as the preclinical candidate. We describe",
    "entities": [
      {
        "text": "x38",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "the thorough profiling of the series, identifying key risks such as formation of",
    "entities": []
  },
  {
    "text": "genotoxic metabolites and high clearance, which were successfully addressed",
    "entities": [
      {
        "text": "genotoxic metabolites",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "during lead optimization. In addition, we disclose the in vitro and in vivo",
    "entities": []
  },
  {
    "text": "evaluation of (S)- x38 DNDI-6510 in pharmacokinetic and pharmacodynamic models,",
    "entities": [
      {
        "text": "x38",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "exploring multiple approaches to ameliorate rodent-specific metabolic clearance,",
    "entities": []
  },
  {
    "text": "and show that both co-dosing of (S)- x38 DNDI-6510 with an ABT inhibitor and",
    "entities": [
      {
        "text": "x38",
        "label": "PERSON"
      },
      {
        "text": "ABT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "utilizing a metabolically humanized mouse model (8HUM) achieve significant",
    "entities": []
  },
  {
    "text": "improvements in exposure. Through comparisons of ABT co-dosing and humanized",
    "entities": [
      {
        "text": "ABT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "mouse models in efficacy experiments, we demonstrate that continuous exposure",
    "entities": [
      {
        "text": "mouse",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "over cellular EC 90 is required for SARS-CoV-2 antiviral efficacy in vivo in an",
    "entities": [
      {
        "text": "EC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "antiviral model using a mouse-adapted SARS-CoV-2 strain. Finally, (S)- x38",
    "entities": [
      {
        "text": "x38",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "DNDI-6510 was assessed in maximum tolerated dose experiments in two species,",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "demonstrating significant in vivo PXR-linked auto-induction of metabolism,",
    "entities": [
      {
        "text": "PXR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "leading to the discontinuation of this compound. In summary, we report the",
    "entities": []
  },
  {
    "text": "successful effort to overcome series-specific AMES liabilities in a lead",
    "entities": [
      {
        "text": "AMES",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "development program. Downstream optimization of existing series will require",
    "entities": []
  },
  {
    "text": "in-depth optimization of rodent-specific liabilities and metabolic induction",
    "entities": []
  },
  {
    "text": "SARS-CoV-2 NSP13 interacts with TEAD to suppress Hippo-YAP signaling.",
    "entities": [
      {
        "text": "Hippo-YAP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "The Hippo pathway controls organ development, homeostasis, and regeneration",
    "entities": [
      {
        "text": "Hippo",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "primarily by modulating YAP/TEAD-mediated gene expression. Although emerging",
    "entities": [
      {
        "text": "YAP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "studies report Hippo-YAP dysfunction after viral infection, it is largely",
    "entities": [
      {
        "text": "Hippo-YAP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "unknown in the context of severe acute respiratory syndrome coronavirus 2",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(SARS-CoV-2). Here, we analyzed RNA sequencing data from induced pluripotent",
    "entities": [
      {
        "text": "RNA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "stem cell-derived cardiomyocytes (iPSC-CMs) and SARS-CoV-2-infected human lung",
    "entities": []
  },
  {
    "text": "samples, and observed a decrease in YAP target gene expression. In screening",
    "entities": [
      {
        "text": "YAP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "SARS-CoV-2 nonstructural proteins, we found that nonstructural protein 13",
    "entities": [
      {
        "text": "13",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(NSP13), a conserved coronavirus helicase, inhibits YAP transcriptional activity",
    "entities": [
      {
        "text": "YAP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "independent of the upstream Hippo kinases LATS1/2. Consistently, introducing",
    "entities": [
      {
        "text": "Hippo",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "NSP13 into cardiomyocytes suppresses an active form of YAP (YAP5SA) in vivo .",
    "entities": [
      {
        "text": "NSP13",
        "label": "ORG"
      },
      {
        "text": "YAP",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Subsequent investigations on NSP13 mutants revealed that NSP13 helicase",
    "entities": [
      {
        "text": "NSP13",
        "label": "LOC"
      },
      {
        "text": "NSP13",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "activity, including DNA binding and unwinding, is crucial for suppressing YAP",
    "entities": [
      {
        "text": "YAP",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "transactivation. Mechanistically, TEAD4 serves as a platform to recruit NSP13",
    "entities": [
      {
        "text": "TEAD4",
        "label": "ORG"
      },
      {
        "text": "NSP13\n",
        "label": "FAC"
      }
    ]
  },
  {
    "text": "and YAP. NSP13 likely inactivates the YAP/TEAD4 transcription complex by",
    "entities": [
      {
        "text": "YAP",
        "label": "PERSON"
      },
      {
        "text": "NSP13",
        "label": "PERSON"
      },
      {
        "text": "the YAP/TEAD4",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "remodeling chromatin to recruit proteins, such as transcription termination",
    "entities": []
  },
  {
    "text": "factor 2 (TTF2), to bind the YAP/TEAD/NSP13 complex. These findings reveal a",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "novel YAP/TEAD regulatory mechanism and uncover molecular insights into",
    "entities": [
      {
        "text": "YAP",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Hippo-YAP regulation after SARS-CoV-2 infection.",
    "entities": [
      {
        "text": "Hippo-YAP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Comprehensive investigation of SARS-CoV-2 intestinal pathogenesis in Drosophila.",
    "entities": [
      {
        "text": "Drosophila",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "El Kamali L, Nagy P, Girard J, Buchon N, Mavingui P, El-Kalamouni C, Osman D.",
    "entities": [
      {
        "text": "El Kamali L",
        "label": "GPE"
      },
      {
        "text": "Nagy P",
        "label": "ORG"
      },
      {
        "text": "Girard J",
        "label": "PERSON"
      },
      {
        "text": "Buchon N",
        "label": "PERSON"
      },
      {
        "text": "Mavingui",
        "label": "GPE"
      },
      {
        "text": "El-Kalamouni C",
        "label": "ORG"
      },
      {
        "text": "Osman D.\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Gastrointestinal (GI) manifestations have been increasingly reported in COVID-19",
    "entities": [
      {
        "text": "GI",
        "label": "ORG"
      },
      {
        "text": "COVID-19",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "patients. Here, we use the Drosophila melanogaster midgut model to investigate",
    "entities": [
      {
        "text": "Drosophila",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "SARS-CoV-2-induced GI pathogenesis. The fly midgut exhibits susceptibility to",
    "entities": [
      {
        "text": "GI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "orally administered virus, resulting in disrupted epithelial architecture,",
    "entities": []
  },
  {
    "text": "reduced organ size, and altered visceral muscle dynamics. These effects are",
    "entities": []
  },
  {
    "text": "accompanied by sustained proliferation of intestinal stem cells alongside",
    "entities": []
  },
  {
    "text": "decreased replenishment and viability of differentiated cells. Transcriptomic",
    "entities": []
  },
  {
    "text": "profiling reveals biphasic perturbations in midgut gene expression, particularly",
    "entities": [
      {
        "text": "midgut",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "in pathways related to lipid metabolism. Intriguingly, SARS-CoV-2 elicits a",
    "entities": []
  },
  {
    "text": "dichotomous effect on lipid homeostasis, with lipid droplet accumulation in the",
    "entities": []
  },
  {
    "text": "posterior midgut and depletion in anterior segments. Treatment with Plitidepsin,",
    "entities": [
      {
        "text": "Plitidepsin",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "a COVID-19 drug candidate, mitigates most SARS-CoV-2 pathogenic features in both",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "the Drosophila midgut and human pulmonary cells, while modulating basal lipid",
    "entities": [
      {
        "text": "Drosophila",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "droplet homeostasis in uninfected conditions. These findings establish the",
    "entities": []
  },
  {
    "text": "Drosophila midgut as a potent model for studying SARS-CoV-2 GI pathogenesis and",
    "entities": [
      {
        "text": "Drosophila",
        "label": "ORG"
      },
      {
        "text": "GI",
        "label": "FAC"
      }
    ]
  },
  {
    "text": "evaluating antiviral compounds.",
    "entities": []
  },
  {
    "text": "Susceptible host dynamics explain pathogen resilience to perturbations.",
    "entities": []
  },
  {
    "text": "A major priority for epidemiological research in a time of anthropogenic change",
    "entities": []
  },
  {
    "text": "is understanding how infectious disease dynamics respond to perturbations.",
    "entities": []
  },
  {
    "text": "Interventions to slow the spread of SARS-CoV-2 significantly disrupted the",
    "entities": []
  },
  {
    "text": "transmission of other human pathogens. As interventions lifted, whether and when",
    "entities": []
  },
  {
    "text": "respiratory pathogens would eventually return to their pre-pandemic dynamics",
    "entities": []
  },
  {
    "text": "remains to be answered. Here, we present a framework for estimating pathogen",
    "entities": []
  },
  {
    "text": "resilience based on how fast epidemic patterns approach their pre-pandemic,",
    "entities": []
  },
  {
    "text": "endemic dynamics and analyze relevant time series data from Hong Kong, Canada,",
    "entities": [
      {
        "text": "Hong Kong",
        "label": "GPE"
      },
      {
        "text": "Canada",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Korea, and the US. By quantifying the resilience of common respiratory",
    "entities": [
      {
        "text": "Korea",
        "label": "GPE"
      },
      {
        "text": "US",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "pathogens, we are able to predict when each pathogen will eventually return to",
    "entities": []
  },
  {
    "text": "its pre-pandemic dynamics. Our predictions closely match the observed deviations",
    "entities": []
  },
  {
    "text": "(or lack thereof) from the pre-COVID dynamics of respiratory pathogens.",
    "entities": []
  },
  {
    "text": "Discrepancies between predicted and observed dynamics indicate the long-term",
    "entities": []
  },
  {
    "text": "impacts of pandemic perturbations, suggesting that some pathogens may be",
    "entities": []
  },
  {
    "text": "converging to a different endemic cycle. Finally, we show that the replenishment",
    "entities": []
  },
  {
    "text": "rate of the susceptible population is a key determinant of pathogen resilience,",
    "entities": []
  },
  {
    "text": "which in turn determines the sensitivity of a system to stochastic",
    "entities": []
  },
  {
    "text": "perturbations. Overall, our analysis highlights the persistent nature of common",
    "entities": []
  },
  {
    "text": "respiratory pathogens compared to vaccine-preventable infections, such as",
    "entities": []
  },
  {
    "text": "A combination TLR7/8 and RIG-I agonist adjuvant reverts asthmatic allergic",
    "entities": []
  },
  {
    "text": "sensitization and prevents aggravated influenza infection in OVA-sensitized",
    "entities": []
  },
  {
    "text": "Allergen-specific immunotherapy (AIT) is the only disease-modifying treatment",
    "entities": [
      {
        "text": "Allergen",
        "label": "PERSON"
      },
      {
        "text": "AIT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "currently available to treat allergy. However, it has limitations, as most",
    "entities": []
  },
  {
    "text": "allergens are poorly immunogenic, resulting in an AIT process that can take",
    "entities": [
      {
        "text": "AIT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "years. Therefore, adjuvant selection becomes critical to achieve a more",
    "entities": [
      {
        "text": "years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "efficacious therapy. Our group has developed and tested an amphiphilic TLR7/8",
    "entities": [
      {
        "text": "TLR7/8",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "agonist (IMDQ) and a RIG-I agonist (SDI) that used alone, or in combination,",
    "entities": [
      {
        "text": "IMDQ",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "have demonstrated strong adjuvant activity for influenza and SARS-CoV-2 vaccines",
    "entities": []
  },
  {
    "text": "in preclinical models. Here we describe the effect of these adjuvants in the",
    "entities": []
  },
  {
    "text": "sensitization of preclinical models with the ovalbumin (OVA) asthmatic allergic",
    "entities": []
  },
  {
    "text": "model via an in-depth humoral and cellular immune profiling. We assess their",
    "entities": []
  },
  {
    "text": "immune skewing and tolerance inducing capacities in previously sensitized",
    "entities": []
  },
  {
    "text": "preclinical models with different genetic backgrounds (C57BL/6 vs. BALB/c mice).",
    "entities": []
  },
  {
    "text": "Moreover, we evaluate their effect in an unrelated antigenic challenge with",
    "entities": []
  },
  {
    "text": "influenza. Finally, we investigate the role of IgG subclasses and T-cell",
    "entities": [
      {
        "text": "IgG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "subpopulations in the protection against OVA challenge conferred by the",
    "entities": [
      {
        "text": "OVA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "combination of IMDQ and SDI. We demonstrate that OVA-immunization in combination",
    "entities": [
      {
        "text": "IMDQ",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "with IMDQ+SDI prevents allergic sensitization via the induction of a balanced",
    "entities": []
  },
  {
    "text": "Type 1/Type 2 response. Furthermore, it can revert the allergic phenotype in",
    "entities": []
  },
  {
    "text": "mice previously sensitized with OVA-Alum, through reducing lung eosinophilia, as",
    "entities": []
  },
  {
    "text": "well as IL-4 and IL-5 production. However, this was dependent on genetic",
    "entities": [
      {
        "text": "IL-5",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "background. IMDQ+SDI sensitization also led to reduced morbidity of a secondary",
    "entities": []
  },
  {
    "text": "influenza challenge in OVA-sensitized mice. Finally, we demonstrated that IgG2c,",
    "entities": [
      {
        "text": "influenza",
        "label": "PERSON"
      },
      {
        "text": "IgG2c",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "by itself, cannot protect from allergic sensitization and that both CD4 + and",
    "entities": []
  },
  {
    "text": "CD8 + T-cells are needed for IMDQ+SDI prevention of eosinophil recruitment and",
    "entities": []
  },
  {
    "text": "activation upon intranasal OVA-challenge.",
    "entities": []
  },
  {
    "text": "PUM2 binds SARS-CoV-2 RNA and PUM1 mildly reduces viral RNA levels, but neither",
    "entities": [
      {
        "text": "PUM1",
        "label": "ORG"
      },
      {
        "text": "RNA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "protein affects progeny virus production.",
    "entities": []
  },
  {
    "text": "Phan N, Zaytseva Y, Lin CC, Mishra M, Sun W, Pawlica P.",
    "entities": [
      {
        "text": "Phan N",
        "label": "PERSON"
      },
      {
        "text": "Zaytseva Y",
        "label": "PERSON"
      },
      {
        "text": "Lin CC",
        "label": "PERSON"
      },
      {
        "text": "Mishra M",
        "label": "PERSON"
      },
      {
        "text": "Pawlica P.\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "of gene expression found across plants, animals, and yeast. They bind Pumilio",
    "entities": [
      {
        "text": "Pumilio\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Response Elements (PREs) on messenger RNAs (mRNAs) to modulate mRNA stability",
    "entities": [
      {
        "text": "Response Elements",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and translation. PUMs have been implicated in diverse cellular processes,",
    "entities": []
  },
  {
    "text": "including stem cell maintenance, neurogenesis, and cell cycle regulation. They",
    "entities": []
  },
  {
    "text": "have also been reported to negatively regulate innate immunity genes and to",
    "entities": []
  },
  {
    "text": "participate in viral RNA sensing. Previous high-throughput interactome studies",
    "entities": [
      {
        "text": "RNA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "revealed that PUMs bind SARS-CoV-2 RNA. We found that SARS-CoV-2 transcripts",
    "entities": [
      {
        "text": "SARS-CoV-2 RNA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "contain multiple conserved PREs, some of which are preferentially bound by PUM2.",
    "entities": []
  },
  {
    "text": "Surprisingly, altering PUM levels does not affect the production of progeny",
    "entities": [
      {
        "text": "PUM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "virions. However, depletion of PUM1 slightly increases intracellular viral RNA",
    "entities": [
      {
        "text": "RNA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "levels, suggesting that PUM1 either plays a mild antiviral role against",
    "entities": []
  },
  {
    "text": "SARS-CoV-2 or regulates a host factor that promotes viral replication. Notably,",
    "entities": []
  },
  {
    "text": "PUM1 also negatively regulates innate immunity gene expression both at steady",
    "entities": []
  },
  {
    "text": "state and during SARS-CoV-2 infection. Our findings support a complex",
    "entities": []
  },
  {
    "text": "immunomodulatory role for PUM1, acting both as a negative regulator of innate",
    "entities": [
      {
        "text": "PUM1",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "immunity genes and a mild inhibitor of SARS-CoV-2 RNA accumulation. However, in",
    "entities": [
      {
        "text": "SARS-CoV-2 RNA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "cell culture, these roles appear negligible based on viral progeny output.",
    "entities": []
  },
  {
    "text": "Whether the multiple PREs found in the SARS-CoV-2 genome contribute to evasion",
    "entities": []
  },
  {
    "text": "of PUM1 activity remains an open question.",
    "entities": []
  },
  {
    "text": "The Renin-Angiotensin System Modulates SARS-CoV-2 Entry via ACE2 Receptor.",
    "entities": [
      {
        "text": "The Renin-Angiotensin System Modulates",
        "label": "ORG"
      },
      {
        "text": "ACE2 Receptor",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "The RAS plays a central role in cardiovascular regulation and has gained",
    "entities": [
      {
        "text": "RAS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "prominence in the pathogenesis of COVID-19 due to the critical function of ACE2",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      },
      {
        "text": "ACE2\n",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "as the entry receptor for SARS-CoV-2. Angiotensin IV, but not angiotensin II,",
    "entities": [
      {
        "text": "Angiotensin IV",
        "label": "PERSON"
      },
      {
        "text": "II",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "has recently been reported to enhance the binding between the viral spike",
    "entities": []
  },
  {
    "text": "protein and ACE2. To investigate the virological significance of this effect, we",
    "entities": [
      {
        "text": "ACE2",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "developed a single-round infection assay using SARS-CoV-2 viral-like particles",
    "entities": []
  },
  {
    "text": "expressing the spike protein. Our results demonstrate that while angiotensin II",
    "entities": [
      {
        "text": "II",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "does not affect viral infectivity across concentrations ranging from 40 nM to",
    "entities": [
      {
        "text": "40 nM",
        "label": "TIME"
      }
    ]
  },
  {
    "text": "400 nM, angiotensin IV enhances viral entry at a low concentration but exhibits",
    "entities": [
      {
        "text": "IV",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "dose-dependent inhibition at higher concentrations. These findings highlight the",
    "entities": []
  },
  {
    "text": "unique dual role of angiotensin IV in modulating SARS-CoV-2 entry. In silico",
    "entities": [
      {
        "text": "IV",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "molecular docking simulations indicate that angiotensin IV was predicted to",
    "entities": [
      {
        "text": "IV",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "associate with the S1 domain near the receptor-binding domain in the open spike",
    "entities": [
      {
        "text": "S1",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "conformation. Given that reported plasma concentrations of angiotensin IV range",
    "entities": [
      {
        "text": "IV",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "widely from 17 pM to 81 nM, these levels may be sufficient to promote, rather",
    "entities": [
      {
        "text": "17 pM",
        "label": "TIME"
      },
      {
        "text": "81 nM",
        "label": "TIME"
      }
    ]
  },
  {
    "text": "than inhibit, SARS-CoV-2 infection. This study identifies a novel link between",
    "entities": []
  },
  {
    "text": "RAS-derived peptides and SARS-CoV-2 infectivity, offering new insights into",
    "entities": [
      {
        "text": "RAS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "COVID-19 pathophysiology and informing potential therapeutic strategies.",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Uncovering the Pathophysiological Pattern of Expression from Integrated Analysis",
    "entities": [
      {
        "text": "the Pathophysiological Pattern of Expression",
        "label": "ORG"
      },
      {
        "text": "Integrated Analysis",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "across Uniformly Processed RNA Sequencing COVID-19 Datasets.",
    "entities": [
      {
        "text": "Uniformly",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: Post-acute sequelae of SARS-CoV-2 infection (PASC) affects millions",
    "entities": [
      {
        "text": "millions",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "globally, yet the molecular mechanisms underlying acute COVID-19 and its chronic",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "sequelae remain poorly understood.",
    "entities": [
      {
        "text": "sequelae",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "METHODS: We performed an integrative transcriptomic analysis of three",
    "entities": [
      {
        "text": "three",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "independent RNA-seq datasets, capturing the complete COVID-19 pathophysiology",
    "entities": [
      {
        "text": "COVID-19",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "from health through acute severe infection to post-acute sequelae and mortality",
    "entities": []
  },
  {
    "text": "(n=142 total samples). We implemented a containerized analytical pipeline from",
    "entities": []
  },
  {
    "text": "these three RNA-seq datasets.",
    "entities": [
      {
        "text": "three",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "RESULTS: Our analysis reveals striking molecular dichotomies contrasting disease",
    "entities": []
  },
  {
    "text": "phases with profound clinical implications. Acute severe/critical COVID-19",
    "entities": [
      {
        "text": "COVID-19\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "reveals predominant enrichment of TNF-\u03b1 signaling via NF-\u03baB pathways (normalized",
    "entities": [
      {
        "text": "TNF",
        "label": "ORG"
      },
      {
        "text": "NF-\u03baB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "enrichment score >2.5, FDR <0.001), reflecting a cytokine storm pathophysiology",
    "entities": [
      {
        "text": "2.5",
        "label": "CARDINAL"
      },
      {
        "text": "FDR",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "characterized by rapid inflammatory developments involving IL-6, TNF-\u03b1, and",
    "entities": [
      {
        "text": "IL-6",
        "label": "ORG"
      },
      {
        "text": "TNF",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of Myc Targets V1 and Oxidative Phosphorylation pathways (NES >2.2, FDR <0.005),",
    "entities": [
      {
        "text": "Myc Targets V1",
        "label": "ORG"
      },
      {
        "text": "Oxidative Phosphorylation",
        "label": "ORG"
      },
      {
        "text": "NES",
        "label": "ORG"
      },
      {
        "text": "2.2",
        "label": "CARDINAL"
      },
      {
        "text": "FDR",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "indicating important shifts toward cellular adaptation. Pathway signature",
    "entities": []
  },
  {
    "text": "analysis identifies core differentially expressed genes that reliably",
    "entities": []
  },
  {
    "text": "distinguish disease phases, thereby offering objective biomarkers for precision",
    "entities": [
      {
        "text": "distinguish",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "CONCLUSIONS: These findings establish a comprehensive molecular framework",
    "entities": []
  },
  {
    "text": "distinguishing acute inflammatory from chronic metabolic COVID-19 phases, with",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "potential clinical applicability. TNF-\u03b1/NF-\u03baB pathway signatures identify",
    "entities": []
  },
  {
    "text": "patients at risk for severe disease progression, while Myc/OXPHOS signatures",
    "entities": []
  },
  {
    "text": "allow objective PASC diagnosis, addressing current reliance on subjective and",
    "entities": []
  },
  {
    "text": "eliminative diagnosis. This integrative analytical framework has utility beyond",
    "entities": []
  },
  {
    "text": "COVID-19, offering an applicable approach for precision medicine implementation",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "across other diseases processes.",
    "entities": []
  },
  {
    "text": "CLINICAL SIGNIFICANCE: This study transforms COVID-19 from a symptom-based to a",
    "entities": [
      {
        "text": "COVID-19",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "molecularly-defined disease spectrum, enabling precision diagnosis, prognostic",
    "entities": []
  },
  {
    "text": "monitoring, classification, and targeted therapeutic possibilities based on",
    "entities": []
  },
  {
    "text": "pathway-specific biomarkers rather than subjective clinical assessments.",
    "entities": []
  },
  {
    "text": "Do Work Schedule and Work Position have an Impact on Fatigue among Geothermal",
    "entities": [
      {
        "text": "Geothermal",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "Workers during the COVID-19 Pandemic? An Analysis Using Structural Equation",
    "entities": []
  },
  {
    "text": "(1)Postgraduate Program of Occupational Medicine, Faculty of Medicine,",
    "entities": [
      {
        "text": "Program of Occupational Medicine, Faculty of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Department of Community Medicine, Faculty of Medicine, Universitas Indonesia,",
    "entities": [
      {
        "text": "Community Medicine, Faculty of Medicine",
        "label": "ORG"
      },
      {
        "text": "Indonesia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Faculty of Medicine and Health Sciences, Krida Wacana Christian University,",
    "entities": [
      {
        "text": "Medicine and Health Sciences",
        "label": "ORG"
      },
      {
        "text": "Krida Wacana Christian University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "OBJECTIVES: This study aimed to examine the impact of work schedule and work",
    "entities": []
  },
  {
    "text": "position on fatigue levels among employees at a private geothermal firm in",
    "entities": []
  },
  {
    "text": "Indonesia during the COVID-19 pandemic. The company has modified its work",
    "entities": [
      {
        "text": "Indonesia",
        "label": "GPE"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "schedule considering the COVID-19 epidemic to ensure a continuous supply of",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "energy and meet the needs of the public.",
    "entities": []
  },
  {
    "text": "METHODS: In this cross-sectional study, the dependent variable is fatigue, which",
    "entities": []
  },
  {
    "text": "is classified as a latent variable. Fatigue is assessed using the Indonesian",
    "entities": [
      {
        "text": "Fatigue",
        "label": "PERSON"
      },
      {
        "text": "Indonesian",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "version of the Swedish Occupational Fatigue Inventory (SOFI). Fatigue is a",
    "entities": [
      {
        "text": "the Swedish Occupational Fatigue Inventory",
        "label": "ORG"
      },
      {
        "text": "Fatigue",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "condition that has five dimensions: lack of energy, physical exertion, physical",
    "entities": [
      {
        "text": "five",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "discomfort, sleepiness, and lack of motivation. The observed variables in this",
    "entities": []
  },
  {
    "text": "study include work schedule and work position, which serve as independent",
    "entities": []
  },
  {
    "text": "variables. Using structural equation modeling (SEM), we assessed the impact of",
    "entities": []
  },
  {
    "text": "the independent variables on each dimension of fatigue. This approach allowed",
    "entities": []
  },
  {
    "text": "for the analysis of both the measurement and structural models.",
    "entities": []
  },
  {
    "text": "RESULTS: The investigation employed total sampling, involving 132 workers from",
    "entities": [
      {
        "text": "132",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "the company who willingly participated in the study. According to the findings,",
    "entities": []
  },
  {
    "text": "workers' main fatigue dimension was lack of energy. However, the statistical",
    "entities": []
  },
  {
    "text": "analysis did not establish a significant influence of work schedule and work",
    "entities": []
  },
  {
    "text": "CONCLUSION: Based on the findings of the SEM analysis, it is evident that there",
    "entities": []
  },
  {
    "text": "is no statistically significant correlation between work schedules and job",
    "entities": []
  },
  {
    "text": "positions with various dimensions of fatigue assessed using the SOFI",
    "entities": [
      {
        "text": "SOFI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "questionnaire. These dimensions include lack of energy, physical exertion,",
    "entities": []
  },
  {
    "text": "physical discomfort, sleepiness, and lack of motivation. While this outcome",
    "entities": []
  },
  {
    "text": "suggests that work schedules and job positions may not directly influence",
    "entities": []
  },
  {
    "text": "fatigue levels as measured in this study, it underscores the importance of",
    "entities": []
  },
  {
    "text": "implementing occupational health and safety management systems. Additionally,",
    "entities": []
  },
  {
    "text": "promoting good work practices such as offering flexible working hours may help",
    "entities": [
      {
        "text": "hours",
        "label": "TIME"
      }
    ]
  },
  {
    "text": "address potential fatigue concerns among employees. However, further research is",
    "entities": []
  },
  {
    "text": "necessary to explore additional variables that could potentially impact fatigue",
    "entities": []
  },
  {
    "text": "levels in the context of the COVID-19 pandemic and beyond.",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "\u00a9 The Author(s) 2025.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: All authors declared no conflicts of interest.",
    "entities": []
  },
  {
    "text": "Cross-sectional Cranial CT Imaging Findings and Patterns in Clinically Diagnosed",
    "entities": [
      {
        "text": "Cranial CT Imaging Findings",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "COVID-19 Cases in a Tertiary Referral Center.",
    "entities": [
      {
        "text": "COVID-19 Cases",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Vascular and Interventional Radiology Section, Department of Radiology,",
    "entities": [
      {
        "text": "Interventional Radiology Section,",
        "label": "ORG"
      },
      {
        "text": "Department of Radiology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Philippine General Hospital, University of the Philippines Manila.",
    "entities": [
      {
        "text": "Philippine General Hospital, University of the Philippines",
        "label": "ORG"
      },
      {
        "text": "Manila",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: Coronavirus Disease 2019 (COVID-19), caused by the SARS-CoV-2 virus,",
    "entities": [
      {
        "text": "2019",
        "label": "DATE"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "presents not only as a respiratory ailment but also poses risks of neurological",
    "entities": []
  },
  {
    "text": "complications whose underlying mechanisms remain unclear. These complications",
    "entities": []
  },
  {
    "text": "range from mild to severe and may involve direct invasion of the central nervous",
    "entities": []
  },
  {
    "text": "system (CNS), disruption of the blood-brain barrier, or systemic cytokine",
    "entities": [
      {
        "text": "CNS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "effects. Diagnostic challenges persist due to the suboptimal sensitivity of",
    "entities": []
  },
  {
    "text": "RT-PCR assays.",
    "entities": [
      {
        "text": "RT-PCR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "OBJECTIVE: The present study aimed to review the contrast and non-contrast",
    "entities": []
  },
  {
    "text": "enhanced cranial CT images of all diagnosed COVID-19 patients in a tertiary",
    "entities": [
      {
        "text": "CT",
        "label": "ORG"
      },
      {
        "text": "COVID-19",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "referral center with the clinical impression of non-traumatic and nonoperative",
    "entities": []
  },
  {
    "text": "CNS pathologies.",
    "entities": [
      {
        "text": "CNS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "METHODS: We conducted a cross-sectional study analyzing CT images of COVID-19",
    "entities": [
      {
        "text": "CT",
        "label": "ORG"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "patients with neurological symptoms. Among 51 included patients, plain CT scans",
    "entities": [
      {
        "text": "51",
        "label": "CARDINAL"
      },
      {
        "text": "CT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "were predominantly used, revealing no acute infarcts or hemorrhages in the",
    "entities": []
  },
  {
    "text": "majority, while frontal lobe involvement was notable in cases with pathology.",
    "entities": []
  },
  {
    "text": "Chronic infarcts or ischemic changes were observed in over half of the cases,",
    "entities": [
      {
        "text": "over half",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "primarily affecting the anterior circulation. Only one case of meningitis was",
    "entities": [
      {
        "text": "Only one",
        "label": "CARDINAL"
      },
      {
        "text": "meningitis",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "RESULTS: In the final analysis, 51 patients met the inclusion criteria out of",
    "entities": [
      {
        "text": "51",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "the initial 64 enrolled. The study population, predominantly male with a mean",
    "entities": [
      {
        "text": "64",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "age of 58.02 \u00b1 20.87 years, mainly comprised patients solely diagnosed with",
    "entities": [
      {
        "text": "58.02",
        "label": "CARDINAL"
      },
      {
        "text": "20.87 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "COVID-19. Plain CT scans were favored over contrast-enhanced scans (76.50%, n =",
    "entities": [
      {
        "text": "76.50%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "39). While most patients had no acute infarcts or hemorrhages, the frontal lobe",
    "entities": [
      {
        "text": "39",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "was commonly affected among stroke patients (9.8%, n = 5). Additionally, a",
    "entities": [
      {
        "text": "9.8%",
        "label": "PERCENT"
      },
      {
        "text": "5",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "significant portion of patients without acute stroke findings exhibited chronic",
    "entities": []
  },
  {
    "text": "infarcts or ischemic changes (57.69%, n = 15).",
    "entities": [
      {
        "text": "57.69%",
        "label": "PERCENT"
      },
      {
        "text": "15",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "CONCLUSIONS: This study sheds light on the radiological patterns of CNS",
    "entities": [
      {
        "text": "CNS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "involvement in COVID-19 patients, highlighting frequent frontal lobe involvement",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "possibly attributed to hypercoagulability and endotheliitis. Further research",
    "entities": []
  },
  {
    "text": "with larger sample sizes and MRI utilization is recommended to enhance our",
    "entities": []
  },
  {
    "text": "understanding of CNS manifestations in COVID-19. This study contributes to",
    "entities": [
      {
        "text": "CNS",
        "label": "ORG"
      },
      {
        "text": "COVID-19",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "understanding COVID-19 neurological sequelae, particularly in terms of",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "radiological patterns, among patients presenting with neurological symptoms. The",
    "entities": []
  },
  {
    "text": "findings highlight the need for comprehensive evaluation and management of",
    "entities": []
  },
  {
    "text": "Utilization of Oxford Nanopore Technology for human infectious disease detection",
    "entities": []
  },
  {
    "text": "and surveillance in Africa: a scoping review.",
    "entities": [
      {
        "text": "Africa",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "(1)Department of Pediatrics, Division of Pediatric Infectious Diseases,",
    "entities": [
      {
        "text": "Pediatrics, Division of Pediatric Infectious Diseases",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University of Minnesota, Minneapolis, MN, USA.",
    "entities": [
      {
        "text": "University of Minnesota",
        "label": "ORG"
      },
      {
        "text": "Minneapolis",
        "label": "GPE"
      },
      {
        "text": "MN,",
        "label": "ORG"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Medical Microbiology and Parasitology, Faculty of Clinical",
    "entities": [
      {
        "text": "Medical Microbiology and Parasitology, Faculty of Clinical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Sciences, College of Health Sciences, University of Jos, Jos, Plateau State,",
    "entities": [
      {
        "text": "Sciences, College of Health Sciences",
        "label": "ORG"
      },
      {
        "text": "University of Jos,",
        "label": "ORG"
      },
      {
        "text": "Plateau State",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Health Sciences Libraries, University of Minnesota, Minneapolis, MN, USA.",
    "entities": [
      {
        "text": "3)Health Sciences Libraries",
        "label": "ORG"
      },
      {
        "text": "University of Minnesota",
        "label": "ORG"
      },
      {
        "text": "Minneapolis",
        "label": "GPE"
      },
      {
        "text": "MN,",
        "label": "ORG"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Pediatrics and Division of Critical Care, University of",
    "entities": [
      {
        "text": "Pediatrics and Division of Critical Care, University of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)Department of Pediatrics and Division of Critical Care, Hennepin County",
    "entities": [
      {
        "text": "Pediatrics and Division of Critical Care",
        "label": "ORG"
      },
      {
        "text": "Hennepin County",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Medical Center, Minneapolis, MN, USA.",
    "entities": [
      {
        "text": "Minneapolis",
        "label": "GPE"
      },
      {
        "text": "MN,",
        "label": "ORG"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Department of Animal Science, College of Food, Agricultural and Natural",
    "entities": [
      {
        "text": "Animal Science, College of Food, Agricultural and Natural",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Resources Science, University of Minnesota, Saint Paul, MN, USA.",
    "entities": [
      {
        "text": "Resources Science, University of Minnesota",
        "label": "ORG"
      },
      {
        "text": "Saint Paul",
        "label": "GPE"
      },
      {
        "text": "MN,",
        "label": "ORG"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Department of Medical Microbiology, University of Jos and Jos University",
    "entities": [
      {
        "text": "Medical Microbiology",
        "label": "ORG"
      },
      {
        "text": "University of Jos and",
        "label": "ORG"
      },
      {
        "text": "Jos University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Teaching Hospital, Faculty of Basic Clinical Sciences, College of Health",
    "entities": [
      {
        "text": "Teaching Hospital, Faculty of Basic Clinical Sciences",
        "label": "ORG"
      },
      {
        "text": "College of Health\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(8)Department of Paediatrics, Faculty of Clinical Sciences, College of Health",
    "entities": [
      {
        "text": "Paediatrics, Faculty of Clinical Sciences",
        "label": "ORG"
      },
      {
        "text": "College of Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Sciences, University of Jos and Jos University Teaching Hospital, Jos, Plateau",
    "entities": [
      {
        "text": "University of Jos and Jos University Teaching Hospital",
        "label": "ORG"
      },
      {
        "text": "Jos",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(#)Contributed equally",
    "entities": []
  },
  {
    "text": "Background. Nanopore-based sequencing by Oxford Nanopore Technologies (ONT)",
    "entities": [
      {
        "text": "Oxford Nanopore Technologies",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "offers rapid, cost-effective and portable sequencing. As an emerging technology,",
    "entities": []
  },
  {
    "text": "ONT must be evaluated for efficacy and practical application in both high- and",
    "entities": [
      {
        "text": "ONT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "low-resource settings. This scoping review (SR) aimed to (1) describe how",
    "entities": [
      {
        "text": "SR",
        "label": "ORG"
      },
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "nanopore technology is used in Africa for surveillance and diagnosis of human",
    "entities": [
      {
        "text": "Africa",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "infectious diseases, (2) describe how nanopore technology aids in the real-time",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "detection of infectious pathogens in Africa and (3) identify challenges and",
    "entities": [
      {
        "text": "Africa",
        "label": "LOC"
      },
      {
        "text": "3",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "opportunities for utilizing nanopore technology in Africa to study infectious",
    "entities": [
      {
        "text": "Africa",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "diseases. Methods. This SR followed the Joanna Briggs Institute Reviewer's",
    "entities": [
      {
        "text": "SR",
        "label": "ORG"
      },
      {
        "text": "the Joanna Briggs Institute Reviewer's",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Manual framework for SRs. English language studies published from 1 January 2008",
    "entities": [
      {
        "text": "English",
        "label": "LANGUAGE"
      },
      {
        "text": "1 January 2008",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "to 30 April 2024 that used ONT on human specimens collected in Africa and",
    "entities": [
      {
        "text": "30 April 2024",
        "label": "DATE"
      },
      {
        "text": "ONT",
        "label": "ORG"
      },
      {
        "text": "Africa",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "targeted \u22651 microbial agent were included. Searches were performed in Embase,",
    "entities": [
      {
        "text": "\u22651",
        "label": "GPE"
      },
      {
        "text": "Embase",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Medline, PubMed, CINAHL and the Cochrane Library. The protocol was publicly",
    "entities": [
      {
        "text": "Medline",
        "label": "ORG"
      },
      {
        "text": "PubMed",
        "label": "ORG"
      },
      {
        "text": "the Cochrane Library",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "available on the Open Science Framework Bastug et al. (Nanopore Sequencing for",
    "entities": [
      {
        "text": "the Open Science Framework Bastug",
        "label": "ORG"
      },
      {
        "text": "Nanopore Sequencing",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Infectious Diseases Surveillance and Diagnostics in Africa: a Scoping Review",
    "entities": [
      {
        "text": "Africa",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "2024) prior to data collection. Two independent reviewers screened studies using",
    "entities": [
      {
        "text": "2024",
        "label": "DATE"
      },
      {
        "text": "Two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Covidence, and data was extracted using a custom REDCap instrument. Descriptive",
    "entities": []
  },
  {
    "text": "statistics and data visualization were performed in Microsoft Excel. Results.",
    "entities": [
      {
        "text": "Microsoft Excel",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "One thousand one hundred sixty-two studies were identified and 93 (8%) underwent",
    "entities": [
      {
        "text": "One thousand one hundred sixty-two",
        "label": "CARDINAL"
      },
      {
        "text": "93",
        "label": "CARDINAL"
      },
      {
        "text": "8%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "full-text review. The portable MinION Mk1B was the most common ONT device (65%",
    "entities": [
      {
        "text": "65%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "of studies). Eighty-eight studies analysed specimens from a single African",
    "entities": [
      {
        "text": "Eighty-eight",
        "label": "CARDINAL"
      },
      {
        "text": "African",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "country. Of these, 45% were sequenced in the same country, 7% in a different",
    "entities": [
      {
        "text": "45%",
        "label": "PERCENT"
      },
      {
        "text": "7%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "African country and 11% in a non-African country, while 32% did not specify the",
    "entities": [
      {
        "text": "African",
        "label": "NORP"
      },
      {
        "text": "11%",
        "label": "PERCENT"
      },
      {
        "text": "non-African",
        "label": "NORP"
      },
      {
        "text": "32%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "location. Specimen types included direct patient specimens (62%) and cultured",
    "entities": [
      {
        "text": "62%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "isolates (35%), or a combination of both. Blood, serum or plasma was most common",
    "entities": [
      {
        "text": "35%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "(35%), followed by naso- or oropharyngeal specimens (27%). Forty-four studies",
    "entities": [
      {
        "text": "35%",
        "label": "PERCENT"
      },
      {
        "text": "27%",
        "label": "PERCENT"
      },
      {
        "text": "Forty-four",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "used ONT during an active infectious disease outbreak, 25 of which studied",
    "entities": [
      {
        "text": "ONT",
        "label": "ORG"
      },
      {
        "text": "25",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Seventy-two",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      },
      {
        "text": "Seventy-two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "studies used ONT for genomic surveillance of infectious pathogens or antibiotic",
    "entities": [
      {
        "text": "ONT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "resistance genes, and one study used ONT for a direct clinical application.",
    "entities": [
      {
        "text": "one",
        "label": "CARDINAL"
      },
      {
        "text": "ONT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "African-affiliated authors were included as first, middle and last authors in",
    "entities": [
      {
        "text": "African",
        "label": "NORP"
      },
      {
        "text": "first",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "46% of studies, and 15% were published by entirely African-affiliated teams. Ten",
    "entities": [
      {
        "text": "46%",
        "label": "PERCENT"
      },
      {
        "text": "15%",
        "label": "PERCENT"
      },
      {
        "text": "African",
        "label": "NORP"
      },
      {
        "text": "Ten",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "studies published information on workflow timeline, and five studies published",
    "entities": [
      {
        "text": "five",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "the per-specimen cost. Conclusions. ONT can enable timely and affordable",
    "entities": []
  },
  {
    "text": "sequencing in African countries as demonstrated through a small number of",
    "entities": [
      {
        "text": "African",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "studies that accomplished these goals individually. Most studies used ONT for",
    "entities": [
      {
        "text": "ONT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "genomic surveillance of pathogens or antimicrobial resistance genes, while only",
    "entities": []
  },
  {
    "text": "one study used ONT directly for a real-time clinical application. A small number",
    "entities": [
      {
        "text": "one",
        "label": "CARDINAL"
      },
      {
        "text": "ONT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of studies described a short interval between specimen collection and sequence",
    "entities": []
  },
  {
    "text": "result, supporting that clinical applications are possible. There is a need for",
    "entities": []
  },
  {
    "text": "improved reporting of ONT methodology including pipeline timelines, cost, use of",
    "entities": [
      {
        "text": "ONT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "barcoding, flow cell models and the use of negative controls. Publications that",
    "entities": []
  },
  {
    "text": "provide these details will enhance reproducibility and support the development",
    "entities": []
  },
  {
    "text": "of new studies using ONT for the diagnosis and surveillance of infectious",
    "entities": [
      {
        "text": "ONT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "diseases in low-resource settings.",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025 The Authors.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: The authors declare no conflicts of interest for",
    "entities": []
  },
  {
    "text": "this work. Thirty-one studies included multiple co-first authors, and 21 studies",
    "entities": [
      {
        "text": "Thirty-one",
        "label": "CARDINAL"
      },
      {
        "text": "21",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "included multiple co-last authors. Fourteen studies (15%) were composed of only",
    "entities": [
      {
        "text": "Fourteen",
        "label": "CARDINAL"
      },
      {
        "text": "15%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "authors who were affiliated with African institutions, while two studies (2%)",
    "entities": [
      {
        "text": "African",
        "label": "NORP"
      },
      {
        "text": "two",
        "label": "CARDINAL"
      },
      {
        "text": "2%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "did not include an African-affiliated author. The most common authorship team",
    "entities": [
      {
        "text": "African",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "structure included having an author affiliated with an African institution",
    "entities": [
      {
        "text": "African",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "(termed \u2018African-affiliated\u2019) in all three positions of the paper, i.e. as",
    "entities": [
      {
        "text": "African",
        "label": "NORP"
      },
      {
        "text": "three",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "first, middle and last authors (N=52, 56%, Fig. 4). Fig. 4.African-affiliated",
    "entities": [
      {
        "text": "first",
        "label": "ORDINAL"
      },
      {
        "text": "56%",
        "label": "PERCENT"
      },
      {
        "text": "Fig",
        "label": "PERSON"
      },
      {
        "text": "Fig",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "authors present in different authorship positions amongst studies.",
    "entities": []
  },
  {
    "text": "The Essential Network (TEN): consulting stakeholders and experts to better",
    "entities": [
      {
        "text": "The Essential Network",
        "label": "ORG"
      },
      {
        "text": "TEN",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "understand implementation of a blended care mental health support services for",
    "entities": []
  },
  {
    "text": "Australian health professionals.",
    "entities": [
      {
        "text": "Australian",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Coleshill M(1)(2), Fransisca K(3), Du X(3), Black M(1)(4), Newby JM(1)(4),",
    "entities": [
      {
        "text": "Coleshill",
        "label": "ORG"
      },
      {
        "text": "Fransisca K(3",
        "label": "PERSON"
      },
      {
        "text": "Du X(3",
        "label": "ORG"
      },
      {
        "text": "Newby JM(1)(4",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Black Dog Institute, Sydney, Australia.",
    "entities": [
      {
        "text": "Sydney",
        "label": "GPE"
      },
      {
        "text": "Australia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)UNSW Medicine & Health, University of New South Wales, Sydney, Australia.",
    "entities": [
      {
        "text": "2)UNSW Medicine & Health",
        "label": "ORG"
      },
      {
        "text": "University of New South Wales",
        "label": "ORG"
      },
      {
        "text": "Sydney",
        "label": "GPE"
      },
      {
        "text": "Australia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)School of Psychological Sciences, Macquarie University, Sydney, Australia.",
    "entities": [
      {
        "text": "Psychological Sciences",
        "label": "ORG"
      },
      {
        "text": "Macquarie University",
        "label": "ORG"
      },
      {
        "text": "Sydney",
        "label": "GPE"
      },
      {
        "text": "Australia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)School of Psychology, University of New South Wales, Sydney, Australia.",
    "entities": [
      {
        "text": "Psychology, University of New South Wales",
        "label": "ORG"
      },
      {
        "text": "Sydney",
        "label": "GPE"
      },
      {
        "text": "Australia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "OBJECTIVE: The Essential Network (TEN) is a blended care mental health support",
    "entities": [
      {
        "text": "The Essential Network",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "service for Australian health professionals. We conducted a series of",
    "entities": [
      {
        "text": "Australian",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "semi-structured interviews with key stakeholders and researchers to understand",
    "entities": []
  },
  {
    "text": "health professionals' needs, canvas suggested changes to TEN, and examine",
    "entities": [
      {
        "text": "TEN",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "methods of improving service uptake.",
    "entities": []
  },
  {
    "text": "METHOD: Nine semi-structured individual or group interviews were conducted with",
    "entities": [
      {
        "text": "METHOD",
        "label": "ORG"
      },
      {
        "text": "Nine",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "10 TEN stakeholders (external stakeholders) and eight interviews were conducted",
    "entities": [
      {
        "text": "10",
        "label": "CARDINAL"
      },
      {
        "text": "TEN",
        "label": "CARDINAL"
      },
      {
        "text": "eight",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "with 18 researchers or related roles with experience implementing or evaluating",
    "entities": [
      {
        "text": "18",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "mental health services for health professionals (internal experts).",
    "entities": []
  },
  {
    "text": "De-identified transcripts were thematically analysed using an inductive and",
    "entities": []
  },
  {
    "text": "deductive approach.",
    "entities": []
  },
  {
    "text": "RESULTS: Participants highlighted the need for confidentiality, with mandatory",
    "entities": []
  },
  {
    "text": "reporting concerns being a key barrier to health professionals engaging with",
    "entities": []
  },
  {
    "text": "mental health services. External stakeholders viewed digital services as",
    "entities": []
  },
  {
    "text": "advantageous due to accessibility and anonymity, although both groups noted that",
    "entities": []
  },
  {
    "text": "concerns around effectiveness were a barrier to engagement with digital",
    "entities": []
  },
  {
    "text": "services. Both groups agreed that peer endorsement was key to implementation.",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: Digital services were viewed as promising, but best employed",
    "entities": []
  },
  {
    "text": "alongside person-to-person options in a blended care format. Services that",
    "entities": []
  },
  {
    "text": "address the unique workplace culture of healthcare, including stigma and",
    "entities": []
  },
  {
    "text": "systemic barriers to help-seeking, can create effective and scalable support for",
    "entities": []
  },
  {
    "text": "health professionals.",
    "entities": []
  },
  {
    "text": "Plain Language Summary: What is already known about this topic: (1) Health",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "professionals are at a greater risk of poor mental health compared to the",
    "entities": []
  },
  {
    "text": "general public. (2) The COVID-19 pandemic has placed further strain upon health",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "professionals, highlighting the need for more tailored mental health services.",
    "entities": []
  },
  {
    "text": "(3) Cultural and systemic issues exist within healthcare that act as barriers to",
    "entities": []
  },
  {
    "text": "help-seeking. What this topic adds: (1) Digital services were viewed as best",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "employed alongside person-to-person services in a blended care format. (2) In",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "addition to already established barriers, the volume of information health",
    "entities": []
  },
  {
    "text": "professionals receive may have obscured information about relevant support",
    "entities": []
  },
  {
    "text": "services. (3) Peer endorsement was seen as crucial to effectively driving the",
    "entities": [
      {
        "text": "3",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "usage of mental health support services for health professionals.",
    "entities": []
  },
  {
    "text": "\u00a9 2024 The Author(s). Published by Informa UK Limited, trading as Taylor &",
    "entities": [
      {
        "text": "2024",
        "label": "DATE"
      },
      {
        "text": "Informa UK Limited",
        "label": "ORG"
      },
      {
        "text": "Taylor &\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Francis Group.",
    "entities": [
      {
        "text": "Francis Group",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: TEN is supported by funding from the Australian",
    "entities": [
      {
        "text": "TEN",
        "label": "CARDINAL"
      },
      {
        "text": "Australian",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Government Department of Health. Authors MJC and MJB are supported by funding",
    "entities": [
      {
        "text": "Government Department of Health",
        "label": "ORG"
      },
      {
        "text": "MJB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "for TEN from the Australian Government Department of Health. The funding body",
    "entities": [
      {
        "text": "TEN",
        "label": "CARDINAL"
      },
      {
        "text": "the Australian Government Department of Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "played no role in the design of the study and collection, analysis, and",
    "entities": []
  },
  {
    "text": "interpretation of data or in the writing of this manuscript.",
    "entities": []
  },
  {
    "text": "18. Aust J Psychol. 2024 Oct 14;76(1):2408019. doi:",
    "entities": [
      {
        "text": "18",
        "label": "CARDINAL"
      },
      {
        "text": "2024",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Adolescent and young adult sleep and sleep-related behaviour change before and",
    "entities": []
  },
  {
    "text": "during the COVID-19 pandemic lockdown in Canada.",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      },
      {
        "text": "Canada",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Carmona NE(1), Kutana S(1), Sumantry D(1), Marway O(1), Carney A(1), Amestoy",
    "entities": [
      {
        "text": "Carmona NE(1",
        "label": "ORG"
      },
      {
        "text": "Kutana",
        "label": "PERSON"
      },
      {
        "text": "Amestoy",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "M(1), Usyatynsky A(1), Carney CE(1).",
    "entities": [
      {
        "text": "Usyatynsky",
        "label": "ORG"
      },
      {
        "text": "Carney CE(1",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Department of Psychology, Toronto Metropolitan University, Toronto, Canada.",
    "entities": [
      {
        "text": "Psychology, Toronto Metropolitan University",
        "label": "ORG"
      },
      {
        "text": "Toronto",
        "label": "GPE"
      },
      {
        "text": "Canada",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: Sleep disturbance is common in adolescents and young adults (AYAs),",
    "entities": []
  },
  {
    "text": "impacted by stress and academic/scheduling demands that conflict with biological",
    "entities": []
  },
  {
    "text": "phase delay. COVID-19 lockdowns allowed us to study sleep in AYAs when there are",
    "entities": []
  },
  {
    "text": "lessened scheduling demands. Additionally, we could test whether a sleep",
    "entities": []
  },
  {
    "text": "self-management app was helpful during lockdowns.",
    "entities": []
  },
  {
    "text": "METHOD: AYAs (ages 15-24 years) before (Pre-Lockdown; n = 65) and during",
    "entities": [
      {
        "text": "METHOD",
        "label": "ORG"
      },
      {
        "text": "15-24 years",
        "label": "DATE"
      },
      {
        "text": "Pre-Lockdown",
        "label": "PERSON"
      },
      {
        "text": "65",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "lockdowns in Canada (Lockdown; n = 40) completed sleep diaries on the app; set",
    "entities": [
      {
        "text": "Canada",
        "label": "GPE"
      },
      {
        "text": "Lockdown",
        "label": "ORG"
      },
      {
        "text": "40",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "goals based on generated feedback; and completed more sleep diaries pursuing",
    "entities": []
  },
  {
    "text": "whatever post-feedback goals they set.",
    "entities": []
  },
  {
    "text": "RESULTS: The Lockdown group reported later and less variable rise times (RT) and",
    "entities": [
      {
        "text": "Lockdown",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "spent more time in bed (TIB), both awake and asleep. Pre-Lockdown set a goal to",
    "entities": [
      {
        "text": "TIB",
        "label": "ORG"
      },
      {
        "text": "Pre-Lockdown",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "reduce RT variability whereas Lockdown set a goal to decrease TIB, and AYAs made",
    "entities": [
      {
        "text": "Lockdown",
        "label": "PERSON"
      },
      {
        "text": "TIB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "behaviour changes to meet their goals. For both groups, sleep onset, duration of",
    "entities": []
  },
  {
    "text": "awakenings, sleep duration and efficiency, and insomnia severity significantly",
    "entities": []
  },
  {
    "text": "improved at endpoint.",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: AYAs slept differently during lockdowns, perhaps due to decreased",
    "entities": []
  },
  {
    "text": "scheduling. The pandemic revealed the need for accessible strategies to improve",
    "entities": []
  },
  {
    "text": "sleep health. Findings support the feasibility of using evidence-based apps, and",
    "entities": [
      {
        "text": "apps",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "that AYAs can effectively use self-management tools across variable global and",
    "entities": []
  },
  {
    "text": "social contexts to improve their sleep.",
    "entities": []
  },
  {
    "text": "Plain Language Summary: What is already known about this topic: Adolescents and",
    "entities": []
  },
  {
    "text": "young adults (AYAs) experience myriad sleep problems that result from an",
    "entities": []
  },
  {
    "text": "interaction between (1) biological factors promoting later bedtimes while still",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "requiring more time to recovery from sleep debt than adults, (2) environmental",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "factors such as early school start times, and (3) behavioural factors that delay",
    "entities": [
      {
        "text": "3",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "bedtime and increase pre-sleep arousal.Surveys conducted during initial COVID-19",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "lockdowns indicated increased rates of sleep disturbance in AYAs.AYAs unique",
    "entities": []
  },
  {
    "text": "sleep needs and low access to care indicate that tailored, digital",
    "entities": []
  },
  {
    "text": "self-management tools may be an optimal strategy to improve sleep health in this",
    "entities": []
  },
  {
    "text": "group. What this study adds: Using a transdiagnostic sleep app, we found that",
    "entities": []
  },
  {
    "text": "AYAs completing sleep diaries during lockdowns spent more time in bed resulting",
    "entities": []
  },
  {
    "text": "in more time asleep and more time awake, and their rise time shifted later and",
    "entities": []
  },
  {
    "text": "became more consistent.AYAs before and during lockdowns set different goals to",
    "entities": []
  },
  {
    "text": "improve their sleep, but both groups used the app to set and make progress",
    "entities": []
  },
  {
    "text": "towards their sleep goals and experienced improvements in sleep parameters and",
    "entities": []
  },
  {
    "text": "subjective insomnia severity.Our data provide initial support for the use of",
    "entities": []
  },
  {
    "text": "tailored digital solutions to reach this at-need group and indicate that AYAs",
    "entities": []
  },
  {
    "text": "flexibly use self-management tools to improve their sleep health under shifting",
    "entities": []
  },
  {
    "text": "Conflict of interest statement: Colleen E. Carney is the creator of DOZE and the",
    "entities": [
      {
        "text": "Colleen E. Carney",
        "label": "PERSON"
      },
      {
        "text": "DOZE",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "principal investigator of this study and does not receive any royalties for",
    "entities": []
  },
  {
    "text": "DOZE. The other authors have no conflicts to disclose.",
    "entities": []
  },
  {
    "text": "19. Aust J Psychol. 2024 Jul 31;76(1):2384373. doi:",
    "entities": [
      {
        "text": "19",
        "label": "CARDINAL"
      },
      {
        "text": "2024",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "The association between gratitude and distress tolerance in undergraduate",
    "entities": []
  },
  {
    "text": "students: the mediating effect of hope and fear of COVID-19.",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Firat University, Department of Business Administration, Elazig, Turkey.",
    "entities": [
      {
        "text": "1)Firat University, Department of Business Administration",
        "label": "ORG"
      },
      {
        "text": "Elazig",
        "label": "GPE"
      },
      {
        "text": "Turkey",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "OBJECTIVE: The COVID-19 pandemic negatively affected the mental health of people",
    "entities": [
      {
        "text": "COVID-19",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "all over the world. The distress tolerance of individuals may make them more",
    "entities": []
  },
  {
    "text": "resilient to negative emotions. Therefore, this study aimed to examine the",
    "entities": []
  },
  {
    "text": "mediating roles of hope and fear of COVID-19 in the relationship between",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "gratitude and distress tolerance.",
    "entities": []
  },
  {
    "text": "METHOD: This study was designed as STROBE cross-sectional reporting guidelines,",
    "entities": [
      {
        "text": "METHOD",
        "label": "ORG"
      },
      {
        "text": "STROBE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and included 440 health science students enrolled in a public university in",
    "entities": [
      {
        "text": "440",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Turkey. Participants completed the Gratitude Questionnaire-6, Distress Tolerance",
    "entities": [
      {
        "text": "Turkey",
        "label": "GPE"
      },
      {
        "text": "Distress Tolerance",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Scale, Hope Scale, and Fear of COVID-19 scale.",
    "entities": []
  },
  {
    "text": "RESULTS: The direct link between gratitude and distress tolerance was not",
    "entities": []
  },
  {
    "text": "significant. Hope was positively associated with gratitude and distress",
    "entities": []
  },
  {
    "text": "tolerance, whereas fear of COVID-19 was negatively associated with gratitude,",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "hope, and distress tolerance. Hope and fear of COVID-19 do not sequentially",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "mediate the link between gratitude and distress tolerance.",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: The positive relationship between gratitude and distress tolerance",
    "entities": []
  },
  {
    "text": "was mediated only by hope. The findings of our study are important as they",
    "entities": []
  },
  {
    "text": "emphasise that individuals with high dispositional gratitude and hope may",
    "entities": []
  },
  {
    "text": "improve their distress tolerance abilities. For dispositional gratitude to",
    "entities": []
  },
  {
    "text": "improve the ability to tolerate distress, additional efforts to provide",
    "entities": []
  },
  {
    "text": "individuals with this ability may be necessary.",
    "entities": []
  },
  {
    "text": "Plain Language Summary: What is already known about this topic: (1) The COVID-19",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "epidemic has increased psychological distress such as anxiety and fear. (2) Poor",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "distress tolerance causes negative emotions to be experienced more intensely.",
    "entities": []
  },
  {
    "text": "(3) Gratitude and hope improve mental health. What this topic adds: (1) In the",
    "entities": [
      {
        "text": "3",
        "label": "CARDINAL"
      },
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "COVID-19 epidemic, the relationships between distress tolerance as well as",
    "entities": []
  },
  {
    "text": "positive (hope and gratitude) and negative psychology (fear of COVID-19)",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "variables were not examined. (2) Gratitude and hope may improve distress",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "tolerance. (3) In order for gratitude to improve distress tolerance ability,",
    "entities": [
      {
        "text": "3",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "skill development training may be needed to equip individuals with this ability.",
    "entities": []
  },
  {
    "text": "Conflict of interest statement: No potential conflict of interest was reported",
    "entities": []
  },
  {
    "text": "by the author(s).",
    "entities": []
  },
  {
    "text": "The BASIC Ph model in communication and building individual and group resilience",
    "entities": []
  },
  {
    "text": "in crises. An example of use during the refugee crisis in Poland.",
    "entities": [
      {
        "text": "Poland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(1)The Maria Grzegorzewska University, Institute of Psychology, Warsaw, Poland.",
    "entities": [
      {
        "text": "Maria Grzegorzewska University",
        "label": "ORG"
      },
      {
        "text": "Institute of Psychology",
        "label": "ORG"
      },
      {
        "text": "Warsaw",
        "label": "GPE"
      },
      {
        "text": "Poland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Community Stress Prevention Center, Kiryat Shmona, Israel.",
    "entities": [
      {
        "text": "Stress Prevention Center",
        "label": "ORG"
      },
      {
        "text": "Kiryat Shmona",
        "label": "PERSON"
      },
      {
        "text": "Israel",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "PURPOSE: Everyday difficulties, but also new threats experienced by individuals",
    "entities": [
      {
        "text": "PURPOSE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and whole societies, are sources of stress that, due to their intensity,",
    "entities": []
  },
  {
    "text": "occurrence over time and in the absence of adequate support, can trigger crises",
    "entities": []
  },
  {
    "text": "and traumatic experiences. Examples of the latter are COVID-19 or military",
    "entities": [
      {
        "text": "COVID-19",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "action in Europe, among other things, and the related wave of refugees who have",
    "entities": [
      {
        "text": "Europe",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "sought refuge in many Western European countries since February 2022 in",
    "entities": [
      {
        "text": "Western European",
        "label": "NORP"
      },
      {
        "text": "February 2022",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "particular. This is why it is so important to cultivate resilience and the",
    "entities": []
  },
  {
    "text": "ability to cope effectively cope with stress not only at the individual level",
    "entities": []
  },
  {
    "text": "but also in entire social groups, and to nurture the resources not only of those",
    "entities": []
  },
  {
    "text": "already experiencing crises and mental health disorders, but also of entire",
    "entities": []
  },
  {
    "text": "VIEWS: The BASIC Ph model devised by Prof. Mooli Lahad (2013) is a tool for",
    "entities": [
      {
        "text": "Mooli Lahad",
        "label": "PERSON"
      },
      {
        "text": "2013",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "effective crisis communication and thus building individual and social",
    "entities": []
  },
  {
    "text": "resilience. It has been successfully implemented for several decades in the",
    "entities": [
      {
        "text": "several decades",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "process of educating individuals and social groups about stress and forming new,",
    "entities": []
  },
  {
    "text": "effective ways of coping with it, thereby building mental resilience in",
    "entities": []
  },
  {
    "text": "situations such as natural disasters, epidemics, wars, migration, and refugee",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: The article presents the application of the BASIC Ph model in the",
    "entities": []
  },
  {
    "text": "example of the refugee crisis and its use for people experiencing the trauma of",
    "entities": []
  },
  {
    "text": "war and forced migration, as well as citizens of host and migrant-supporting",
    "entities": []
  },
  {
    "text": "countries.",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025 Institute of Psychiatry and Neurology.",
    "entities": [
      {
        "text": "Institute of Psychiatry and Neurology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: None.",
    "entities": []
  },
  {
    "text": "[Distance between place of residence and location of maternal deaths: Regional,",
    "entities": []
  },
  {
    "text": "OBJECTIVE: To analyze the distance between the place of residence and the",
    "entities": []
  },
  {
    "text": "location of maternal deaths in Brazil from 2018 to 2023, taking into account",
    "entities": [
      {
        "text": "Brazil",
        "label": "GPE"
      },
      {
        "text": "2018",
        "label": "DATE"
      },
      {
        "text": "2023",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "territorial, ethnic-racial, and regional inequalities.",
    "entities": []
  },
  {
    "text": "METHODS: An ecological study was conducted using data from Brazil's Mortality",
    "entities": [
      {
        "text": "Brazil",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Information System (SIM) and the Live Birth Information System (Sinasc).",
    "entities": [
      {
        "text": "SIM",
        "label": "ORG"
      },
      {
        "text": "the Live Birth Information System",
        "label": "ORG"
      },
      {
        "text": "Sinasc",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Distances between the municipalities of residence and those where maternal",
    "entities": []
  },
  {
    "text": "deaths occurred were calculated using the Open Source Routing Machine (OSRM)",
    "entities": [
      {
        "text": "the Open Source Routing Machine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "API. The maternal mortality ratio (MMR), defined as the number of maternal",
    "entities": [
      {
        "text": "API",
        "label": "ORG"
      },
      {
        "text": "MMR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "deaths per 100 000 live births, was estimated according to distance intervals,",
    "entities": [
      {
        "text": "100",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "race/skin color, age group, pandemic period, and municipal population size.",
    "entities": []
  },
  {
    "text": "RESULTS: A total of 10 911 maternal deaths were recorded in Brazil during the",
    "entities": [
      {
        "text": "10 911",
        "label": "CARDINAL"
      },
      {
        "text": "Brazil",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "study period. The majority (56.7%) occurred without inter-municipal travel.",
    "entities": [
      {
        "text": "56.7%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "Travel distances greater than 500 km were more frequent among indigenous women",
    "entities": []
  },
  {
    "text": "and women under 20 years of age. In these cases, the MMR was higher, reaching",
    "entities": [
      {
        "text": "20 years of age",
        "label": "DATE"
      },
      {
        "text": "MMR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "772.5 deaths per 100 000 live births during the COVID-19 pandemic (2020 and",
    "entities": [
      {
        "text": "772.5",
        "label": "CARDINAL"
      },
      {
        "text": "100",
        "label": "CARDINAL"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      },
      {
        "text": "2020",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "2021). Among indigenous women, the average travel distance was the highest",
    "entities": [
      {
        "text": "2021",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "across all groups, reaching 533 km in 2020 and 2021. Municipalities with fewer",
    "entities": [
      {
        "text": "533 km",
        "label": "QUANTITY"
      },
      {
        "text": "2020",
        "label": "DATE"
      },
      {
        "text": "2021",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "than 50 000 inhabitants accounted for 58.2% of inter-municipal travel.",
    "entities": [
      {
        "text": "58.2%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "CONCLUSIONS: Travel distances were longer in contexts of greater social and",
    "entities": []
  },
  {
    "text": "territorial vulnerability, such as among indigenous women and residents of less",
    "entities": []
  },
  {
    "text": "populated areas. The findings underscore the need for public policies that",
    "entities": []
  },
  {
    "text": "address territorial inequalities and expand geographic access to ensure safe and",
    "entities": []
  },
  {
    "text": "timely obstetric care.",
    "entities": []
  },
  {
    "text": "Paraneoplastic Amyopathic Dermatomyositis Associated With a Bone and Medullary",
    "entities": []
  },
  {
    "text": "Location of Breast Adenocarcinoma.",
    "entities": []
  },
  {
    "text": "(1)Department of Medical Oncology, Centre Hospitalo-Universitaire Mohammed VI,",
    "entities": [
      {
        "text": "Medical Oncology",
        "label": "ORG"
      },
      {
        "text": "Mohammed VI",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(2)Department of Medical Oncology, Cadi Ayyad University, Marrakesh, MAR.",
    "entities": [
      {
        "text": "Medical Oncology",
        "label": "ORG"
      },
      {
        "text": "Cadi Ayyad University",
        "label": "ORG"
      },
      {
        "text": "Marrakesh",
        "label": "GPE"
      },
      {
        "text": "MAR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Paraneoplastic amyopathic dermatomyositis (ADM) is a rare connective tissue",
    "entities": [
      {
        "text": "ADM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "disease presenting with characteristic dermatomyositis-like skin findings in the",
    "entities": []
  },
  {
    "text": "absence of muscle involvement. It is associated with malignancies in 15%-30% of",
    "entities": [
      {
        "text": "15%-30%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "cases and may portend a fatal outcome, especially when linked to advanced",
    "entities": []
  },
  {
    "text": "cancers. We report the case of a 58-year-old woman who presented with",
    "entities": [
      {
        "text": "58-year-old",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "progressive low back pain and erythroderma. Imaging revealed diffuse bone",
    "entities": []
  },
  {
    "text": "metastases, and bone biopsy confirmed a poorly differentiated adenocarcinoma of",
    "entities": []
  },
  {
    "text": "erythema and other cutaneous findings consistent with ADM. The patient was",
    "entities": [
      {
        "text": "ADM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "started on endocrine therapy with palbociclib and letrozole, along with",
    "entities": []
  },
  {
    "text": "corticosteroids and hydroxychloroquine, resulting in partial clinical",
    "entities": []
  },
  {
    "text": "improvement. However, within six months of diagnosis, she developed severe",
    "entities": [
      {
        "text": "six months",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "COVID-19 pneumonia, complicated by pancytopenia and sepsis, and ultimately",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "succumbed to multiorgan failure despite intensive care support. This case",
    "entities": []
  },
  {
    "text": "underlines the importance of recognizing paraneoplastic ADM as an initial",
    "entities": [
      {
        "text": "ADM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "manifestation of malignancy. A multidisciplinary approach is key, but the",
    "entities": []
  },
  {
    "text": "prognosis largely depends on the cancer's burden and complications such as",
    "entities": []
  },
  {
    "text": "treatment-induced immunosuppression.",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025, Haboub et al.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "al.",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Human subjects: Informed consent for treatment",
    "entities": []
  },
  {
    "text": "and open access publication was obtained or waived by all participants in this",
    "entities": []
  },
  {
    "text": "study. Conflicts of interest: In compliance with the ICMJE uniform disclosure",
    "entities": [
      {
        "text": "ICMJE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "form, all authors declare the following: Payment/services info: All authors have",
    "entities": []
  },
  {
    "text": "declared that no financial support was received from any organization for the",
    "entities": []
  },
  {
    "text": "submitted work. Financial relationships: All authors have declared that they",
    "entities": []
  },
  {
    "text": "have no financial relationships at present or within the previous three years",
    "entities": [
      {
        "text": "the previous three years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "with any organizations that might have an interest in the submitted work. Other",
    "entities": []
  },
  {
    "text": "relationships: All authors have declared that there are no other relationships",
    "entities": []
  },
  {
    "text": "or activities that could appear to have influenced the submitted work.",
    "entities": []
  },
  {
    "text": "A Rare Case of Polymicrobial Empyema Associated With COVID-19 Infection",
    "entities": []
  },
  {
    "text": "Complicated by a Bronchopleural Fistula.",
    "entities": []
  },
  {
    "text": "(1)Internal Medicine, Nepalese Army Institute of Health Sciences, Kathmandu,",
    "entities": [
      {
        "text": "Medicine, Nepalese Army Institute of Health Sciences",
        "label": "ORG"
      },
      {
        "text": "Kathmandu",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Internal Medicine, MedStar Franklin Square Medical Center, Baltimore, USA.",
    "entities": [
      {
        "text": "Baltimore",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Internal Medicine, Tribhuvan University Institute of Medicine, Kathmandu,",
    "entities": [
      {
        "text": "Tribhuvan University Institute of Medicine",
        "label": "ORG"
      },
      {
        "text": "Kathmandu",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Empyema is a rare but serious complication in patients with COVID-19, and its",
    "entities": [
      {
        "text": "Empyema",
        "label": "ORG"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "association with bronchopleural fistula (BPF) is even more uncommon. We present",
    "entities": [
      {
        "text": "BPF",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "the case of a 40-year-old woman with a history of intravenous drug use who",
    "entities": [
      {
        "text": "40-year-old",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "developed polymicrobial empyema in the setting of COVID-19, further complicated",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "by BPF. She presented with hypoxic respiratory failure, leukocytosis, and lactic",
    "entities": [
      {
        "text": "BPF",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "acidosis. Imaging revealed a large right-sided hydropneumothorax and bilateral",
    "entities": []
  },
  {
    "text": "lung opacities. Broad-spectrum antibiotics, antivirals, and corticosteroids were",
    "entities": []
  },
  {
    "text": "initiated, and 3 liters of purulent fluid were drained via chest tube,",
    "entities": [
      {
        "text": "3",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "confirming empyema. Cultures identified multiple pathogens, including",
    "entities": []
  },
  {
    "text": "Bacteroides fragilis, Arcanobacterium hemolyticum, methicillin-sensitive",
    "entities": [
      {
        "text": "Arcanobacterium",
        "label": "LOC"
      },
      {
        "text": "methicillin",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Staphylococcus aureus, and Group C/G streptococci. Persistent air leak and",
    "entities": [
      {
        "text": "Group C/G",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "incomplete lung re-expansion led to a diagnosis of BPF. The patient was",
    "entities": [
      {
        "text": "BPF",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "successfully managed with prolonged antibiotic therapy and chest tube drainage",
    "entities": []
  },
  {
    "text": "without requiring surgical or bronchoscopic intervention. This case highlights",
    "entities": []
  },
  {
    "text": "the importance of recognizing and conservatively managing small BPFs in",
    "entities": []
  },
  {
    "text": "COVID-19-associated empyema, emphasizing the potential for non-surgical",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "resolution in select cases.",
    "entities": []
  },
  {
    "text": "Impact of the COVID-19 Pandemic on Clostridioides difficile Infection Rates in a",
    "entities": []
  },
  {
    "text": "Tertiary Hospital: A Retrospective Comparative Study.",
    "entities": [
      {
        "text": "Tertiary Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Department of Critical Care Medicine, Westmead Hospital, Sydney, AUS.",
    "entities": [
      {
        "text": "Critical Care Medicine",
        "label": "ORG"
      },
      {
        "text": "Westmead Hospital",
        "label": "ORG"
      },
      {
        "text": "Sydney",
        "label": "GPE"
      },
      {
        "text": "AUS",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Critical Care Medicine, Maitland Hospital, Newcastle, AUS.",
    "entities": [
      {
        "text": "Critical Care Medicine",
        "label": "ORG"
      },
      {
        "text": "Maitland Hospital",
        "label": "ORG"
      },
      {
        "text": "Newcastle",
        "label": "GPE"
      },
      {
        "text": "AUS",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Introduction The impact of the COVID-19 pandemic on the incidence of",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Clostridioides difficile infection (CDI) remains uncertain, with conflicting",
    "entities": [
      {
        "text": "CDI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "findings reported in the literature. While some studies have shown an increase",
    "entities": []
  },
  {
    "text": "in CDI cases, others have found no significant change. This study aimed to",
    "entities": [
      {
        "text": "CDI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "compare healthcare-associated CDI incidence rates (including community-onset and",
    "entities": [
      {
        "text": "compare healthcare-",
        "label": "ORG"
      },
      {
        "text": "CDI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "hospital-onset cases) between the pre-COVID-19 and COVID-19 periods at our",
    "entities": [
      {
        "text": "COVID-19",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "institution, with secondary analyses of ICU and hospital length of stay,",
    "entities": [
      {
        "text": "ICU",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "mortality, severity, and recurrence rates. Methods This single-center",
    "entities": []
  },
  {
    "text": "retrospective study at Wollongong Hospital compared CDI rates before and during",
    "entities": [
      {
        "text": "Wollongong Hospital",
        "label": "ORG"
      },
      {
        "text": "CDI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "the COVID-19 pandemic. Adult patients with diarrhea and confirmed CDI were",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      },
      {
        "text": "CDI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "included. Data on demographics, comorbidities, antibiotic use, hospital and ICU",
    "entities": [
      {
        "text": "ICU",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "length of stay, mortality, and infection control metrics were analyzed. CDI",
    "entities": [
      {
        "text": "CDI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "incidence was calculated per 1,000 patient-days and per 1,000 admissions.",
    "entities": [
      {
        "text": "1,000",
        "label": "CARDINAL"
      },
      {
        "text": "1,000",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Results Among 544 CDI cases (215 pre-COVID-19 and 329 during COVID-19), 291",
    "entities": [
      {
        "text": "544",
        "label": "CARDINAL"
      },
      {
        "text": "CDI",
        "label": "ORG"
      },
      {
        "text": "215",
        "label": "CARDINAL"
      },
      {
        "text": "329",
        "label": "CARDINAL"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      },
      {
        "text": "291",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(53.5%) were community-onset and 253 (46.5%) hospital-onset. There were no",
    "entities": [
      {
        "text": "53.5%",
        "label": "PERCENT"
      },
      {
        "text": "253",
        "label": "CARDINAL"
      },
      {
        "text": "46.5%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "significant differences between the two periods in CDI type (p = 0.599), time to",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      },
      {
        "text": "CDI",
        "label": "ORG"
      },
      {
        "text": "0.599",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "acquisition (p = 0.388), severity (17.2% vs. 19.5%), ICU admission (18.1% vs.",
    "entities": [
      {
        "text": "0.388",
        "label": "CARDINAL"
      },
      {
        "text": "17.2%",
        "label": "PERCENT"
      },
      {
        "text": "19.5%",
        "label": "PERCENT"
      },
      {
        "text": "ICU",
        "label": "ORG"
      },
      {
        "text": "18.1%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "20.4%), ICU (p = 0.415) or hospital length of stay (p = 0.788), or mortality",
    "entities": [
      {
        "text": "20.4%",
        "label": "PERCENT"
      },
      {
        "text": "ICU",
        "label": "ORG"
      },
      {
        "text": "0.415",
        "label": "CARDINAL"
      },
      {
        "text": "0.788",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(9.3% vs. 8.8%). However, CDI recurrence was significantly higher during the",
    "entities": [
      {
        "text": "9.3%",
        "label": "PERCENT"
      },
      {
        "text": "8.8%",
        "label": "PERCENT"
      },
      {
        "text": "CDI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "COVID-19 period (10.9% vs. 5.6%, p < 0.05), as were incidence rates per 1,000",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      },
      {
        "text": "10.9%",
        "label": "PERCENT"
      },
      {
        "text": "5.6%",
        "label": "PERCENT"
      },
      {
        "text": "1,000",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "vs. 0.45, p < 0.001). Hand hygiene compliance in general wards declined slightly",
    "entities": [
      {
        "text": "0.45",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "but significantly (from 88.5% to 87.9%, p = 0.003), while ICU compliance",
    "entities": [
      {
        "text": "88.5%",
        "label": "PERCENT"
      },
      {
        "text": "87.9%",
        "label": "PERCENT"
      },
      {
        "text": "0.003",
        "label": "CARDINAL"
      },
      {
        "text": "ICU",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "remained stable. Conclusion The incidence of CDI was significantly higher during",
    "entities": [
      {
        "text": "CDI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "the COVID-19 period compared to the pre-COVID-19 period at our institution.",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "These findings underscore the importance of strengthened antimicrobial",
    "entities": []
  },
  {
    "text": "stewardship and preventive measures during healthcare crises.",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025, Shabana et al.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Shabana",
        "label": "GPE"
      },
      {
        "text": "al.",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "study. Illawarra Shoalhaven Local Health District Research Office and Clinical",
    "entities": [
      {
        "text": "Illawarra Shoalhaven Local Health District Research Office",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Governance Unit issued approval ISLHDQA242. Animal subjects: All authors have",
    "entities": []
  },
  {
    "text": "confirmed that this study did not involve animal subjects or tissue. Conflicts",
    "entities": []
  },
  {
    "text": "of interest: In compliance with the ICMJE uniform disclosure form, all authors",
    "entities": [
      {
        "text": "ICMJE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "declare the following: Payment/services info: All authors have declared that no",
    "entities": []
  },
  {
    "text": "financial support was received from any organization for the submitted work.",
    "entities": []
  },
  {
    "text": "Financial relationships: All authors have declared that they have no financial",
    "entities": []
  },
  {
    "text": "relationships at present or within the previous three years with any",
    "entities": [
      {
        "text": "the previous three years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "organizations that might have an interest in the submitted work. Other",
    "entities": []
  },
  {
    "text": "A paradigm shift in simulating affinity maturation to elicit broadly",
    "entities": []
  },
  {
    "text": "(1)Biomedical Engineering Graduate Program, University of Colorado Boulder,",
    "entities": [
      {
        "text": "Engineering Graduate Program",
        "label": "ORG"
      },
      {
        "text": "University of Colorado Boulder",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Boulder, CO, United States.",
    "entities": [
      {
        "text": "Boulder, CO",
        "label": "ORG"
      },
      {
        "text": "United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Chemical and Biological Engineering, University of Colorado",
    "entities": [
      {
        "text": "Chemical",
        "label": "ORG"
      },
      {
        "text": "Biological Engineering",
        "label": "ORG"
      },
      {
        "text": "University of Colorado",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Boulder, Boulder, CO, United States.",
    "entities": [
      {
        "text": "Boulder",
        "label": "GPE"
      },
      {
        "text": "Boulder, CO",
        "label": "ORG"
      },
      {
        "text": "United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Broadly neutralizing antibodies (bnAbs) offer a promising route to protect",
    "entities": []
  },
  {
    "text": "against rapidly evolving pathogens such as HIV, influenza, and SARS-CoV-2, yet",
    "entities": []
  },
  {
    "text": "eliciting them through vaccination remains a significant challenge. A key to",
    "entities": []
  },
  {
    "text": "this problem lies in understanding antibody affinity maturation (AM), the",
    "entities": []
  },
  {
    "text": "evolutionary process within germinal centers (GCs) that shapes the B cell and",
    "entities": []
  },
  {
    "text": "thus antibody response. Traditionally, AM has been viewed as favoring the",
    "entities": []
  },
  {
    "text": "selection of B cells with the highest-affinity B cell receptors (BCRs) through",
    "entities": []
  },
  {
    "text": "competitive interplays. However, emerging evidence suggests that GCs are more",
    "entities": []
  },
  {
    "text": "permissive, allowing B cells with a broad range of affinities to persist,",
    "entities": []
  },
  {
    "text": "thereby promoting clonal diversity and enabling the rare emergence of bnAbs.",
    "entities": [
      {
        "text": "bnAbs",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "This review reassesses affinity-based selection models and proposes a new",
    "entities": []
  },
  {
    "text": "paradigm that integrates multifactorial processes, including stochastic B cell",
    "entities": []
  },
  {
    "text": "decisions within GC dynamics, antigen extraction efficiency influenced by",
    "entities": [
      {
        "text": "GC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "probabilistic bond rupture, and avidity-driven BCR binding alterations and",
    "entities": []
  },
  {
    "text": "representations on multivalent antigens. We highlight how advanced AM",
    "entities": []
  },
  {
    "text": "simulations that move beyond affinity as the sole determinant provide a more",
    "entities": []
  },
  {
    "text": "realistic and predictive representation of AM, marking a major step forward in",
    "entities": []
  },
  {
    "text": "developing strategies to promote effective immune responses against highly",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025 Nakarin and Sprenger.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Sprenger",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "Adverse Effects of the Long-term use of an N95 Respirator in Healthcare Workers.",
    "entities": [
      {
        "text": "N95 Respirator",
        "label": "ORG"
      },
      {
        "text": "Healthcare Workers",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "OBJECTIVES: Healthcare workers must take stringent infection control measures",
    "entities": [
      {
        "text": "OBJECTIVES",
        "label": "ORG"
      },
      {
        "text": "Healthcare",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "against coronavirus disease. Previous reports have indicated that N95",
    "entities": [
      {
        "text": "N95",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "respirators cause fatigue, discomfort, and physical symptoms, such as headaches.",
    "entities": []
  },
  {
    "text": "We aimed to comparatively analyze the effect of the use of surgical and N95",
    "entities": [
      {
        "text": "N95",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "respirators for long hours on the performance of healthcare workers. This is the",
    "entities": [
      {
        "text": "long hours",
        "label": "TIME"
      }
    ]
  },
  {
    "text": "first study to validate the effect of wearing N95 respirators on work",
    "entities": [
      {
        "text": "first",
        "label": "ORDINAL"
      },
      {
        "text": "N95",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "efficiency.",
    "entities": []
  },
  {
    "text": "MATERIALS AND METHODS: This study was conducted from April 2021 to October 2021",
    "entities": [
      {
        "text": "April 2021 to October 2021",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "during the COVID-19 pandemic in Japan. Healthy healthcare workers at an",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      },
      {
        "text": "Japan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "emergency department were subjected to a performance task program comprising",
    "entities": []
  },
  {
    "text": "four tasks conducted before and after wearing a surgical mask/N95 respirator for",
    "entities": [
      {
        "text": "four",
        "label": "CARDINAL"
      },
      {
        "text": "N95",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "at least 4 h, and the results were compared.",
    "entities": [
      {
        "text": "at least 4",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "RESULTS: The study included 17 (male, 8 [47.1%]) healthcare workers. The age",
    "entities": [
      {
        "text": "17",
        "label": "CARDINAL"
      },
      {
        "text": "8",
        "label": "CARDINAL"
      },
      {
        "text": "47.1%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "ranged from 22 to 32 (mean, 26.6) years. For each task, the rate of change in",
    "entities": [
      {
        "text": "22",
        "label": "CARDINAL"
      },
      {
        "text": "32",
        "label": "CARDINAL"
      },
      {
        "text": "26.6) years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "the percentage of correct responses, rate of decline in reaction time, and rate",
    "entities": []
  },
  {
    "text": "of decline in reaction time for correct responses were calculated before and",
    "entities": []
  },
  {
    "text": "after wearing the two types of masks. There was no statistically significant",
    "entities": []
  },
  {
    "text": "difference in the rate of decline in reaction time between the masks for all",
    "entities": []
  },
  {
    "text": "tasks. However, there was a trend toward a high rate of decline in the",
    "entities": []
  },
  {
    "text": "alphanumeric detection task.",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: Using an N95 respirator for 4 h continuously did not adversely",
    "entities": [
      {
        "text": "N95",
        "label": "ORG"
      },
      {
        "text": "4",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "affect work efficiency. Although prolonged work under conditions of discomfort",
    "entities": []
  },
  {
    "text": "should be avoided, it is unlikely that N95 respirators will adversely affect the",
    "entities": [
      {
        "text": "N95",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "performance of healthcare workers.",
    "entities": []
  },
  {
    "text": "\u00a9 2025 The Juntendo Medical Society.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "The Juntendo Medical Society",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: The authors declare that they have no competing",
    "entities": []
  },
  {
    "text": "interests to disclose.",
    "entities": []
  },
  {
    "text": "Mobility-informed metapopulation models predict the spatio-temporal spread of",
    "entities": []
  },
  {
    "text": "Pandey A, Zhong L, Rennert L.",
    "entities": [
      {
        "text": "Zhong L",
        "label": "PERSON"
      },
      {
        "text": "Rennert L.\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Understanding the spatiotemporal dynamics of infectious disease spread is",
    "entities": []
  },
  {
    "text": "critical for anticipating epidemic trajectories and guiding public health",
    "entities": []
  },
  {
    "text": "responses. Accurate forecasts of where and when outbreaks are likely to emerge",
    "entities": []
  },
  {
    "text": "can support efficient resource allocation, particularly during the early stages",
    "entities": []
  },
  {
    "text": "of epidemics when surveillance data are limited. In this study, we used",
    "entities": []
  },
  {
    "text": "empirical human mobility data derived from county-level commuting and air",
    "entities": []
  },
  {
    "text": "traffic flows, and a theoretical mobility model (the radiation model) to study",
    "entities": []
  },
  {
    "text": "the relative order of epidemic onset across spatial scales. These mobility",
    "entities": []
  },
  {
    "text": "models were incorporated into a metapopulation framework to predict the spread",
    "entities": []
  },
  {
    "text": "of three major respiratory pathogens: COVID-19, seasonal influenza, and",
    "entities": [
      {
        "text": "three",
        "label": "CARDINAL"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "respiratory syncytial virus (RSV). We applied this framework to county-level",
    "entities": [
      {
        "text": "RSV",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "transmission within South Carolina and state-level introductions across the",
    "entities": [
      {
        "text": "South Carolina",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "United States. In both empirical and theoretical mobility scenarios, we found",
    "entities": [
      {
        "text": "United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "that effective distance, a network-based measure of mobility-informed proximity,",
    "entities": []
  },
  {
    "text": "reliably predicts the relative timing of epidemic onset. These results",
    "entities": []
  },
  {
    "text": "demonstrate that mobility-informed metapopulation models can capture consistent",
    "entities": []
  },
  {
    "text": "spatiotemporal patterns across disease systems and spatial scales, even in the",
    "entities": []
  },
  {
    "text": "absence of detailed epidemiological parameters. This highlights their potential",
    "entities": []
  },
  {
    "text": "as scalable, data-efficient tools for outbreak forecasting and early public",
    "entities": []
  },
  {
    "text": "health planning.",
    "entities": []
  },
  {
    "text": "Machine Learning and Probabilistic Approaches for Forecasting COVID-19",
    "entities": [
      {
        "text": "Machine Learning",
        "label": "PERSON"
      },
      {
        "text": "Probabilistic Approaches for Forecasting COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Transmission and Cases.",
    "entities": []
  },
  {
    "text": "Hossain MS, Goyal R, Martin NK, DeGruttola V, Ahammed T, McMahan C, Rennert L.",
    "entities": [
      {
        "text": "Hossain MS",
        "label": "PERSON"
      },
      {
        "text": "Martin NK",
        "label": "PERSON"
      },
      {
        "text": "DeGruttola V",
        "label": "ORG"
      },
      {
        "text": "Ahammed",
        "label": "PERSON"
      },
      {
        "text": "Rennert L.\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Forecasting the effective reproductive number ( R t ) and COVID-19 case counts",
    "entities": [
      {
        "text": "COVID-19",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "are critical for guiding public health responses. We developed a machine",
    "entities": []
  },
  {
    "text": "learning and probabilistic forecasting framework to predict R t and daily case",
    "entities": [
      {
        "text": "daily",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "counts at the county level in South Carolina (SC). Our approach utilized initial",
    "entities": [
      {
        "text": "South Carolina",
        "label": "GPE"
      },
      {
        "text": "SC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "R t estimates from EpiNow2 R package refined with spatial (covariate-adjusted)",
    "entities": []
  },
  {
    "text": "smoothing. We then generated R t forecasts using an ensemble of regression,",
    "entities": []
  },
  {
    "text": "Random Forest, and XGBoost models, and predicted case counts with a",
    "entities": [
      {
        "text": "Random Forest",
        "label": "ORG"
      },
      {
        "text": "XGBoost",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "probabilistic Poisson model. This ensemble-based approach consistently",
    "entities": [
      {
        "text": "Poisson",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "outperformed EpiNow2 across different forecast horizons (7-day, 14-day, and",
    "entities": [
      {
        "text": "7-day",
        "label": "DATE"
      },
      {
        "text": "14-day",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "21-day). In the first forecast period (November 11, 2020 - February 02, 2021),",
    "entities": [
      {
        "text": "21-day",
        "label": "DATE"
      },
      {
        "text": "first",
        "label": "ORDINAL"
      },
      {
        "text": "November 11",
        "label": "DATE"
      },
      {
        "text": "2020 - February 02, 2021",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "the ensemble achieved a median percentage agreement (PA) across counties of",
    "entities": []
  },
  {
    "text": "94.4% (IQR: 93.8% - 95.3%) for 7-day ahead R t forecast, compared to 87.0% (IQR:",
    "entities": [
      {
        "text": "94.4%",
        "label": "PERCENT"
      },
      {
        "text": "IQR",
        "label": "ORG"
      },
      {
        "text": "93.8% - 95.3%",
        "label": "PERCENT"
      },
      {
        "text": "7-day",
        "label": "DATE"
      },
      {
        "text": "87.0%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "84.4% - 89.4%) from EpiNow2. In the second period (December 11, 2022 - March 04,",
    "entities": [
      {
        "text": "84.4%",
        "label": "PERCENT"
      },
      {
        "text": "89.4%",
        "label": "PERCENT"
      },
      {
        "text": "the second period",
        "label": "DATE"
      },
      {
        "text": "December 11",
        "label": "DATE"
      },
      {
        "text": "2022 - March 04",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "2023), the ensemble attained a 93.0% median PA across counties for Rt forecast",
    "entities": [
      {
        "text": "2023",
        "label": "DATE"
      },
      {
        "text": "93.0%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "(IQR: 91.3% - 94.1%), while EpiNow2 reached 86.8% (IQR: 82.5% - 89.2%). Similar",
    "entities": [
      {
        "text": "91.3% - 94.1%",
        "label": "PERCENT"
      },
      {
        "text": "86.8%",
        "label": "PERCENT"
      },
      {
        "text": "IQR",
        "label": "ORG"
      },
      {
        "text": "82.5% - 89.2%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "trends were observed for case forecast, with the ensemble model demonstrating",
    "entities": []
  },
  {
    "text": "improved stability and performance. Combining spatial smoothing with ensemble",
    "entities": []
  },
  {
    "text": "modeling improves epidemic forecasting by enhancing predictive performance and",
    "entities": []
  },
  {
    "text": "Enhancing Pandemic Prediction: A Deep Learning Approach Using Transformer Neural",
    "entities": []
  },
  {
    "text": "Networks and Multi-Source Data Fusion for Infectious Disease Forecasting.",
    "entities": [
      {
        "text": "Multi-Source Data Fusion for Infectious Disease Forecasting",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Wu J, Tanim S, Woo M, Ahammed T, Rennert L.",
    "entities": [
      {
        "text": "Wu J",
        "label": "PERSON"
      },
      {
        "text": "Tanim S",
        "label": "PERSON"
      },
      {
        "text": "Woo M",
        "label": "ORG"
      },
      {
        "text": "Ahammed",
        "label": "PERSON"
      },
      {
        "text": "Rennert L.\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "The Covid-19 pandemic has highlighted the urgent need for accurate prediction of",
    "entities": []
  },
  {
    "text": "pandemic trends. We propose a deep learning model for predicting Covid-19 cases",
    "entities": []
  },
  {
    "text": "and deaths at the county level through transformer neural networks with",
    "entities": []
  },
  {
    "text": "social media sentiment analysis to capture both temporal (historical trends) and",
    "entities": []
  },
  {
    "text": "spatial (geographical relationships) dynamics within time series data.",
    "entities": []
  },
  {
    "text": "Additionally, we develop multi-level and multi-scale attention mechanisms for",
    "entities": []
  },
  {
    "text": "adaptive time-frequency analysis. Across three Omicron variant waves (December",
    "entities": [
      {
        "text": "three",
        "label": "CARDINAL"
      },
      {
        "text": "Omicron",
        "label": "ORG"
      },
      {
        "text": "December",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "2021 through February 2023), the model demonstrated strong performance in",
    "entities": [
      {
        "text": "2021",
        "label": "DATE"
      },
      {
        "text": "February 2023",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "predicting county-level Covid-19 cases and deaths, with median county agreement",
    "entities": []
  },
  {
    "text": "accuracy ranging from 74.0% to 82.6% for one-week case forecasts and 68.7% to",
    "entities": [
      {
        "text": "74.0%",
        "label": "PERCENT"
      },
      {
        "text": "82.6%",
        "label": "PERCENT"
      },
      {
        "text": "one-week",
        "label": "DATE"
      },
      {
        "text": "68.7%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "79.6% for 5-week case forecasts. Median county agreement accuracy for deaths",
    "entities": [
      {
        "text": "79.6%",
        "label": "PERCENT"
      },
      {
        "text": "5-week",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "ranged from 83.2% to 86.3% for one-week forecasts and 84.3% to 87.2% for",
    "entities": [
      {
        "text": "83.2%",
        "label": "PERCENT"
      },
      {
        "text": "86.3%",
        "label": "PERCENT"
      },
      {
        "text": "one-week",
        "label": "DATE"
      },
      {
        "text": "84.3%",
        "label": "PERCENT"
      },
      {
        "text": "87.2%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "five-week forecasts. Incorporating social media data yielded mild to moderate",
    "entities": [
      {
        "text": "five-week",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "improvement in forecasting accuracy. Overall, the proposed model yielded",
    "entities": []
  },
  {
    "text": "substantial improvements compared to a baseline persistence model utilizing the",
    "entities": []
  },
  {
    "text": "last observation carried forward. By integrating real-time data and capturing",
    "entities": []
  },
  {
    "text": "complex pandemic dynamics, this approach surpasses traditional methods. Its high",
    "entities": []
  },
  {
    "text": "accuracy and generalizability make it a valuable tool for enhancing public",
    "entities": []
  },
  {
    "text": "health preparedness and response strategies in future outbreaks.",
    "entities": []
  },
  {
    "text": "Gaps in Artificial Intelligence Research for Rural Health in the United States:",
    "entities": [
      {
        "text": "Artificial Intelligence Research for Rural Health",
        "label": "ORG"
      },
      {
        "text": "the United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "A Scoping Review.",
    "entities": []
  },
  {
    "text": "Brown KE, Davis SE.",
    "entities": [
      {
        "text": "Davis SE",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "BACKGROUND: Artificial intelligence (AI) has impacted healthcare at urban and",
    "entities": [
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "academic medical centers globally. The current focus on AI deployments in urban",
    "entities": [
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "areas and the history of US urban-rural digital divides raises concerns that the",
    "entities": [
      {
        "text": "US",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "promise of AI may not be realized in rural communities. This may exacerbate",
    "entities": [
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "well-documented health disparities. Without the benefits of AI-driven",
    "entities": []
  },
  {
    "text": "improvements in patient outcomes and increased efficiency, rural healthcare",
    "entities": []
  },
  {
    "text": "facilities may fall farther behind their urban counterparts and rural hospital",
    "entities": []
  },
  {
    "text": "METHODS: We conducted a scoping review following the PRISMA guidelines. We",
    "entities": [
      {
        "text": "PRISMA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "included peer-reviewed, original research studies indexed in PubMed, Embase, and",
    "entities": [
      {
        "text": "PubMed",
        "label": "ORG"
      },
      {
        "text": "Embase",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "WebOfScience after January 1, 2010 and through April 29, 2025. Studies were",
    "entities": [
      {
        "text": "January 1, 2010",
        "label": "DATE"
      },
      {
        "text": "April 29, 2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "required to discuss the development, implementation, or evaluation of AI tools",
    "entities": [
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "in rural US healthcare, including frameworks that help facilitate AI development",
    "entities": [
      {
        "text": "US",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "FINDINGS: Our search strategy found 26 studies meeting inclusion criteria after",
    "entities": [
      {
        "text": "26",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "full text screening with 14 papers discussing predictive AI models and 12 papers",
    "entities": [
      {
        "text": "14",
        "label": "CARDINAL"
      },
      {
        "text": "AI",
        "label": "ORG"
      },
      {
        "text": "12",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "discussing data or research infrastructure. AI models most commonly targeted",
    "entities": [
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "resource allocation and distribution. Few studies explored model deployment and",
    "entities": []
  },
  {
    "text": "impact. Half noted the lack of data and analytic resources as a limitation to",
    "entities": [
      {
        "text": "Half",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "both development and validation. None of the studies discussed examples of",
    "entities": []
  },
  {
    "text": "generative AI being trained, evaluated, or deployed in a rural setting.",
    "entities": [
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "INTERPRETATION: Practical limitations may be influencing and limiting the types",
    "entities": []
  },
  {
    "text": "of AI models evaluated in the rural US. We noted validation of tools in the",
    "entities": [
      {
        "text": "AI",
        "label": "ORG"
      },
      {
        "text": "US",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "rural US was underwhelming, and ultimately, neglected. With few studies moving",
    "entities": [
      {
        "text": "US",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "beyond AI model design and development stages, there is a clear gap in our",
    "entities": [
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "understanding of how to reliably validate, deploy, and sustain AI models in",
    "entities": [
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "rural settings to advance health in all communities.",
    "entities": []
  },
  {
    "text": "FUNDING: National Library of Medicine.",
    "entities": []
  },
  {
    "text": "RESEARCH IN CONTEXT: Evidence before this study: Clinical artificial",
    "entities": []
  },
  {
    "text": "intelligence (AI)-both for prediction modeling and generative tools- tools",
    "entities": []
  },
  {
    "text": "promise to reduce care delays, improve diagnosis and treatment decision-making,",
    "entities": []
  },
  {
    "text": "reduce care costs, and improve efficiency to reduce provider workload and",
    "entities": []
  },
  {
    "text": "enhance practice management. Unfortunately, efforts to deploy artificial",
    "entities": []
  },
  {
    "text": "intelligence (AI)-both for prediction modeling and generative tools-in",
    "entities": []
  },
  {
    "text": "healthcare are advancing, primarily at large academic medical centers and in",
    "entities": [
      {
        "text": "healthcare",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "urban areas. An emerging new digital divide in the use of clinical AI could",
    "entities": [
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "exacerbate the well-documented health disparities between urban and rural",
    "entities": []
  },
  {
    "text": "communities in the United States. A better understanding of if and how AI is",
    "entities": [
      {
        "text": "the United States",
        "label": "GPE"
      },
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "being developed, deployed, and evaluated across rural US communities is",
    "entities": [
      {
        "text": "US",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "necessary to identify resources gaps and challenges to broad AI use in all",
    "entities": [
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "communities.Added value of this study: This study analyzes the current state of",
    "entities": []
  },
  {
    "text": "artificial intelligence research in the rural United States. For predictive AI",
    "entities": [
      {
        "text": "United States",
        "label": "GPE"
      },
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "models, applications most commonly targeted resource allocation and",
    "entities": []
  },
  {
    "text": "distribution. We noted several attempts to predict resource utilization of",
    "entities": []
  },
  {
    "text": "patients who were either tested or tested positive to COVID-19. However, we",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "noted few AI solutions for acute medical events faced by rural patients, such as",
    "entities": [
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "trauma and stroke, despite worse outcomes for rural patients suffering from",
    "entities": []
  },
  {
    "text": "these acute events. The limited availability of time-critical specialties such",
    "entities": []
  },
  {
    "text": "as trauma/emergency medicine, neurology, and cardiology in rural areas often",
    "entities": []
  },
  {
    "text": "necessitates patients with such conditions be transferred to larger, more",
    "entities": []
  },
  {
    "text": "resourced hospitals. Practical limitations may be influencing and limiting the",
    "entities": []
  },
  {
    "text": "types of AI models evaluated in rural US medical facilities. The most frequent",
    "entities": [
      {
        "text": "AI",
        "label": "ORG"
      },
      {
        "text": "US",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "model employed were tree-based ensembles, such as random forests and",
    "entities": []
  },
  {
    "text": "gradient-boosting trees. Our review also highlighted few studies of AI models",
    "entities": [
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "moving beyond the design and develop stages, leaving a clear gap in our",
    "entities": []
  },
  {
    "text": "understanding of how to deploy and sustain predictive AI models in rural",
    "entities": [
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "settings. Several challenges noted in the reviewed studies may provide insight",
    "entities": []
  },
  {
    "text": "into this lack of translation from research to implementation. We note that",
    "entities": []
  },
  {
    "text": "validation of A tools in the rural US was underwhelming, and ultimately,",
    "entities": [
      {
        "text": "US",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "neglected. The most common form of model validation employed was a single random",
    "entities": []
  },
  {
    "text": "holdout test set. Half of the included papers mentioned a lack of reliable data",
    "entities": [
      {
        "text": "Half",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "sources or limited data volume as a potential challenge in developing and",
    "entities": []
  },
  {
    "text": "adopting AI/ML tools. The use of patient-level EHR data was often limited to",
    "entities": [
      {
        "text": "AI/ML",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "what was available to the authors or at a specific medical center.Implications",
    "entities": []
  },
  {
    "text": "of all the available evidence: Our review indicates a gap and highlights",
    "entities": []
  },
  {
    "text": "opportunity for innovation in leveraging AI tools to predict and support",
    "entities": [
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "patients in rural communities. Further research is needed to enhance the",
    "entities": []
  },
  {
    "text": "translation of state-of-the-art modeling techniques into effective AI tools for",
    "entities": [
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "use in the rural US, including exploring partnerships between academic medical",
    "entities": [
      {
        "text": "US",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "centers and rural communities and solutions to logistic challenges of such",
    "entities": []
  },
  {
    "text": "partnerships, including data and resource sharing.",
    "entities": []
  },
  {
    "text": "Epidemiology of Aspergillosis Diagnoses in the U.S. using a National EHR",
    "entities": [
      {
        "text": "Epidemiology of Aspergillosis Diagnoses",
        "label": "ORG"
      },
      {
        "text": "U.S.",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Morgan Bustamante BL, Martinez EG, Lee A, Kane NJ, Camponuri SK, Reynolds RM,",
    "entities": [
      {
        "text": "Morgan Bustamante BL",
        "label": "PERSON"
      },
      {
        "text": "Lee A",
        "label": "PERSON"
      },
      {
        "text": "Kane NJ",
        "label": "PERSON"
      },
      {
        "text": "Camponuri SK",
        "label": "ORG"
      },
      {
        "text": "Reynolds",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Snow TT, Bartels JGE, Hoffman M, White TC, Remais JV.",
    "entities": [
      {
        "text": "Bartels JGE",
        "label": "PERSON"
      },
      {
        "text": "Hoffman M",
        "label": "PERSON"
      },
      {
        "text": "White TC",
        "label": "ORG"
      },
      {
        "text": "Remais JV",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "IMPORTANCE: Aspergillosis is an under-recognized fungal infection associated",
    "entities": []
  },
  {
    "text": "with rising hospitalizations, concerns about antifungal resistance, and",
    "entities": []
  },
  {
    "text": "substantial morbidity and mortality in the U.S. Yet, national data on",
    "entities": [
      {
        "text": "U.S.",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "aspergillosis remain fragmented due to absence of centralized surveillance.",
    "entities": []
  },
  {
    "text": "OBJECTIVE: To examine demographic and geographic variation and temporal trends",
    "entities": []
  },
  {
    "text": "in aspergillosis prevalence in the U.S. from 2013 to 2023; to assess how the",
    "entities": [
      {
        "text": "U.S.",
        "label": "GPE"
      },
      {
        "text": "2013",
        "label": "DATE"
      },
      {
        "text": "2023",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "COVID-19 pandemic influenced prevalence across population subgroups.",
    "entities": []
  },
  {
    "text": "DESIGN: Retrospective cohort study using a large, national electronic health",
    "entities": []
  },
  {
    "text": "SETTING: 142 healthcare systems in the U.S. using Oracle Health EHR systems,",
    "entities": [
      {
        "text": "142",
        "label": "CARDINAL"
      },
      {
        "text": "U.S.",
        "label": "GPE"
      },
      {
        "text": "Oracle Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "PARTICIPANTS: Adults aged 18 years and older who received care between January",
    "entities": [
      {
        "text": "aged 18 years",
        "label": "DATE"
      },
      {
        "text": "between January\n",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "1, 2013, and December 31, 2023. The cohort included over 76 million patients,",
    "entities": [
      {
        "text": "1, 2013",
        "label": "DATE"
      },
      {
        "text": "December 31, 2023",
        "label": "DATE"
      },
      {
        "text": "over 76 million",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "and over 127 million person-years, with 20,764 aspergillosis diagnoses.",
    "entities": [
      {
        "text": "over 127 million",
        "label": "CARDINAL"
      },
      {
        "text": "20,764",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "EXPOSURES: Calendar year, patient characteristics (age, sex, race, ethnicity,",
    "entities": [
      {
        "text": "Calendar year",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "residence type), and state of residence. COVID-19 was treated as a time-varying",
    "entities": []
  },
  {
    "text": "MAIN OUTCOMES AND MEASURES: Annual and overall prevalence of aspergillosis per",
    "entities": [
      {
        "text": "MAIN",
        "label": "ORG"
      },
      {
        "text": "Annual",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "100,000 person-years; adjusted prevalence ratios (aPRs) by demographic group and",
    "entities": [
      {
        "text": "100,000",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "state, estimated using quasi-Poisson and Bayesian spatiotemporal regression.",
    "entities": [
      {
        "text": "Bayesian",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "COVID-19-related shifts in prevalence were assessed using estimated marginal",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "RESULTS: Between 2013 and 2023, aspergillosis prevalence increased 5% annually,",
    "entities": [
      {
        "text": "Between 2013 and 2023",
        "label": "DATE"
      },
      {
        "text": "5%",
        "label": "PERCENT"
      },
      {
        "text": "annually",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "peaking in 2022. Rhode Island had the highest aPR across all years; Utah the",
    "entities": [
      {
        "text": "2022",
        "label": "DATE"
      },
      {
        "text": "Rhode Island",
        "label": "GPE"
      },
      {
        "text": "all years",
        "label": "DATE"
      },
      {
        "text": "Utah",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "lowest. Prevalence was higher in males (aPR: 1.37), older adults (aPR for \u226565",
    "entities": [
      {
        "text": "1.37",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "vs. 18 to 34: 4.95), and urban residents (rural aPR: 0.86). Post-COVID-19,",
    "entities": [
      {
        "text": "18",
        "label": "CARDINAL"
      },
      {
        "text": "34",
        "label": "CARDINAL"
      },
      {
        "text": "4.95",
        "label": "CARDINAL"
      },
      {
        "text": "0.86",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "prevalence increased disproportionately among Hispanic or Latino patients and",
    "entities": [
      {
        "text": "Hispanic",
        "label": "NORP"
      },
      {
        "text": "Latino",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "several racial minority groups. Suggestive trends of increasing prevalence were",
    "entities": []
  },
  {
    "text": "also observed among rural residents.",
    "entities": []
  },
  {
    "text": "CONCLUSIONS AND RELEVANCE: This study provides the most comprehensive national",
    "entities": [
      {
        "text": "CONCLUSIONS",
        "label": "ORG"
      },
      {
        "text": "RELEVANCE",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "assessment to date of aspergillosis patterns in the U.S., revealing evidence of",
    "entities": [
      {
        "text": "U.S.",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "rising prevalence and emerging disparities shaped by the COVID-19 pandemic.",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Clinicians should consider regional and demographic risk patterns to support",
    "entities": [
      {
        "text": "Clinicians",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "earlier diagnosis, guide antifungal treatment, and improve outcomes-especially",
    "entities": []
  },
  {
    "text": "among older adults and populations disproportionately affected by COVID-19.",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Clinicians practicing in rural or underserved areas should be particularly",
    "entities": [
      {
        "text": "Clinicians",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "mindful of shifting risk profiles and advocate for improved diagnostic resources",
    "entities": []
  },
  {
    "text": "to reduce delays in care.",
    "entities": []
  },
  {
    "text": "QUESTION: How has aspergillosis prevalence changed in the U.S. over time, and",
    "entities": [
      {
        "text": "U.S.",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "how did the COVID-19 pandemic influence prevalence among demographic and",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "geographic subgroups?",
    "entities": []
  },
  {
    "text": "FINDINGS: In a nationally representative EHR cohort of over 76 million adults,",
    "entities": [
      {
        "text": "over 76 million",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "aspergillosis prevalence increased by 5% annually from 2013 to 2023. After the",
    "entities": [
      {
        "text": "5%",
        "label": "PERCENT"
      },
      {
        "text": "annually",
        "label": "DATE"
      },
      {
        "text": "2013",
        "label": "DATE"
      },
      {
        "text": "2023",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "emergence of COVID-19, prevalence increased disproportionately among Hispanic or",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      },
      {
        "text": "Hispanic",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Latino patients and racial minority groups.",
    "entities": []
  },
  {
    "text": "MEANING: Findings suggest increasing aspergillosis prevalence in the U.S., with",
    "entities": [
      {
        "text": "U.S.",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "indications of widening disparities. While subject to data limitations, these",
    "entities": []
  },
  {
    "text": "trends underscore the importance of considering regional and demographic factors",
    "entities": []
  },
  {
    "text": "in clinical decision-making, particularly for populations disproportionately",
    "entities": []
  },
  {
    "text": "affected by COVID-19.",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Granular Insights:A Wastewater-Based Machine Learning Approach for Localized",
    "entities": []
  },
  {
    "text": "COVID-19 Hospitalization Forecasting.",
    "entities": [
      {
        "text": "COVID-19 Hospitalization Forecasting",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Tabassum N, Chowdhury MM, McMahan CS, Self S, Isanovic M, Correa-Velez K,",
    "entities": [
      {
        "text": "Tabassum N",
        "label": "PERSON"
      },
      {
        "text": "Chowdhury MM",
        "label": "PERSON"
      },
      {
        "text": "McMahan CS",
        "label": "PERSON"
      },
      {
        "text": "Isanovic M",
        "label": "PERSON"
      },
      {
        "text": "Correa-Velez K",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Wastewater based epidemiology (WBE) is a valuable tool for monitoring emerging",
    "entities": [
      {
        "text": "WBE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "disease trends in a community. Specifically, early predictions of",
    "entities": []
  },
  {
    "text": "hospitalization in a community can help reduce the strain on healthcare services",
    "entities": []
  },
  {
    "text": "and facilitate better planning and preparation. This study examines the use of",
    "entities": []
  },
  {
    "text": "SARS-CoV-2 RNA concentrations in wastewater to predict COVID-19 hospitalizations",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "in South Carolina. We analyzed SARS-CoV-2 RNA concentration collected from six",
    "entities": [
      {
        "text": "South Carolina",
        "label": "GPE"
      },
      {
        "text": "six",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "wastewater treatment plants (WWTPs) across South Carolina from April 19, 2020 to",
    "entities": [
      {
        "text": "South Carolina",
        "label": "GPE"
      },
      {
        "text": "April 19, 2020",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "February 2, 2021 to predict COVID-19-related hospitalizations across WWTPs and",
    "entities": [
      {
        "text": "February 2, 2021",
        "label": "DATE"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "43 associated ZIP codes. Poisson regression and random forest models were",
    "entities": [
      {
        "text": "43",
        "label": "CARDINAL"
      },
      {
        "text": "Poisson",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "utilized to forecast 7-day, 14-day, and 21-day ahead COVID-19 hospitalizations.",
    "entities": [
      {
        "text": "7-day",
        "label": "DATE"
      },
      {
        "text": "14-day",
        "label": "DATE"
      },
      {
        "text": "21-day",
        "label": "DATE"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Model performance was validated against statewide hospitalization claims data.",
    "entities": []
  },
  {
    "text": "Model accuracy was strongest for 14-day ahead prediction, with the random forest",
    "entities": [
      {
        "text": "14-day",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "models achieving a median percentage agreement (PA) of 91.16% (IQR =",
    "entities": [
      {
        "text": "91.16%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "86.49-91.84%) across WWTPs and 78.12% (IQR = 67.99-84.53%) across ZIP codes.",
    "entities": [
      {
        "text": "86.49-91.84%",
        "label": "PERCENT"
      },
      {
        "text": "78.12%",
        "label": "PERCENT"
      },
      {
        "text": "67.99-84.53%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "These findings demonstrate that WBE offers a robust and timely approach for",
    "entities": [
      {
        "text": "WBE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "predicting hospitalizations at fine geographic scales. This modeling framework",
    "entities": []
  },
  {
    "text": "can be adapted to other infectious diseases to enhance surveillance and response",
    "entities": []
  },
  {
    "text": "Surveillance of coronaviruses in wild aquatic birds in Hong Kong: expanded",
    "entities": [
      {
        "text": "Hong Kong",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "genetic diversity and discovery of novel subgenus in the Deltacoronavirus.",
    "entities": []
  },
  {
    "text": "(1)School of Public Health, LKS Faculty of Medicine, The University of Hong",
    "entities": [
      {
        "text": "1)School of Public Health",
        "label": "ORG"
      },
      {
        "text": "The University of Hong\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Kong, G/F, Patrick Manson Building (North Wing), 7 Sassoon Road, Pokfulam, Hong",
    "entities": [
      {
        "text": "G/F",
        "label": "ORG"
      },
      {
        "text": "Patrick Manson Building",
        "label": "PERSON"
      },
      {
        "text": "North Wing",
        "label": "GPE"
      },
      {
        "text": "Sassoon Road",
        "label": "LOC"
      },
      {
        "text": "Pokfulam",
        "label": "GPE"
      },
      {
        "text": "Hong\n",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Agriculture, Fisheries and Conservation Department, Government of the Hong",
    "entities": [
      {
        "text": "Fisheries and Conservation Department, Government of the Hong\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Kong Special Administrative Region, 5/F, Cheung Sha Wan Government Offices, 303",
    "entities": [
      {
        "text": "Kong Special Administrative Region",
        "label": "ORG"
      },
      {
        "text": "5",
        "label": "CARDINAL"
      },
      {
        "text": "Cheung Sha Wan Government Offices",
        "label": "ORG"
      },
      {
        "text": "303",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(3)Centre for Immunology and Infection, Unit 1111-1113, 11/F, Building 17W, 17",
    "entities": [
      {
        "text": "3)Centre",
        "label": "CARDINAL"
      },
      {
        "text": "1111-1113",
        "label": "DATE"
      },
      {
        "text": "11",
        "label": "CARDINAL"
      },
      {
        "text": "17",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Science Park West Avenue, Hong Kong Science and Technology Park, Shatin, New",
    "entities": [
      {
        "text": "Hong Kong Science and Technology Park",
        "label": "GPE"
      },
      {
        "text": "Shatin",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State",
    "entities": [
      {
        "text": "Institute of Physico-Chemical Biology",
        "label": "ORG"
      },
      {
        "text": "Lomonosov Moscow State",
        "label": "FAC"
      }
    ]
  },
  {
    "text": "University, Building A, Leninskie Gory, Gagarinsky District, Moscow 119899,",
    "entities": [
      {
        "text": "Leninskie Gory",
        "label": "PERSON"
      },
      {
        "text": "Gagarinsky District",
        "label": "GPE"
      },
      {
        "text": "Moscow",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Medical Microbiology, Leiden University Center of Infectious",
    "entities": [
      {
        "text": "Medical Microbiology",
        "label": "ORG"
      },
      {
        "text": "Leiden University Center of Infectious\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Diseases, Leiden University Medical Center, Albinusdreef 2, P.O. Box 9600, E4-P,",
    "entities": [
      {
        "text": "Leiden University Medical Center",
        "label": "ORG"
      },
      {
        "text": "P.O. Box 9600",
        "label": "ORG"
      },
      {
        "text": "E4-P",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "Leiden 2300 RC, South Holland, The Netherlands.",
    "entities": [
      {
        "text": "Leiden 2300 RC",
        "label": "ORG"
      },
      {
        "text": "South Holland",
        "label": "GPE"
      },
      {
        "text": "The Netherlands",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)HKU-Pasteur Research Pole, School of Public Health, LKS Faculty of Medicine,",
    "entities": [
      {
        "text": "6)HKU-Pasteur Research Pole, School of Public Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "The University of Hong Kong, 7/F, Hong Kong Jockey Club Building for",
    "entities": [
      {
        "text": "The University of Hong Kong",
        "label": "ORG"
      },
      {
        "text": "Hong Kong",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Interdisciplinary Research, 5 Sassoon Road, Pokfulam, Hong Kong SAR, China.",
    "entities": [
      {
        "text": "Interdisciplinary Research",
        "label": "ORG"
      },
      {
        "text": "5",
        "label": "CARDINAL"
      },
      {
        "text": "Sassoon Road",
        "label": "LOC"
      },
      {
        "text": "Pokfulam",
        "label": "GPE"
      },
      {
        "text": "Hong Kong SAR",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Migratory birds may carry emerging viruses over long distances. Regular",
    "entities": [
      {
        "text": "Migratory",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "surveillance and metagenomic analysis were employed to explore the diversity of",
    "entities": []
  },
  {
    "text": "avian coronaviruses at Hong Kong's Mai Po Wetland. We tested a total of 3239",
    "entities": [
      {
        "text": "avian",
        "label": "NORP"
      },
      {
        "text": "Hong Kong's",
        "label": "GPE"
      },
      {
        "text": "Mai Po Wetland",
        "label": "FAC"
      },
      {
        "text": "3239",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "samples collected from 2018 to 2024, among which the prevalence rate of viruses",
    "entities": [
      {
        "text": "2018 to 2024",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "of the genus Gammacoronavirus (64.4%) was higher than that of Deltacoronavirus",
    "entities": [
      {
        "text": "Gammacoronavirus",
        "label": "PERSON"
      },
      {
        "text": "64.4%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "(35.6%). The host species were identified for 79.8% of the coronavirus-positive",
    "entities": [
      {
        "text": "35.6%",
        "label": "PERCENT"
      },
      {
        "text": "79.8%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "samples. Two deltacoronaviruses with full-genome sequences and one nearly",
    "entities": [
      {
        "text": "Two",
        "label": "CARDINAL"
      },
      {
        "text": "one",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "complete gammacoronavirus genome were identified in faecal samples of three bird",
    "entities": [
      {
        "text": "three",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "species. We also predicted putative transcriptional regulatory sequences and",
    "entities": []
  },
  {
    "text": "3CLpro and PLpro cleavage sites for these viruses. Results from our phylogenetic",
    "entities": [
      {
        "text": "3CLpro",
        "label": "CARDINAL"
      },
      {
        "text": "PLpro",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "analysis and pairwise amino acid identity comparisons, using the International",
    "entities": []
  },
  {
    "text": "Committee on Taxonomy of Viruses classification criteria based on the DEmARC",
    "entities": []
  },
  {
    "text": "framework, indicate that black-faced spoonbill coronavirus (BSCoV, strain",
    "entities": []
  },
  {
    "text": "MP22-1474) prototypes a new subgenus. Great cormorant coronavirus (GCCoV, strain",
    "entities": [
      {
        "text": "1474",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "MP18-1070) and falcated duck coronavirus (FDCoV, strain MP22-196) belong to two",
    "entities": [
      {
        "text": "1070",
        "label": "DATE"
      },
      {
        "text": "two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "previously known species while diverging most profoundly from known viruses of",
    "entities": []
  },
  {
    "text": "these species. Two recombination events may have contributed to the evolution of",
    "entities": [
      {
        "text": "Two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "FDCoV MP22-196 in genome regions from ORF1b to the S gene and from the M gene to",
    "entities": [
      {
        "text": "FDCoV MP22-196",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "the N gene. The cophylogenetic analysis between avian hosts and coronaviruses",
    "entities": [
      {
        "text": "N",
        "label": "GPE"
      },
      {
        "text": "avian",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "provides evidence for a strong linkage between viruses of the genus",
    "entities": []
  },
  {
    "text": "Gammacoronavirus and the birds of order Anseriformes. This study highlights the",
    "entities": [
      {
        "text": "Gammacoronavirus",
        "label": "PERSON"
      },
      {
        "text": "Anseriformes",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "importance of ongoing surveillance for coronaviruses in wild migratory birds.",
    "entities": []
  },
  {
    "text": "\u00a9 The Author(s) 2025. Published by Oxford University Press.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Oxford University Press",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Comparative transcriptome profiling of the lumbosacral dorsal root ganglia",
    "entities": [
      {
        "text": "lumbosacral",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "reveals sexually dimorphic gene expression in a murine model of",
    "entities": []
  },
  {
    "text": "coronavirus-induced neurodegeneration.",
    "entities": []
  },
  {
    "text": "Foley TC(1), Yesupatham SK(1), Miller-Dawson J(1), Malykhina AP(1).",
    "entities": [
      {
        "text": "Foley",
        "label": "PERSON"
      },
      {
        "text": "Yesupatham SK(1",
        "label": "PERSON"
      },
      {
        "text": "Miller-Dawson",
        "label": "ORG"
      },
      {
        "text": "Malykhina AP(1",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(1)Division of Urology, Department of Surgery, University of Colorado Anschutz",
    "entities": [
      {
        "text": "Urology, Department of Surgery, University of Colorado",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "INTRODUCTION: Neuroinflammation of the central nervous system (CNS) triggers",
    "entities": [
      {
        "text": "CNS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "long-lasting neurodegenerative changes associated with the development of",
    "entities": []
  },
  {
    "text": "neurogenic dysfunction in the pelvic organs. We previously described the",
    "entities": []
  },
  {
    "text": "symptoms of voiding dysfunction in a mouse model of multiple sclerosis (MS)",
    "entities": []
  },
  {
    "text": "induced by a coronaviral infection with mouse hepatitis virus (MHV). The aim of",
    "entities": [
      {
        "text": "MHV",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "the current study was to identify immune, inflammatory and neuronal changes in",
    "entities": []
  },
  {
    "text": "the lumbosacral (L6-S2) dorsal root ganglia (DRG) innervating the lower urinary",
    "entities": [
      {
        "text": "lumbosacral",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "tract (LUT) after severe neurodegeneration in the CNS.",
    "entities": [
      {
        "text": "CNS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "METHODS: Adult C57BL/6 male (N=18) and female (N=18) mice received either an",
    "entities": [
      {
        "text": "Adult",
        "label": "PERSON"
      },
      {
        "text": "N=18",
        "label": "ORG"
      },
      {
        "text": "N=18",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "intracranial injection of MHV (coronavirus-induced encephalomyelitis, CIE",
    "entities": [
      {
        "text": "MHV",
        "label": "ORG"
      },
      {
        "text": "CIE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "group), or sterile saline (control group). Dorsal root ganglia were collected",
    "entities": []
  },
  {
    "text": "from mice of both sexes at 1 and 4 weeks, followed by isolation of total RNA and",
    "entities": [
      {
        "text": "1 and 4 weeks",
        "label": "DATE"
      },
      {
        "text": "RNA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "bulk RNA sequencing.",
    "entities": [
      {
        "text": "RNA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "RESULTS: Transcriptome analysis of LS DRG identified a sex dependent expression",
    "entities": []
  },
  {
    "text": "of the genes at baseline with females having an increased expression of the",
    "entities": []
  },
  {
    "text": "immune system and extracellular matrix (ECM) related differentially expressed",
    "entities": [
      {
        "text": "ECM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "genes (DEGs) whereas males showed an upregulation of the genes belonging to",
    "entities": []
  },
  {
    "text": "protein synthesis, folding, and post-translational phosphorylation. Acute",
    "entities": []
  },
  {
    "text": "involving the families of interferons (Ifna2, Ifng, Ifnl1), interleukins (Il1a,",
    "entities": []
  },
  {
    "text": "Il1b, Il6), toll-like receptors (Tlr9, Tlr7), and guanylate-binding proteins",
    "entities": []
  },
  {
    "text": "(GTPases, Gbp) in both, CIE males and females. However, at a later stage of",
    "entities": [
      {
        "text": "CIE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "neurodegeneration (4 wks post-infection), the number of upregulated DEGs was",
    "entities": [
      {
        "text": "4",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "down 6-fold in CIE males, whereas in CIE females the downregulated pathways were",
    "entities": [
      {
        "text": "6-fold",
        "label": "CARDINAL"
      },
      {
        "text": "CIE",
        "label": "ORG"
      },
      {
        "text": "CIE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "predominant, and mostly included genes encoding motor proteins (Myh7, Myl2,",
    "entities": [
      {
        "text": "Myh7",
        "label": "PERSON"
      },
      {
        "text": "Myl2",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Myl3, Tnnt1, TnnI1, Dnah5). Among the pathways upregulated in males but",
    "entities": []
  },
  {
    "text": "downregulated in females at both time points were phagosome formation pathway,",
    "entities": []
  },
  {
    "text": "neutrophil extracellular trap signaling, and hepatic fibrosis pathway.",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: This study confirmed a differential expression of immune,",
    "entities": []
  },
  {
    "text": "inflammatory, and neural DEGs in sensory ganglia of male and female mice",
    "entities": []
  },
  {
    "text": "undergoing CNS neurodegeneration and neuroinflammation. The obtained results",
    "entities": [
      {
        "text": "CNS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "suggest a functional role of sex-dependent sensory interoception in the",
    "entities": []
  },
  {
    "text": "development of neurogenic LUTS in a coronavirus-induced murine model of MS.",
    "entities": [
      {
        "text": "MS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "AJCEU Copyright \u00a9 2025.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "35. Pediatr Discov. 2025 May 19;3(2):e70001. doi: 10.1002/pdi3.70001. eCollection",
    "entities": [
      {
        "text": "35",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "May 19;3(2):e70001",
        "label": "DATE"
      },
      {
        "text": "10.1002",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Risk Factors and Clinical Features of Deterioration in 739 COVID-19 Affected",
    "entities": [
      {
        "text": "739",
        "label": "CARDINAL"
      },
      {
        "text": "COVID-19 Affected",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Children Aged Under 14 Years in Zhuhai, China: A Multicenter, Retrospective",
    "entities": [
      {
        "text": "Children Aged",
        "label": "PERSON"
      },
      {
        "text": "14 Years",
        "label": "DATE"
      },
      {
        "text": "Zhuhai",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      },
      {
        "text": "Multicenter",
        "label": "PERSON"
      },
      {
        "text": "Retrospective",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Department of Pediatric Rheumatology and Immunology Zhuhai Center for",
    "entities": [
      {
        "text": "Pediatric Rheumatology and Immunology Zhuhai Center",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Maternal and Child Health Care Zhuhai Guangdong China.",
    "entities": [
      {
        "text": "Guangdong",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Pediatrics Zhuhai People's Hospital Zhuhai Guangdong China.",
    "entities": [
      {
        "text": "Pediatrics Zhuhai People's Hospital",
        "label": "ORG"
      },
      {
        "text": "Zhuhai",
        "label": "GPE"
      },
      {
        "text": "Guangdong",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Pediatrics Xiangzhou District People's Hospital Zhuhai",
    "entities": [
      {
        "text": "Zhuhai",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Pediatrics Zhuhai Fifth People's Hospital Zhuhai Guangdong",
    "entities": [
      {
        "text": "Pediatrics Zhuhai Fifth People's Hospital",
        "label": "ORG"
      },
      {
        "text": "Zhuhai",
        "label": "GPE"
      },
      {
        "text": "Guangdong",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Pediatrics The Fifth Affiliated Hospital of Zunyi Medical",
    "entities": [
      {
        "text": "Pediatrics The Fifth Affiliated Hospital of Zunyi Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "To retrospectively analyze the clinical characteristics of children with severe",
    "entities": []
  },
  {
    "text": "acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, this study",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "involved 739 children with SARS-CoV-2 infection who were admitted to multiple",
    "entities": [
      {
        "text": "739",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "medical institutions in Zhuhai City from December 15, 2022 to January 24, 2023.",
    "entities": [
      {
        "text": "Zhuhai City",
        "label": "GPE"
      },
      {
        "text": "December 15, 2022 to January 24, 2023",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Epidemiological and clinical data were collected and analyzed using statistical",
    "entities": []
  },
  {
    "text": "methods to understand the disease characteristics. The onset and progression of",
    "entities": []
  },
  {
    "text": "SARS-CoV-2 infection in children were significantly associated with age",
    "entities": []
  },
  {
    "text": "distribution, basic illness, vaccination status, exposure history, and family",
    "entities": []
  },
  {
    "text": "clustering. The most common clinical symptoms were fever (91.7%) and cough",
    "entities": [
      {
        "text": "91.7%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "(81.6%). Laboratory findings indicated elevated neutrophil count,",
    "entities": [
      {
        "text": "81.6%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, prothrombin time,",
    "entities": []
  },
  {
    "text": "and procalcitonin, creatine kinase, D-dimer, and IL-6 levels, along with",
    "entities": [
      {
        "text": "creatine kinase",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "decreased lymphocyte count, platelet count, and lymphocyte-to-monocyte ratio.",
    "entities": []
  },
  {
    "text": "Lung computed tomography (CT) showed imaging changes strongly linked to severe",
    "entities": [
      {
        "text": "Lung",
        "label": "PERSON"
      },
      {
        "text": "CT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "infection. After receiving anti-inflammatory, symptomatic, supportive, and",
    "entities": []
  },
  {
    "text": "antipathogen therapies, 74% of the children displayed clinical symptomatic",
    "entities": [
      {
        "text": "74%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "relief, 26% of the children were cured and discharged, and there were no",
    "entities": [
      {
        "text": "26%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "fatalities. In Zhuhai, children infected with SARS-CoV-2 commonly exhibit",
    "entities": [
      {
        "text": "Zhuhai",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "family-based transmission, with fever and cough as the predominant symptoms.",
    "entities": []
  },
  {
    "text": "Factors, such as young age, basic illness, specific laboratory markers, and",
    "entities": []
  },
  {
    "text": "patchy exudative changes on lung CT scans, served as critical indicators of",
    "entities": [
      {
        "text": "CT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "severe infection. Early detection and monitoring of these factors, along with",
    "entities": []
  },
  {
    "text": "timely vaccination against novel coronavirus, can mitigate disease severity and",
    "entities": []
  },
  {
    "text": "\u00a9 2025 The Author(s). Pediatric Discovery published by John Wiley & Sons",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Discovery",
        "label": "PRODUCT"
      },
      {
        "text": "John Wiley & Sons",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Australia, Ltd on behalf of Children's Hospital of Chongqing Medical University.",
    "entities": [
      {
        "text": "Australia",
        "label": "GPE"
      },
      {
        "text": "Children's Hospital of Chongqing Medical University",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: The authors declare no conflicts of interest.",
    "entities": []
  },
  {
    "text": "36. Aust J Psychol. 2025 Jun 29;77(1):2519037. doi:",
    "entities": [
      {
        "text": "36",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "doi",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "COVID-19 Unmasked: trajectories, risk and protective factors for mental health",
    "entities": [
      {
        "text": "COVID-19 Unmasked",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "outcomes in young Australian children during the first year of the COVID-19",
    "entities": [
      {
        "text": "Australian",
        "label": "NORP"
      },
      {
        "text": "the first year",
        "label": "DATE"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Vasileva M(1), Alisic E(2), Cobham VE(3), Gash T(4), Hoeboer CM(5)(6)(7), Hoehn",
    "entities": [
      {
        "text": "Vasileva",
        "label": "GPE"
      },
      {
        "text": "Cobham VE(3",
        "label": "PERSON"
      },
      {
        "text": "Hoeboer",
        "label": "GPE"
      },
      {
        "text": "Hoehn",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(1)Department of Child and Adolescent Psychiatry, Psychosomatics and",
    "entities": [
      {
        "text": "Child and Adolescent Psychiatry",
        "label": "ORG"
      },
      {
        "text": "Psychosomatics",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Psychotherapy, Carl Von Ossietzky University Oldenburg, Oldenburg, Germany.",
    "entities": [
      {
        "text": "Psychotherapy",
        "label": "GPE"
      },
      {
        "text": "Carl Von Ossietzky",
        "label": "PERSON"
      },
      {
        "text": "Oldenburg",
        "label": "GPE"
      },
      {
        "text": "Oldenburg",
        "label": "GPE"
      },
      {
        "text": "Germany",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)School of Population and Global Health, University of Melbourne, Melbourne,",
    "entities": [
      {
        "text": "Population and Global Health",
        "label": "ORG"
      },
      {
        "text": "University of Melbourne",
        "label": "ORG"
      },
      {
        "text": "Melbourne",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)School of Psychology, The University of Queensland, Queensland, Australia.",
    "entities": [
      {
        "text": "The University of Queensland",
        "label": "ORG"
      },
      {
        "text": "Queensland",
        "label": "GPE"
      },
      {
        "text": "Australia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Queensland Centre for Perinatal and Infant Mental Health, Children's Health",
    "entities": [
      {
        "text": "Centre for Perinatal",
        "label": "ORG"
      },
      {
        "text": "Infant Mental Health, Children's Health\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Queensland Hospital Health Service, Brisbane, Australia.",
    "entities": [
      {
        "text": "Queensland Hospital Health Service",
        "label": "ORG"
      },
      {
        "text": "Brisbane",
        "label": "GPE"
      },
      {
        "text": "Australia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Psychiatry, Amsterdam UMC, Amsterdam, the Netherlands.",
    "entities": [
      {
        "text": "5)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Psychiatry",
        "label": "ORG"
      },
      {
        "text": "Amsterdam UMC",
        "label": "GPE"
      },
      {
        "text": "Amsterdam",
        "label": "GPE"
      },
      {
        "text": "Netherlands",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Amsterdam Public Health, Mental Health, Amsterdam, the Netherlands.",
    "entities": [
      {
        "text": "6)Amsterdam Public Health, Mental Health",
        "label": "ORG"
      },
      {
        "text": "Amsterdam",
        "label": "GPE"
      },
      {
        "text": "Netherlands",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Department of Child Psychiatry and Psychology, Amsterdam UMC, Amsterdam",
    "entities": [
      {
        "text": "Child Psychiatry and Psychology",
        "label": "ORG"
      },
      {
        "text": "Amsterdam UMC",
        "label": "GPE"
      },
      {
        "text": "Amsterdam",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Reproduction & Development research institute, Amsterdam, the Netherlands.",
    "entities": [
      {
        "text": "Reproduction & Development",
        "label": "ORG"
      },
      {
        "text": "Amsterdam",
        "label": "GPE"
      },
      {
        "text": "Netherlands",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(8)Centre for Health Research and School of Psychology and Wellbeing, University",
    "entities": [
      {
        "text": "Health Research and School of Psychology and Wellbeing",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of Southern Queensland, Springfield, Australia.",
    "entities": [
      {
        "text": "Southern Queensland",
        "label": "GPE"
      },
      {
        "text": "Springfield",
        "label": "GPE"
      },
      {
        "text": "Australia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(9)Manna Institute, University of Southern Queensland, Toowoomba, Australia.",
    "entities": [
      {
        "text": "9)Manna Institute, University of Southern Queensland",
        "label": "ORG"
      },
      {
        "text": "Toowoomba",
        "label": "GPE"
      },
      {
        "text": "Australia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(10)Griffith Centre for Mental Health, School of Applied Psychology, Griffith",
    "entities": [
      {
        "text": "10)Griffith Centre for Mental Health, School of Applied Psychology",
        "label": "ORG"
      },
      {
        "text": "Griffith",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "University, Brisbane, Australia.",
    "entities": [
      {
        "text": "University",
        "label": "ORG"
      },
      {
        "text": "Brisbane",
        "label": "GPE"
      },
      {
        "text": "Australia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(11)Child Health Research Centre, The University of Queensland, Brisbane,",
    "entities": [
      {
        "text": "11)Child Health Research Centre",
        "label": "ORG"
      },
      {
        "text": "The University of Queensland",
        "label": "ORG"
      },
      {
        "text": "Brisbane",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "OBJECTIVE: Emerging evidence suggests a negative impact of COVID-19 on",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "children's mental health. The aims of this study were to examine trajectories of",
    "entities": []
  },
  {
    "text": "mental health in children younger than 6 years as well as risk and protective",
    "entities": [
      {
        "text": "6 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "factors during the first year of the pandemic.",
    "entities": [
      {
        "text": "the first year",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "METHOD: In a prospective, longitudinal online study, data were collected on N =",
    "entities": [
      {
        "text": "METHOD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "837 children aged 1 to 5 years in Australia between May and July 2020 and after",
    "entities": [
      {
        "text": "837",
        "label": "CARDINAL"
      },
      {
        "text": "aged 1 to 5 years",
        "label": "DATE"
      },
      {
        "text": "Australia",
        "label": "GPE"
      },
      {
        "text": "May and July 2020",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "3, 6 and 12 months, with n = 257 participating at all 4 timepoints. Individual",
    "entities": [
      {
        "text": "3",
        "label": "CARDINAL"
      },
      {
        "text": "6",
        "label": "DATE"
      },
      {
        "text": "12 months",
        "label": "DATE"
      },
      {
        "text": "257",
        "label": "CARDINAL"
      },
      {
        "text": "4",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "trajectories ofanxiety, anger/irritability, depressive symptoms and sleep",
    "entities": []
  },
  {
    "text": "disturbance were analysed using latent growth mixture modelling.",
    "entities": []
  },
  {
    "text": "RESULTS: The results showed that 1 in 4 children experienced moderate to severe",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      },
      {
        "text": "4",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "symptoms in each problem domain. The overall means for depressive symptoms,",
    "entities": []
  },
  {
    "text": "anger/irritability, and sleep disturbance decreased while anxiety increased over",
    "entities": []
  },
  {
    "text": "time. For most outcomes, two individual trajectories were identified:",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "moderate/high-decreasing (26-29%) andlow-increasing. Important predictors were",
    "entities": [
      {
        "text": "26-29%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "negative COVID-19 related impact on daily life, caregiver distress, lower child",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "positive affect and self-regulation.",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: The current results highlight that the pandemic indirectly affected",
    "entities": []
  },
  {
    "text": "young children's mental health, especially in the presence of risk factors such",
    "entities": []
  },
  {
    "text": "as caregiver distress and poor child self-regulation skills.",
    "entities": []
  },
  {
    "text": "Plain Language Summary: What is already known about this topic: Previous studies",
    "entities": []
  },
  {
    "text": "with children and adolescents have indicated an increase in mental health",
    "entities": []
  },
  {
    "text": "difficulties, especially anxiety, in the first year of the pandemic.There are",
    "entities": [
      {
        "text": "the first year",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "few longitudinal studies mostly using group means in within-pandemic data of",
    "entities": []
  },
  {
    "text": "mental health difficulties in young children.It is likely that children follow",
    "entities": []
  },
  {
    "text": "different trajectories depending on individual coping capacities, experiences,",
    "entities": []
  },
  {
    "text": "and relationships with their parents and within their families. What this topic",
    "entities": []
  },
  {
    "text": "adds: This is the first study focusing on individual trajectories of mental",
    "entities": [
      {
        "text": "first",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "health in Australian children younger than 6 years during the first year of the",
    "entities": [
      {
        "text": "Australian",
        "label": "NORP"
      },
      {
        "text": "6 years",
        "label": "DATE"
      },
      {
        "text": "the first year",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "pandemic.This study indicated that 1 in 4 children younger than 6 years",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      },
      {
        "text": "4",
        "label": "CARDINAL"
      },
      {
        "text": "6 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "experienced moderate to severe mental health symptoms with increasing overall",
    "entities": []
  },
  {
    "text": "mean scores for depressive symptoms, anger/irritability, and sleep disturbance",
    "entities": []
  },
  {
    "text": "and decreasing anxiety over time.Negative COVID-19 impact on daily life,",
    "entities": []
  },
  {
    "text": "caregiver distress and child difficulties in self-regulation were significant",
    "entities": []
  },
  {
    "text": "predictors of moderate to high trajectories of child mental health difficulties.",
    "entities": []
  },
  {
    "text": "\u00a9 2025 The Author(s). Published by Informa UK Limited, trading as Taylor &",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Informa UK Limited",
        "label": "ORG"
      },
      {
        "text": "Taylor &\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Post Hoc Analysis of Anxiety and Behavioral Changes in Japanese Patients With",
    "entities": [
      {
        "text": "Japanese",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Inflammatory Bowel Disease due to the COVID-19 Pandemic: Relationship Between",
    "entities": []
  },
  {
    "text": "Municipal Population at the Place of Residence and Anxiety.",
    "entities": [
      {
        "text": "the Place of Residence and Anxiety",
        "label": "FAC"
      }
    ]
  },
  {
    "text": "(1)Department of Gastroenterology and Hepatology Sapporo Medical University",
    "entities": [
      {
        "text": "Sapporo Medical University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "School of Medicine Sapporo Japan.",
    "entities": [
      {
        "text": "School of Medicine Sapporo Japan",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Center for Translational Research, The Institute of Medical Science, The",
    "entities": [
      {
        "text": "2)Center",
        "label": "CARDINAL"
      },
      {
        "text": "Translational Research",
        "label": "ORG"
      },
      {
        "text": "The Institute of Medical Science",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University of Tokyo Minato-ku Japan.",
    "entities": [
      {
        "text": "University of Tokyo",
        "label": "ORG"
      },
      {
        "text": "Japan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Division of Gastroenterology, Department of Internal Medicine Iwate Medical",
    "entities": [
      {
        "text": "Gastroenterology, Department of Internal Medicine Iwate Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University Morioka Japan.",
    "entities": [
      {
        "text": "Japan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Gastroenterology and Hepatology Kyorin University School of",
    "entities": []
  },
  {
    "text": "(5)Department of Gastroenterology and Hepatology Osaka University Graduate",
    "entities": []
  },
  {
    "text": "School of Medicine Suita Japan.",
    "entities": [
      {
        "text": "School of Medicine Suita Japan",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(6)Division of Gastroenterology and Hepatology, Department of Internal Medicine",
    "entities": [
      {
        "text": "Gastroenterology and Hepatology, Department of Internal Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(7)Department of Gastroenterology and Advanced Endoscopy Fujita Health",
    "entities": [
      {
        "text": "Gastroenterology",
        "label": "ORG"
      },
      {
        "text": "Advanced",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University School of Medicine Toyoake Japan.",
    "entities": [
      {
        "text": "University School of Medicine Toyoake",
        "label": "ORG"
      },
      {
        "text": "Japan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(8)Department of Internal Medicine II Shimane University Faculty of Medicine",
    "entities": [
      {
        "text": "Internal Medicine II Shimane University Faculty of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(9)Department of Gastroenterology, Faculty of Medicine Fukuoka University",
    "entities": [
      {
        "text": "Gastroenterology, Faculty of Medicine Fukuoka University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(10)Department of Gastroenterology IBD Center, Tsujinaka Hospital Kashiwanoha",
    "entities": [
      {
        "text": "10)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Gastroenterology IBD Center",
        "label": "ORG"
      },
      {
        "text": "Tsujinaka Hospital",
        "label": "ORG"
      },
      {
        "text": "Kashiwanoha",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(11)First Department of Medicine Hamamatsu University School of Medicine",
    "entities": [
      {
        "text": "11)First Department of Medicine Hamamatsu University School of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(12)Center for Gastroenterology, Urasoe General Hospital Urasoe Japan.",
    "entities": [
      {
        "text": "12)Center",
        "label": "CARDINAL"
      },
      {
        "text": "Gastroenterology",
        "label": "ORG"
      },
      {
        "text": "Urasoe General Hospital",
        "label": "ORG"
      },
      {
        "text": "Japan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(13)Department of General Medicine Asahikawa Medical University Hospital",
    "entities": [
      {
        "text": "13)Department",
        "label": "CARDINAL"
      },
      {
        "text": "General Medicine Asahikawa Medical University Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(14)Third Department of Internal Medicine Kansai Medical University Hirakata",
    "entities": [
      {
        "text": "14)Third Department of Internal Medicine Kansai Medical University Hirakata",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(15)Department of Gastroenterology Hyogo Medical University Nishinomiya Japan.",
    "entities": [
      {
        "text": "15)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Gastroenterology Hyogo Medical University Nishinomiya Japan",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(16)Department of Internal Medicine for Inflammatory Bowel Disease Toyama",
    "entities": [
      {
        "text": "16)Department",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "University Hospital Toyama Japan.",
    "entities": [
      {
        "text": "University Hospital",
        "label": "ORG"
      },
      {
        "text": "Toyama Japan",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(17)Division of Gastroenterology Tohoku University Hospital Sendai Japan.",
    "entities": [
      {
        "text": "Gastroenterology Tohoku University Hospital",
        "label": "ORG"
      },
      {
        "text": "Japan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(18)Department of Gastroenterology Sameshima Hospital Kagoshima Japan.",
    "entities": [
      {
        "text": "18)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Gastroenterology Sameshima Hospital Kagoshima Japan",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(20)Division of Gastroenterology Matsuyama Red Cross Hospital Matsuyama Japan.",
    "entities": [
      {
        "text": "20)Division",
        "label": "CARDINAL"
      },
      {
        "text": "Matsuyama Japan",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(21)Department of Gastroenterology Kagawa Prefectural Central Hospital Takamatsu",
    "entities": [
      {
        "text": "21)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Gastroenterology Kagawa Prefectural Central Hospital Takamatsu",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(22)Inflammatory Bowel Disease Center, Sapporo Higashi Tokushukai Hospital",
    "entities": [
      {
        "text": "22)Inflammatory",
        "label": "CARDINAL"
      },
      {
        "text": "Bowel Disease Center",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(23)Department of Gastroenterology, Hematology and Clinical Immunology Hirosaki",
    "entities": [
      {
        "text": "23)Department",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "University Graduate School of Medicine Hirosaki Japan.",
    "entities": [
      {
        "text": "University Graduate School of Medicine Hirosaki Japan",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(24)Division of Gastroenterology and Hepatology, Department of Internal Medicine",
    "entities": [
      {
        "text": "Department of Internal Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "The Jikei University School of Medicine Minato-ku Japan.",
    "entities": [
      {
        "text": "The Jikei University School of Medicine Minato-ku",
        "label": "ORG"
      },
      {
        "text": "Japan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(25)Department of Gastroenterology Dokkyo Medical University Mibu Japan.",
    "entities": [
      {
        "text": "25)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Gastroenterology Dokkyo Medical University",
        "label": "ORG"
      },
      {
        "text": "Mibu Japan",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(26)Department of Gastroenterology Fukuoka University Chikushi Hospital",
    "entities": [
      {
        "text": "26)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Gastroenterology Fukuoka University Chikushi Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(28)Division of Gastroenterology, Graduate School of Medical and Dental Sciences",
    "entities": [
      {
        "text": "28)Division",
        "label": "CARDINAL"
      },
      {
        "text": "Graduate School of Medical",
        "label": "ORG"
      },
      {
        "text": "Dental Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(29)Department of Gastroenterology and Hepatology, Dentistry and Pharmaceutical",
    "entities": [
      {
        "text": "29)Department",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Sciences Okayama University Graduate School of Medicine Okayama Japan.",
    "entities": [
      {
        "text": "Sciences Okayama University Graduate School of Medicine Okayama Japan",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(30)Division of Gastroenterology, Department of Internal Medicine, Faculty of",
    "entities": [
      {
        "text": "Department of Internal Medicine, Faculty",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medicine Saga University Saga Japan.",
    "entities": [
      {
        "text": "Medicine Saga University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(31)Department of Internal Medicine National Defense Medical College Tokorozawa",
    "entities": [
      {
        "text": "31)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Internal Medicine National Defense Medical College",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(32)Division of Gastroenterology Tohoku Medical and Pharmaceutical University",
    "entities": [
      {
        "text": "32)Division",
        "label": "CARDINAL"
      },
      {
        "text": "Pharmaceutical University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(33)Department of Gastroenterology and Hepatology Nagoya University Graduate",
    "entities": [
      {
        "text": "33)Department",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "School of Medicine Nagoya Japan.",
    "entities": [
      {
        "text": "School of Medicine Nagoya",
        "label": "ORG"
      },
      {
        "text": "Japan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "AIMS: The Japan COVID-19 Survey and the Questionnaire for Inflammatory Bowel",
    "entities": [
      {
        "text": "The Japan COVID-19 Survey",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Disease (J-DESIRE) identified multiple factors associated with anxiety regarding",
    "entities": []
  },
  {
    "text": "the novel coronavirus disease 2019 (COVID-19). However, no regional differences",
    "entities": [
      {
        "text": "2019",
        "label": "DATE"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "in anxiety were observed. In this post hoc analysis of J-DESIRE, we investigated",
    "entities": [
      {
        "text": "J-DESIRE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "the relationship between the municipal population size at the place of residence",
    "entities": []
  },
  {
    "text": "(MPSPR) and anxiety among patients with IBD in Japan during the COVID-19",
    "entities": [
      {
        "text": "MPSPR",
        "label": "PERSON"
      },
      {
        "text": "Japan",
        "label": "GPE"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "METHODS AND RESULTS: We analyzed 2958 questionnaires collected from patients",
    "entities": [
      {
        "text": "2958",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "with IBD aged \u2265 16 years between March 2020 and June 2021. The primary endpoint",
    "entities": [
      {
        "text": "IBD",
        "label": "ORG"
      },
      {
        "text": "\u2265",
        "label": "GPE"
      },
      {
        "text": "16 years",
        "label": "DATE"
      },
      {
        "text": "March 2020 and June 2021",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "was the association between the visual analogue scale (VAS) scores of anxiety",
    "entities": []
  },
  {
    "text": "and MPSPR during the COVID-19 pandemic. The mean VAS score for anxiety was",
    "entities": [
      {
        "text": "MPSPR",
        "label": "PERSON"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "higher than the overall mean VAS score in municipalities with large and small",
    "entities": [
      {
        "text": "VAS",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "populations, while it was lower in municipalities with medium populations.",
    "entities": []
  },
  {
    "text": "Therefore, we categorized the population into three groups based on MPSPR:",
    "entities": [
      {
        "text": "three",
        "label": "CARDINAL"
      },
      {
        "text": "MPSPR",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "\u2264 150 000, 150 001-1 000 000, and \u2265 1 000 001. The three groups had different",
    "entities": [
      {
        "text": "150 000",
        "label": "CARDINAL"
      },
      {
        "text": "150",
        "label": "CARDINAL"
      },
      {
        "text": "\u2265",
        "label": "PERSON"
      },
      {
        "text": "1 000",
        "label": "CARDINAL"
      },
      {
        "text": "001",
        "label": "CARDINAL"
      },
      {
        "text": "three",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "background factors, contents of anxiety, and sources of information regarding",
    "entities": []
  },
  {
    "text": "therapeutic drugs. These differences may have led to differences in the degree",
    "entities": []
  },
  {
    "text": "and content of anxiety.",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: We investigated the association between anxiety in Japanese",
    "entities": [
      {
        "text": "Japanese",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "patients with IBD and MPSPR nationwide during the COVID-19 pandemic in Japan.",
    "entities": [
      {
        "text": "IBD",
        "label": "ORG"
      },
      {
        "text": "MPSPR",
        "label": "PERSON"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      },
      {
        "text": "Japan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "The results obtained in this analysis are useful not only in special situations",
    "entities": []
  },
  {
    "text": "such as the COVID-19 pandemic but also for considering regional differences in",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "\u00a9 2025 The Author(s). JGH Open published by Journal of Gastroenterology and",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Journal of Gastroenterology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Hepatology Foundation and John Wiley & Sons Australia, Ltd.",
    "entities": [
      {
        "text": "Hepatology Foundation",
        "label": "ORG"
      },
      {
        "text": "John Wiley & Sons Australia, Ltd.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Takayuki Matsumoto reports receiving personal",
    "entities": [
      {
        "text": "Takayuki Matsumoto",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "fees from Janssen, Tanabe\u2010Mitsubishi Pharmaceutical, EA Pharma, Takeda",
    "entities": [
      {
        "text": "Janssen",
        "label": "GPE"
      },
      {
        "text": "Tanabe\u2010Mitsubishi Pharmaceutical",
        "label": "ORG"
      },
      {
        "text": "Pharma",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Pharmaceutical, and scholarship grants from Nippon Kayaku, Tanabe\u2010Mitsubishi",
    "entities": [
      {
        "text": "Nippon Kayaku",
        "label": "GPE"
      },
      {
        "text": "Tanabe\u2010Mitsubishi",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Pharmaceutical. Minoru Matsuura reports receiving personal fees from AbbVie GK,",
    "entities": [
      {
        "text": "Minoru Matsuura",
        "label": "PERSON"
      },
      {
        "text": "AbbVie GK",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Janssen Pharmaceutical K.K., Takeda Pharmaceutical Co. Ltd., Pfizer Inc.,",
    "entities": [
      {
        "text": "Janssen Pharmaceutical K.K., Takeda Pharmaceutical Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "Pfizer Inc.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Mochida Pharmaceutical Co. Ltd., JIMRO Co. Ltd., Kissei Pharmaceutical Co. Ltd.,",
    "entities": [
      {
        "text": "Mochida Pharmaceutical Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "JIMRO Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "Kissei Pharmaceutical Co. Ltd.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Nippon Kayaku Co. Ltd., Kyorin Pharmaceutical Co. Ltd., Zeria Pharmaceutical Co.",
    "entities": [
      {
        "text": "Nippon Kayaku Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "Kyorin Pharmaceutical Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "Zeria Pharmaceutical Co.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Ltd., Viatris Inc., Sandoz K.K., and EA pharma Co. Ltd. Katsuyoshi Matsuoka",
    "entities": [
      {
        "text": "Viatris Inc.",
        "label": "ORG"
      },
      {
        "text": "Sandoz K.K.",
        "label": "ORG"
      },
      {
        "text": "EA pharma Co.",
        "label": "ORG"
      },
      {
        "text": "Katsuyoshi Matsuoka",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "reports receiving personal fees from Mitsubishi Tanabe Pharma, AbbVie, Takeda",
    "entities": [
      {
        "text": "Mitsubishi Tanabe Pharma",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Pharmaceutical Co. Ltd., Kyorin Pharmaceutical Co. Ltd., Kissei Pharmaceutical",
    "entities": [
      {
        "text": "Pharmaceutical Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "Kyorin Pharmaceutical Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "Kissei Pharmaceutical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Co. Ltd., Gilead Sciences Inc., Eli Lilly, Nippon Kayaku Co. Ltd., Celltrion",
    "entities": [
      {
        "text": "Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "Gilead Sciences Inc.",
        "label": "ORG"
      },
      {
        "text": "Eli Lilly",
        "label": "ORG"
      },
      {
        "text": "Nippon Kayaku Co. Ltd.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Healthcare, research grants from Janssen Pharmaceutical, and scholarship grants",
    "entities": [
      {
        "text": "Healthcare",
        "label": "ORG"
      },
      {
        "text": "Janssen Pharmaceutical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Nippon Kayaku Co. Ltd. Shunji Ishihara reports receiving personal fees from",
    "entities": [
      {
        "text": "Nippon Kayaku Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "Ishihara",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Takeda Pharmaceutical Co. Ltd. Mitsubishi Tanabe Pharma Corporation, Janssen",
    "entities": [
      {
        "text": "Takeda Pharmaceutical Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "Mitsubishi Tanabe Pharma Corporation",
        "label": "ORG"
      },
      {
        "text": "Janssen\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Pharmaceutical K.K., Nippon Kayaku Co. Ltd., Mochida Pharmaceutical Co., Zeria",
    "entities": [
      {
        "text": "K.K.",
        "label": "ORG"
      },
      {
        "text": "Nippon Kayaku Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "Mochida Pharmaceutical Co.",
        "label": "ORG"
      },
      {
        "text": "Zeria",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Pharmaceutical Co. Ltd., Otsuka Pharmaceutical Co. Ltd., JIMRO Co. Ltd., EA",
    "entities": [
      {
        "text": "Pharmaceutical Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "Otsuka Pharmaceutical Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "JIMRO Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "EA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Pharma Co. Ltd., AbbVie GK, KISSEI Pharmaceutical Co., KYORIN Pharmaceutical Co.",
    "entities": [
      {
        "text": "Pharma Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "AbbVie GK",
        "label": "PERSON"
      },
      {
        "text": "KISSEI Pharmaceutical Co.",
        "label": "ORG"
      },
      {
        "text": "KYORIN Pharmaceutical Co.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Ltd., Pfizer Japan Inc., and Miyarisan Pharmaceutical Co. Fumihito Hirai reports",
    "entities": [
      {
        "text": "Pfizer Japan Inc.",
        "label": "ORG"
      },
      {
        "text": "Miyarisan Pharmaceutical Co.",
        "label": "ORG"
      },
      {
        "text": "Fumihito Hirai",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "receiving personal fees from AbbVie GK, EA Pharma Co. Ltd., Janssen",
    "entities": [
      {
        "text": "AbbVie GK",
        "label": "PERSON"
      },
      {
        "text": "EA Pharma Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "Janssen",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Pharmaceutical K.K., Mochida Pharmaceutical Co. Ltd., Mitsubishi Tanabe Pharma",
    "entities": [
      {
        "text": "K.K.",
        "label": "ORG"
      },
      {
        "text": "Mochida Pharmaceutical Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "Mitsubishi Tanabe Pharma",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Co., Takeda Pharmaceutical Co. Ltd., research grants from Eli Lily Japan K.K.,",
    "entities": [
      {
        "text": "Takeda Pharmaceutical Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "Eli Lily Japan K.K.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Janssen Pharmaceutical K.K., AbbVie GK., and scholarship grants from AbbVie GK,",
    "entities": [
      {
        "text": "Janssen Pharmaceutical K.K.",
        "label": "ORG"
      },
      {
        "text": "AbbVie GK",
        "label": "PERSON"
      },
      {
        "text": "AbbVie GK",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "EA Pharma Co. Ltd., Otsuka Pharmaceutical Co. Ltd., Kyorin Pharmaceutical Co.",
    "entities": [
      {
        "text": "EA Pharma Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "Otsuka Pharmaceutical Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "Kyorin Pharmaceutical Co.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Ltd., Mochida Pharmaceutical Co. Ltd., Mitsubishi Tanabe Pharma Co. Ken Takeuchi",
    "entities": [
      {
        "text": "Mochida Pharmaceutical Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "Mitsubishi Tanabe Pharma Co.",
        "label": "ORG"
      },
      {
        "text": "Ken Takeuchi",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "reports receiving personal fees from Mochida, AbbVie, Janssen pharma, Pfizer,",
    "entities": [
      {
        "text": "Mochida",
        "label": "ORG"
      },
      {
        "text": "AbbVie",
        "label": "PERSON"
      },
      {
        "text": "Janssen",
        "label": "NORP"
      },
      {
        "text": "Pfizer",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "and EA Pharma, and research grants from AbbVie, Takeda, Eli Lilly, Celgene, Shin",
    "entities": [
      {
        "text": "EA Pharma",
        "label": "ORG"
      },
      {
        "text": "AbbVie",
        "label": "LAW"
      },
      {
        "text": "Takeda",
        "label": "PRODUCT"
      },
      {
        "text": "Eli Lilly",
        "label": "ORG"
      },
      {
        "text": "Celgene",
        "label": "PERSON"
      },
      {
        "text": "Shin",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Nippon Biomedical Laboratories, EA Pharma, Astra Zeneca, and Janssen pharma.",
    "entities": [
      {
        "text": "Nippon Biomedical Laboratories",
        "label": "ORG"
      },
      {
        "text": "Pharma",
        "label": "PERSON"
      },
      {
        "text": "Astra Zeneca",
        "label": "PERSON"
      },
      {
        "text": "Janssen",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Nobuhiro Ueno reports receiving grants from Pfizer Inc. Makoto Naganuma reports",
    "entities": [
      {
        "text": "Nobuhiro Ueno",
        "label": "PERSON"
      },
      {
        "text": "Pfizer Inc.",
        "label": "ORG"
      },
      {
        "text": "Makoto Naganuma",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "receiving research grant fees from Mitsubishi Tanabe Pharma Corporation, AbbVie",
    "entities": [
      {
        "text": "Mitsubishi Tanabe Pharma Corporation",
        "label": "ORG"
      },
      {
        "text": "AbbVie",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "GK, Kyorin Pharmaceutical Co. Ltd., Alfresa Pharma Corporation and lecture fees",
    "entities": [
      {
        "text": "GK",
        "label": "GPE"
      },
      {
        "text": "Kyorin Pharmaceutical Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "Alfresa Pharma Corporation",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "from Tanabe Pharma Corporation, AbbVie GK, Takeda Pharmaceutical Co. Ltd., JIMRO",
    "entities": [
      {
        "text": "Tanabe Pharma Corporation",
        "label": "ORG"
      },
      {
        "text": "AbbVie GK",
        "label": "PERSON"
      },
      {
        "text": "Takeda Pharmaceutical Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "JIMRO",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Co. Ltd., Janssen Pharmaceutical K.K., Gilead Sciences Inc. EA Pharma Co. Ltd.,",
    "entities": [
      {
        "text": "Janssen Pharmaceutical K.K.",
        "label": "ORG"
      },
      {
        "text": "Gilead Sciences Inc.",
        "label": "ORG"
      },
      {
        "text": "EA Pharma Co. Ltd.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and Mochida Pharmaceutical Co. Ltd. Kenji Watanabe reports receiving personal",
    "entities": [
      {
        "text": "Mochida Pharmaceutical Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "Kenji Watanabe",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "fees from, AbbVie Japan Co. Ltd., EA Pharma Co. Ltd., Pfizer Japan Inc., Takeda",
    "entities": [
      {
        "text": "AbbVie Japan Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "EA Pharma Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "Pfizer Japan Inc.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Pharmaceutical Co. Ltd., Mitsubishi Tanabe Pharma Corporation, Kyorin",
    "entities": [
      {
        "text": "Pharmaceutical Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "Mitsubishi Tanabe Pharma Corporation",
        "label": "ORG"
      },
      {
        "text": "Kyorin",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Pharmaceutical Co. Ltd., Mochida Pharmaceutical Co. Ltd., and Kissei",
    "entities": [
      {
        "text": "Pharmaceutical Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "Mochida Pharmaceutical Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "Kissei",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Pharmaceutical Co. Ltd., research grants from EA Pharma Co. Ltd., Takeda",
    "entities": [
      {
        "text": "Pharmaceutical Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "EA Pharma Co. Ltd.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Pharmaceutical Co. Ltd., and EP\u2010CRSU Co. Ltd., scholarship grants from AbbVie",
    "entities": [
      {
        "text": "Pharmaceutical Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "AbbVie",
        "label": "LAW"
      }
    ]
  },
  {
    "text": "Japan Co. Ltd., EA Pharma Co. Ltd., Mitsubishi Tanabe Pharma Corporation, JIMRO",
    "entities": [
      {
        "text": "Japan Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "EA Pharma Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "Mitsubishi Tanabe Pharma Corporation",
        "label": "ORG"
      },
      {
        "text": "JIMRO",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Co. Ltd., and Nippon Kayaku Co. Ltd., and endowed chair from AbbVie Japan Co.",
    "entities": [
      {
        "text": "Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "Nippon Kayaku Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "AbbVie Japan Co.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Ltd., EA Pharma Co. Ltd., Mitsubishi Tanabe Pharma Corporation, ZERIA",
    "entities": [
      {
        "text": "EA Pharma Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "Mitsubishi Tanabe Pharma Corporation",
        "label": "ORG"
      },
      {
        "text": "ZERIA",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Pharmaceutical Co. Ltd., JIMRO Co. Ltd., Otsuka Pharmaceutical Factory Inc.,",
    "entities": [
      {
        "text": "Pharmaceutical Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "JIMRO Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "Otsuka Pharmaceutical Factory Inc.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Asahi Kasei Medical Co. Ltd., and Mochida Pharmaceutical Co. Ltd. Satoshi Motoya",
    "entities": [
      {
        "text": "Asahi Kasei Medical Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "Mochida Pharmaceutical Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "Satoshi Motoya",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "reports receiving personal fees from AbbVie GK, Mitsubishi\u2010Tanabe Pharma",
    "entities": [
      {
        "text": "AbbVie GK",
        "label": "PRODUCT"
      },
      {
        "text": "Mitsubishi\u2010Tanabe Pharma",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Corporation, Mochida Pharma Corporation, Takeda Pharmaceutical Corporation, and",
    "entities": [
      {
        "text": "Mochida Pharma Corporation",
        "label": "ORG"
      },
      {
        "text": "Takeda Pharmaceutical Corporation",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Janssen Pharmaceutical K.K., and scholarship grants from AbbVie GK, Eli Lilly",
    "entities": [
      {
        "text": "Janssen Pharmaceutical K.K.",
        "label": "ORG"
      },
      {
        "text": "AbbVie GK",
        "label": "PERSON"
      },
      {
        "text": "Eli Lilly",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Japan K.K., and Janssen Pharmaceutical K.K. Atsuo Maemoto reports receiving",
    "entities": [
      {
        "text": "Japan",
        "label": "GPE"
      },
      {
        "text": "K.K.",
        "label": "ORG"
      },
      {
        "text": "Janssen Pharmaceutical K.K. Atsuo Maemoto",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "research grants from Gilead Sciences Inc., Janssen Pharmaceutical K.K., Eli",
    "entities": [
      {
        "text": "Gilead Sciences Inc.",
        "label": "ORG"
      },
      {
        "text": "Janssen Pharmaceutical K.K.",
        "label": "ORG"
      },
      {
        "text": "Eli",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Saruta reports receiving personal fees from AbbVie GK, Janssen Pharmaceutical",
    "entities": [
      {
        "text": "AbbVie GK",
        "label": "PERSON"
      },
      {
        "text": "Janssen Pharmaceutical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "K.K., Mitsubishi Tanabe Pharma Co. Ltd., Takeda Pharmaceutical Co. Ltd., EA",
    "entities": [
      {
        "text": "K.K.",
        "label": "ORG"
      },
      {
        "text": "Mitsubishi Tanabe Pharma Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "Takeda Pharmaceutical Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "EA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Pharma Co. Ltd., Kissei Pharmaceutical Co. Ltd., Mochida Pharmaceutical Co.",
    "entities": [
      {
        "text": "Pharma Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "Kissei Pharmaceutical Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "Mochida Pharmaceutical Co.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Ltd., Viatris Pharmaceutical Co. Ltd., Nobelpharma Co. Ltd., and Gilead Sciences",
    "entities": [
      {
        "text": "Viatris Pharmaceutical Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "Nobelpharma Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "Gilead Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "K.K., research grants from AbbVie GK, CMIC CMO Co. Ltd., PPD\u2010SNBL K.K., and",
    "entities": [
      {
        "text": "K.K.",
        "label": "ORG"
      },
      {
        "text": "AbbVie GK",
        "label": "PERSON"
      },
      {
        "text": "CMIC CMO Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "K.K.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "scholarship grants from AbbVie GK, Zeria Pharmaceutical Co. Ltd., Mochida",
    "entities": [
      {
        "text": "AbbVie GK",
        "label": "PERSON"
      },
      {
        "text": "Zeria Pharmaceutical Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "Mochida",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Pharmaceutical Co. Ltd., and Kissei Pharmaceutical Co. Ltd. Hiroki Tanaka",
    "entities": [
      {
        "text": "Pharmaceutical Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "Kissei Pharmaceutical Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "Hiroki Tanaka",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "reports receiving personal fees from JIMRO Co. Ltd., AbbVie GK, EA Pharma Co.",
    "entities": [
      {
        "text": "JIMRO Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "AbbVie GK",
        "label": "PERSON"
      },
      {
        "text": "EA Pharma Co.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Ltd., Kyorin Pharmaceutical Co. Ltd., Mochida Pharmaceutical Co. Ltd., Kissei",
    "entities": [
      {
        "text": "Kyorin Pharmaceutical Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "Mochida Pharmaceutical Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "Kissei",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Pharmaceutical Co. Ltd., Eisai Co. Ltd., Mitsubishi Tanabe Pharma Corporation,",
    "entities": [
      {
        "text": "Pharmaceutical Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "Eisai Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "Mitsubishi Tanabe Pharma Corporation",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Janssen Pharmaceutical K.K., Nikkiso Co. Ltd., Takeda Pharmaceutical, and",
    "entities": [
      {
        "text": "Janssen Pharmaceutical K.K., Nikkiso Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "Takeda Pharmaceutical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "research grants from AbbVie GK, Janssen Pharmaceutical K.K., EA Pharma, Takeda",
    "entities": [
      {
        "text": "AbbVie GK",
        "label": "PERSON"
      },
      {
        "text": "Janssen Pharmaceutical K.K.",
        "label": "ORG"
      },
      {
        "text": "Pharma",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Pharmaceutical. Tadakazu Hisamatsu reports receiving personal fees from EA",
    "entities": [
      {
        "text": "Tadakazu Hisamatsu",
        "label": "PERSON"
      },
      {
        "text": "EA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "pharma Co. Ltd., AbbVie GK, Janssen Pharmaceutical K.K., Pfizer Inc., Nichi\u2010Iko",
    "entities": [
      {
        "text": "pharma Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "AbbVie GK",
        "label": "PERSON"
      },
      {
        "text": "Janssen Pharmaceutical K.K.",
        "label": "ORG"
      },
      {
        "text": "Pfizer Inc.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Pharmaceutical Co. Ltd., JIMRO Co., Mochida Pharmaceutical Co. Ltd., Eli Lilly,",
    "entities": [
      {
        "text": "Pharmaceutical Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "JIMRO Co.",
        "label": "ORG"
      },
      {
        "text": "Mochida Pharmaceutical Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "Eli Lilly",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Gilead Sciences, Bristol Myers Squibb, and Takeda Pharmaceutical Co. Ltd.,",
    "entities": [
      {
        "text": "Gilead Sciences",
        "label": "ORG"
      },
      {
        "text": "Bristol Myers Squibb",
        "label": "ORG"
      },
      {
        "text": "Takeda Pharmaceutical Co. Ltd.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "research grants from Kissei Pharmaceutical Co. Ltd. and EA pharma Co. Ltd., and",
    "entities": [
      {
        "text": "Kissei Pharmaceutical Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "EA pharma Co. Ltd.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "scholarship grants from Mitsubishi Tanabe Pharma Corporation, EA pharma Co.",
    "entities": [
      {
        "text": "Mitsubishi Tanabe Pharma Corporation",
        "label": "ORG"
      },
      {
        "text": "EA pharma Co.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Ltd., AbbVie GK, JIMRO Co. Ltd., Zeria Pharmaceutical Co. Ltd., Kyorin",
    "entities": [
      {
        "text": "AbbVie GK",
        "label": "PERSON"
      },
      {
        "text": "JIMRO Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "Zeria Pharmaceutical Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "Kyorin",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Pharmaceutical Co. Ltd., Nippon Kayaku Co. Ltd., Takeda Pharmaceutical Co. Ltd.,",
    "entities": [
      {
        "text": "Pharmaceutical Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "Nippon Kayaku Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "Takeda Pharmaceutical Co. Ltd.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Pfizer Inc., Boston Scientific Corporation, and Mochida Pharmaceutical Co. Ltd.",
    "entities": [
      {
        "text": "Pfizer Inc.",
        "label": "ORG"
      },
      {
        "text": "Boston Scientific Corporation",
        "label": "ORG"
      },
      {
        "text": "Mochida Pharmaceutical Co. Ltd.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Hiroshi Nakase reports receiving personal fees from Mitsubishi Tanabe Pharma",
    "entities": [
      {
        "text": "Hiroshi Nakase",
        "label": "PERSON"
      },
      {
        "text": "Mitsubishi Tanabe Pharma",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Corporation, Abbvie Inc., Janssen Pharmaceutical K.K, VIATRIS Inc., Pfizer Japan",
    "entities": [
      {
        "text": "Corporation, Abbvie Inc.",
        "label": "ORG"
      },
      {
        "text": "Janssen Pharmaceutical K.K",
        "label": "ORG"
      },
      {
        "text": "VIATRIS Inc.",
        "label": "ORG"
      },
      {
        "text": "Pfizer Japan",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Co. Ltd., Gilead Sciences Inc., Daiichi Sankyo Co. Ltd., and research grants",
    "entities": [
      {
        "text": "Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "Gilead Sciences Inc.",
        "label": "ORG"
      },
      {
        "text": "Daiichi Sankyo Co. Ltd.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "from Hoya Group Pentax Medical, Abbvie Inc., Mitsubishi Tanabe Pharma",
    "entities": [
      {
        "text": "Hoya Group Pentax Medical, Abbvie Inc.",
        "label": "ORG"
      },
      {
        "text": "Mitsubishi Tanabe Pharma",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Corporation, Mochida Pharmaceutical Co. Ltd., AYUMI Pharmaceutical Corporation,",
    "entities": [
      {
        "text": "Mochida Pharmaceutical Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "AYUMI Pharmaceutical Corporation",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and scholarship grants from Abbvie Inc., Otsuka Pharmaceutical Co. Ltd., EA",
    "entities": [
      {
        "text": "Abbvie Inc.",
        "label": "ORG"
      },
      {
        "text": "Otsuka Pharmaceutical Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "EA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Pharma Co. Ltd., TAIHO Pharmaceutical Co. Ltd., Nippon Kayaku Co. Ltd.,",
    "entities": [
      {
        "text": "Pharma Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "TAIHO Pharmaceutical Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "Nippon Kayaku Co. Ltd.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Mitsubishi Tanabe Pharma Corporation, Takeda Pharmaceutical Co. Ltd. He was",
    "entities": [
      {
        "text": "Mitsubishi Tanabe Pharma Corporation",
        "label": "ORG"
      },
      {
        "text": "Takeda Pharmaceutical Co. Ltd.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "endowed chair by MIYARISAN Pharmaceutical Co., JIMRO Co. Ltd., KYORIN",
    "entities": [
      {
        "text": "MIYARISAN Pharmaceutical Co.",
        "label": "ORG"
      },
      {
        "text": "JIMRO Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "KYORIN\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Pharmaceutical Co. Ltd., Mochida Pharmaceutical Co. Ltd.",
    "entities": [
      {
        "text": "Pharmaceutical Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "Mochida Pharmaceutical Co. Ltd.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "38. Front Health Serv. 2025 Jul 1;5:1650412. doi: 10.3389/frhs.2025.1650412.",
    "entities": [
      {
        "text": "38",
        "label": "CARDINAL"
      },
      {
        "text": "Front Health Serv",
        "label": "ORG"
      },
      {
        "text": "10.3389",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Correction: External relationships as implementation determinants in",
    "entities": []
  },
  {
    "text": "community-engaged, equity-focused COVID-19 vaccination events.",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Moore R(1), Callaghan-Koru J(1), Vincenzo JL(2), Patton SK(3), Spear MJ(4),",
    "entities": [
      {
        "text": "Callaghan-Koru",
        "label": "PERSON"
      },
      {
        "text": "Vincenzo JL(2",
        "label": "PERSON"
      },
      {
        "text": "Patton SK(3",
        "label": "PERSON"
      },
      {
        "text": "Spear MJ(4",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Curran GM(8)(9).",
    "entities": []
  },
  {
    "text": "(1)Office of Community Health and Research, College of Medicine, University of",
    "entities": [
      {
        "text": "Community Health and Research, College of Medicine, University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Arkansas for Medical Sciences Northwest, Springdale, AR, United States.",
    "entities": [
      {
        "text": "Arkansas",
        "label": "GPE"
      },
      {
        "text": "Medical Sciences Northwest",
        "label": "ORG"
      },
      {
        "text": "Springdale",
        "label": "GPE"
      },
      {
        "text": "AR",
        "label": "GPE"
      },
      {
        "text": "United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Geriatrics, College of Health Professions, University of Arkansas for Medical",
    "entities": [
      {
        "text": "2)Geriatrics",
        "label": "CARDINAL"
      },
      {
        "text": "College of Health Professions",
        "label": "ORG"
      },
      {
        "text": "University of Arkansas for Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Sciences Northwest, Fayetteville, AR, United States.",
    "entities": [
      {
        "text": "Sciences Northwest",
        "label": "PERSON"
      },
      {
        "text": "Fayetteville",
        "label": "GPE"
      },
      {
        "text": "AR",
        "label": "GPE"
      },
      {
        "text": "United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Nursing, College of Education and Health Professions, University of Arkansas,",
    "entities": [
      {
        "text": "College of Education",
        "label": "ORG"
      },
      {
        "text": "Health Professions",
        "label": "ORG"
      },
      {
        "text": "University of Arkansas",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Fayetteville, AR, United States.",
    "entities": [
      {
        "text": "Fayetteville",
        "label": "GPE"
      },
      {
        "text": "AR",
        "label": "GPE"
      },
      {
        "text": "United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Office of Community Health and Research, University of Arkansas for Medical",
    "entities": [
      {
        "text": "Community Health and Research, University of Arkansas for Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Sciences Northwest, Springdale, AR, United States.",
    "entities": [
      {
        "text": "Sciences Northwest",
        "label": "PERSON"
      },
      {
        "text": "Springdale",
        "label": "GPE"
      },
      {
        "text": "AR",
        "label": "GPE"
      },
      {
        "text": "United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Family Medicine, Family Medicine Residency Training Program,",
    "entities": [
      {
        "text": "Family Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "College of Medicine, University of Arkansas for Medical Sciences Northwest,",
    "entities": [
      {
        "text": "College of Medicine, University of Arkansas for Medical Sciences Northwest",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(6)Consulate General of Arkansas, Republic of the Marshall Islands, Springdale,",
    "entities": [
      {
        "text": "6)Consulate",
        "label": "CARDINAL"
      },
      {
        "text": "Arkansas",
        "label": "GPE"
      },
      {
        "text": "Republic of the Marshall Islands",
        "label": "ORG"
      },
      {
        "text": "Springdale",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "AR, United States.",
    "entities": [
      {
        "text": "United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Arkansas Coalition of Marshallese, Springdale, AR, United States.",
    "entities": [
      {
        "text": "Marshallese",
        "label": "NORP"
      },
      {
        "text": "Springdale",
        "label": "GPE"
      },
      {
        "text": "AR",
        "label": "GPE"
      },
      {
        "text": "United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(8)Department of Pharmacy Practice, College of Pharmacy, University of Arkansas",
    "entities": [
      {
        "text": "Pharmacy Practice",
        "label": "ORG"
      },
      {
        "text": "College of Pharmacy,",
        "label": "ORG"
      },
      {
        "text": "University of Arkansas",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "for Medical Sciences, Little Rock, AR, United States.",
    "entities": [
      {
        "text": "Medical Sciences",
        "label": "ORG"
      },
      {
        "text": "Little Rock",
        "label": "GPE"
      },
      {
        "text": "AR",
        "label": "GPE"
      },
      {
        "text": "United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(9)Center for Mental Healthcare and Outcomes Research, Central Arkansas Veterans",
    "entities": [
      {
        "text": "Mental Healthcare",
        "label": "ORG"
      },
      {
        "text": "Outcomes Research",
        "label": "ORG"
      },
      {
        "text": "Central Arkansas",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Healthcare System, North Little Rock, AR, United States.",
    "entities": [
      {
        "text": "Healthcare System",
        "label": "ORG"
      },
      {
        "text": "North Little Rock, AR",
        "label": "GPE"
      },
      {
        "text": "United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "[This corrects the article DOI: 10.3389/frhs20241338622.].",
    "entities": [
      {
        "text": "10.3389",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Ramos, Takamaru, McElfish and Curran.",
    "entities": [
      {
        "text": "Ramos",
        "label": "ORG"
      },
      {
        "text": "Takamaru",
        "label": "PERSON"
      },
      {
        "text": "McElfish",
        "label": "PERSON"
      },
      {
        "text": "Curran",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Advances in gas-exchange physiology and pathophysiology.",
    "entities": []
  },
  {
    "text": "(1)Pulmonary Imaging Laboratory, UC San Diego Health Sciences, La Jolla, CA.",
    "entities": [
      {
        "text": "Imaging Laboratory",
        "label": "ORG"
      },
      {
        "text": "UC San Diego Health Sciences",
        "label": "ORG"
      },
      {
        "text": "La Jolla",
        "label": "GPE"
      },
      {
        "text": "CA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Department of Radiology, University of California, San Diego, La Jolla, CA.",
    "entities": [
      {
        "text": "Radiology, University of California,",
        "label": "ORG"
      },
      {
        "text": "San Diego",
        "label": "GPE"
      },
      {
        "text": "La Jolla",
        "label": "GPE"
      },
      {
        "text": "CA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Department of Medicine, University of California, San Diego, La Jolla, CA.",
    "entities": [
      {
        "text": "Medicine, University of California,",
        "label": "ORG"
      },
      {
        "text": "San Diego",
        "label": "GPE"
      },
      {
        "text": "La Jolla",
        "label": "GPE"
      },
      {
        "text": "CA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Although respiratory gas exchange is a mature field, recent research brings new",
    "entities": []
  },
  {
    "text": "insights and techniques for patient evaluation. While some gases suffer",
    "entities": []
  },
  {
    "text": "pulmonary diffusion limitation, others do not, explained by comparing their",
    "entities": []
  },
  {
    "text": "solubility in the alveolar wall to their solubility (dissociation curve slope)",
    "entities": []
  },
  {
    "text": "in blood. Well-established concepts of shunt and deadspace are revisited with",
    "entities": []
  },
  {
    "text": "new computerized analyses and measurement approaches showing that in COVID-19,",
    "entities": [
      {
        "text": "COVID-19",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "abnormal gas exchange reflects not just shunts but also alveolar deadspace",
    "entities": []
  },
  {
    "text": "suggesting vascular obstruction (sometimes persisting for months). So-called",
    "entities": [
      {
        "text": "months",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "\"silent hypoxia\" in COVID-19 likely reflects normal variation in hypoxic",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "ventilatory responsiveness; in most patients, arterial PCO2 is normal or",
    "entities": []
  },
  {
    "text": "reduced. Evidence that COVID-19 impairs neurological pathways of breathing",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "control is not strong. Finally, we review O2 transport from air to mitochondria",
    "entities": [
      {
        "text": "O2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "as an interactive system (lungs, heart, blood, tissues) where all components",
    "entities": []
  },
  {
    "text": "function in ways that affect each other. This systems approach enables",
    "entities": []
  },
  {
    "text": "separation and quantification of central and peripheral contributions to",
    "entities": []
  },
  {
    "text": "impaired O2 transport.",
    "entities": [
      {
        "text": "O2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "40. Front Public Health. 2025 Jul 1;13:1603708. doi: 10.3389/fpubh.2025.1603708.",
    "entities": [
      {
        "text": "40",
        "label": "CARDINAL"
      },
      {
        "text": "Front Public Health",
        "label": "ORG"
      },
      {
        "text": "10.3389",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Italian healthcare professionals' role in advancing reforms within the Italian",
    "entities": [
      {
        "text": "Italian",
        "label": "NORP"
      },
      {
        "text": "Italian",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "National Healthcare System, as outlined in the National Recovery and Resilience",
    "entities": [
      {
        "text": "National Healthcare System",
        "label": "ORG"
      },
      {
        "text": "the National Recovery and Resilience",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Department of Experimental and Clinical Medicine, University of Florence,",
    "entities": [
      {
        "text": "Experimental",
        "label": "ORG"
      },
      {
        "text": "Clinical Medicine",
        "label": "ORG"
      },
      {
        "text": "University of Florence",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Florence, Italy.",
    "entities": [
      {
        "text": "Florence",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Centro Studi SAPIS Foundation, Italian National Federation of Orders of",
    "entities": [
      {
        "text": "2)Centro",
        "label": "CARDINAL"
      },
      {
        "text": "Studi SAPIS Foundation",
        "label": "ORG"
      },
      {
        "text": "Italian National Federation of Orders",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Radiographers and Technical, Rehabilitation, and Prevention Health Professions",
    "entities": [
      {
        "text": "Radiographers and Technical, Rehabilitation",
        "label": "ORG"
      },
      {
        "text": "Prevention Health Professions",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Research Centre, Rome, Italy.",
    "entities": [
      {
        "text": "Research Centre",
        "label": "GPE"
      },
      {
        "text": "Rome",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Italy.",
    "entities": [
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Ministry of Health, Rome, Italy.",
    "entities": [
      {
        "text": "Rome",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)MEDGLOX, Ivrea, Italy.",
    "entities": [
      {
        "text": "6)MEDGLOX, Ivrea,",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Department of Health Sciences, University of Florence, Florence, Italy.",
    "entities": [
      {
        "text": "Health Sciences",
        "label": "ORG"
      },
      {
        "text": "University of Florence, Florence",
        "label": "ORG"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(8)School of Human Sciences, University of Florence, Florence, Italy.",
    "entities": [
      {
        "text": "Human Sciences",
        "label": "ORG"
      },
      {
        "text": "University of Florence, Florence",
        "label": "ORG"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "INTRODUCTION: In 2021, the National Recovery and Resilience Plan (PNRR) outlined",
    "entities": [
      {
        "text": "2021",
        "label": "DATE"
      },
      {
        "text": "the National Recovery and Resilience Plan",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "the foundational pillars for Italy's economic recovery following the COVID-19",
    "entities": [
      {
        "text": "Italy",
        "label": "GPE"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "pandemic. Within PNRR's Mission 6 \"Health\", guidelines were established to",
    "entities": []
  },
  {
    "text": "reform the Italian healthcare system, focusing on community-based services and",
    "entities": [
      {
        "text": "Italian",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "digitalization. This ambitious reform aims to shift from a hospital-centred",
    "entities": []
  },
  {
    "text": "model to a patient-centred one that promotes integrated provision of social and",
    "entities": []
  },
  {
    "text": "healthcare services.",
    "entities": []
  },
  {
    "text": "METHODS: The lack of institutional working groups to incorporate input from all",
    "entities": []
  },
  {
    "text": "Italian recognized healthcare professionals into PNRR's implementation, the",
    "entities": [
      {
        "text": "Italian",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "National Federation of Orders of Radiographers and Technical, Rehabilitative,",
    "entities": [
      {
        "text": "National Federation of Orders of Radiographers and Technical, Rehabilitative",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and Prevention Health Professionals (FNO TSRM & PSTRP) addressed this gap by",
    "entities": []
  },
  {
    "text": "initiating a study.",
    "entities": []
  },
  {
    "text": "RESULTS: The contributions from the 19 Italian Allied Health Professionals",
    "entities": [
      {
        "text": "19",
        "label": "CARDINAL"
      },
      {
        "text": "Italian",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "(AHPs) affiliated with the FNO TSRM & PSTRP were collected to identify priority",
    "entities": [
      {
        "text": "the FNO TSRM & PSTRP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "areas and formulate actionable recommendations aimed at enhancing the",
    "entities": []
  },
  {
    "text": "organizational model of reformed Italian healthcare system outlined by the PNRR,",
    "entities": [
      {
        "text": "Italian",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "which had been predominantly focused on nursing care.",
    "entities": []
  },
  {
    "text": "DISCUSSION: Adopting a multi-professional and multidisciplinary approach could",
    "entities": []
  },
  {
    "text": "better address social and health needs of the population by leveraging the",
    "entities": []
  },
  {
    "text": "expertise of all registered Italian health professionals. This approach aligns",
    "entities": [
      {
        "text": "Italian",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Italian healthcare system with European standards, addressing issues such as",
    "entities": [
      {
        "text": "Italian",
        "label": "NORP"
      },
      {
        "text": "European",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "task shifting and shortages in professional resources. Ultimately, this study",
    "entities": []
  },
  {
    "text": "provides concrete insights for Italian policymakers and healthcare leaders to",
    "entities": [
      {
        "text": "Italian",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "foster greater inclusion of Italian AHPs in the design and implementation of the",
    "entities": [
      {
        "text": "Italian",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "current and future reforms on national healthcare system.",
    "entities": []
  },
  {
    "text": "DOI: 10.3389/fpubh.2025.1603708",
    "entities": [
      {
        "text": "10.3389",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: PG was employed by company MEDGLOX. The",
    "entities": []
  },
  {
    "text": "remaining authors declare that the research was conducted in the absence of any",
    "entities": []
  },
  {
    "text": "commercial or financial relationships that could be construed as a potential",
    "entities": []
  },
  {
    "text": "conflict of interest.",
    "entities": []
  },
  {
    "text": "41. Front Public Health. 2025 Jul 1;13:1566167. doi: 10.3389/fpubh.2025.1566167.",
    "entities": [
      {
        "text": "41",
        "label": "CARDINAL"
      },
      {
        "text": "Front Public Health",
        "label": "ORG"
      },
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "1;13:1566167",
        "label": "CARDINAL"
      },
      {
        "text": "10.3389",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Challenges and opportunities for early childhood intervention services in",
    "entities": []
  },
  {
    "text": "Singapore: addressing user satisfaction.",
    "entities": [
      {
        "text": "Singapore",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(1)Public Policy and Global Affairs Programme, School of Social Sciences,",
    "entities": [
      {
        "text": "Policy and Global Affairs Programme",
        "label": "ORG"
      },
      {
        "text": "School of Social Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Nanyang Technological University (NTU), Singapore, Singapore.",
    "entities": [
      {
        "text": "Nanyang Technological University",
        "label": "ORG"
      },
      {
        "text": "NTU",
        "label": "ORG"
      },
      {
        "text": "Singapore",
        "label": "GPE"
      },
      {
        "text": "Singapore",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Psychology, School of Social Sciences, Nanyang Technological",
    "entities": [
      {
        "text": "2)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Psychology, School of Social Sciences",
        "label": "ORG"
      },
      {
        "text": "Nanyang",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "University (NTU), Singapore, Singapore.",
    "entities": [
      {
        "text": "University (NTU",
        "label": "ORG"
      },
      {
        "text": "Singapore",
        "label": "GPE"
      },
      {
        "text": "Singapore",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)The Centre for Research in Child Development at the National Institution of",
    "entities": [
      {
        "text": "3)The Centre for Research in Child Development",
        "label": "ORG"
      },
      {
        "text": "the National Institution of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Education, Nanyang Technological University (NTU), Singapore, Singapore.",
    "entities": [
      {
        "text": "Nanyang Technological University",
        "label": "ORG"
      },
      {
        "text": "NTU",
        "label": "ORG"
      },
      {
        "text": "Singapore",
        "label": "GPE"
      },
      {
        "text": "Singapore",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Neonatology, KK Women's and Children's Hospital, Singapore,",
    "entities": [
      {
        "text": "Neonatology",
        "label": "GPE"
      },
      {
        "text": "KK Women's",
        "label": "ORG"
      },
      {
        "text": "Children's Hospital",
        "label": "WORK_OF_ART"
      },
      {
        "text": "Singapore",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Child Development and Neonatology, KK Women's and Children's",
    "entities": [
      {
        "text": "Child Development and Neonatology",
        "label": "ORG"
      },
      {
        "text": "KK Women's",
        "label": "ORG"
      },
      {
        "text": "Children",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(6)Department of Child Development, KK Women's and Children's Hospital,",
    "entities": [
      {
        "text": "Child Development",
        "label": "ORG"
      },
      {
        "text": "KK Women's",
        "label": "ORG"
      },
      {
        "text": "Children's Hospital",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "(7)Department of Paediatrics, Yong Loo Lin School of Medicine, National",
    "entities": [
      {
        "text": "Paediatrics",
        "label": "GPE"
      },
      {
        "text": "Yong Loo Lin School of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University of Singapore, Singapore, Singapore.",
    "entities": [
      {
        "text": "University of Singapore",
        "label": "ORG"
      },
      {
        "text": "Singapore",
        "label": "GPE"
      },
      {
        "text": "Singapore",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(8)Institute for Human Development and Potential, Agency for Science, Technology",
    "entities": [
      {
        "text": "Human Development and Potential, Agency for",
        "label": "ORG"
      },
      {
        "text": "Science, Technology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and Research, Singapore, Singapore.",
    "entities": [
      {
        "text": "Research",
        "label": "GPE"
      },
      {
        "text": "Singapore",
        "label": "GPE"
      },
      {
        "text": "Singapore",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(10)Early Mental Potential and Wellbeing Research (EMPOWER) Centre, Nanyang",
    "entities": [
      {
        "text": "10)Early",
        "label": "CARDINAL"
      },
      {
        "text": "Mental Potential and Wellbeing Research",
        "label": "ORG"
      },
      {
        "text": "Centre",
        "label": "GPE"
      },
      {
        "text": "Nanyang",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Technological University (NTU), Singapore, Singapore.",
    "entities": [
      {
        "text": "Technological University",
        "label": "ORG"
      },
      {
        "text": "NTU",
        "label": "ORG"
      },
      {
        "text": "Singapore",
        "label": "GPE"
      },
      {
        "text": "Singapore",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Since the COVID-19 pandemic, there has been a gap between primary stakeholders'",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "ex ante expectations of adaptive early childhood intervention (ECI) services and",
    "entities": [
      {
        "text": "ECI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "their actual experiences with these services. This is despite governments' and",
    "entities": []
  },
  {
    "text": "service operators' swift pivot from on-site service delivery to home-based,",
    "entities": []
  },
  {
    "text": "virtual and hybrid modes, and cross-sector collaboration with private providers",
    "entities": []
  },
  {
    "text": "and pre-schools. In this article, we share our preliminary evidence from",
    "entities": []
  },
  {
    "text": "in-depth interviews with parents and clinicians regarding the perceived",
    "entities": [
      {
        "text": "clinicians",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "challenges to post-pandemic ECI services. We discuss how the crisis has",
    "entities": [
      {
        "text": "ECI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "triggered a paradigm change, especially regarding potential drivers for",
    "entities": []
  },
  {
    "text": "satisfactory services in the Singapore context.",
    "entities": [
      {
        "text": "Singapore",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "DOI: 10.3389/fpubh.2025.1566167",
    "entities": [
      {
        "text": "10.3389",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "42. Front Public Health. 2025 Jul 1;13:1618347. doi: 10.3389/fpubh.2025.1618347.",
    "entities": [
      {
        "text": "42",
        "label": "CARDINAL"
      },
      {
        "text": "Front Public Health",
        "label": "ORG"
      },
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "10.3389",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "How politics affect pandemic forecasting: spatio-temporal early warning",
    "entities": []
  },
  {
    "text": "capabilities of different geo-social media topics in the context of state-level",
    "entities": []
  },
  {
    "text": "political leaning.",
    "entities": []
  },
  {
    "text": "(1)IT:U Interdisciplinary Transformation University Austria, Linz, Austria.",
    "entities": [
      {
        "text": "1)IT",
        "label": "CARDINAL"
      },
      {
        "text": "U Interdisciplinary Transformation University",
        "label": "ORG"
      },
      {
        "text": "Linz",
        "label": "GPE"
      },
      {
        "text": "Austria",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Geoinformatics Department - Z_GIS, University of Salzburg, Salzburg, Austria.",
    "entities": [
      {
        "text": "University of Salzburg",
        "label": "ORG"
      },
      {
        "text": "Salzburg",
        "label": "GPE"
      },
      {
        "text": "Austria",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Center for Geographic Analysis, Harvard University, Cambridge, MA, United",
    "entities": [
      {
        "text": "Geographic Analysis",
        "label": "ORG"
      },
      {
        "text": "Harvard University",
        "label": "ORG"
      },
      {
        "text": "Cambridge",
        "label": "GPE"
      },
      {
        "text": "MA",
        "label": "GPE"
      },
      {
        "text": "United",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "States.",
    "entities": [
      {
        "text": "States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Machine Intelligence Group for the Betterment of Health and the Environment,",
    "entities": [
      {
        "text": "Intelligence Group",
        "label": "ORG"
      },
      {
        "text": "the Betterment of Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Northeastern University, Boston, MA, United States.",
    "entities": [
      {
        "text": "Northeastern University",
        "label": "ORG"
      },
      {
        "text": "Boston",
        "label": "GPE"
      },
      {
        "text": "MA",
        "label": "GPE"
      },
      {
        "text": "United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Harvard T. H. Chan School of Public Health, Department of Epidemiology,",
    "entities": [
      {
        "text": "T. H. Chan School of Public Health",
        "label": "ORG"
      },
      {
        "text": "Department of Epidemiology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Boston, MA, United States.",
    "entities": [
      {
        "text": "Boston",
        "label": "GPE"
      },
      {
        "text": "MA",
        "label": "GPE"
      },
      {
        "text": "United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Interdisciplinary Centre of Scientific Computing, Heidelberg University,",
    "entities": [
      {
        "text": "Centre of Scientific Computing",
        "label": "ORG"
      },
      {
        "text": "Heidelberg University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(8)GIScience Chair, Heidelberg University, Heidelberg, Germany.",
    "entities": [
      {
        "text": "Heidelberg University",
        "label": "ORG"
      },
      {
        "text": "Heidelberg",
        "label": "GPE"
      },
      {
        "text": "Germany",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(9)Colorado School of Public Health, University of Colorado Boulder, Aurora, CO,",
    "entities": [
      {
        "text": "School of Public Health",
        "label": "ORG"
      },
      {
        "text": "University of Colorado Boulder",
        "label": "ORG"
      },
      {
        "text": "Aurora",
        "label": "GPE"
      },
      {
        "text": "CO",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(10)Department of Infectious Diseases, Heidelberg University Hospital,",
    "entities": [
      {
        "text": "10)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Heidelberg University Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "OBJECTIVES: Due to political polarization, adherence to public health measures",
    "entities": []
  },
  {
    "text": "varied across US states during the COVID-19 pandemic. Although social media",
    "entities": [
      {
        "text": "US",
        "label": "GPE"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "posts have been shown effective in anticipating COVID-19 surges, the impact of",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "political leaning on the effectiveness of different topics for early warning",
    "entities": []
  },
  {
    "text": "remains mostly unexplored. Our study examines the spatio-temporal early warning",
    "entities": []
  },
  {
    "text": "potential of different geo-social media topics across republican, democrat, and",
    "entities": [
      {
        "text": "republican",
        "label": "NORP"
      },
      {
        "text": "democrat",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "METHODS: Using keyword filtering, we identified eight COVID-19-related",
    "entities": [
      {
        "text": "eight",
        "label": "CARDINAL"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "geo-social media topics. We then utilized Chatterjee's rank correlation to",
    "entities": [
      {
        "text": "geo-social",
        "label": "PERSON"
      },
      {
        "text": "Chatterjee",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "assess their early warning capability for COVID-19 cases 7 to 42 days in advance",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      },
      {
        "text": "7 to 42 days",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "across six infection waves. A mixed-effect model was used to evaluate the impact",
    "entities": [
      {
        "text": "six",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "of timeframe and political leaning on the early warning capabilities of these",
    "entities": []
  },
  {
    "text": "topics.",
    "entities": []
  },
  {
    "text": "RESULTS: Many topics exhibited significant spatial clustering over time, with",
    "entities": []
  },
  {
    "text": "quarantine and vaccination-related posts occurring in opposing spatial regimes",
    "entities": []
  },
  {
    "text": "in the second timeframe. We also found significant variation in the early",
    "entities": [
      {
        "text": "second",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "warning capabilities of geo-social media topics over time and across political",
    "entities": []
  },
  {
    "text": "clusters. In detail, quarantine related geo-social media post were significantly",
    "entities": []
  },
  {
    "text": "less correlated to COVID-19 cases in republican states than in democrat states.",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      },
      {
        "text": "republican",
        "label": "NORP"
      },
      {
        "text": "democrat",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Further, preventive measure and quarantine-related posts exhibited declining",
    "entities": []
  },
  {
    "text": "correlations to COVID-19 cases over time, while the correlations of vaccine and",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "virus-related posts with COVID-19 infections.",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "CONCLUSION: Our results highlight the need for a dynamic spatially targeted",
    "entities": []
  },
  {
    "text": "approach that accounts for both how regional geosocial media topics of interest",
    "entities": []
  },
  {
    "text": "change over time and the impact of local political ideology on their",
    "entities": []
  },
  {
    "text": "epidemiological early warning capabilities.",
    "entities": []
  },
  {
    "text": "DOI: 10.3389/fpubh.2025.1618347",
    "entities": [
      {
        "text": "10.3389",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "43. Oxf Med Case Reports. 2025 Jul 14;2025(7):omaf102. doi: 10.1093/omcr/omaf102.",
    "entities": [
      {
        "text": "43",
        "label": "CARDINAL"
      },
      {
        "text": "Oxf Med Case Reports",
        "label": "PERSON"
      },
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "10.1093",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "eCollection 2025 Jul.",
    "entities": [
      {
        "text": "eCollection",
        "label": "ORG"
      },
      {
        "text": "2025 Jul.",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Catastrophic antiphospholipid syndrome in a young patient: a case report of",
    "entities": []
  },
  {
    "text": "(1)Florida international University Herbert Wertheim College of Medicine,",
    "entities": [
      {
        "text": "1)Florida",
        "label": "CARDINAL"
      },
      {
        "text": "University Herbert Wertheim College of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Florida, United States.",
    "entities": [
      {
        "text": "Florida",
        "label": "GPE"
      },
      {
        "text": "United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Research Associate, King Hussein Cancer Center, Amman, Jordan.",
    "entities": [
      {
        "text": "Amman",
        "label": "GPE"
      },
      {
        "text": "Jordan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Internship, Princess Basma Teaching Hospital, Irbid, Jordan.",
    "entities": [
      {
        "text": "Princess Basma Teaching Hospital",
        "label": "ORG"
      },
      {
        "text": "Irbid",
        "label": "PERSON"
      },
      {
        "text": "Jordan",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(4)Applied Science Research Center, Applied Science Private University, Amman,",
    "entities": [
      {
        "text": "Science Research Center",
        "label": "ORG"
      },
      {
        "text": "Applied Science Private University",
        "label": "ORG"
      },
      {
        "text": "Amman",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Ross University School of Medicine, Florida, United States.",
    "entities": [
      {
        "text": "University School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Florida",
        "label": "GPE"
      },
      {
        "text": "United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)University of Jordan, Amman, Jordan.",
    "entities": [
      {
        "text": "Jordan",
        "label": "GPE"
      },
      {
        "text": "Amman",
        "label": "GPE"
      },
      {
        "text": "Jordan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Faculty of Medicine, University of Kalamoon, Al-Nabk, Syria.",
    "entities": [
      {
        "text": "Medicine, University of Kalamoon",
        "label": "ORG"
      },
      {
        "text": "Al-Nabk",
        "label": "PERSON"
      },
      {
        "text": "Syria",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Catastrophic Antiphospholipid Syndrome (CAPS) is a rare serious form of APS",
    "entities": [
      {
        "text": "Catastrophic Antiphospholipid Syndrome",
        "label": "ORG"
      },
      {
        "text": "APS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "characterized by thrombosis in multiple organs and a cytokine storm. We report a",
    "entities": []
  },
  {
    "text": "complex case of a 28-year-old female that tested positive for COVID-19 with a",
    "entities": [
      {
        "text": "28-year-old",
        "label": "DATE"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "medical history of deep vein thrombosis, pulmonary embolus and systemic lupus",
    "entities": []
  },
  {
    "text": "erythematosus, with underlying APC, complicating her case of CAPS in multiple",
    "entities": [
      {
        "text": "APC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "organs. Computed Tomography (CT) PE reveled extensive pulmonary emboli and an",
    "entities": [
      {
        "text": "Computed Tomography (CT) PE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "elevated right/left ventricular ratio (RV/LV). CT of the abdomen and pelvis",
    "entities": [
      {
        "text": "RV/LV",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "showed gastritis, ascites and anasarca, fluid accumulation and small bilateral",
    "entities": []
  },
  {
    "text": "pleural effusions. Urinalysis showed low levels of albumin, urine protein 4+ g,",
    "entities": [
      {
        "text": "pleural",
        "label": "GPE"
      },
      {
        "text": "4",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "and hyperlipidemia. Laboratory test indicated that the patient has developed a",
    "entities": []
  },
  {
    "text": "worsening non oliguric acute kidney injury and renal biopsy revealed",
    "entities": []
  },
  {
    "text": "necrotizing. This is a complex case that contributes to the understanding of",
    "entities": []
  },
  {
    "text": "CAPS and highlights the challenges of its diagnosis and management.",
    "entities": []
  },
  {
    "text": "interests.",
    "entities": []
  },
  {
    "text": "Trends in turnover and turbulence at a large academic medical center before and",
    "entities": []
  },
  {
    "text": "during COVID-19: Analyzing structured clinical research professional roles.",
    "entities": []
  },
  {
    "text": "(1)Duke Office of Clinical Research, Duke University, Durham, NC, USA.",
    "entities": [
      {
        "text": "Office of Clinical Research",
        "label": "ORG"
      },
      {
        "text": "Duke University",
        "label": "ORG"
      },
      {
        "text": "Durham",
        "label": "GPE"
      },
      {
        "text": "NC",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)School of Medicine, Duke University, Durham, NC, USA.",
    "entities": [
      {
        "text": "Duke University",
        "label": "ORG"
      },
      {
        "text": "Durham",
        "label": "GPE"
      },
      {
        "text": "NC",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Clinical and Translational Science Institute, Duke University, Durham, NC,",
    "entities": [
      {
        "text": "Translational Science Institute",
        "label": "ORG"
      },
      {
        "text": "Duke University",
        "label": "ORG"
      },
      {
        "text": "Durham",
        "label": "GPE"
      },
      {
        "text": "NC",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Rewards and Recognition, Duke Human Resources, Duke University, Durham, NC,",
    "entities": [
      {
        "text": "Recognition",
        "label": "ORG"
      },
      {
        "text": "Duke Human Resources",
        "label": "ORG"
      },
      {
        "text": "Duke University",
        "label": "ORG"
      },
      {
        "text": "Durham",
        "label": "GPE"
      },
      {
        "text": "NC",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "INTRODUCTION: High workforce turbulence has plagued clinical research, becoming",
    "entities": []
  },
  {
    "text": "intensified during the COVID-19 pandemic, especially for patient-facing workers.",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "In a time of great uncertainty and risk among healthcare workers, researchers",
    "entities": []
  },
  {
    "text": "included, the pandemic also brought increased demand for research studies in",
    "entities": []
  },
  {
    "text": "volume, speed, and complexity, triggering elevated staff turnover. This has",
    "entities": []
  },
  {
    "text": "posed significant hurdles for employers, especially research sites, where",
    "entities": []
  },
  {
    "text": "retaining skilled patient-facing clinical research professionals (CRPs) is",
    "entities": []
  },
  {
    "text": "pivotal for sustaining medical innovation. Lack of job standardization and",
    "entities": []
  },
  {
    "text": "advancement pathways has been noted to play an important role both in turnover",
    "entities": []
  },
  {
    "text": "and contributes to the inability to accurately measure workforce trends. To",
    "entities": []
  },
  {
    "text": "address these factors, Duke University adopted a competency-based job",
    "entities": [
      {
        "text": "Duke University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "classification system for CRPs in 2016.",
    "entities": [
      {
        "text": "2016",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "METHODS: Since that adoption of competency-based jobs, employee-level staffing",
    "entities": []
  },
  {
    "text": "data for all CRPs have been tracked monthly, creating a master data file from",
    "entities": [
      {
        "text": "monthly",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "September 2016 through June 2024. This study updates previous analyses,",
    "entities": [
      {
        "text": "September 2016 through June 2024",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "evaluating turnover and turbulence rates, and demographic changes in the CRP",
    "entities": [
      {
        "text": "CRP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "workforce over this period.",
    "entities": []
  },
  {
    "text": "RESULTS: Over the last six years, the Duke CRP workforce remained relatively",
    "entities": [
      {
        "text": "the last six years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "stable. Voluntary turnover rates fluctuated, peaking at 19.1% in FY 2021 during",
    "entities": [
      {
        "text": "19.1%",
        "label": "PERCENT"
      },
      {
        "text": "FY",
        "label": "GPE"
      },
      {
        "text": "2021",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "the COVID-19 pandemic, and have steadily declined each year since then.",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      },
      {
        "text": "each year",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "CONCLUSIONS: Despite national workforce challenges exacerbated by the pandemic,",
    "entities": []
  },
  {
    "text": "our data indicate that proactive measures to standardize clinical research jobs",
    "entities": []
  },
  {
    "text": "and assess the resultant well-defined site-based employee data may have",
    "entities": []
  },
  {
    "text": "mitigated extremes in workforce turnover at Duke University. Turbulence rates,",
    "entities": [
      {
        "text": "Duke University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "while stabilizing, signal areas for further study.",
    "entities": []
  },
  {
    "text": "DOI: 10.1017/cts.2025.10063",
    "entities": [
      {
        "text": "10.1017",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Academic influencers: Clinical and Translational Science scholars and trainees",
    "entities": []
  },
  {
    "text": "at the intersection of influential scholarship and public attention.",
    "entities": []
  },
  {
    "text": "(1)Georgia Clinical and Translational Science Alliance, Emory University School",
    "entities": [
      {
        "text": "Clinical and Translational Science Alliance",
        "label": "ORG"
      },
      {
        "text": "Emory University School",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of Medicine, Atlanta, GA, USA.",
    "entities": [
      {
        "text": "Medicine",
        "label": "GPE"
      },
      {
        "text": "Atlanta",
        "label": "GPE"
      },
      {
        "text": "GA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Emory University Rollins School of Public Health, Atlanta, GA, USA.",
    "entities": [
      {
        "text": "University Rollins School of Public Health",
        "label": "ORG"
      },
      {
        "text": "Atlanta",
        "label": "GPE"
      },
      {
        "text": "GA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Case Western Reserve University, Cleveland, OH, USA.",
    "entities": [
      {
        "text": "3)Case",
        "label": "CARDINAL"
      },
      {
        "text": "Western Reserve University",
        "label": "ORG"
      },
      {
        "text": "Cleveland",
        "label": "GPE"
      },
      {
        "text": "OH",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Virginia Commonwealth University, Psychiatry, Wright Regional Center for",
    "entities": [
      {
        "text": "4)Virginia",
        "label": "CARDINAL"
      },
      {
        "text": "Commonwealth University",
        "label": "ORG"
      },
      {
        "text": "Wright Regional Center",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Clinical and Translational Science, Richmond, VA, USA.",
    "entities": [
      {
        "text": "Richmond",
        "label": "GPE"
      },
      {
        "text": "VA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)University of North Carolina, Chapel Hill, NC, USA.",
    "entities": [
      {
        "text": "North Carolina",
        "label": "GPE"
      },
      {
        "text": "Chapel Hill",
        "label": "GPE"
      },
      {
        "text": "NC",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "INTRODUCTION: Clinical and Translational Science trainees are motivated to",
    "entities": []
  },
  {
    "text": "publish influential research. However, the extent to which this work gains",
    "entities": []
  },
  {
    "text": "influence with the public is largely unknown.",
    "entities": []
  },
  {
    "text": "METHODS: The authors identified over 30,000 publications that received KL2 or",
    "entities": [
      {
        "text": "30,000",
        "label": "CARDINAL"
      },
      {
        "text": "KL2",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "TL1 grant support through a Clinical and Translational Science Awards hub, from",
    "entities": []
  },
  {
    "text": "2006 through January 2024. The Altmetric Explorer database was then used, to",
    "entities": [
      {
        "text": "2006 through January 2024",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "collect references in sources such as news articles, tweets, and blogs. We",
    "entities": []
  },
  {
    "text": "investigated bibliometric characteristics and content areas, provide",
    "entities": []
  },
  {
    "text": "illustrative examples of influence, and determine the characteristics most",
    "entities": []
  },
  {
    "text": "likely to gain public attention.",
    "entities": []
  },
  {
    "text": "RESULTS: Articles were published in 3,923 journals with a mean Journal Impact",
    "entities": [
      {
        "text": "3,923",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Factor (JIF) of 5.78, a mean Relative Citation Ratio (RCR) score of 2.02, and",
    "entities": [
      {
        "text": "JIF",
        "label": "ORG"
      },
      {
        "text": "5.78",
        "label": "CARDINAL"
      },
      {
        "text": "Citation Ratio",
        "label": "PERSON"
      },
      {
        "text": "RCR",
        "label": "ORG"
      },
      {
        "text": "2.02",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "were cited an average of 33.7 times, totaling 1,017,291 citations. Over 4,800",
    "entities": [
      {
        "text": "33.7",
        "label": "CARDINAL"
      },
      {
        "text": "1,017,291",
        "label": "CARDINAL"
      },
      {
        "text": "Over 4,800",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "were referenced in policy and were mentioned in over 64K news articles, 7K blog",
    "entities": [
      {
        "text": "64",
        "label": "CARDINAL"
      },
      {
        "text": "K news",
        "label": "ORG"
      },
      {
        "text": "7",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "posts, and 480K X (Twitter) posts. The mean Altmetric Attention Score was 28.9,",
    "entities": [
      {
        "text": "480",
        "label": "CARDINAL"
      },
      {
        "text": "Altmetric Attention Score",
        "label": "ORG"
      },
      {
        "text": "28.9",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "with 18.5% having scores of 20 or higher. Nearly 30% were related to COVID-19,",
    "entities": [
      {
        "text": "18.5%",
        "label": "PERCENT"
      },
      {
        "text": "20",
        "label": "CARDINAL"
      },
      {
        "text": "Nearly 30%",
        "label": "PERCENT"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "indicating close public attention to this important health topic. Regression",
    "entities": []
  },
  {
    "text": "analyses indicate that higher JIF, being published after 2020, receiving more",
    "entities": [
      {
        "text": "JIF",
        "label": "ORG"
      },
      {
        "text": "2020",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Mendeley downloads, higher RCR scores, being cited by in policy, and fewer",
    "entities": [
      {
        "text": "RCR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "academic citations, were more likely to receive altmetric attention.",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: By demonstrating how supported research has influence beyond",
    "entities": []
  },
  {
    "text": "academia to become \"Academic Influencers,\" this study represents a significant",
    "entities": []
  },
  {
    "text": "advance in our ability to evaluate translational research impact.",
    "entities": []
  },
  {
    "text": "DOI: 10.1017/cts.2025.10067",
    "entities": [
      {
        "text": "10.1017",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: The authors declare none.",
    "entities": []
  },
  {
    "text": "46. Muscle Nerve. 2025 Jul 16. doi: 10.1002/mus.28479. Online ahead of print.",
    "entities": [
      {
        "text": "46",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "10.1002",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Virtual EMG: Safe and Effective Remote Supervision and Reporting.",
    "entities": []
  },
  {
    "text": "Brouillette K(1), Bacher C(2), Kassardjian CD(3)(4)(5).",
    "entities": [
      {
        "text": "Bacher C(2",
        "label": "PERSON"
      },
      {
        "text": "Kassardjian CD(3)(4)(5",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)McGill University, Faculty of Medicine and Health Sciences, Montreal, Quebec,",
    "entities": [
      {
        "text": "University, Faculty of Medicine and Health Sciences",
        "label": "ORG"
      },
      {
        "text": "Montreal",
        "label": "GPE"
      },
      {
        "text": "Quebec",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Scarborough Health Network, Toronto, Ontario, Canada.",
    "entities": [
      {
        "text": "Health Network",
        "label": "ORG"
      },
      {
        "text": "Toronto",
        "label": "GPE"
      },
      {
        "text": "Ontario",
        "label": "GPE"
      },
      {
        "text": "Canada",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Division of Neurology, Department of Medicine, University of Toronto, St.",
    "entities": [
      {
        "text": "Neurology, Department of Medicine, University of Toronto",
        "label": "ORG"
      },
      {
        "text": "St.",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Investigator, li Ka Shing Knowledge Institute, St. Michael's Hospital,",
    "entities": [
      {
        "text": "Ka Shing Knowledge Institute",
        "label": "ORG"
      },
      {
        "text": "St. Michael's Hospital",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Neurology Quality and Innovation Lab (NQIL), Toronto, Ontario, Canada.",
    "entities": [
      {
        "text": "Quality and Innovation Lab",
        "label": "ORG"
      },
      {
        "text": "Toronto",
        "label": "GPE"
      },
      {
        "text": "Ontario",
        "label": "GPE"
      },
      {
        "text": "Canada",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "The COVID-19 pandemic accelerated the implementation of virtual care in",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "healthcare, revealing challenges and opportunities in the use of remote",
    "entities": [
      {
        "text": "healthcare",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "healthcare services. Electromyography (EMG) traditionally requires in-person",
    "entities": [
      {
        "text": "EMG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "interaction, limiting access for patients in remote or underserved areas. This",
    "entities": []
  },
  {
    "text": "study explores the feasibility of performing needle EMG remotely, a concept",
    "entities": [
      {
        "text": "EMG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "referred to as \"virtual EMG,\" whereby an experienced clinician supervises a",
    "entities": [
      {
        "text": "EMG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "technician from a different location using virtual tools. We developed a system",
    "entities": []
  },
  {
    "text": "utilizing remote video technology, a high-resolution camera, and Bluetooth",
    "entities": []
  },
  {
    "text": "communication devices to allow real-time observation and guidance of EMG",
    "entities": [
      {
        "text": "EMG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "procedures. The system was tested across three phases: (1) initial setup within",
    "entities": [
      {
        "text": "three",
        "label": "CARDINAL"
      },
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "the same facility, (2) refinement with higher quality video and communication",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "tools, and (3) application in a clinical scenario involving a complex patient",
    "entities": [
      {
        "text": "3",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "case. Our findings suggest that virtual EMG can be performed safely and",
    "entities": [
      {
        "text": "EMG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "effectively, providing accurate diagnostic information while reducing the need",
    "entities": []
  },
  {
    "text": "for patient travel and in-person contact. The implementation of virtual EMG has",
    "entities": [
      {
        "text": "EMG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "rural and remote areas, aligning with the healthcare goals of enhancing patient",
    "entities": []
  },
  {
    "text": "experience, reducing costs, and promoting access. Further investigations are",
    "entities": []
  },
  {
    "text": "needed to validate this approach across various clinical scenarios and",
    "entities": []
  },
  {
    "text": "geographical locations.",
    "entities": []
  },
  {
    "text": "\u00a9 2025 Wiley Periodicals LLC.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Wiley Periodicals",
        "label": "ORG"
      },
      {
        "text": "LLC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "47. Small. 2025 Jul 16:e2500719. doi: 10.1002/smll.202500719. Online ahead of",
    "entities": [
      {
        "text": "47",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "16",
        "label": "CARDINAL"
      },
      {
        "text": "10.1002",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Polysialosides Outperform Sulfated Analogs for Binding with SARS-CoV-2.",
    "entities": []
  },
  {
    "text": "DC(3), Bhatia S(10).",
    "entities": [
      {
        "text": "Bhatia",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(2)Department of Chemistry, TDL Govt. College for Women Murthal, Sonipat,",
    "entities": [
      {
        "text": "Chemistry",
        "label": "ORG"
      },
      {
        "text": "TDL Govt",
        "label": "ORG"
      },
      {
        "text": "Sonipat",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Freie Universit\u00e4t Berlin, Institute of Pharmacy, Biopharmaceuticals,",
    "entities": [
      {
        "text": "Universit\u00e4t Berlin",
        "label": "GPE"
      },
      {
        "text": "Institute of Pharmacy, Biopharmaceuticals",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Freie Universit\u00e4t Berlin, SupraFAB, Department of Biology, Chemistry and",
    "entities": [
      {
        "text": "Universit\u00e4t Berlin",
        "label": "GPE"
      },
      {
        "text": "SupraFAB,",
        "label": "ORG"
      },
      {
        "text": "Department of Biology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Pharmacy, and Department of Physics, Altensteinstr. 23a, 14195, Berlin, Germany.",
    "entities": [
      {
        "text": "Department of Physics",
        "label": "ORG"
      },
      {
        "text": "23a, 14195",
        "label": "DATE"
      },
      {
        "text": "Berlin",
        "label": "GPE"
      },
      {
        "text": "Germany",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Berlin, Germany.",
    "entities": [
      {
        "text": "Berlin",
        "label": "GPE"
      },
      {
        "text": "Germany",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Institute of Virology, Campus Berlin Mitte, Charit\u00e9 - Universit\u00e4tsmedizin",
    "entities": [
      {
        "text": "Campus Berlin Mitte",
        "label": "PERSON"
      },
      {
        "text": "Charit\u00e9 - Universit\u00e4tsmedizin",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Core-Facility BioSupraMol, Institute of Chemistry and Biochemistry, Fabeckstra\u00dfe",
    "entities": [
      {
        "text": "Core-Facility BioSupraMol",
        "label": "ORG"
      },
      {
        "text": "Institute of Chemistry",
        "label": "ORG"
      },
      {
        "text": "Fabeckstra\u00dfe",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "36a, 14195, Berlin, Germany.",
    "entities": [
      {
        "text": "36a, 14195",
        "label": "DATE"
      },
      {
        "text": "Berlin",
        "label": "GPE"
      },
      {
        "text": "Germany",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Germany.",
    "entities": [
      {
        "text": "Germany",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(9)Department of Pathobiology and Diagnostic Medicine, Kansas State University,",
    "entities": [
      {
        "text": "Pathobiology and Diagnostic Medicine",
        "label": "ORG"
      },
      {
        "text": "Kansas State University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(10)Department of Chemistry, Faculty of Science and Engineering, Swansea",
    "entities": [
      {
        "text": "10)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Chemistry, Faculty of Science and Engineering",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University, Singleton Campus, Swansea, SA2 8PP, United Kingdom.",
    "entities": [
      {
        "text": "Singleton Campus, Swansea",
        "label": "PERSON"
      },
      {
        "text": "8PP",
        "label": "PERSON"
      },
      {
        "text": "United Kingdom",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Both polysialosides and polysulfates are known to interact with the receptor",
    "entities": []
  },
  {
    "text": "binding domain (RBD) of the SARS-CoV-2 spike protein. However, a comprehensive",
    "entities": [
      {
        "text": "RBD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "site by site analysis of their binding affinities and potential synergistic",
    "entities": []
  },
  {
    "text": "antiviral effects have not been performed. Here, we report on the synthesis of",
    "entities": []
  },
  {
    "text": "polysialosides with nanomolar binding affinities to spike proteins of SARS-CoV-2",
    "entities": []
  },
  {
    "text": "in solution using microscale thermophoresis. The dendritic polyglycerol based",
    "entities": []
  },
  {
    "text": "polysialosides dPG500SA0.55 and dPG500SA0.25, with a dissociation constant Kd of",
    "entities": []
  },
  {
    "text": "4.78 nm and 10.85 nm, respectively, bind \u2248500 times stronger than the high",
    "entities": [
      {
        "text": "4.78",
        "label": "CARDINAL"
      },
      {
        "text": "10.85",
        "label": "CARDINAL"
      },
      {
        "text": "\u2248500",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "density polysulfated analog dPG500S0.55, to intact SARS-CoV-2 virus particles or",
    "entities": []
  },
  {
    "text": "isolated spike protein. In fact, the presence of sulfate groups in a",
    "entities": []
  },
  {
    "text": "heteromultivalent compound dPG500SA0.20S0.20 weakens the binding to spike",
    "entities": []
  },
  {
    "text": "proteins. A polycarboxylated analog does not bind to SARS-CoV-2, ruling out that",
    "entities": []
  },
  {
    "text": "the interaction of polysialoside is simply driven by electrostatics. Using",
    "entities": []
  },
  {
    "text": "explicit-solvent all-atom molecular dynamics simulations and ensemble docking",
    "entities": []
  },
  {
    "text": "studies, atomistic details are obtained on the interaction of different",
    "entities": []
  },
  {
    "text": "functional groups with the SARS-CoV-2 RBD. The data support the conclusion that",
    "entities": []
  },
  {
    "text": "sialosides interact stronger than sulfates for their binding with RBD of",
    "entities": [
      {
        "text": "RBD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "SARS-CoV-2. Notably, the most affine binder dPG500SA0.55 inhibits SARS-CoV-2",
    "entities": []
  },
  {
    "text": "(WT, D614G) replication up to 98.6% at 0.5 \u00b5m concentrations.",
    "entities": [
      {
        "text": "D614G",
        "label": "PERSON"
      },
      {
        "text": "98.6%",
        "label": "PERCENT"
      },
      {
        "text": "0.5",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "\u00a9 2025 The Author(s). Small published by Wiley\u2010VCH GmbH.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Wiley\u2010VCH GmbH.\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "How COVID-19 Treatment in Pregnancy Reflects Healthcare Utilization During a",
    "entities": [
      {
        "text": "Pregnancy Reflects Healthcare Utilization",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Pandemic: A Two-Stage Individual Participant Data Meta-Analysis Combining",
    "entities": [
      {
        "text": "Two",
        "label": "CARDINAL"
      },
      {
        "text": "Meta-Analysis Combining",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Case-Based Registries.",
    "entities": []
  },
  {
    "text": "RT(14), Cecatti JG(14), Costa ML(14), Sanin-Blair J(15), Tolosa JE(15)(16)(17),",
    "entities": [
      {
        "text": "Cecatti",
        "label": "NORP"
      },
      {
        "text": "Costa",
        "label": "NORP"
      },
      {
        "text": "Sanin-Blair J(15",
        "label": "ORG"
      },
      {
        "text": "Tolosa JE(15)(16)(17",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Schuler-Faccini L(34), Goncalves Pereira N(35), Etchegaray A(36), Nieto-Calvache",
    "entities": [
      {
        "text": "Schuler",
        "label": "ORG"
      },
      {
        "text": "Goncalves Pereira N(35",
        "label": "PERSON"
      },
      {
        "text": "Etchegaray A(36",
        "label": "PERSON"
      },
      {
        "text": "Nieto-Calvache",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Materno-Fetal and Obstetrics Research Unit, Department \"Femme-M\u00e8re-Enfant\",",
    "entities": [
      {
        "text": "1)Materno-Fetal and Obstetrics Research Unit",
        "label": "ORG"
      },
      {
        "text": "Femme-M\u00e8re-Enfant",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "(2)Institute of Primary Health Care (BIHAM), University of Bern, Bern,",
    "entities": [
      {
        "text": "2)Institute",
        "label": "CARDINAL"
      },
      {
        "text": "University of Bern",
        "label": "ORG"
      },
      {
        "text": "Bern",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Graduate School for Health Sciences (GHS), University of Bern, Bern,",
    "entities": [
      {
        "text": "3)Graduate School for Health Sciences",
        "label": "ORG"
      },
      {
        "text": "University of Bern",
        "label": "ORG"
      },
      {
        "text": "Bern",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)Department of Data Science and Biostatistics, Julius Global Health,",
    "entities": [
      {
        "text": "5)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Data Science and Biostatistics",
        "label": "ORG"
      },
      {
        "text": "Julius Global Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University Medical Center Utrecht (UMCU), Utrecht, the Netherlands.",
    "entities": [
      {
        "text": "University Medical Center Utrecht",
        "label": "ORG"
      },
      {
        "text": "UMCU",
        "label": "ORG"
      },
      {
        "text": "Utrecht",
        "label": "GPE"
      },
      {
        "text": "Netherlands",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Department of Obstetrics, Wilhelmina Children's Hospital, University Medical",
    "entities": [
      {
        "text": "Obstetrics",
        "label": "GPE"
      },
      {
        "text": "University Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Center Utrecht (UMCU), Utrecht, the Netherlands.",
    "entities": [
      {
        "text": "UMCU",
        "label": "ORG"
      },
      {
        "text": "Utrecht",
        "label": "GPE"
      },
      {
        "text": "Netherlands",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Department of Obstetrics and Gynecology, Riviera-Chablais Hospital, Rennaz,",
    "entities": [
      {
        "text": "Obstetrics and Gynecology",
        "label": "ORG"
      },
      {
        "text": "Riviera-Chablais Hospital",
        "label": "ORG"
      },
      {
        "text": "Rennaz",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(8)Department of Global Health, The George Washington University Milken",
    "entities": [
      {
        "text": "Global Health",
        "label": "ORG"
      },
      {
        "text": "The George Washington University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Institute School of Public Health, Washington, DC, USA.",
    "entities": [
      {
        "text": "Institute School of Public Health",
        "label": "ORG"
      },
      {
        "text": "Washington, DC,",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(9)Saudi Food and Drug Authority, Riyadh, Saudi Arabia.",
    "entities": [
      {
        "text": "Food and Drug Authority",
        "label": "ORG"
      },
      {
        "text": "Riyadh",
        "label": "GPE"
      },
      {
        "text": "Saudi Arabia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(11)Obstetrics and Gynecology Department, Hospital Universitario La Paz, Madrid,",
    "entities": [
      {
        "text": "11)Obstetrics and Gynecology Department",
        "label": "ORG"
      },
      {
        "text": "Hospital Universitario La",
        "label": "FAC"
      },
      {
        "text": "Madrid",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(12)School of Medicine, Universidad Francisco de Vitoria, Madrid, Spain.",
    "entities": [
      {
        "text": "12)School",
        "label": "CARDINAL"
      },
      {
        "text": "Universidad Francisco de Vitoria",
        "label": "PERSON"
      },
      {
        "text": "Madrid",
        "label": "GPE"
      },
      {
        "text": "Spain",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(13)University of Padova, Padova, Italy.",
    "entities": [
      {
        "text": "13)University",
        "label": "CARDINAL"
      },
      {
        "text": "Padova",
        "label": "GPE"
      },
      {
        "text": "Padova",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(14)Department of Obstetrics and Gynecology, Universidade Estadual de Campinas",
    "entities": [
      {
        "text": "Obstetrics and Gynecology",
        "label": "ORG"
      },
      {
        "text": "Estadual de Campinas",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(16)St. Luke's University Health Network, Bethlehem, PA, USA.",
    "entities": [
      {
        "text": "Luke's University Health Network",
        "label": "ORG"
      },
      {
        "text": "Bethlehem",
        "label": "GPE"
      },
      {
        "text": "PA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(17)Oregon Health & Science University, Oregon, USA.",
    "entities": [
      {
        "text": "17)Oregon Health & Science University",
        "label": "ORG"
      },
      {
        "text": "Oregon",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(18)Helen Schneider Hospital for Women, Rabin Medical Center, and the Faculty of",
    "entities": [
      {
        "text": "18)Helen",
        "label": "CARDINAL"
      },
      {
        "text": "Schneider Hospital for Women",
        "label": "ORG"
      },
      {
        "text": "Rabin Medical Center",
        "label": "ORG"
      },
      {
        "text": "the Faculty of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medical and Health Sciences, Tel-Aviv University, Tel Aviv, Israel.",
    "entities": [
      {
        "text": "Medical and Health Sciences",
        "label": "ORG"
      },
      {
        "text": "Tel-Aviv University",
        "label": "ORG"
      },
      {
        "text": "Tel Aviv",
        "label": "GPE"
      },
      {
        "text": "Israel",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(19)Maternal-Fetal Medicine Department, BCNatal-Fetal Medicine Research Center,",
    "entities": [
      {
        "text": "19)Maternal-Fetal Medicine Department",
        "label": "ORG"
      },
      {
        "text": "BCNatal-Fetal Medicine Research Center",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Barcelona, Spain.",
    "entities": [
      {
        "text": "Barcelona",
        "label": "GPE"
      },
      {
        "text": "Spain",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(20)Department of Obstetrics and Gynecology, H\u00f4pital NOVO Site de Pontoise,",
    "entities": [
      {
        "text": "20)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Obstetrics and Gynecology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(21)Department of Obstetrics, Maternit\u00e9 Poissy Saint Germain, Poissy, France.",
    "entities": [
      {
        "text": "21)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Poissy",
        "label": "PERSON"
      },
      {
        "text": "France",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(22)Obstetrics Division, Department of Pediatrics, Gynecology, and Obstetrics,",
    "entities": [
      {
        "text": "22)Obstetrics Division",
        "label": "ORG"
      },
      {
        "text": "Department of Pediatrics, Gynecology",
        "label": "ORG"
      },
      {
        "text": "Obstetrics",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Geneva University Hospitals, and Faculty of Medicine, Geneva, Switzerland.",
    "entities": [
      {
        "text": "Geneva University Hospitals",
        "label": "ORG"
      },
      {
        "text": "Faculty of Medicine",
        "label": "ORG"
      },
      {
        "text": "Geneva",
        "label": "GPE"
      },
      {
        "text": "Switzerland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(23)Department of Obstetrics and Gynecology, RHNE, Neuch\u00e2tel, Switzerland.",
    "entities": [
      {
        "text": "23)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Obstetrics and Gynecology",
        "label": "ORG"
      },
      {
        "text": "RHNE",
        "label": "ORG"
      },
      {
        "text": "Neuch\u00e2tel",
        "label": "GPE"
      },
      {
        "text": "Switzerland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(24)Department of Obstetrics and Feto-Maternal Medicine, University Hospital of",
    "entities": [
      {
        "text": "24)Department",
        "label": "CARDINAL"
      },
      {
        "text": "University Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Bern, University of Bern, Bern, Switzerland.",
    "entities": [
      {
        "text": "Bern",
        "label": "ORG"
      },
      {
        "text": "University of Bern",
        "label": "ORG"
      },
      {
        "text": "Bern",
        "label": "GPE"
      },
      {
        "text": "Switzerland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(25)Department of Obstetrics and Gynecology, Cantonal Hospital Aarau, Aarau,",
    "entities": [
      {
        "text": "25)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Obstetrics and Gynecology",
        "label": "ORG"
      },
      {
        "text": "Cantonal Hospital Aarau",
        "label": "ORG"
      },
      {
        "text": "Aarau",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(26)Department of Obstetrics and Gynecology, University Hospital Basel, Basel,",
    "entities": [
      {
        "text": "Obstetrics and Gynecology",
        "label": "ORG"
      },
      {
        "text": "University Hospital Basel",
        "label": "ORG"
      },
      {
        "text": "Basel",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(27)Division of Obstetrics, Baden Cantonal Hospital, Baden, Switzerland.",
    "entities": [
      {
        "text": "27)Division of Obstetrics",
        "label": "ORG"
      },
      {
        "text": "Baden Cantonal Hospital",
        "label": "ORG"
      },
      {
        "text": "Baden",
        "label": "GPE"
      },
      {
        "text": "Switzerland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(28)Medical Research Center, Kateb University, Kabul, Afghanistan.",
    "entities": [
      {
        "text": "28)Medical Research Center",
        "label": "ORG"
      },
      {
        "text": "Kateb University",
        "label": "ORG"
      },
      {
        "text": "Kabul",
        "label": "GPE"
      },
      {
        "text": "Afghanistan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(29)Department of Research, Afghanistan National Charity Organization for",
    "entities": [
      {
        "text": "29)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Afghanistan National Charity Organization",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Special Diseases (ANCOSD), Kabul, Afghanistan.",
    "entities": [
      {
        "text": "Special Diseases",
        "label": "ORG"
      },
      {
        "text": "ANCOSD",
        "label": "ORG"
      },
      {
        "text": "Kabul",
        "label": "GPE"
      },
      {
        "text": "Afghanistan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(30)Department of Obstetrics and Gynecology, Medical School, University of",
    "entities": [
      {
        "text": "30)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Obstetrics and Gynecology, Medical School, University of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Lisbon; Santa Maria University Hospital, Lisbon, Portugal.",
    "entities": [
      {
        "text": "Lisbon",
        "label": "GPE"
      },
      {
        "text": "Santa Maria University Hospital",
        "label": "ORG"
      },
      {
        "text": "Lisbon",
        "label": "GPE"
      },
      {
        "text": "Portugal",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(31)School of Health Sciences (HESAV), University of Applied Sciences and Arts",
    "entities": [
      {
        "text": "31)School of Health Sciences",
        "label": "ORG"
      },
      {
        "text": "HESAV",
        "label": "ORG"
      },
      {
        "text": "University of Applied Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(32)Department of Obstetrics and Fetal Medicine, Necker-Enfants Malades",
    "entities": [
      {
        "text": "32)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Obstetrics and Fetal Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Hospital, Paris, France.",
    "entities": [
      {
        "text": "Paris",
        "label": "GPE"
      },
      {
        "text": "France",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(33)Department of Gynecology and Obstetrics, Ente Ospedaliero Cantonale, Lugano,",
    "entities": [
      {
        "text": "Lugano",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(36)Fetal Medicine Unit, Hospital Universitario Austral, Buenos Aires,",
    "entities": [
      {
        "text": "36)Fetal Medicine Unit",
        "label": "ORG"
      },
      {
        "text": "Hospital Universitario Austral",
        "label": "ORG"
      },
      {
        "text": "Buenos Aires",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(38)Department of Obstetrics and Gynecology, Rotunda Hospital, Dublin, Ireland.",
    "entities": [
      {
        "text": "Obstetrics and Gynecology",
        "label": "ORG"
      },
      {
        "text": "Rotunda Hospital",
        "label": "ORG"
      },
      {
        "text": "Dublin",
        "label": "GPE"
      },
      {
        "text": "Ireland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(40)Department of Obstetrics and Gynecology, Stadtspital Triemli, Z\u00fcrich,",
    "entities": [
      {
        "text": "Obstetrics and Gynecology",
        "label": "ORG"
      },
      {
        "text": "Z\u00fcrich",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(41)Department of Epidemiology of Microbial Diseases, Yale School of Public",
    "entities": [
      {
        "text": "Epidemiology of Microbial Diseases",
        "label": "ORG"
      },
      {
        "text": "Yale School of Public",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Health, New Haven, USA.",
    "entities": [
      {
        "text": "New Haven",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(42)Department of Gynecology and Obstetrics, Hospital of the Upper Valais, Visp,",
    "entities": [
      {
        "text": "42)Department of Gynecology and Obstetrics, Hospital of",
        "label": "MONEY"
      },
      {
        "text": "Visp",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(44)Department of Obstetrics, Grabs Hospital, Grabs, Switzerland.",
    "entities": [
      {
        "text": "Obstetrics, Grabs Hospital",
        "label": "ORG"
      },
      {
        "text": "Grabs",
        "label": "GPE"
      },
      {
        "text": "Switzerland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(45)West French Guiana Hospital Center, University of French Guiana, Saint",
    "entities": [
      {
        "text": "French",
        "label": "NORP"
      },
      {
        "text": "Guiana Hospital Center,",
        "label": "ORG"
      },
      {
        "text": "University of French Guiana",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(46)Division of Infectious Diseases, Department of Pediatrics, David Geffen UCLA",
    "entities": [
      {
        "text": "46)Division",
        "label": "CARDINAL"
      },
      {
        "text": "Department of Pediatrics",
        "label": "ORG"
      },
      {
        "text": "David Geffen UCLA",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "School of Medicine, Los Angeles, CA, USA.",
    "entities": [
      {
        "text": "School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Los Angeles",
        "label": "GPE"
      },
      {
        "text": "CA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(47)Department of Obstetrics, CHU Lille, Univ Lille, ULR 2694-METRICS, Lille,",
    "entities": [
      {
        "text": "47)Department of Obstetrics",
        "label": "ORG"
      },
      {
        "text": "Univ Lille",
        "label": "PERSON"
      },
      {
        "text": "ULR",
        "label": "PERSON"
      },
      {
        "text": "Lille",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(48)Department of Obstetrics and Gynecology, Bordeaux University Hospital,",
    "entities": [
      {
        "text": "Obstetrics and Gynecology",
        "label": "ORG"
      },
      {
        "text": "Bordeaux University Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(50)Department of Obstetrics, Kantonsspital Baselland, Liestal, Switzerland.",
    "entities": [
      {
        "text": "50)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Kantonsspital Baselland",
        "label": "ORG"
      },
      {
        "text": "Liestal",
        "label": "ORG"
      },
      {
        "text": "Switzerland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(51)Obstetrics and Gynecology Department, Faculty of Medicine, Universitas",
    "entities": [
      {
        "text": "51)Obstetrics and Gynecology Department",
        "label": "ORG"
      },
      {
        "text": "Faculty of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(52)Department of Obstetrics Gynecology, \"Koco Gliozheni' University Hospital,",
    "entities": [
      {
        "text": "Obstetrics Gynecology",
        "label": "ORG"
      },
      {
        "text": "Koco Gliozheni' University Hospital",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "(53)Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht",
    "entities": [
      {
        "text": "53)Division of Pharmacoepidemiology and Clinical Pharmacology",
        "label": "ORG"
      },
      {
        "text": "Utrecht",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the",
    "entities": [
      {
        "text": "Institute for Pharmaceutical Sciences",
        "label": "ORG"
      },
      {
        "text": "Utrecht University",
        "label": "ORG"
      },
      {
        "text": "Utrecht",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Netherlands.",
    "entities": [
      {
        "text": "Netherlands",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(54)Service of Pharmacy, Lausanne University Hospital and University of",
    "entities": [
      {
        "text": "Lausanne University Hospital and University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "PURPOSE: To describe an international response to the COVID-19 pandemic by",
    "entities": [
      {
        "text": "PURPOSE",
        "label": "ORG"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "estimating the prevalence of medication use for COVID-19 treatment in pregnancy,",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "stratified by hospitalization, trimester of pregnancy, and country.",
    "entities": []
  },
  {
    "text": "METHODS: We conducted a two-stage individual participant data meta-analysis of",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "proportions from primary data on medications used to treat COVID-19 during",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "pregnancy. A common data model was developed to pool the data from",
    "entities": []
  },
  {
    "text": "single-country and international registries. Data from pregnant individuals with",
    "entities": []
  },
  {
    "text": "COVID-19 between February 2020 and October 2022 were included in study platforms",
    "entities": [
      {
        "text": "between February 2020 and October 2022",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "across 9 data sources. Patient information was abstracted from medical records.",
    "entities": [
      {
        "text": "9",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "RESULTS: Among 24 937 pregnant individuals, the pooled prevalences of",
    "entities": [
      {
        "text": "24 937",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "individuals receiving medications to treat COVID-19 were: 34.7% heparin, 9.8%",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      },
      {
        "text": "34.7%",
        "label": "PERCENT"
      },
      {
        "text": "9.8%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "Prevalence of medication use was higher in hospitalized individuals than in",
    "entities": []
  },
  {
    "text": "non-hospitalized individuals: 58.4% versus 17.9% for heparin, 26.9% versus 5.7%",
    "entities": [
      {
        "text": "58.4%",
        "label": "PERCENT"
      },
      {
        "text": "17.9%",
        "label": "PERCENT"
      },
      {
        "text": "26.9%",
        "label": "PERCENT"
      },
      {
        "text": "5.7%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "for antibiotics, 17.5% versus 1.3% for corticosteroids, 10.3% versus 0.3% for",
    "entities": [
      {
        "text": "17.5%",
        "label": "PERCENT"
      },
      {
        "text": "1.3%",
        "label": "PERCENT"
      },
      {
        "text": "10.3%",
        "label": "PERCENT"
      },
      {
        "text": "0.3%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "antivirals, and 4.5% versus 0.1% for antimalarials. The prevalence of",
    "entities": [
      {
        "text": "4.5%",
        "label": "PERCENT"
      },
      {
        "text": "0.1%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "corticosteroid use was lower in the first trimester (0.1%) compared with the",
    "entities": [
      {
        "text": "first",
        "label": "ORDINAL"
      },
      {
        "text": "0.1%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "second (7.2%) and third (4.9%) trimesters of pregnancy. The prevalence of",
    "entities": [
      {
        "text": "second",
        "label": "ORDINAL"
      },
      {
        "text": "7.2%",
        "label": "PERCENT"
      },
      {
        "text": "third",
        "label": "ORDINAL"
      },
      {
        "text": "4.9%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "medications differed widely across countries.",
    "entities": []
  },
  {
    "text": "CONCLUSION: Medication to treat COVID-19 was more frequently used in pregnant",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "individuals hospitalized for COVID-19. Corticosteroids were used less in the",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "first trimester of pregnancy. The differences in use between countries could",
    "entities": [
      {
        "text": "first",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "reflect differences in the clinical management and access to medications for",
    "entities": []
  },
  {
    "text": "this population at risk of severe disease.",
    "entities": []
  },
  {
    "text": "\u00a9 2025 John Wiley & Sons Ltd.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "John Wiley & Sons Ltd.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "PMID: 40665803 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40665803",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "T Cell Response Evaluation After A Fifth Dose of an Inactivated SARS-CoV-2",
    "entities": []
  },
  {
    "text": "Vaccine Using Multiparametric Flow Cytometry.",
    "entities": []
  },
  {
    "text": "(1)Millennium Institute on Immunology and Immunotherapy, Facultad de Ciencias",
    "entities": [
      {
        "text": "Institute on Immunology",
        "label": "ORG"
      },
      {
        "text": "Facultad de Ciencias",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(2)Millennium Institute on Immunology and Immunotherapy, Programa de",
    "entities": [
      {
        "text": "Institute on Immunology",
        "label": "ORG"
      },
      {
        "text": "Programa",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "The T cell response induced by SARS-CoV-2 vaccines is an essential component of",
    "entities": []
  },
  {
    "text": "immune protection against COVID-19. Multiparametric flow cytometry analysis",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "emerges as a valuable tool for in-depth assessment of T cell phenotype nuances",
    "entities": []
  },
  {
    "text": "that occur after booster vaccination, such as a fifth dose of an inactivated",
    "entities": [
      {
        "text": "fifth",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "SARS-CoV-2 vaccine. Figure created with BioRender.com.",
    "entities": [
      {
        "text": "BioRender.com",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "PMID: 40665756 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40665756",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "of print.",
    "entities": []
  },
  {
    "text": "Complications of Carotid Artery Stenting: A Real-World Cohort Study in Canada",
    "entities": [
      {
        "text": "Canada",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "before and during the COVID-19 Pandemic.",
    "entities": []
  },
  {
    "text": "S(1), Singh N(5)(6), Chakraborty S(2)(7), Portela de Oliveira E(2)(7),",
    "entities": [
      {
        "text": "Singh N(5)(6",
        "label": "GPE"
      },
      {
        "text": "Chakraborty",
        "label": "ORG"
      },
      {
        "text": "Portela de Oliveira",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Department of Medicine, University of Ottawa, Ottawa, Canada.",
    "entities": [
      {
        "text": "Medicine, University of Ottawa",
        "label": "ORG"
      },
      {
        "text": "Ottawa",
        "label": "GPE"
      },
      {
        "text": "Canada",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Ottawa Hospital Research Institute, Ottawa, Canada.",
    "entities": [
      {
        "text": "2)Ottawa Hospital Research Institute",
        "label": "ORG"
      },
      {
        "text": "Ottawa",
        "label": "GPE"
      },
      {
        "text": "Canada",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Medical Imaging, Division of Radiology, University of Ottawa,",
    "entities": [
      {
        "text": "Medical Imaging",
        "label": "ORG"
      },
      {
        "text": "Division of Radiology",
        "label": "ORG"
      },
      {
        "text": "University of Ottawa",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Department of Surgery and School of Epidemiology and Public Health, Division",
    "entities": [
      {
        "text": "Surgery and School of Epidemiology and Public Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of Vascular and Endovascular Surgery, University of Ottawa, Ottawa, Canada.",
    "entities": [
      {
        "text": "Vascular",
        "label": "LOC"
      },
      {
        "text": "University of Ottawa",
        "label": "ORG"
      },
      {
        "text": "Ottawa",
        "label": "GPE"
      },
      {
        "text": "Canada",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Neurosciences, Radiology and Community Health Sciences,",
    "entities": [
      {
        "text": "Neurosciences, Radiology and Community Health Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University of Calgary, Calgary, Canada.",
    "entities": [
      {
        "text": "University of Calgary",
        "label": "ORG"
      },
      {
        "text": "Calgary",
        "label": "GPE"
      },
      {
        "text": "Canada",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Department of Internal Medicine (Neurology Division), Rady Faculty of Health",
    "entities": [
      {
        "text": "Internal Medicine (Neurology Division",
        "label": "ORG"
      },
      {
        "text": "Rady Faculty of Health\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Sciences, University of Manitoba, Winnipeg, Canada.",
    "entities": [
      {
        "text": "University of Manitoba",
        "label": "ORG"
      },
      {
        "text": "Winnipeg",
        "label": "GPE"
      },
      {
        "text": "Canada",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Department of Radiology, Radiation Oncology and Medical Physics, University",
    "entities": [
      {
        "text": "Radiology, Radiation Oncology and Medical Physics",
        "label": "ORG"
      },
      {
        "text": "University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "BACKGROUND AND OBJECTIVES: Although carotid endarterectomy (CEA) or carotid",
    "entities": [
      {
        "text": "OBJECTIVES",
        "label": "ORG"
      },
      {
        "text": "CEA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "artery stenting (CAS) is recommended for symptomatic extracranial carotid",
    "entities": [
      {
        "text": "CAS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "stenosis of 50-99%, the COVID-19 pandemic significantly impacted resources. CAS",
    "entities": [
      {
        "text": "50-99%",
        "label": "PERCENT"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      },
      {
        "text": "CAS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "therefore offered potential advantages as access to the angiosuite was seemingly",
    "entities": []
  },
  {
    "text": "easier than access to operating rooms. The primary objective was to determine",
    "entities": []
  },
  {
    "text": "the frequency of serious and non-serious complications following CAS before and",
    "entities": [
      {
        "text": "CAS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "during the COVID-19 pandemic.",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "METHODS: We performed a retrospective cohort study of consecutive patients who",
    "entities": []
  },
  {
    "text": "received CAS at the Ottawa Hospital, Canada, from June 2019 to May 2021. We",
    "entities": [
      {
        "text": "CAS",
        "label": "ORG"
      },
      {
        "text": "the Ottawa Hospital",
        "label": "FAC"
      },
      {
        "text": "Canada",
        "label": "GPE"
      },
      {
        "text": "June 2019",
        "label": "DATE"
      },
      {
        "text": "May 2021",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "reviewed baseline demographics, imaging, as well as intraprocedural and",
    "entities": []
  },
  {
    "text": "postprocedural complications based on chart review. We performed multivariable",
    "entities": []
  },
  {
    "text": "logistic regression to determine associations between clinical and safety",
    "entities": []
  },
  {
    "text": "RESULTS: We included 47 patients in the pre-pandemic period and 93 patients in",
    "entities": [
      {
        "text": "47",
        "label": "CARDINAL"
      },
      {
        "text": "93",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "the pandemic period (mean age = 70.4 years; 54% female; P = 0.287 for age and P",
    "entities": [
      {
        "text": "70.4 years",
        "label": "DATE"
      },
      {
        "text": "54%",
        "label": "PERCENT"
      },
      {
        "text": "0.287",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "= 0.962 for sex, respectively). The combined rate of intraprocedural and",
    "entities": [
      {
        "text": "0.962",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "postprocedural serious complications (ischemic stroke, intracerebral hemorrhage,",
    "entities": []
  },
  {
    "text": "myocardial infarction or death) was 7.1%. Eight strokes occurred, and one",
    "entities": [
      {
        "text": "7.1%",
        "label": "PERCENT"
      },
      {
        "text": "Eight",
        "label": "CARDINAL"
      },
      {
        "text": "one",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "patient with a postprocedural ischemic stroke died 11 days after stenting.",
    "entities": [
      {
        "text": "11 days",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Complication rates were similar before and during the pandemic (aOR 1.040, 95%",
    "entities": [
      {
        "text": "1.040",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "CI 0.466-2.321). The number of referrals for CEA during the pandemic period",
    "entities": [
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.466-2.321",
        "label": "CARDINAL"
      },
      {
        "text": "CEA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "decreased by 50%.",
    "entities": [
      {
        "text": "50%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "CONCLUSION: In this cohort of consecutive patients undergoing CAS at a Canadian",
    "entities": [
      {
        "text": "CAS",
        "label": "ORG"
      },
      {
        "text": "Canadian",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "comprehensive stroke center before and during the COVID-19 pandemic, the rates",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of stroke and death were similar to pre-pandemic conditions and were generally",
    "entities": []
  },
  {
    "text": "consistent with the published literature.",
    "entities": []
  },
  {
    "text": "51. Nat Prod Res. 2025 Jul 15:1-8. doi: 10.1080/14786419.2025.2528971. Online",
    "entities": [
      {
        "text": "51",
        "label": "CARDINAL"
      },
      {
        "text": "Nat Prod Res",
        "label": "PERSON"
      },
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "ahead of print.",
    "entities": []
  },
  {
    "text": "Phytochemical analysis of elderberry (Sambucus nigra): focus on non-anthocyanin",
    "entities": [
      {
        "text": "Sambucus",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)National Center for Natural Products Research, School of Pharmacy, University",
    "entities": [
      {
        "text": "Center for Natural Products Research",
        "label": "ORG"
      },
      {
        "text": "School of Pharmacy",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of Mississippi, University, MS, USA.",
    "entities": [
      {
        "text": "Mississippi",
        "label": "GPE"
      },
      {
        "text": "University",
        "label": "GPE"
      },
      {
        "text": "MS",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Division of Pharmacognosy, Department of Bio-Molecular Sciences, School of",
    "entities": [
      {
        "text": "Pharmacognosy, Department of Bio-Molecular Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Pharmacy, University of Mississippi, University, MS, USA.",
    "entities": [
      {
        "text": "University of Mississippi",
        "label": "ORG"
      },
      {
        "text": "University",
        "label": "GPE"
      },
      {
        "text": "MS",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Elderberry (Sambucus nigra) has received considerable attention for its",
    "entities": [
      {
        "text": "Elderberry",
        "label": "PERSON"
      },
      {
        "text": "Sambucus",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "health-promoting properties, particularly during the COVID-19 pandemic, when its",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "products became one of the top-selling herbal supplements in the United States.",
    "entities": [
      {
        "text": "the United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "While the anthocyanin profile of elderberry is well characterised, comprehensive",
    "entities": []
  },
  {
    "text": "studies of its non-anthocyanin constituents are underexplored. An in-depth",
    "entities": []
  },
  {
    "text": "phytochemical investigation of dried elderberry fruits, focusing on",
    "entities": []
  },
  {
    "text": "non-anthocyanin constituents, led to the discovery of a novel iridoid glycoside",
    "entities": []
  },
  {
    "text": "named elderberoside (1). Additionally, ten known metabolites were isolated,",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      },
      {
        "text": "ten",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "including an iridoid (2), an alkaloid (3), and eight flavonoids (4-11).",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      },
      {
        "text": "3",
        "label": "CARDINAL"
      },
      {
        "text": "eight",
        "label": "CARDINAL"
      },
      {
        "text": "4-11",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Structural elucidation of these compounds was achieved through detailed",
    "entities": []
  },
  {
    "text": "one-dimensional (1D) and two-dimensional (2D) nuclear magnetic resonance (NMR)",
    "entities": [
      {
        "text": "one",
        "label": "CARDINAL"
      },
      {
        "text": "two",
        "label": "CARDINAL"
      },
      {
        "text": "NMR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "spectroscopy and confirmed by mass spectrometry.",
    "entities": []
  },
  {
    "text": "52. Hum Vaccin Immunother. 2025 Dec;21(1):2528409. doi:",
    "entities": [
      {
        "text": "52",
        "label": "CARDINAL"
      },
      {
        "text": "Hum Vaccin Immunother",
        "label": "PERSON"
      },
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Economic evaluations of vaccines against respiratory infections in adults in",
    "entities": []
  },
  {
    "text": "Southeast Asia: A systematic review.",
    "entities": [
      {
        "text": "Southeast Asia",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "(1)Department of Health Sciences, University of Groningen, University Medical",
    "entities": [
      {
        "text": "Health Sciences",
        "label": "ORG"
      },
      {
        "text": "University of Groningen, University Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Faculty of Public Health, Thai Nguyen University of Medicine and Pharmacy,",
    "entities": [
      {
        "text": "Public Health",
        "label": "ORG"
      },
      {
        "text": "Thai Nguyen University of Medicine and Pharmacy",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Center of Excellence in Higher Education for Pharmaceutical Care Innovation,",
    "entities": [
      {
        "text": "Excellence in Higher Education for Pharmaceutical Care Innovation",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Department of Economics, Econometrics, and Finance, University of Groningen,",
    "entities": [
      {
        "text": "Economics, Econometrics",
        "label": "ORG"
      },
      {
        "text": "Finance",
        "label": "ORG"
      },
      {
        "text": "University of Groningen",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)Division of Pharmacology & Therapy, Faculty of Medicine, Universitas",
    "entities": [
      {
        "text": "Pharmacology & Therapy, Faculty of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(6)Department of Economics, Econometrics and Finance, Faculty of Economics and",
    "entities": [
      {
        "text": "Economics",
        "label": "ORG"
      },
      {
        "text": "Econometrics",
        "label": "ORG"
      },
      {
        "text": "Faculty of Economics",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Business, University of Groningen, Groningen, Netherlands.",
    "entities": [
      {
        "text": "Business, University of Groningen",
        "label": "ORG"
      },
      {
        "text": "Groningen",
        "label": "GPE"
      },
      {
        "text": "Netherlands",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Faculty of Management Sciences, Open University, Heerlen, Netherlands.",
    "entities": [
      {
        "text": "Management Sciences",
        "label": "ORG"
      },
      {
        "text": "Open University",
        "label": "ORG"
      },
      {
        "text": "Heerlen",
        "label": "GPE"
      },
      {
        "text": "Netherlands",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Respiratory infections significantly impact adult health in Southeast Asia, yet",
    "entities": [
      {
        "text": "Southeast Asia",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "vaccine coverage remains low. This systematic review evaluated the economic",
    "entities": []
  },
  {
    "text": "evaluations of vaccines targeting respiratory infections in the region. A",
    "entities": []
  },
  {
    "text": "comprehensive search was conducted across several databases, including",
    "entities": []
  },
  {
    "text": "MEDLINE/PubMed, EMBASE, NHSEED, CINAHL, EconLit, Web of Science, Scopus, and",
    "entities": [
      {
        "text": "MEDLINE/PubMed",
        "label": "ORG"
      },
      {
        "text": "EMBASE",
        "label": "ORG"
      },
      {
        "text": "NHSEED",
        "label": "ORG"
      },
      {
        "text": "EconLit",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Cochrane Library, up to April 24, 2024. Nineteen eligible studies were",
    "entities": [
      {
        "text": "Cochrane Library",
        "label": "PERSON"
      },
      {
        "text": "April 24, 2024",
        "label": "DATE"
      },
      {
        "text": "Nineteen",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "identified, focusing primarily on influenza (8 studies) and COVID-19 vaccines (7",
    "entities": [
      {
        "text": "8",
        "label": "CARDINAL"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      },
      {
        "text": "7",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "studies), with fewer studies on pneumococcal (2 studies), varicella (1 study),",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      },
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "and pertussis (1 study) vaccines. Overall, influenza, COVID-19 (boosters), and",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      },
      {
        "text": "COVID-19",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "pneumococcal vaccines were found to be cost-effective or highly cost-effective",
    "entities": []
  },
  {
    "text": "compared to no-vaccine or no-booster scenarios. The only study on maternal",
    "entities": []
  },
  {
    "text": "pertussis vaccination found it not to be cost-effective. The most common",
    "entities": []
  },
  {
    "text": "parameters considered in sensitivity analyses were vaccine efficacy and discount",
    "entities": []
  },
  {
    "text": "rates. This review highlights the economic evaluations of influenza, COVID-19,",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and pneumococcal vaccines in Southeast Asia, providing essential evidence to",
    "entities": [
      {
        "text": "Southeast Asia",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "guide vaccine policy. Future studies should address limitations in model",
    "entities": []
  },
  {
    "text": "selection, incorporate herd immunity, ensure the model validation (i.e. validity",
    "entities": []
  },
  {
    "text": "of cost and benefit measurements), and explore the cost-effectiveness of other",
    "entities": []
  },
  {
    "text": "vaccines across the region.",
    "entities": []
  },
  {
    "text": "PMID: 40665593 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40665593",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "53. Nephrology (Carlton). 2025 Jul;30(7):e70097. doi: 10.1111/nep.70097.",
    "entities": [
      {
        "text": "53",
        "label": "CARDINAL"
      },
      {
        "text": "Carlton",
        "label": "ORG"
      },
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "10.1111",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Machine Learning Models for Predicting Acute and Chronic Kidney Diseases During",
    "entities": [
      {
        "text": "Predicting Acute",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "the Post-Covid-19 Pandemic.",
    "entities": []
  },
  {
    "text": "(1)Quantitative Life Sciences, McGill University, Qu\u00e9bec, Canada.",
    "entities": [
      {
        "text": "Life Sciences",
        "label": "ORG"
      },
      {
        "text": "McGill University",
        "label": "ORG"
      },
      {
        "text": "Qu\u00e9bec",
        "label": "GPE"
      },
      {
        "text": "Canada",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)McGill Genome Centre, McGill University, Qu\u00e9bec, Canada.",
    "entities": [
      {
        "text": "2)McGill",
        "label": "CARDINAL"
      },
      {
        "text": "Genome Centre",
        "label": "ORG"
      },
      {
        "text": "McGill University",
        "label": "ORG"
      },
      {
        "text": "Qu\u00e9bec",
        "label": "GPE"
      },
      {
        "text": "Canada",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Canada Excellence Research Chair in Genomic Medicine, McGill University,",
    "entities": [
      {
        "text": "Excellence Research Chair",
        "label": "ORG"
      },
      {
        "text": "Genomic Medicine",
        "label": "ORG"
      },
      {
        "text": "McGill University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Department of Human Genetics, McGill University, Qu\u00e9bec, Canada.",
    "entities": [
      {
        "text": "Human Genetics",
        "label": "ORG"
      },
      {
        "text": "McGill University",
        "label": "ORG"
      },
      {
        "text": "Qu\u00e9bec",
        "label": "GPE"
      },
      {
        "text": "Canada",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Diabetes, Endocrinology and Nutrition, Kyoto University",
    "entities": [
      {
        "text": "Diabetes, Endocrinology and Nutrition",
        "label": "ORG"
      },
      {
        "text": "Kyoto University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Graduate School of Medicine, Kyoto, Japan.",
    "entities": [
      {
        "text": "Graduate School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Kyoto",
        "label": "GPE"
      },
      {
        "text": "Japan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "54. J Rural Health. 2025 Jun;41(3):e70049. doi: 10.1111/jrh.70049.",
    "entities": [
      {
        "text": "54",
        "label": "CARDINAL"
      },
      {
        "text": "J Rural Health",
        "label": "ORG"
      },
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "10.1111/jrh.70049",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Enduring lessons from the COVID-19 pandemic: Advancing virtual care for",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "substance use disorders in rural America.",
    "entities": [
      {
        "text": "America",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "LaPorte TM(1), McGinnis S(1), Lacy G(1).",
    "entities": [
      {
        "text": "LaPorte TM(1",
        "label": "PERSON"
      },
      {
        "text": "McGinnis S(1",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Center for Human Services Research, University at Albany, Albany, New York,",
    "entities": [
      {
        "text": "Human Services Research, University at Albany",
        "label": "ORG"
      },
      {
        "text": "Albany",
        "label": "GPE"
      },
      {
        "text": "New York",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "PURPOSE: This study explores how rural substance use disorder (SUD) treatment",
    "entities": [
      {
        "text": "PURPOSE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "providers in New York State adapted to pandemic-era policy changes by rapidly",
    "entities": [
      {
        "text": "New York State",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "adopting virtual care, identifying both challenges and opportunities to inform",
    "entities": []
  },
  {
    "text": "METHODS: Thematic analysis of qualitative data from individual interviews with",
    "entities": []
  },
  {
    "text": "12 SUD treatment providers and a focus group with an additional 6 providers in",
    "entities": [
      {
        "text": "12",
        "label": "CARDINAL"
      },
      {
        "text": "an additional 6",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "rural New York State was conducted between February and May 2021, capturing",
    "entities": [
      {
        "text": "New York State",
        "label": "GPE"
      },
      {
        "text": "between February and May 2021",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "experiences with virtual care during the COVID-19 pandemic.",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "FINDINGS: The pandemic drove swift virtual care adoption, overcoming some rural",
    "entities": []
  },
  {
    "text": "barriers to SUD treatment access, like limited transportation and provider",
    "entities": []
  },
  {
    "text": "shortages. Providers noted enhanced flexibility, allowing more person-centered",
    "entities": []
  },
  {
    "text": "care adapting to clients' logistical challenges. However, limitations emerged,",
    "entities": []
  },
  {
    "text": "including digital access disparities, reduced client accountability, and",
    "entities": []
  },
  {
    "text": "challenges establishing therapeutic relationships-especially for new clients or",
    "entities": []
  },
  {
    "text": "group sessions. Virtual care effectiveness varied by treatment stage, client",
    "entities": []
  },
  {
    "text": "demographics, and access to reliable technology.",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: Although virtual care presents opportunities to expand rural SUD",
    "entities": []
  },
  {
    "text": "treatment access, a hybrid model combining in-person and virtual care may better",
    "entities": []
  },
  {
    "text": "meet diverse client needs. Addressing technological inequities and tailoring",
    "entities": []
  },
  {
    "text": "approaches to individual circumstances are essential for future interventions.",
    "entities": []
  },
  {
    "text": "\u00a9 2025 National Rural Health Association.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "National Rural Health Association",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "PMID: 40665549 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40665549",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "55. Asia Pac J Public Health. 2025 Jul 15:10105395251360151. doi:",
    "entities": [
      {
        "text": "55",
        "label": "CARDINAL"
      },
      {
        "text": "Asia Pac J Public Health",
        "label": "ORG"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "10.1177/10105395251360151. Online ahead of print.",
    "entities": [
      {
        "text": "10.1177/10105395251360151",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Effect of the COVID-19 Pandemic on Trends in Influenza Vaccination and Health",
    "entities": [
      {
        "text": "Influenza Vaccination and Health\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Screening Among Korean Adults.",
    "entities": [
      {
        "text": "Korean",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "(1)Department of Family Medicine, Korea University Guro Hospital, Seoul,",
    "entities": [
      {
        "text": "Family Medicine",
        "label": "ORG"
      },
      {
        "text": "Korea University Guro Hospital",
        "label": "ORG"
      },
      {
        "text": "Seoul",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Republic of Korea.",
    "entities": [
      {
        "text": "Korea",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Family Medicine, Gil Medical Center, Gachon University College",
    "entities": [
      {
        "text": "Family Medicine",
        "label": "ORG"
      },
      {
        "text": "Gil Medical Center",
        "label": "ORG"
      },
      {
        "text": "Gachon University College",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of Medicine, Incheon, Republic of Korea.",
    "entities": [
      {
        "text": "Incheon",
        "label": "GPE"
      },
      {
        "text": "Republic of Korea",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Research and Analysis, National Health Insurance Service Ilsan",
    "entities": [
      {
        "text": "Research and Analysis",
        "label": "ORG"
      },
      {
        "text": "National Health Insurance Service Ilsan",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Hospital, Goyang, Republic of Korea.",
    "entities": [
      {
        "text": "Goyang",
        "label": "PERSON"
      },
      {
        "text": "Republic of Korea",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "This study examined the effects of coronavirus disease 2019 (COVID-19) on",
    "entities": [
      {
        "text": "2019",
        "label": "DATE"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "influenza vaccination and health screening trends in Korea. A total of 49 299",
    "entities": [
      {
        "text": "influenza vaccination",
        "label": "PERSON"
      },
      {
        "text": "Korea",
        "label": "GPE"
      },
      {
        "text": "49 299",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "individuals aged \u226519 years who participated in the Korea National Health and",
    "entities": [
      {
        "text": "the Korea National Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Nutrition Examination Survey in 2013-2015, 2016-2019, or 2020-2022 (the COVID-19",
    "entities": [
      {
        "text": "Nutrition Examination Survey",
        "label": "ORG"
      },
      {
        "text": "2013-2015",
        "label": "DATE"
      },
      {
        "text": "2016-2019",
        "label": "DATE"
      },
      {
        "text": "2020-2022",
        "label": "DATE"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "era) with available information on influenza vaccination, health screening, and",
    "entities": []
  },
  {
    "text": "cancer screening status were included. Multivariate regression models were used",
    "entities": []
  },
  {
    "text": "to compare the estimated prevalences of behaviors during these 3 phases. The",
    "entities": [
      {
        "text": "3",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "COVID-19 pandemic arrested the increasing health screening trend and reversed",
    "entities": []
  },
  {
    "text": "the increasing cancer screening trend, whereas the influenza vaccination rate",
    "entities": []
  },
  {
    "text": "continuously increased, irrespective of the COVID-19 pandemic. However, subgroup",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "analysis revealed: (1) that during the COVID-19 pandemic, no increasing trend in",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "influenza vaccination was evident for older adults (\u226565 years old) or",
    "entities": [
      {
        "text": "influenza vaccination",
        "label": "PERSON"
      },
      {
        "text": "years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "individuals with a lower socioeconomic status and (2) that even during COVID-19",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "pandemic, older adults and women were more actively screened. In conclusion, the",
    "entities": []
  },
  {
    "text": "COVID-19 pandemic significantly affected influenza vaccination and health",
    "entities": []
  },
  {
    "text": "screening rates among Korean adults but affected specific populations",
    "entities": [
      {
        "text": "Korean",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "differently.",
    "entities": []
  },
  {
    "text": "Association of COPD With Clinical Outcomes After Hospital Admission in",
    "entities": [
      {
        "text": "Association of COPD With Clinical Outcomes After Hospital Admission",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "SARS-CoV-2 Patients During the Omicron Variant Period: A Retrospective Cohort",
    "entities": []
  },
  {
    "text": "(1)Department of Pulmonary and Critical Care Medicine, Hebei Medical University,",
    "entities": [
      {
        "text": "Pulmonary and Critical Care Medicine",
        "label": "ORG"
      },
      {
        "text": "Hebei Medical University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Department of Pulmonary and Critical Care Medicine, China-Japan Friendship",
    "entities": [
      {
        "text": "Pulmonary and Critical Care Medicine",
        "label": "ORG"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Hospital, National Clinical Research Center of Respiratory Diseases, Beijing,",
    "entities": [
      {
        "text": "National Clinical Research Center of Respiratory Diseases",
        "label": "ORG"
      },
      {
        "text": "Beijing",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Pulmonary and Critical Care Medicine, Tangshan Gongren",
    "entities": [
      {
        "text": "Pulmonary and Critical Care Medicine",
        "label": "ORG"
      },
      {
        "text": "Tangshan Gongren",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(4)Department of Pulmonary and Critical Care Medicine, The Second Hospital of",
    "entities": [
      {
        "text": "Pulmonary and Critical Care Medicine",
        "label": "ORG"
      },
      {
        "text": "The Second Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Hebei Medical University, Shijiazhuang, China.",
    "entities": [
      {
        "text": "Hebei Medical University",
        "label": "ORG"
      },
      {
        "text": "Shijiazhuang",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: Pre-Omicron studies identified chronic obstructive pulmonary disease",
    "entities": [
      {
        "text": "Pre-Omicron",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(COPD) as a significant risk factor for adverse COVID-19 outcomes. Given",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Omicron's altered pathogenicity and widespread population-level immunity, the",
    "entities": [
      {
        "text": "Omicron",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "association between COPD and COVID-19 outcomes warrants reassessment in light of",
    "entities": [
      {
        "text": "COPD",
        "label": "ORG"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "the variant's distinct clinical profile. We evaluated whether COPD remained a",
    "entities": [
      {
        "text": "COPD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "risk factor for poor clinical outcomes among hospitalized patients with",
    "entities": []
  },
  {
    "text": "SARS-CoV-2 infection during Omicron predominance.",
    "entities": [
      {
        "text": "Omicron",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "METHODS: We conducted a two-center retrospective cohort study of 1176 adults",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      },
      {
        "text": "1176",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "hospitalized with confirmed Omicron infection between January 2022 and December",
    "entities": [
      {
        "text": "Omicron",
        "label": "ORG"
      },
      {
        "text": "January 2022",
        "label": "DATE"
      },
      {
        "text": "December",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "2023 in Northern China. Patients were stratified by pre-existing COPD status. To",
    "entities": [
      {
        "text": "2023",
        "label": "DATE"
      },
      {
        "text": "Northern China",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "address confounding by treatment selection, inverse probability weighting (IPW)",
    "entities": []
  },
  {
    "text": "was applied based on the likelihood of receiving inhaled corticosteroids.",
    "entities": []
  },
  {
    "text": "Multivariable logistic regression models, adjusted for comorbidities, disease",
    "entities": []
  },
  {
    "text": "severity (as measured by the PSI), inflammatory markers (CRP, D-dimer, NLR,",
    "entities": [
      {
        "text": "PSI",
        "label": "ORG"
      },
      {
        "text": "CRP",
        "label": "ORG"
      },
      {
        "text": "NLR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "LDH), and treatment regimens, were used to evaluate the associations between",
    "entities": []
  },
  {
    "text": "COPD and in-hospital outcomes.",
    "entities": []
  },
  {
    "text": "RESULTS: Among 1176 patients (337 COPD; 839 non-COPD), COPD patients had",
    "entities": [
      {
        "text": "1176",
        "label": "DATE"
      },
      {
        "text": "337",
        "label": "CARDINAL"
      },
      {
        "text": "839",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "significantly lower PSI scores and lower levels of systemic inflammation despite",
    "entities": [
      {
        "text": "PSI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "a higher prevalence of respiratory comorbidities. In unadjusted models, COPD was",
    "entities": []
  },
  {
    "text": "associated with reduced odds of mortality (OR 0.52), respiratory failure (OR",
    "entities": [
      {
        "text": "0.52",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "0.24), and ventilatory support. However, after IPW adjustment, these",
    "entities": [
      {
        "text": "0.24",
        "label": "CARDINAL"
      },
      {
        "text": "IPW",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "associations were no longer statistically significant (mortality: adjusted OR",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: COPD was not independently associated with increased risk of",
    "entities": []
  },
  {
    "text": "mortality, respiratory failure, or ventilatory support in hospitalized",
    "entities": []
  },
  {
    "text": "Omicron-infected patients after rigorous adjustment for confounding. These",
    "entities": [
      {
        "text": "Omicron",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "findings suggest a shifting risk profile for COPD during Omicron predominance,",
    "entities": [
      {
        "text": "Omicron",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "likely influenced by variant tropism, treatment effects, and altered",
    "entities": []
  },
  {
    "text": "inflammatory responses. Future prospective studies are warranted to validate",
    "entities": []
  },
  {
    "text": "these findings and explore the mechanisms underlying this observed shift.",
    "entities": []
  },
  {
    "text": "\u00a9 2025 The Author(s). The Clinical Respiratory Journal published by John Wiley &",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "The Clinical Respiratory Journal",
        "label": "ORG"
      },
      {
        "text": "John Wiley &\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "PMID: 40665508 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40665508",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "57. Disaster Med Public Health Prep. 2025 Jul 16;19:e185. doi:",
    "entities": [
      {
        "text": "57",
        "label": "CARDINAL"
      },
      {
        "text": "Disaster Med Public Health Prep",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Journaling During a Disaster: Challenges and Opportunities for Data Collection.",
    "entities": []
  },
  {
    "text": "(1)https://ror.org/00b30xv10University of Pennsylvania, Department of Sociology,",
    "entities": [
      {
        "text": "1)https://ror.org/00b30xv10University",
        "label": "CARDINAL"
      },
      {
        "text": "Department of Sociology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)https://ror.org/052w4zt36American University, Department of Sociology,",
    "entities": [
      {
        "text": "2)https://ror.org/052w4zt36American University, Department of Sociology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Washington DC, USA.",
    "entities": [
      {
        "text": "Washington DC",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)https://ror.org/047s2c258University of Maryland, Department of African",
    "entities": [
      {
        "text": "Maryland",
        "label": "GPE"
      },
      {
        "text": "Department of African\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "American and Africana Studies, Department of Sociology, College Park, MD, USA.",
    "entities": [
      {
        "text": "American",
        "label": "NORP"
      },
      {
        "text": "Africana Studies",
        "label": "ORG"
      },
      {
        "text": "Department of Sociology, College Park",
        "label": "ORG"
      },
      {
        "text": "MD",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)https://ror.org/047s2c258University of Maryland, Department of Education,",
    "entities": [
      {
        "text": "Maryland",
        "label": "GPE"
      },
      {
        "text": "Department of Education",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "College Park, MD, USA.",
    "entities": [
      {
        "text": "College Park",
        "label": "GPE"
      },
      {
        "text": "MD",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)https://ror.org/00y4zzh67George Washington University Miliken School of",
    "entities": [
      {
        "text": "5)https://ror.org/00y4zzh67George",
        "label": "CARDINAL"
      },
      {
        "text": "Washington University Miliken School",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Public Health, Department of Epidemiology, Washington DC, USA.",
    "entities": [
      {
        "text": "Public Health, Department of Epidemiology",
        "label": "ORG"
      },
      {
        "text": "Washington DC",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "OBJECTIVES: This paper describes challenges and opportunities for data",
    "entities": []
  },
  {
    "text": "collection during a disaster, focusing on how young adults in the United States",
    "entities": [
      {
        "text": "the United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "navigated the initial period of the COVID-19 pandemic--a disaster which",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "introduced significant uncertainty and precarity both for individuals and the",
    "entities": []
  },
  {
    "text": "research process.",
    "entities": []
  },
  {
    "text": "METHODS: This paper draws on lessons from a small exploratory study which used",
    "entities": []
  },
  {
    "text": "RESULTS: Journaling addressed 3 key challenges to collecting data during a",
    "entities": [
      {
        "text": "3",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "public health crisis: 1) accessing respondents when preparation time and",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "resources are limited; 2) ensuring protection for both participants and",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "researchers in a context when human interaction is severely constrained; and 3)",
    "entities": [
      {
        "text": "3",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "needing both rapid response and flexibility in research design and data",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: Journaling techniques are a feasible, efficient and effective tool",
    "entities": []
  },
  {
    "text": "that can be adapted and utilized in various disaster contexts, including other",
    "entities": []
  },
  {
    "text": "pandemics and extreme climate events.",
    "entities": []
  },
  {
    "text": "PMID: 40665496 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40665496",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "58. Hum Vaccin Immunother. 2025 Dec;21(1):2533639. doi:",
    "entities": [
      {
        "text": "58",
        "label": "CARDINAL"
      },
      {
        "text": "Hum Vaccin Immunother",
        "label": "PERSON"
      },
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "From institutional trust to digital literacy: Socioeconomic and political",
    "entities": []
  },
  {
    "text": "determinants of COVID-19 vaccine hesitancy among Czech adults based on a",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      },
      {
        "text": "Czech",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "(1)Department of Public Health, Faculty of Medicine, Masaryk University, Brno,",
    "entities": [
      {
        "text": "Public Health, Faculty of Medicine",
        "label": "ORG"
      },
      {
        "text": "Masaryk University",
        "label": "ORG"
      },
      {
        "text": "Brno",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(2)Masaryk Centre for Global Health (MCGH), Department of Public Health, Faculty",
    "entities": [
      {
        "text": "Centre for Global Health",
        "label": "ORG"
      },
      {
        "text": "Department of Public Health, Faculty",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of Medicine, Masaryk University, Brno, Czech Republic.",
    "entities": [
      {
        "text": "Medicine, Masaryk University",
        "label": "ORG"
      },
      {
        "text": "Brno",
        "label": "GPE"
      },
      {
        "text": "Czech Republic",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Vaccine hesitancy remains a significant public health challenge, particularly",
    "entities": [
      {
        "text": "Vaccine",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "during pandemics when high immunization rates are crucial. While individual",
    "entities": []
  },
  {
    "text": "psychological antecedents of vaccine hesitancy have been extensively studied,",
    "entities": []
  },
  {
    "text": "limited empirical evidence exists on how contextual determinants, such as",
    "entities": []
  },
  {
    "text": "socioeconomic status, political trust, and digital literacy, collectively shape",
    "entities": []
  },
  {
    "text": "vaccine-related behaviors, particularly in Central European populations. This",
    "entities": [
      {
        "text": "Central European",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "study explores the key determinants of COVID-19 vaccine hesitancy among Czech",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      },
      {
        "text": "Czech",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "adults. A cross-sectional study was conducted using data from the 48th wave of",
    "entities": [
      {
        "text": "the 48th",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "the Czech national panel survey \u017divot b\u011bhem pandemie [Life During Pandemic],",
    "entities": [
      {
        "text": "Czech",
        "label": "NORP"
      },
      {
        "text": "\u017divot",
        "label": "CARDINAL"
      },
      {
        "text": "Life During Pandemic]",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "carried out in March 2023. The data were obtained via an online questionnaire",
    "entities": [
      {
        "text": "March 2023",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "administered to a nationally representative sample of Czech adults (n = 1,708).",
    "entities": [
      {
        "text": "Czech",
        "label": "NORP"
      },
      {
        "text": "1,708",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Sociodemographic, socioeconomic, and anamnestic variables were examined",
    "entities": []
  },
  {
    "text": "alongside political attitudes. Psychological antecedents of vaccination were",
    "entities": []
  },
  {
    "text": "assessed using the 5C model (confidence, complacency, constraints, risk",
    "entities": []
  },
  {
    "text": "calculation, and collective responsibility), and digital vaccine literacy was",
    "entities": []
  },
  {
    "text": "measured using seven items covering trust in official sources, trust in social",
    "entities": [
      {
        "text": "seven",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "media, and the ability to evaluate and apply vaccine information. Statistical",
    "entities": []
  },
  {
    "text": "analyses included bivariate tests and multivariable regression models to",
    "entities": []
  },
  {
    "text": "identify vaccine uptake and intent determinants. Higher trust in constitutional",
    "entities": []
  },
  {
    "text": "institutions, including the president (OR = 1.55; 95/ CI: 1.38-1.74), government",
    "entities": [
      {
        "text": "1.55",
        "label": "CARDINAL"
      },
      {
        "text": "95/ CI",
        "label": "PERSON"
      },
      {
        "text": "1.38-1.74",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "(1.60; 1.38-1.85), Chamber of Deputies (1.73; 1.48-2.02), and Senate (1.47;",
    "entities": [
      {
        "text": "1.60",
        "label": "CARDINAL"
      },
      {
        "text": "1.38-1.85",
        "label": "CARDINAL"
      },
      {
        "text": "Chamber of Deputies",
        "label": "ORG"
      },
      {
        "text": "1.73",
        "label": "CARDINAL"
      },
      {
        "text": "1.48",
        "label": "CARDINAL"
      },
      {
        "text": "Senate",
        "label": "ORG"
      },
      {
        "text": "1.47",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "1.29-1.69), was significantly associated with higher vaccine uptake. Similarly,",
    "entities": [
      {
        "text": "1.29-1.69",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "positive attitudes toward the integration of Ukrainian refugees into Czech",
    "entities": [
      {
        "text": "Ukrainian",
        "label": "NORP"
      },
      {
        "text": "Czech",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "society - across domains such as work (1.63; 1.39-1.90), housing (1.59;",
    "entities": [
      {
        "text": "1.63",
        "label": "CARDINAL"
      },
      {
        "text": "1.39-1.90",
        "label": "CARDINAL"
      },
      {
        "text": "1.59",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "1.36-1.86), school (1.64; 1.41-1.92), language (1.57; 1.34-1.84), and culture",
    "entities": [
      {
        "text": "1.36",
        "label": "CARDINAL"
      },
      {
        "text": "1.64",
        "label": "CARDINAL"
      },
      {
        "text": "1.41",
        "label": "CARDINAL"
      },
      {
        "text": "1.57",
        "label": "CARDINAL"
      },
      {
        "text": "1.34",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(1.74; 1.50-2.03) - were positively associated with uptake. Greater confidence",
    "entities": [
      {
        "text": "1.74",
        "label": "CARDINAL"
      },
      {
        "text": "1.50",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "in vaccine safety and effectiveness was also a significant predictor (1.51;",
    "entities": [
      {
        "text": "1.51",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "1.44-1.58). In contrast, lower education (0.64; 0.56-0.73), lower income (0.91;",
    "entities": [
      {
        "text": "1.44-1.58",
        "label": "CARDINAL"
      },
      {
        "text": "0.64",
        "label": "CARDINAL"
      },
      {
        "text": "0.56-0.73",
        "label": "CARDINAL"
      },
      {
        "text": "0.91",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "0.86-0.95), female sex (0.60; 0.47-0.76), and higher complacency (0.76;",
    "entities": [
      {
        "text": "0.86",
        "label": "CARDINAL"
      },
      {
        "text": "0.60",
        "label": "CARDINAL"
      },
      {
        "text": "0.47-0.76",
        "label": "CARDINAL"
      },
      {
        "text": "0.76",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "0.73-0.80) were associated with reduced uptake. Respondents with better digital",
    "entities": [
      {
        "text": "0.73",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "vaccine literacy, particularly those more adept at identifying misinformation,",
    "entities": []
  },
  {
    "text": "showed significantly greater vaccine confidence (mean score: 3.62 vs. 3.30,",
    "entities": [
      {
        "text": "3.62",
        "label": "CARDINAL"
      },
      {
        "text": "3.30",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "p < .001). Beyond psychological antecedents, institutional trust, political",
    "entities": []
  },
  {
    "text": "orientation, and digital vaccine literacy significantly shape COVID-19",
    "entities": [
      {
        "text": "COVID-19",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "vaccination behaviors. These findings underscore the importance of targeted",
    "entities": []
  },
  {
    "text": "interventions that address political and digital influences on vaccine",
    "entities": []
  },
  {
    "text": "hesitancy, and they highlight the need for future research to examine the causal",
    "entities": []
  },
  {
    "text": "pathways and longitudinal dynamics underlying these associations, particularly",
    "entities": []
  },
  {
    "text": "within Central and Eastern European contexts.",
    "entities": [
      {
        "text": "Central",
        "label": "ORG"
      },
      {
        "text": "Eastern European",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "PMID: 40665470 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40665470",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Preventive behaviors related to COVID-19 based on social cognitive integrative",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "model constructs among medical students: A cross-sectional study.",
    "entities": []
  },
  {
    "text": "(1)Student Research Committee, Babol University of Medical Sciences, Babol,",
    "entities": [
      {
        "text": "Research Committee",
        "label": "ORG"
      },
      {
        "text": "Babol University of Medical Sciences",
        "label": "ORG"
      },
      {
        "text": "Babol",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(2)Social Determinants of Health Research Center, Health Research Institute,",
    "entities": [
      {
        "text": "Determinants of Health Research Center",
        "label": "ORG"
      },
      {
        "text": "Health Research Institute",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Babol University of Medical Sciences, Babol, Iran. Z.gholamnia@yahoo.com.",
    "entities": [
      {
        "text": "Babol University of Medical Sciences",
        "label": "ORG"
      },
      {
        "text": "Babol",
        "label": "GPE"
      },
      {
        "text": "Iran",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Social Determinants of Health Research Center, Health Research Institute,",
    "entities": [
      {
        "text": "Determinants of Health Research Center",
        "label": "ORG"
      },
      {
        "text": "Health Research Institute",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Babol University of Medical Sciences, Babol, Iran.",
    "entities": [
      {
        "text": "Babol University of Medical Sciences",
        "label": "ORG"
      },
      {
        "text": "Babol",
        "label": "GPE"
      },
      {
        "text": "Iran",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Social Determinants of Health Research Center, Research Institute for",
    "entities": [
      {
        "text": "Determinants of Health Research Center",
        "label": "ORG"
      },
      {
        "text": "Research Institute",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Prevention Non-communicable Diseases, Qazvin University of Medical Sciences,",
    "entities": [
      {
        "text": "Diseases",
        "label": "ORG"
      },
      {
        "text": "Qazvin University of Medical Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "OBJECTIVE: The COVID-19 outbreak in Iran has prompted the investigation of",
    "entities": [
      {
        "text": "COVID-19",
        "label": "PERSON"
      },
      {
        "text": "Iran",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "preventive behaviors in vulnerable and key groups. This descriptive and",
    "entities": []
  },
  {
    "text": "analytical cross-sectional study determined preventive behaviors for COVID-19",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "among medical students using an integrated social cognition model and identified",
    "entities": []
  },
  {
    "text": "influencing factors.",
    "entities": []
  },
  {
    "text": "RESULTS: The study of 650 medical students with a mean age of 24.37 \u00b1 3.78 years",
    "entities": [
      {
        "text": "650",
        "label": "CARDINAL"
      },
      {
        "text": "24.37",
        "label": "CARDINAL"
      },
      {
        "text": "3.78 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "showed that the total scores of the integrated social cognition model and",
    "entities": []
  },
  {
    "text": "COVID-19 prevention behaviors were at the medium level, 85.44 \u00b1 8.70 out of 155",
    "entities": [
      {
        "text": "85.44",
        "label": "CARDINAL"
      },
      {
        "text": "8.70",
        "label": "CARDINAL"
      },
      {
        "text": "155",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "and 10.78 \u00b1 1.99 out of 20 scores, respectively. Univariate and multivariate",
    "entities": [
      {
        "text": "10.78",
        "label": "CARDINAL"
      },
      {
        "text": "1.99",
        "label": "CARDINAL"
      },
      {
        "text": "20 scores",
        "label": "QUANTITY"
      }
    ]
  },
  {
    "text": "regression analysis showed that the variables of marital status (\u03b2=-1.95",
    "entities": []
  },
  {
    "text": "[CI95%=-3.36 to -0.53], P = 0.007), maternal literacy (\u03b2 = 2.59 [CI95%=0.96 to",
    "entities": [
      {
        "text": "0.007",
        "label": "CARDINAL"
      },
      {
        "text": "2.59",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "4.21], P = 0.002), paternal literacy (\u03b2 = 2.47 [CI95%=0.89 to 4.04], P = 0.002),",
    "entities": [
      {
        "text": "4.21",
        "label": "CARDINAL"
      },
      {
        "text": "0.002",
        "label": "CARDINAL"
      },
      {
        "text": "2.47",
        "label": "CARDINAL"
      },
      {
        "text": "4.04",
        "label": "CARDINAL"
      },
      {
        "text": "0.002",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "place of residence (\u03b2 = 3.46 [CI95%=2.14 to 4.79], P = < 0.001), being a native",
    "entities": [
      {
        "text": "3.46",
        "label": "CARDINAL"
      },
      {
        "text": "4.79",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(\u03b2 = 1.70 [CI95%=0.21 to 3.19], P = 0.025), and educational level (\u03b2=-3.16",
    "entities": [
      {
        "text": "1.70",
        "label": "CARDINAL"
      },
      {
        "text": "3.19",
        "label": "CARDINAL"
      },
      {
        "text": "0.025",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "[CI95%=-1.64 to -4.68], P = < 0.001) are strong independent predictors of",
    "entities": []
  },
  {
    "text": "COVID-19 preventive behaviors. Single students, parents with university",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "education, were nondormitory and native, and at the basic science level earned",
    "entities": []
  },
  {
    "text": "higher scores for the model constructs (p < 0.05). These results can be used to",
    "entities": []
  },
  {
    "text": "design an educational intervention for COVID-19 preventive behaviors in medical",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "\u00a9 2025. The Author(s).",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "PMID: 40665427 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40665427",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Declarations. Ethics approval and consent to",
    "entities": []
  },
  {
    "text": "participate: The code of ethics (IR.MUBABOL.HRI.REC.1400.144) was got from the",
    "entities": []
  },
  {
    "text": "Ethics Committee of Babol University of Medical Sciences, and informed consent",
    "entities": [
      {
        "text": "Ethics Committee",
        "label": "ORG"
      },
      {
        "text": "University of Medical Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "was got from the participants. Consent for publication: Not applicable.",
    "entities": []
  },
  {
    "text": "Competing interests: The authors declare no competing interests.",
    "entities": []
  },
  {
    "text": "Burden level and quality of life of caregivers of hemodialysis patient's in",
    "entities": []
  },
  {
    "text": "central India: a mixed-method cross-sectional study.",
    "entities": [
      {
        "text": "India",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Ramasamy S(1)(2), Rathore V(3), Agrawal V(4), Galhotra A(5).",
    "entities": [
      {
        "text": "Agrawal",
        "label": "EVENT"
      },
      {
        "text": "Galhotra A(5",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)School of Public Health (at time of study), All India Institute of Medical",
    "entities": [
      {
        "text": "1)School of Public Health",
        "label": "ORG"
      },
      {
        "text": "All India Institute of Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Sciences, Raipur, Chhattisgarh, India.",
    "entities": [
      {
        "text": "Raipur",
        "label": "GPE"
      },
      {
        "text": "Chhattisgarh",
        "label": "GPE"
      },
      {
        "text": "India",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Vedanta Medical Research Foundation (BALCO Medical Centre), Raipur,",
    "entities": [
      {
        "text": "2)Vedanta Medical Research Foundation",
        "label": "ORG"
      },
      {
        "text": "BALCO Medical Centre",
        "label": "ORG"
      },
      {
        "text": "Raipur",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(3)Department of Nephrology, All India Institute of Medical Sciences, Raipur,",
    "entities": [
      {
        "text": "Nephrology",
        "label": "ORG"
      },
      {
        "text": "All India Institute of Medical Sciences",
        "label": "ORG"
      },
      {
        "text": "Raipur",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(4)Department of Nephrology, Dau Kalyan Singh Post Graduate Institute and",
    "entities": [
      {
        "text": "Nephrology",
        "label": "ORG"
      },
      {
        "text": "Dau Kalyan Singh Post Graduate Institute",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Research center, Raipur, Chhattisgarh, India.",
    "entities": [
      {
        "text": "Raipur",
        "label": "PERSON"
      },
      {
        "text": "Chhattisgarh",
        "label": "GPE"
      },
      {
        "text": "India",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Community & Family Medicine, All India Institute of Medical",
    "entities": [
      {
        "text": "Community & Family Medicine",
        "label": "ORG"
      },
      {
        "text": "All India Institute of Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Sciences, Raipur, Chhattisgarh, India. abhiruchigalhotra@aiimsraipur.edu.in.",
    "entities": [
      {
        "text": "Raipur",
        "label": "GPE"
      },
      {
        "text": "Chhattisgarh",
        "label": "GPE"
      },
      {
        "text": "India",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "PURPOSE: Caregivers of hemodialysis patients are at high risk of developing",
    "entities": [
      {
        "text": "PURPOSE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "reduced quality of life (QoL) and increased caregiver burden.",
    "entities": [
      {
        "text": "QoL",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "AIM: This study aims to explore the level of caregiver burden and quality of",
    "entities": [
      {
        "text": "AIM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "life in caregivers of hemodialysis patients in central India.",
    "entities": [
      {
        "text": "India",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "METHODS: This cross-sectional mixed-method study was undertaken among caregivers",
    "entities": []
  },
  {
    "text": "of stable hemodialysis patients attending a tertiary care hospital in central",
    "entities": [
      {
        "text": "tertiary",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "India. The Zarit Burden Interview (ZBI) and WHOQoL BREF questionnaire measured",
    "entities": [
      {
        "text": "India",
        "label": "GPE"
      },
      {
        "text": "The Zarit Burden Interview",
        "label": "ORG"
      },
      {
        "text": "BREF",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "caregiver burden and QoL. The qualitative data was gathered through in-depth",
    "entities": []
  },
  {
    "text": "interviews using a semi-structured open-ended questionnaire that delved into",
    "entities": []
  },
  {
    "text": "their personal experiences with caregiving. The transcripts of these interviews",
    "entities": []
  },
  {
    "text": "were analysed using applied thematic analysis, allowing for the identification",
    "entities": []
  },
  {
    "text": "and exploration of recurring themes and patterns within the data.",
    "entities": []
  },
  {
    "text": "RESULTS: A total of 105 caregivers took part in this study, with a mean age of",
    "entities": [
      {
        "text": "105",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "40.04 \u00b1 12.96 years. 56 (53.3%) caregivers were female. Most (48.6%, n = 51)",
    "entities": [
      {
        "text": "40.04",
        "label": "CARDINAL"
      },
      {
        "text": "12.96 years",
        "label": "DATE"
      },
      {
        "text": "56",
        "label": "CARDINAL"
      },
      {
        "text": "53.3%",
        "label": "PERCENT"
      },
      {
        "text": "48.6%",
        "label": "PERCENT"
      },
      {
        "text": "51",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "were spouses/partners. Ten caregivers (9.5%) had to change their occupations due",
    "entities": [
      {
        "text": "Ten",
        "label": "CARDINAL"
      },
      {
        "text": "9.5%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "to caregiving responsibilities. 14 (23.33%) had comorbidities (diabetes,",
    "entities": [
      {
        "text": "14",
        "label": "CARDINAL"
      },
      {
        "text": "23.33%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "hypertension, asthma, and arthritis) themselves. The mean caregiver burden level",
    "entities": []
  },
  {
    "text": "(ZBI) was 18.55 \u00b1 7.58. Most (59.0%) experienced mild to moderate burden, while",
    "entities": [
      {
        "text": "ZBI",
        "label": "ORG"
      },
      {
        "text": "18.55",
        "label": "CARDINAL"
      },
      {
        "text": "59.0%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "28.6% reported a high burden. The WHOQoL BREF mean score of various domains of",
    "entities": [
      {
        "text": "28.6%",
        "label": "PERCENT"
      },
      {
        "text": "BREF",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "physical health, psychological, social relationship and environmental was",
    "entities": []
  },
  {
    "text": "35.70 \u00b1 12.14, 44.20 \u00b1 13.28, 44.28 \u00b1 15.10 and 40.07 \u00b1 13.36 respectively. The",
    "entities": [
      {
        "text": "35.70",
        "label": "CARDINAL"
      },
      {
        "text": "12.14",
        "label": "DATE"
      },
      {
        "text": "44.20",
        "label": "CARDINAL"
      },
      {
        "text": "13.28",
        "label": "CARDINAL"
      },
      {
        "text": "44.28",
        "label": "CARDINAL"
      },
      {
        "text": "15.10",
        "label": "CARDINAL"
      },
      {
        "text": "40.07",
        "label": "CARDINAL"
      },
      {
        "text": "13.36",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "thematic analysis revealed, difficulty in continuing education and employment,",
    "entities": []
  },
  {
    "text": "changing jobs, the need to travel long distances to reach dialysis facilities",
    "entities": []
  },
  {
    "text": "and hardship due to COVID-19 pandemic as recurring challenges among caregivers.",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "CONCLUSION: Caregivers of Hemodialysis patients had significant caregiver burden",
    "entities": []
  },
  {
    "text": "and poor QoL. Regular assessment and special attention are needed for these",
    "entities": []
  },
  {
    "text": "PMID: 40665407 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40665407",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Declarations. Ethical approval and consent to",
    "entities": []
  },
  {
    "text": "participate: This study was approved by the Institutional Ethical Committee with",
    "entities": [
      {
        "text": "the Institutional Ethical Committee",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "IEC Proposal No: AIIMSRPR/IEC/2021/1041 from the All India Institute of Medical",
    "entities": [
      {
        "text": "the All India Institute of Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Sciences, Raipur, Chhattisgarh, India. All participants signed an informed",
    "entities": [
      {
        "text": "Raipur",
        "label": "GPE"
      },
      {
        "text": "Chhattisgarh",
        "label": "GPE"
      },
      {
        "text": "India",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "written consent before participation and informed consent was obtained from",
    "entities": []
  },
  {
    "text": "parents and/or legal guardians of minor/illiterate study participants. The study",
    "entities": []
  },
  {
    "text": "was conducted under the principles of the Helsinki Declaration. Consent for",
    "entities": [
      {
        "text": "the Helsinki Declaration",
        "label": "LAW"
      }
    ]
  },
  {
    "text": "publication: Not applicable. Competing interests: The authors declare no",
    "entities": []
  },
  {
    "text": "competing interests.61. Genome Biol. 2025 Jul 15;26(1):205. doi: 10.1186/s13059-025-03669-5.",
    "entities": [
      {
        "text": "Genome Biol",
        "label": "PERSON"
      },
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "15;26(1):205",
        "label": "CARDINAL"
      },
      {
        "text": "10.1186",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Enrichable cross-linkers for mapping direct protein interactions.",
    "entities": []
  },
  {
    "text": "S(8), Jin BK(2)(3), Sablina A(9), Zhou F(1)(10), Chen H(11), Tang S(12)(13),",
    "entities": [
      {
        "text": "Jin BK(2)(3",
        "label": "PERSON"
      },
      {
        "text": "Sablina",
        "label": "NORP"
      },
      {
        "text": "Zhou F(1)(10",
        "label": "PERSON"
      },
      {
        "text": "Chen H(11",
        "label": "PERSON"
      },
      {
        "text": "Tang",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Key Laboratory of Novel Targets and Drug Study for Neural Repair of Zhejiang",
    "entities": [
      {
        "text": "Laboratory of Novel Targets and Drug Study for Neural Repair of Zhejiang",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Province, School of Medicine, Hangzhou City University, Hangzhou, 310015,",
    "entities": [
      {
        "text": "School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Hangzhou City University",
        "label": "ORG"
      },
      {
        "text": "Hangzhou",
        "label": "GPE"
      },
      {
        "text": "310015",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "(2)Life Sciences Institute, Department of Medical Oncology, The Second",
    "entities": [
      {
        "text": "Sciences Institute",
        "label": "ORG"
      },
      {
        "text": "Department of Medical Oncology",
        "label": "ORG"
      },
      {
        "text": "Second",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang",
    "entities": [
      {
        "text": "Affiliated Hospital of Zhejiang University School of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University, Hangzhou, 310058, Zhejiang, China.",
    "entities": [
      {
        "text": "Hangzhou",
        "label": "GPE"
      },
      {
        "text": "310058",
        "label": "DATE"
      },
      {
        "text": "Zhejiang",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Cancer Center, Zhejiang University, Hangzhou, 310058, Zhejiang, China.",
    "entities": [
      {
        "text": "Center, Zhejiang University",
        "label": "ORG"
      },
      {
        "text": "Hangzhou",
        "label": "GPE"
      },
      {
        "text": "310058",
        "label": "DATE"
      },
      {
        "text": "Zhejiang",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)State Key Laboratory of Respiratory Disease, Institute of Drug Discovery,",
    "entities": [
      {
        "text": "Key Laboratory of Respiratory Disease",
        "label": "ORG"
      },
      {
        "text": "Institute of Drug Discovery",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Guangzhou, Institutes of Biomedicine and Health, Chinese Academy of Sciences,",
    "entities": [
      {
        "text": "Guangzhou",
        "label": "GPE"
      },
      {
        "text": "Institutes of Biomedicine",
        "label": "GPE"
      },
      {
        "text": "Chinese Academy of Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)China-New Zealand Belt and Road Joint Laboratory On Biomedicine and Health,",
    "entities": [
      {
        "text": "5)China",
        "label": "CARDINAL"
      },
      {
        "text": "Road Joint Laboratory",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences,",
    "entities": [
      {
        "text": "Guangzhou",
        "label": "GPE"
      },
      {
        "text": "Chinese Academy of Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(6)The State Key Laboratory of Animal Biotech Breeding, Institute of Animal",
    "entities": [
      {
        "text": "State Key Laboratory",
        "label": "ORG"
      },
      {
        "text": "Animal Biotech Breeding",
        "label": "ORG"
      },
      {
        "text": "Institute of Animal",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Science, Chinese Academy of Agricultural Sciences, Beijing, 100193, China.",
    "entities": [
      {
        "text": "Chinese Academy of Agricultural Sciences",
        "label": "ORG"
      },
      {
        "text": "Beijing",
        "label": "GPE"
      },
      {
        "text": "100193",
        "label": "DATE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Liaocheng University, Liaocheng, 252059, Shandong, China.",
    "entities": [
      {
        "text": "7)Liaocheng University",
        "label": "ORG"
      },
      {
        "text": "Liaocheng",
        "label": "PERSON"
      },
      {
        "text": "252059",
        "label": "DATE"
      },
      {
        "text": "Shandong",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(8)Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech",
    "entities": [
      {
        "text": "Institute for Advanced Immunochemical Studies",
        "label": "ORG"
      },
      {
        "text": "ShanghaiTech",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University, Shanghai, 201210, China.",
    "entities": [
      {
        "text": "University",
        "label": "ORG"
      },
      {
        "text": "Shanghai",
        "label": "GPE"
      },
      {
        "text": "201210",
        "label": "DATE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(10)Institute of Biology and Medical Science, Soochow University, Suzhou,",
    "entities": [
      {
        "text": "10)Institute",
        "label": "CARDINAL"
      },
      {
        "text": "Biology and Medical Science, Soochow University",
        "label": "ORG"
      },
      {
        "text": "Suzhou",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(11)Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech",
    "entities": [
      {
        "text": "11)Shanghai Institute for Advanced Immunochemical Studies",
        "label": "ORG"
      },
      {
        "text": "ShanghaiTech",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University, Shanghai, 201210, China. chenhl@shanghaitech.edu.cn.",
    "entities": [
      {
        "text": "University",
        "label": "ORG"
      },
      {
        "text": "Shanghai",
        "label": "GPE"
      },
      {
        "text": "201210",
        "label": "DATE"
      },
      {
        "text": "China",
        "label": "GPE"
      },
      {
        "text": "chenhl@shanghaitech.edu.cn",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(12)State Key Laboratory of Respiratory Disease, Institute of Drug Discovery,",
    "entities": [
      {
        "text": "12)State",
        "label": "CARDINAL"
      },
      {
        "text": "Key Laboratory of Respiratory Disease",
        "label": "ORG"
      },
      {
        "text": "Institute of Drug Discovery",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(13)China-New Zealand Belt and Road Joint Laboratory On Biomedicine and Health,",
    "entities": [
      {
        "text": "13)China",
        "label": "CARDINAL"
      },
      {
        "text": "Road Joint Laboratory",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(14)Key Laboratory of Novel Targets and Drug Study for Neural Repair of Zhejiang",
    "entities": [
      {
        "text": "14)Key Laboratory of Novel Targets and Drug Study for Neural Repair of Zhejiang",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(15)Life Sciences Institute, Department of Medical Oncology, The Second",
    "entities": [
      {
        "text": "Sciences Institute",
        "label": "ORG"
      },
      {
        "text": "Department of Medical Oncology",
        "label": "ORG"
      },
      {
        "text": "Second",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "University, Hangzhou, 310058, Zhejiang, China. l_zhang@zju.edu.cn.",
    "entities": [
      {
        "text": "Hangzhou",
        "label": "GPE"
      },
      {
        "text": "310058",
        "label": "DATE"
      },
      {
        "text": "Zhejiang",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(16)Cancer Center, Zhejiang University, Hangzhou, 310058, Zhejiang, China.",
    "entities": [
      {
        "text": "16)Cancer",
        "label": "CARDINAL"
      },
      {
        "text": "Center, Zhejiang University",
        "label": "ORG"
      },
      {
        "text": "Hangzhou",
        "label": "GPE"
      },
      {
        "text": "310058",
        "label": "DATE"
      },
      {
        "text": "Zhejiang",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(17)Life Sciences Institute, Department of Medical Oncology, The Second",
    "entities": [
      {
        "text": "Sciences Institute",
        "label": "ORG"
      },
      {
        "text": "Department of Medical Oncology",
        "label": "ORG"
      },
      {
        "text": "Second",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "University, Hangzhou, 310058, Zhejiang, China. bingyang@zju.edu.cn.",
    "entities": [
      {
        "text": "Hangzhou",
        "label": "GPE"
      },
      {
        "text": "310058",
        "label": "DATE"
      },
      {
        "text": "Zhejiang",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      },
      {
        "text": "bingyang@zju.edu.cn",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(18)Cancer Center, Zhejiang University, Hangzhou, 310058, Zhejiang, China.",
    "entities": [
      {
        "text": "18)Cancer",
        "label": "CARDINAL"
      },
      {
        "text": "Center, Zhejiang University",
        "label": "ORG"
      },
      {
        "text": "Hangzhou",
        "label": "GPE"
      },
      {
        "text": "310058",
        "label": "DATE"
      },
      {
        "text": "Zhejiang",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: It is crucial to investigate protein functions in specific",
    "entities": []
  },
  {
    "text": "subcellular environments. Cross-linking mass spectrometry is a powerful tool to",
    "entities": []
  },
  {
    "text": "map the direct interactome of proteins by identifying inter-protein cross-links.",
    "entities": []
  },
  {
    "text": "However, it is challenging to identify inter-protein cross-linked peptides due",
    "entities": []
  },
  {
    "text": "to their low abundance.",
    "entities": []
  },
  {
    "text": "RESULTS: We chemically synthesize the cross-linkers ePDES1 and ePDES2 with an",
    "entities": []
  },
  {
    "text": "alkyne group and a compound with azide linked to a phosphate group to enrich for",
    "entities": [
      {
        "text": "alkyne group",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "cross-linked peptides.",
    "entities": []
  },
  {
    "text": "CONCLUSION: Based on the high-quality cross-linking spectra of ePDES1 and",
    "entities": []
  },
  {
    "text": "ePDES2, our methods achieve the identification of hundreds of directly",
    "entities": [
      {
        "text": "hundreds",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "interacting proteins or substrates of thioredoxins in the nucleus and",
    "entities": []
  },
  {
    "text": "PMID: 40665372 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40665372",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "participate: Not applicable for this study. Consent for publication: Not",
    "entities": []
  },
  {
    "text": "applicable. Competing interests: The authors declare no competing interests.",
    "entities": []
  },
  {
    "text": "Remote online teaching beyond COVID-19 pandemic: a qualitative study across",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Physiotherapy programs in Italy.",
    "entities": [
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Unit of Geriatrics, Department of Medicine and Geriatrics, Azienda",
    "entities": [
      {
        "text": "Geriatrics, Department of Medicine",
        "label": "ORG"
      },
      {
        "text": "Geriatrics",
        "label": "GPE"
      },
      {
        "text": "Azienda",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Department of Medical, Surgical and Health Sciences, University of Trieste,",
    "entities": [
      {
        "text": "Health Sciences",
        "label": "ORG"
      },
      {
        "text": "University of Trieste",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Trieste, Italy.",
    "entities": [
      {
        "text": "Trieste",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Experimental and Clinical Medicine, University of Florence,",
    "entities": [
      {
        "text": "Experimental",
        "label": "ORG"
      },
      {
        "text": "Clinical Medicine",
        "label": "ORG"
      },
      {
        "text": "University of Florence",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Largo Brambilla, 3, Florence, 50134, Italy.",
    "entities": [
      {
        "text": "Largo Brambilla",
        "label": "PERSON"
      },
      {
        "text": "3",
        "label": "DATE"
      },
      {
        "text": "Florence",
        "label": "GPE"
      },
      {
        "text": "50134",
        "label": "DATE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Allied Health Professions, Azienda USL Toscana Centro,",
    "entities": [
      {
        "text": "5)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Allied Health Professions",
        "label": "ORG"
      },
      {
        "text": "Azienda USL",
        "label": "PERSON"
      },
      {
        "text": "Toscana Centro",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(6)Humanitas Clinical and Research Center - IRCCS, and Department of Biomedical",
    "entities": [
      {
        "text": "6)Humanitas",
        "label": "CARDINAL"
      },
      {
        "text": "Clinical and Research Center - IRCCS",
        "label": "ORG"
      },
      {
        "text": "Department of Biomedical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Sciences, Humanitas University, Milan, Italy.",
    "entities": [
      {
        "text": "Humanitas University",
        "label": "ORG"
      },
      {
        "text": "Milan",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: With the lockdown imposed by the Coronavirus Disease 2019 (COVID-19)",
    "entities": [
      {
        "text": "the Coronavirus Disease 2019",
        "label": "LOC"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "pandemic, remote online teaching (ROT) became pivotal in the rapid",
    "entities": [
      {
        "text": "ROT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "reorganization imposed on the healthcare professions' educational programs.",
    "entities": []
  },
  {
    "text": "Physiotherapy programs were particularly affected, as they are characterized by",
    "entities": []
  },
  {
    "text": "hard and soft skills that are hardly learned with ROT. The purpose of the",
    "entities": [
      {
        "text": "ROT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "present study was to investigate the experiences and opinions on ROT by",
    "entities": [
      {
        "text": "ROT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "faculties involved in the education and training of Physiotherapy students",
    "entities": []
  },
  {
    "text": "during the pandemic, and on its possible application thereafter.",
    "entities": []
  },
  {
    "text": "METHODS: Following accreditated checklists for qualitative research,",
    "entities": []
  },
  {
    "text": "semi-structured interviews were conducted by members of the National Directorate",
    "entities": [
      {
        "text": "the National Directorate",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of the Physiotherapy programs in Italy. Academic directors (AD) and clinical",
    "entities": [
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "training coordinators (CTC) of Italian Physiotherapy programs were randomly",
    "entities": [
      {
        "text": "Italian",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "selected and interviewed, to collect their experiences and opinions on the use",
    "entities": []
  },
  {
    "text": "of ROT before, during, and after the COVID-19 pandemic. Iterative rounds of",
    "entities": [
      {
        "text": "ROT",
        "label": "ORG"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "readings and discussions were conducted to analyze the interviews.",
    "entities": []
  },
  {
    "text": "RESULTS: A total of 22 participants were interviewed, reaching a satisfactory",
    "entities": [
      {
        "text": "22",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "level of saturation. Before the COVID-19 pandemic, ROT was used sporadically in",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      },
      {
        "text": "ROT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "academic activities; during the pandemic, participants familiarized themselves",
    "entities": []
  },
  {
    "text": "rapidly with this new approach, which was generally abandoned thereafter. After",
    "entities": []
  },
  {
    "text": "initial difficulties, most participants recognized the importance of ROT in",
    "entities": [
      {
        "text": "ROT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "preserving education during the lockdown. A negative impact on Physiotherapy",
    "entities": [
      {
        "text": "Physiotherapy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "students was occasionally reported, especially during their final exam and",
    "entities": []
  },
  {
    "text": "thesis dissertation. Despite the limitations of ROT in Physiotherapy education,",
    "entities": [
      {
        "text": "ROT",
        "label": "ORG"
      },
      {
        "text": "Physiotherapy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "participants recognized its advantages in supporting administrative tasks,",
    "entities": []
  },
  {
    "text": "sharing lectures, and creating international programs. Its potential for",
    "entities": []
  },
  {
    "text": "pedagogical innovation and the opportunity for investments in Internet-based",
    "entities": []
  },
  {
    "text": "didactic approaches were also underlined.",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: ROT was perceived as an important tool to preserve Physiotherapy",
    "entities": [
      {
        "text": "ROT",
        "label": "ORG"
      },
      {
        "text": "Physiotherapy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "programs during the COVID-19 pandemic. Although it was in general discontinued",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "after the pandemic, many participants believed that it might contribute to",
    "entities": []
  },
  {
    "text": "establishing a \"new normal\" didactic paradigm in Physiotherapy education.",
    "entities": [
      {
        "text": "Physiotherapy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "DOI: 10.1186/s12909-025-07386-2",
    "entities": [
      {
        "text": "10.1186",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40665301 [Indexed for MEDLINE]",
    "entities": []
  },
  {
    "text": "participate: The study adheres to the Declaration of Helsinki. The study did not",
    "entities": [
      {
        "text": "the Declaration of Helsinki",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "require Ethics Committee review, according to the \u201cEthics and data protection\u201d",
    "entities": [
      {
        "text": "Ethics Committee",
        "label": "ORG"
      },
      {
        "text": "Ethics",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "regulations of the European advisory body and European Commission [29, 30].",
    "entities": [
      {
        "text": "European",
        "label": "NORP"
      },
      {
        "text": "European Commission",
        "label": "ORG"
      },
      {
        "text": "29",
        "label": "CARDINAL"
      },
      {
        "text": "30",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Informed consent for registration and its use was obtained from each participant",
    "entities": []
  },
  {
    "text": "at the start of registration. Consent for publication: N.A. Competing interests:",
    "entities": []
  },
  {
    "text": "The authors declare no competing interests.",
    "entities": []
  },
  {
    "text": "Being a professional nurse until retirement - a qualitative interview study in",
    "entities": []
  },
  {
    "text": "(1)Alice Salomon University of Applied Sciences, Alice Salomon Platz 5, 12628,",
    "entities": [
      {
        "text": "Salomon University of Applied Sciences",
        "label": "ORG"
      },
      {
        "text": "Alice Salomon Platz",
        "label": "PERSON"
      },
      {
        "text": "5, 12628",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "(3)Alice Salomon University of Applied Sciences, Alice Salomon Platz 5, 12628,",
    "entities": [
      {
        "text": "Salomon University of Applied Sciences",
        "label": "ORG"
      },
      {
        "text": "Alice Salomon Platz",
        "label": "PERSON"
      },
      {
        "text": "5, 12628",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Berlin, Germany. graeske@ash-berlin.eu.",
    "entities": [
      {
        "text": "Berlin",
        "label": "GPE"
      },
      {
        "text": "Germany",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: Nurses are crucial to the global healthcare system, yet there is a",
    "entities": []
  },
  {
    "text": "growing shortage, exacerbated by demographic shifts and the coronavirus disease",
    "entities": []
  },
  {
    "text": "2019 (COVID-19) pandemic. The International Council of Nurses projects a deficit",
    "entities": [
      {
        "text": "2019",
        "label": "DATE"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      },
      {
        "text": "The International Council of Nurses",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of 13 million nurses worldwide in the near future, contributing to missed",
    "entities": [
      {
        "text": "13 million",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "nursing care and jeopardizing patient safety. Although extensive research has",
    "entities": []
  },
  {
    "text": "explored reasons why nurses leave the profession, far less is known about the",
    "entities": []
  },
  {
    "text": "factors that support their long-term commitment and retention until retirement.",
    "entities": []
  },
  {
    "text": "Hence, study aimed to identify the factors contributing to long-term retention",
    "entities": []
  },
  {
    "text": "of nurses in the profession, particularly those who stay until retirement.",
    "entities": []
  },
  {
    "text": "METHODS: This qualitative study used semi-structured expert interviews with 22",
    "entities": [
      {
        "text": "22",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "nurses in Germany who had at least 30 years of work experience, aiming to",
    "entities": [
      {
        "text": "Germany",
        "label": "GPE"
      },
      {
        "text": "at least 30 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "explore the personal, organizational, and societal factors that have supported",
    "entities": []
  },
  {
    "text": "their continued engagement in the profession. A purposive sampling method was",
    "entities": []
  },
  {
    "text": "used to select participants from various care settings, including acute,",
    "entities": []
  },
  {
    "text": "long-term, and outpatient care. Data were audio- and video-recorded,",
    "entities": []
  },
  {
    "text": "transcribed, and analyzed using content-structuring qualitative content",
    "entities": [
      {
        "text": "transcribed",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "analysis. Thematic categories were developed using a structured content analysis",
    "entities": []
  },
  {
    "text": "approach following Kuckartz, supported by both deductive and inductive coding",
    "entities": [
      {
        "text": "Kuckartz",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "via the MAXQDA software to identify key themes related to job retention.",
    "entities": []
  },
  {
    "text": "RESULTS: The analysis revealed three overarching thematic categories: personal",
    "entities": [
      {
        "text": "three",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "resources and motivations, organizational context and working conditions, and",
    "entities": []
  },
  {
    "text": "recognition and social value. The first category includes factors such as career",
    "entities": [
      {
        "text": "recognition",
        "label": "ORG"
      },
      {
        "text": "first",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "choice motives, personal values, and generation-specific influences, all of",
    "entities": []
  },
  {
    "text": "which are significant contributors to long-term career commitment. The category",
    "entities": []
  },
  {
    "text": "organizational context and working conditions, including job satisfaction,",
    "entities": []
  },
  {
    "text": "work-time control, role clarity, and coping strategies, plays a pivotal role in",
    "entities": []
  },
  {
    "text": "retaining nurses. The third category encompassed the perceived value of nursing",
    "entities": [
      {
        "text": "third",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "work in society, appreciation from patients and peers, and the professional",
    "entities": []
  },
  {
    "text": "identity fostered by meaningful recognition.",
    "entities": []
  },
  {
    "text": "DISCUSSION: This study provides valuable insights into the factors that",
    "entities": []
  },
  {
    "text": "contribute to nurses' decisions to stay in the profession until retirement.",
    "entities": []
  },
  {
    "text": "While many studies emphasize the challenges and negative aspects of nursing that",
    "entities": []
  },
  {
    "text": "lead to attrition, this research highlights the positive factors that promote",
    "entities": []
  },
  {
    "text": "job retention. Addressing these factors, such as improving working conditions,",
    "entities": []
  },
  {
    "text": "ensuring adequate recognition, and supporting personal values and career",
    "entities": [
      {
        "text": "recognition",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "motivations, could enhance nurse retention strategies. These findings underscore",
    "entities": []
  },
  {
    "text": "the importance of retention-focused strategies that enhance meaning in work,",
    "entities": []
  },
  {
    "text": "professional identity, and workplace culture-shifting the policy lens from",
    "entities": []
  },
  {
    "text": "attrition prevention to long-term engagement.",
    "entities": []
  },
  {
    "text": "CLINICAL TRIAL NUMBER: Not applicable.",
    "entities": []
  },
  {
    "text": "Conflict of interest statement: Declarations. Human ethics and consent to",
    "entities": []
  },
  {
    "text": "participate: This study involved no patients, medical interventions, or",
    "entities": []
  },
  {
    "text": "vulnerable persons. It was conducted solely with adult nursing professionals who",
    "entities": []
  },
  {
    "text": "voluntarily participated and provided informed consent. In accordance with the",
    "entities": []
  },
  {
    "text": "Information Sheet on Regulations Governing the Ethics Committee of Alice Salomon",
    "entities": [
      {
        "text": "the Ethics Committee",
        "label": "ORG"
      },
      {
        "text": "Alice Salomon",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "University of Applied Sciences Berlin [Satzung der Ethikkommission der Alice",
    "entities": [
      {
        "text": "University of Applied Sciences Berlin",
        "label": "ORG"
      },
      {
        "text": "Alice\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Salomon Hochschule Berlin] [58], ethical review is recommended for research",
    "entities": [
      {
        "text": "Salomon Hochschule",
        "label": "PERSON"
      },
      {
        "text": "58",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "involving potential risks to participants. As this qualitative,",
    "entities": []
  },
  {
    "text": "non-interventional study posed no such risks, formal ethics approval was not",
    "entities": []
  },
  {
    "text": "required. The study was conducted in alignment with national ethical standards",
    "entities": []
  },
  {
    "text": "and adhered to the principles of the Declaration of Helsinki and the ICN Code of",
    "entities": [
      {
        "text": "the Declaration of Helsinki",
        "label": "WORK_OF_ART"
      },
      {
        "text": "the ICN Code",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Ethics. Consent for publication: Not applicable. Competing interests: The",
    "entities": []
  },
  {
    "text": "authors declare no competing interests.",
    "entities": []
  },
  {
    "text": "64. BMC Public Health. 2025 Jul 15;25(1):2459. doi: 10.1186/s12889-025-23648-6.",
    "entities": [
      {
        "text": "64",
        "label": "CARDINAL"
      },
      {
        "text": "BMC Public Health",
        "label": "ORG"
      },
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "10.1186",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "The optimal strategy for seasonal influenza vaccination to prevent",
    "entities": []
  },
  {
    "text": "high-intensity level of influenza epidemics in Zhejiang, China: an integrated",
    "entities": [
      {
        "text": "Zhejiang",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "transmission-dynamic and health-economic modeling analysis.",
    "entities": []
  },
  {
    "text": "(1)Department of Emergency Medicine, Second Affiliated Hospital, Department of",
    "entities": [
      {
        "text": "Emergency Medicine",
        "label": "ORG"
      },
      {
        "text": "Second Affiliated Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Epidemiology and Biostatistics, School of Public Health, The Key Laboratory of",
    "entities": [
      {
        "text": "School of Public Health",
        "label": "ORG"
      },
      {
        "text": "The Key Laboratory",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Intelligent Preventive Medicine of Zhejiang Province, Zhejiang University School",
    "entities": [
      {
        "text": "Intelligent Preventive Medicine",
        "label": "ORG"
      },
      {
        "text": "Zhejiang Province",
        "label": "GPE"
      },
      {
        "text": "Zhejiang University School",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of Medicine, Hangzhou, China.",
    "entities": [
      {
        "text": "Medicine",
        "label": "GPE"
      },
      {
        "text": "Hangzhou",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Quzhou People's Hospital, No.100 of Minjiang Street, Quzhou, 32400, Zhejiang,",
    "entities": [
      {
        "text": "2)Quzhou People's Hospital",
        "label": "ORG"
      },
      {
        "text": "Minjiang Street",
        "label": "FAC"
      },
      {
        "text": "Quzhou",
        "label": "GPE"
      },
      {
        "text": "32400",
        "label": "DATE"
      },
      {
        "text": "Zhejiang",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Public Health, Ningbo No.2 Hospital, Ningbo, China.",
    "entities": [
      {
        "text": "Public Health",
        "label": "ORG"
      },
      {
        "text": "Ningbo No.2 Hospital",
        "label": "ORG"
      },
      {
        "text": "Ningbo",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Communicable Disease Control and Prevention, Zhejiang",
    "entities": [
      {
        "text": "Communicable Disease Control and Prevention",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Provincial Center for Disease Control and Prevention, Hangzhou, China.",
    "entities": [
      {
        "text": "Provincial Center for Disease Control and Prevention",
        "label": "ORG"
      },
      {
        "text": "Hangzhou",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Emergency Medicine, Second Affiliated Hospital, Department of",
    "entities": [
      {
        "text": "Emergency Medicine",
        "label": "ORG"
      },
      {
        "text": "Second Affiliated Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of Medicine, Hangzhou, China. yangshigui@zju.edu.cn.",
    "entities": [
      {
        "text": "Medicine",
        "label": "GPE"
      },
      {
        "text": "Hangzhou",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: Although Seasonal Influenza Vaccination (SIV) is a crucial",
    "entities": [
      {
        "text": "Seasonal Influenza Vaccination",
        "label": "ORG"
      },
      {
        "text": "SIV",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "preventive measure, achieving sufficient coverage to completely control",
    "entities": []
  },
  {
    "text": "influenza epidemics poses a significant challenge. This study aims to evaluate",
    "entities": [
      {
        "text": "influenza",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "optimal strategies for SIV to prevent high-intensity level of influenza",
    "entities": [
      {
        "text": "SIV",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "epidemics in Zhejiang Province, China. High-intensity outbreaks were defined as",
    "entities": [
      {
        "text": "Zhejiang Province",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "weekly incidence rates above 72.2 per 100,000.",
    "entities": [
      {
        "text": "weekly",
        "label": "DATE"
      },
      {
        "text": "72.2",
        "label": "CARDINAL"
      },
      {
        "text": "100,000",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "METHODS: This study estimated the incidence of influenza from 2018 to 2023 in",
    "entities": [
      {
        "text": "2018",
        "label": "DATE"
      },
      {
        "text": "2023",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Zhejiang Province, China, using influenza weekly surveillance data. We developed",
    "entities": [
      {
        "text": "Zhejiang Province",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      },
      {
        "text": "weekly",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "a Susceptible-Vaccinated-Infectious-Recovered-Susceptible (SVIRS) model to",
    "entities": [
      {
        "text": "SVIRS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "simulate influenza transmission and used a decision tree to assess seven",
    "entities": [
      {
        "text": "seven",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "vaccination strategies aimed at preventing high-intensity influenza outbreaks.",
    "entities": []
  },
  {
    "text": "These strategies differed in vaccine coverage across the three age groups: 0-14",
    "entities": [
      {
        "text": "three",
        "label": "CARDINAL"
      },
      {
        "text": "0",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "years, 15-59 years, and 60 + years, despite having the same overall vaccination",
    "entities": [
      {
        "text": "years",
        "label": "DATE"
      },
      {
        "text": "15-59 years",
        "label": "DATE"
      },
      {
        "text": "60 + years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "coverage.",
    "entities": []
  },
  {
    "text": "RESULTS: Between 2018 and 2020, influenza incidence in Zhejiang Province",
    "entities": [
      {
        "text": "Between 2018 and 2020",
        "label": "DATE"
      },
      {
        "text": "Zhejiang Province",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "followed typical seasonal patterns. However, during the COVID-19 pandemic, these",
    "entities": [
      {
        "text": "seasonal",
        "label": "DATE"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "patterns became irregular, culminating in a high-intensity influenza season in",
    "entities": []
  },
  {
    "text": "2022-2023. Model simulations indicated that increasing population-wide",
    "entities": [
      {
        "text": "2022-2023",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "vaccination coverage to 36.17% could effectively prevent outbreaks from",
    "entities": [
      {
        "text": "36.17%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "escalating to high-intensity levels. Among various allocation strategies for",
    "entities": []
  },
  {
    "text": "additional vaccines, targeting individuals aged 0-14 years and those aged 60",
    "entities": [
      {
        "text": "0-14 years",
        "label": "DATE"
      },
      {
        "text": "60",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "years and older was found to be the most effective. This approach reduced the",
    "entities": []
  },
  {
    "text": "peak weekly incidence rate from the observed 182.83 to a predicted 42.28 per",
    "entities": [
      {
        "text": "weekly",
        "label": "DATE"
      },
      {
        "text": "182.83",
        "label": "CARDINAL"
      },
      {
        "text": "42.28",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "100,000, saved 23.45 CNY per capita, and yielded a health gain of 0.0102",
    "entities": [
      {
        "text": "100,000",
        "label": "CARDINAL"
      },
      {
        "text": "23.45",
        "label": "CARDINAL"
      },
      {
        "text": "0.0102",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "quality-adjusted life days (QALDs) per person.",
    "entities": []
  },
  {
    "text": "CONCLUSION: Achieving a population-wide vaccination coverage beyond 36.17% is",
    "entities": [
      {
        "text": "36.17%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "projected to prevent high-intensity level of influenza epidemics. Targeting the",
    "entities": []
  },
  {
    "text": "0-14 years and 60 + years age groups proves to be the most cost-effective",
    "entities": [
      {
        "text": "0-14 years",
        "label": "DATE"
      },
      {
        "text": "60 + years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "strategy under constrained coverage conditions. These findings highlight the",
    "entities": []
  },
  {
    "text": "importance of age-prioritized vaccination policies to optimize resource",
    "entities": []
  },
  {
    "text": "allocation and mitigate the impact of influenza outbreaks, particularly in",
    "entities": []
  },
  {
    "text": "regions with limited healthcare capacity.",
    "entities": []
  },
  {
    "text": "DOI: 10.1186/s12889-025-23648-6",
    "entities": [
      {
        "text": "10.1186",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40665279 [Indexed for MEDLINE]",
    "entities": []
  },
  {
    "text": "participate: The study did not require ethics approval and consent to",
    "entities": []
  },
  {
    "text": "participate because it did not include individual-level information, ensuring no",
    "entities": []
  },
  {
    "text": "privacy concerns. Consent for publication: Not applicable. Competing interests:",
    "entities": []
  },
  {
    "text": "65. BMC Public Health. 2025 Jul 15;25(1):2463. doi: 10.1186/s12889-025-23666-4.",
    "entities": [
      {
        "text": "65",
        "label": "CARDINAL"
      },
      {
        "text": "BMC Public Health",
        "label": "ORG"
      },
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "10.1186",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Factors associated with anemia among pregnant and lactating women during the",
    "entities": []
  },
  {
    "text": "COVID-19 pandemic in the targeted municipalities of five selected provinces in",
    "entities": [
      {
        "text": "five",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Nepal: a cross-sectional study.",
    "entities": []
  },
  {
    "text": "(1)Baliyo Nepal Nutrition Initiative, Kathmandu, Nepal. pratik.rachit@gmail.com.",
    "entities": [
      {
        "text": "Nepal Nutrition Initiative",
        "label": "ORG"
      },
      {
        "text": "Kathmandu",
        "label": "GPE"
      },
      {
        "text": "Nepal",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Vertex Foods and Beverages Pvt. Ltd., Kathmandu, Nepal.",
    "entities": [
      {
        "text": "2)Vertex Foods",
        "label": "ORG"
      },
      {
        "text": "Beverages Pvt. Ltd.",
        "label": "ORG"
      },
      {
        "text": "Kathmandu",
        "label": "GPE"
      },
      {
        "text": "Nepal",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Baliyo Nepal Nutrition Initiative, Kathmandu, Nepal.",
    "entities": [
      {
        "text": "Nepal Nutrition Initiative",
        "label": "ORG"
      },
      {
        "text": "Kathmandu",
        "label": "GPE"
      },
      {
        "text": "Nepal",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Vertex Foods and Beverages Pvt. Ltd., Kathmandu, Nepal.",
    "entities": [
      {
        "text": "4)Vertex Foods",
        "label": "ORG"
      },
      {
        "text": "Beverages Pvt. Ltd.",
        "label": "ORG"
      },
      {
        "text": "Kathmandu",
        "label": "GPE"
      },
      {
        "text": "Nepal",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Ministry of Agriculture and Livestock Development, Kathmandu, Nepal.",
    "entities": [
      {
        "text": "Agriculture and Livestock Development",
        "label": "ORG"
      },
      {
        "text": "Kathmandu",
        "label": "GPE"
      },
      {
        "text": "Nepal",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)National Food Research Centre, Nepal Agricultural Research Council,",
    "entities": [
      {
        "text": "6)National Food Research Centre",
        "label": "ORG"
      },
      {
        "text": "Nepal Agricultural Research Council",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "DOI: 10.1186/s12889-025-23666-4",
    "entities": [
      {
        "text": "10.1186",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "participate: All methods of this study were carried out under the Declaration of",
    "entities": [
      {
        "text": "the Declaration of\n",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "Helsinki\u2019s ethical principle for medical research involving human subjects. The",
    "entities": [
      {
        "text": "Helsinki",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "ethical clearance for this study was obtained from the Institutional Review",
    "entities": [
      {
        "text": "the Institutional Review",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Board (IRB) at the Nepal Health Research Council (Reference number: 217/2022).",
    "entities": [
      {
        "text": "IRB",
        "label": "ORG"
      },
      {
        "text": "the Nepal Health Research Council",
        "label": "ORG"
      },
      {
        "text": "217/2022",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "The formal permission was also obtained from the health department of respective",
    "entities": [
      {
        "text": "the health department of respective\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "municipalities. The written informed consent was obtained from all eligible",
    "entities": []
  },
  {
    "text": "participants before proceeding the data collection. In the case of minorities,",
    "entities": []
  },
  {
    "text": "who were under 16 years of age written informed consent was obtained from the",
    "entities": [
      {
        "text": "under 16 years of age",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "parents or legal guardians. Also, the data enumerators elaborated the objectives",
    "entities": []
  },
  {
    "text": "of the study among participants and they were informed about voluntary",
    "entities": []
  },
  {
    "text": "participation, their right to refusal at any point, and the confidentiality of",
    "entities": []
  },
  {
    "text": "their identity. Consent for publication: Not applicable. Competing interests:",
    "entities": []
  },
  {
    "text": "Nasal inhalation of antiviral microparticulate powders to target early infection",
    "entities": [
      {
        "text": "Nasal",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of upper airways.",
    "entities": []
  },
  {
    "text": "(1)Department of Life Sciences and Biotechnology, University of Ferrara, Via",
    "entities": [
      {
        "text": "Life Sciences and Biotechnology",
        "label": "ORG"
      },
      {
        "text": "University of Ferrara",
        "label": "ORG"
      },
      {
        "text": "Via",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Diagnostics and Public Health, University of Verona, Piazzale",
    "entities": [
      {
        "text": "Diagnostics and Public Health",
        "label": "ORG"
      },
      {
        "text": "Piazzale\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(3)Food and Drug Department, University of Parma, Parco Area delle Scienze 27/A,",
    "entities": [
      {
        "text": "3)Food and Drug Department",
        "label": "ORG"
      },
      {
        "text": "University of Parma",
        "label": "ORG"
      },
      {
        "text": "Parco Area delle Scienze",
        "label": "EVENT"
      }
    ]
  },
  {
    "text": "43124, Parma, Italy.",
    "entities": [
      {
        "text": "43124",
        "label": "DATE"
      },
      {
        "text": "Parma",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Unit of Microbiology, The Greater Romagna Area Hub Laboratory, Piazza della",
    "entities": [
      {
        "text": "The Greater Romagna Area Hub Laboratory",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)Department of Medical and Surgical Sciences (DIMEC), University of Bologna,",
    "entities": [
      {
        "text": "Medical and Surgical Sciences",
        "label": "ORG"
      },
      {
        "text": "University of Bologna",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(6)Institute of Materials for Electronics and Magnetism, IMEM-CNR, Parco Area",
    "entities": [
      {
        "text": "Materials for Electronics and Magnetism",
        "label": "ORG"
      },
      {
        "text": "IMEM-CNR",
        "label": "ORG"
      },
      {
        "text": "Parco Area",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "(7)PlumeStars Srl, C/O Food and Drug Department, University of Parma, Parco Area",
    "entities": [
      {
        "text": "7)PlumeStars",
        "label": "CARDINAL"
      },
      {
        "text": "University of Parma",
        "label": "ORG"
      },
      {
        "text": "Parco Area",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "(8)Department of Life Sciences and Biotechnology, University of Ferrara, Via",
    "entities": [
      {
        "text": "Life Sciences and Biotechnology",
        "label": "ORG"
      },
      {
        "text": "University of Ferrara",
        "label": "ORG"
      },
      {
        "text": "Via",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "During the COVID-19 pandemic, several compounds among which chloroquine",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "diphosphate (CqP), have been repurposed as anti-SARS-CoV-2 drugs. Critically,",
    "entities": [
      {
        "text": "CqP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "studies were most often performed by systemic drug administration, whereas the",
    "entities": []
  },
  {
    "text": "early viral infection of human body appeared in the upper respiratory tract.",
    "entities": []
  },
  {
    "text": "This research addressed the delivery strategy for depositing a powder aerosol of",
    "entities": []
  },
  {
    "text": "CqP onto the upper airways by a nasal inhalation act. By formulating the drug as",
    "entities": [
      {
        "text": "CqP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "nasal microparticulate aerodynamic powder, the loco-regional application of",
    "entities": []
  },
  {
    "text": "particle aerosol concentrates the drug primarily on the upper airway epithelia",
    "entities": []
  },
  {
    "text": "where the virus replicates. Nasal microparticulate powders of CqP, with and",
    "entities": [
      {
        "text": "Nasal",
        "label": "ORG"
      },
      {
        "text": "CqP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "without excipients, were engineered by spray drying, obtaining particle size,",
    "entities": []
  },
  {
    "text": "density and morphology suitable for aerosolization and deposition onto the upper",
    "entities": []
  },
  {
    "text": "respiratory tract. The powders were loaded into a pre-metered device for oral",
    "entities": []
  },
  {
    "text": "inhalation of dry powders that was innovatively actuated by a nasal sharp sniff.",
    "entities": []
  },
  {
    "text": "The generated nasal airflow, measured in healthy volunteers, enabled powder dose",
    "entities": []
  },
  {
    "text": "emission from the inhaler. Chloroquine diphosphate microparticles, deposited on",
    "entities": []
  },
  {
    "text": "rabbit nasal mucosa ex vivo, led in less than 45 min to CqP concentrations",
    "entities": [
      {
        "text": "less than 45",
        "label": "CARDINAL"
      },
      {
        "text": "CqP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "within the epithelial cells between 30-70 mM. The in vitro CqP concentrations",
    "entities": [
      {
        "text": "30",
        "label": "CARDINAL"
      },
      {
        "text": "CqP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "inhibiting SARS-CoV-2 replication, were in the \u00b5M range. The virus inhibition",
    "entities": []
  },
  {
    "text": "studied in Vero E6 cells was further enhanced when the cells were pre-treated",
    "entities": [
      {
        "text": "Vero E6",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "with the drug powder before infection. In conclusion, the simple nasal sniff of",
    "entities": []
  },
  {
    "text": "an antiviral aerodynamic powder could be active against airborne viral early",
    "entities": []
  },
  {
    "text": "infection, limiting the exposition of the whole body to undesired drug effects.",
    "entities": []
  },
  {
    "text": "\u00a9 2025. Controlled Release Society.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "DOI: 10.1007/s13346-025-01916-7",
    "entities": [
      {
        "text": "10.1007",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Declarations. Ethics approval: This study was",
    "entities": []
  },
  {
    "text": "performed in line with the principles of the Declaration of Helsinki. Approval",
    "entities": [
      {
        "text": "the Declaration of Helsinki",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "was granted by the Research Ethics Board of the University of Parma (June 11th,",
    "entities": [
      {
        "text": "the Research Ethics Board",
        "label": "ORG"
      },
      {
        "text": "the University of Parma",
        "label": "ORG"
      },
      {
        "text": "June 11th",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "2024, protocol number 0145714). Informed consent: All procedures followed were",
    "entities": [
      {
        "text": "2024",
        "label": "DATE"
      },
      {
        "text": "0145714",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "in accordance with the ethical standards of the responsible committee on human",
    "entities": []
  },
  {
    "text": "experimentation (institutional and national) and with the Helsinki Declaration",
    "entities": [
      {
        "text": "the Helsinki Declaration\n",
        "label": "LAW"
      }
    ]
  },
  {
    "text": "of 1975, as revised in 2000. Informed consent was obtained from all healthy",
    "entities": [
      {
        "text": "1975",
        "label": "DATE"
      },
      {
        "text": "2000",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "volunteers for being included in the study. Competing interest: Emeritus",
    "entities": []
  },
  {
    "text": "Professor Paolo Colombo is the administrator of the innovative SME PlumeStars",
    "entities": [
      {
        "text": "Paolo Colombo",
        "label": "PERSON"
      },
      {
        "text": "SME PlumeStars",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "s.r.l., the Applicant of an Italian patent on \u201cNovel Antiviral Compositions and",
    "entities": [
      {
        "text": "Italian",
        "label": "NORP"
      },
      {
        "text": "\u201cNovel Antiviral Compositions",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Their Use in Therapy and in the Treatment of Viral Infections\u201d (No.",
    "entities": []
  },
  {
    "text": "and Sabrina Banella are the inventors of that patent. Ruggero Bettini and",
    "entities": [
      {
        "text": "Sabrina Banella",
        "label": "PERSON"
      },
      {
        "text": "Ruggero Bettini",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Francesca Buttini, both professors of Pharmaceutical Technology at the Food and",
    "entities": [
      {
        "text": "Francesca Buttini",
        "label": "PERSON"
      },
      {
        "text": "Pharmaceutical Technology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Drug Department of the University of Parma, are co-founders of PlumeStars",
    "entities": [
      {
        "text": "Drug Department",
        "label": "ORG"
      },
      {
        "text": "the University of Parma",
        "label": "ORG"
      },
      {
        "text": "PlumeStars",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "start-up. The other authors have no relevant financial or non-financial",
    "entities": []
  },
  {
    "text": "Hyperglycemia and insulin use in patients with COVID-19 and severe hypoxemia",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "allocated to 12 mg vs. 6 mg of dexamethasone: a secondary analysis of the COVID",
    "entities": [
      {
        "text": "12",
        "label": "CARDINAL"
      },
      {
        "text": "6",
        "label": "CARDINAL"
      },
      {
        "text": "COVID",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "STEROID 2 randomized trial.",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(1)Center of Clinical Research and Disruption of Infectious Diseases (CREDID),",
    "entities": [
      {
        "text": "1)Center",
        "label": "CARDINAL"
      },
      {
        "text": "Clinical Research and Disruption of Infectious Diseases",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Department of Infectious Diseases, Copenhagen University Hospital - Amager",
    "entities": [
      {
        "text": "Copenhagen University Hospital - Amager",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Department of Infectious Diseases, Copenhagen University Hospital -",
    "entities": [
      {
        "text": "Copenhagen University Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Department of Clinical Medicine, University of Copenhagen, Copenhagen,",
    "entities": [
      {
        "text": "Clinical Medicine",
        "label": "ORG"
      },
      {
        "text": "University of Copenhagen",
        "label": "ORG"
      },
      {
        "text": "Copenhagen",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)Department of Public Health, Section of Biostatistics, University of",
    "entities": []
  },
  {
    "text": "(6)Department of Nephrology and Endocrinology, Copenhagen University Hospital,",
    "entities": [
      {
        "text": "Nephrology and Endocrinology",
        "label": "ORG"
      },
      {
        "text": "Copenhagen University Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(7)Department of Immunology and Microbiology, Faculty of Health and Medical",
    "entities": [
      {
        "text": "Immunology and Microbiology, Faculty of Health and Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Sciences, University of Copenhagen, Copenhagen,, Denmark.",
    "entities": [
      {
        "text": "University of Copenhagen",
        "label": "ORG"
      },
      {
        "text": "Copenhagen",
        "label": "ORG"
      },
      {
        "text": "Denmark",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(8)Department of Endocrinology, Copenhagen University Hospital - Amager and",
    "entities": [
      {
        "text": "Copenhagen University Hospital - Amager",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(9)Department of Clinical Biochemistry, Copenhagen University Hospital - Amager",
    "entities": [
      {
        "text": "Clinical Biochemistry",
        "label": "ORG"
      },
      {
        "text": "Copenhagen University Hospital - Amager",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(10)Department of Neuroanaesthesiology, Copenhagen University Hospital -",
    "entities": [
      {
        "text": "10)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Neuroanaesthesiology,",
        "label": "ORG"
      },
      {
        "text": "Copenhagen University Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(11)Department of Anaesthesiology and Intensive Care, Copenhagen University",
    "entities": [
      {
        "text": "11)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Copenhagen University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(12)Department of Anaesthesia and Intensive Care, Copenhagen University Hospital",
    "entities": [
      {
        "text": "12)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Anaesthesia",
        "label": "GPE"
      },
      {
        "text": "Intensive Care",
        "label": "ORG"
      },
      {
        "text": "Copenhagen University Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(13)Department of Respiratory Medicine, Copenhagen University Hospital - Amager",
    "entities": [
      {
        "text": "13)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Respiratory Medicine",
        "label": "ORG"
      },
      {
        "text": "Copenhagen University Hospital - Amager",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(14)Department of Anaesthesia and Intensive Care, Copenhagen University Hospital",
    "entities": [
      {
        "text": "14)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Anaesthesia",
        "label": "GPE"
      },
      {
        "text": "Intensive Care",
        "label": "ORG"
      },
      {
        "text": "Copenhagen University Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(15)Department of Anaesthesia and Intensive Care, Copenhagen University Hospital",
    "entities": [
      {
        "text": "15)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Anaesthesia",
        "label": "GPE"
      },
      {
        "text": "Intensive Care",
        "label": "ORG"
      },
      {
        "text": "Copenhagen University Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "- North Zealand, Hillerod, Denmark.",
    "entities": [
      {
        "text": "North Zealand",
        "label": "GPE"
      },
      {
        "text": "Hillerod",
        "label": "GPE"
      },
      {
        "text": "Denmark",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(16)Department of Anaesthesia and Intensive Care, Zealand University Hospital,",
    "entities": [
      {
        "text": "16)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Anaesthesia",
        "label": "GPE"
      },
      {
        "text": "Intensive Care",
        "label": "GPE"
      },
      {
        "text": "Zealand University Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(17)Department of Anaesthesia, Zealand University Hospital, Slagelse, Denmark.",
    "entities": [
      {
        "text": "17)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Anaesthesia",
        "label": "GPE"
      },
      {
        "text": "Zealand University Hospital",
        "label": "ORG"
      },
      {
        "text": "Slagelse",
        "label": "GPE"
      },
      {
        "text": "Denmark",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(18)Department of Infectious Diseases, Zealand University Hospital, Roskilde,",
    "entities": [
      {
        "text": "18)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Zealand University Hospital",
        "label": "ORG"
      },
      {
        "text": "Roskilde",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(19)Department of Intensive Care, Copenhagen University Hospital -",
    "entities": [
      {
        "text": "Copenhagen University Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(20)Center of Clinical Research and Disruption of Infectious Diseases (CREDID),",
    "entities": [
      {
        "text": "20)Center",
        "label": "CARDINAL"
      },
      {
        "text": "Clinical Research and Disruption of Infectious Diseases",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(21)Centre for Physical Activity Research, Copenhagen University Hospital -",
    "entities": [
      {
        "text": "21)Centre",
        "label": "CARDINAL"
      },
      {
        "text": "Physical Activity Research",
        "label": "ORG"
      },
      {
        "text": "Copenhagen University Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(22)Department of Infectious Diseases, Copenhagen University Hospital - Amager",
    "entities": [
      {
        "text": "22)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Copenhagen University Hospital - Amager",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "BACKGROUND: While dexamethasone has been shown to improve survival in COVID-19,",
    "entities": [
      {
        "text": "COVID-19",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "its dose-response relationship with plasma glucose (PG) levels and insulin",
    "entities": []
  },
  {
    "text": "requirements is poorly understood. This study investigated the impact of 12 mg",
    "entities": [
      {
        "text": "12",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(higher dose) versus 6 mg (standard dose) of dexamethasone on hyper- or",
    "entities": [
      {
        "text": "6",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "hypoglycemic events and the use of insulin.",
    "entities": []
  },
  {
    "text": "METHODS: A secondary analysis of a subpopulation of the COVID STEROID 2 trial.",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Glycemic outcomes were assessed by time-to-event analysis of a hyperglycemic",
    "entities": []
  },
  {
    "text": "(two PG measurements \u2265 11.1 mmol/L), severe hyperglycemic (PG > 20 mmol/L),",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      },
      {
        "text": "PG",
        "label": "ORG"
      },
      {
        "text": "\u2265",
        "label": "GPE"
      },
      {
        "text": "11.1",
        "label": "CARDINAL"
      },
      {
        "text": "20",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "hypoglycemic (< 3.8 mmol/L) event or use of insulin, adjusted for age, diabetes",
    "entities": [
      {
        "text": "3.8",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "status, hospital site, and mechanical ventilation. PG levels were compared",
    "entities": []
  },
  {
    "text": "before and after treatment allocation with linear mixed models to estimate",
    "entities": [
      {
        "text": "linear",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "RESULTS: Of 321 participants, 170 were allocated to the higher dose and 151 to",
    "entities": [
      {
        "text": "321",
        "label": "CARDINAL"
      },
      {
        "text": "170",
        "label": "CARDINAL"
      },
      {
        "text": "151",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "the standard dose of dexamethasone. Time to a hyperglycemic event did not differ",
    "entities": []
  },
  {
    "text": "between groups, whereas severe hyperglycemic events were more frequent in the",
    "entities": []
  },
  {
    "text": "higher dose group (36%) than in the standard dose group (31%) with an adjusted",
    "entities": [
      {
        "text": "36%",
        "label": "PERCENT"
      },
      {
        "text": "31%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "subdistributional hazard ratio of 1.76 (95% CI [1.22-2.54], p = 0.003). Insulin",
    "entities": [
      {
        "text": "1.76",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.22-2.54",
        "label": "CARDINAL"
      },
      {
        "text": "0.003",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "use and hypoglycemic events did not differ between groups. The higher vs.",
    "entities": []
  },
  {
    "text": "standard dose group had an average PG increase of 0.5 mmol/L (95% CI [- 0.2 to",
    "entities": [
      {
        "text": "standard dose group",
        "label": "ORG"
      },
      {
        "text": "0.5",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "CONCLUSION: Higher vs. standard doses of dexamethasone were associated with a",
    "entities": []
  },
  {
    "text": "higher incidence of severe hyperglycemia in patients with COVID-19 and severe",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "hypoxemia, but the average increase in PG was similar between groups.",
    "entities": [
      {
        "text": "PG",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "DOI: 10.1186/s13613-025-01512-5",
    "entities": [
      {
        "text": "10.1186",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "participate: The COVID STEROID 2 trial was approved by the Scientific Ethics",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      },
      {
        "text": "the Scientific Ethics",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Committee of the Capital Region of Denmark (H-20051056) and registered at",
    "entities": [
      {
        "text": "H-20051056",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "ClinicalTrials.gov (NCT04509973) and ctri.nic.in (CTRI/2020/10/028731) on August",
    "entities": [
      {
        "text": "August",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "11th, 2020. The secondary analysis was approved according to Danish Healthcare",
    "entities": [
      {
        "text": "11th",
        "label": "ORDINAL"
      },
      {
        "text": "2020",
        "label": "DATE"
      },
      {
        "text": "Danish Healthcare",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Law \u00a7 46, Sect. 2 by the Capital Region (R-24013197). Consent for publication:",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      },
      {
        "text": "the Capital Region",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Not applicable. Competing interests: T.B. reports grants from Novo Nordisk",
    "entities": [
      {
        "text": "T.B.",
        "label": "GPE"
      },
      {
        "text": "Novo Nordisk",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Foundation, Lundbeck Foundation, Simonsen Foundation, GSK, and Pfizer; personal",
    "entities": [
      {
        "text": "Lundbeck Foundation",
        "label": "ORG"
      },
      {
        "text": "Simonsen Foundation",
        "label": "ORG"
      },
      {
        "text": "GSK",
        "label": "ORG"
      },
      {
        "text": "Pfizer",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "fees from GSK, Pfizer, Bavarian Nordic, Gilead, MSD, Janssen, Moderna and Astra",
    "entities": [
      {
        "text": "GSK",
        "label": "ORG"
      },
      {
        "text": "Pfizer",
        "label": "ORG"
      },
      {
        "text": "Bavarian Nordic",
        "label": "ORG"
      },
      {
        "text": "Gilead",
        "label": "ORG"
      },
      {
        "text": "MSD",
        "label": "ORG"
      },
      {
        "text": "Janssen",
        "label": "GPE"
      },
      {
        "text": "Moderna",
        "label": "GPE"
      },
      {
        "text": "Astra",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Zeneca; outside the submitted work. TPA holds stocks in Novo Nordisk A/S;",
    "entities": [
      {
        "text": "Zeneca",
        "label": "PERSON"
      },
      {
        "text": "Novo Nordisk A/S",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "outside the submitted work. No other disclosures were reported.",
    "entities": []
  },
  {
    "text": "68. J Gen Intern Med. 2025 Jul 15. doi: 10.1007/s11606-025-09715-z. Online ahead",
    "entities": [
      {
        "text": "68",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "10.1007",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Disparities in Monoclonal Antibody (mAb) Treatment Usage in the Military Health",
    "entities": [
      {
        "text": "Monoclonal Antibody",
        "label": "ORG"
      },
      {
        "text": "the Military Health\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "System During the COVID-19 Pandemic.",
    "entities": []
  },
  {
    "text": "(1)The Henry M. Jackson Foundation for the Advancement of Military Medicine,",
    "entities": [
      {
        "text": "Henry M. Jackson Foundation",
        "label": "ORG"
      },
      {
        "text": "the Advancement of Military Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Inc., Bethesda, MD, USA.",
    "entities": [
      {
        "text": "Bethesda",
        "label": "GPE"
      },
      {
        "text": "MD",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)The Henry M. Jackson Foundation for the Advancement of Military Medicine,",
    "entities": [
      {
        "text": "Henry M. Jackson Foundation",
        "label": "PERSON"
      },
      {
        "text": "the Advancement of Military Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Inc., Bethesda, MD, USA. cathaleen.madsen.ctr@usuhs.edu.",
    "entities": [
      {
        "text": "Bethesda",
        "label": "GPE"
      },
      {
        "text": "MD",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Uniformed Services University of the Health Sciences, Bethesda, MD, USA.",
    "entities": [
      {
        "text": "3)Uniformed Services University of the Health Sciences",
        "label": "ORG"
      },
      {
        "text": "Bethesda",
        "label": "GPE"
      },
      {
        "text": "MD",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)SeaStar Medical, Denver, CO, USA.",
    "entities": [
      {
        "text": "4)SeaStar Medical",
        "label": "ORG"
      },
      {
        "text": "Denver",
        "label": "GPE"
      },
      {
        "text": "CO, USA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)Uniformed Services University of the Health Sciences, Bethesda, MD, USA.",
    "entities": [
      {
        "text": "5)Uniformed Services University of the Health Sciences",
        "label": "ORG"
      },
      {
        "text": "Bethesda",
        "label": "GPE"
      },
      {
        "text": "MD",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: Monoclonal antibodies (mAbs) were identified in 2020 as potential",
    "entities": [
      {
        "text": "mAbs",
        "label": "ORG"
      },
      {
        "text": "2020",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "curative agents for COVID-19, particularly in high-risk populations. However,",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "studies report differences in receipt of mAbs by race, sex, and insurance",
    "entities": [
      {
        "text": "mAbs",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "status. We hypothesized that Military Health System (MHS) beneficiaries, who are",
    "entities": [
      {
        "text": "Military Health System",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "universally insured, would have approximately equal uptake of mAbs across",
    "entities": [
      {
        "text": "mAbs",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "sociodemographic categories.",
    "entities": []
  },
  {
    "text": "METHODS: Beneficiaries (active-duty service members, dependents, retirees) aged",
    "entities": []
  },
  {
    "text": "12-64, receiving a COVID-19 diagnosis and outpatient treatment between November",
    "entities": [
      {
        "text": "12-64",
        "label": "DATE"
      },
      {
        "text": "COVID-19",
        "label": "PRODUCT"
      },
      {
        "text": "November",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "9, 2020, and January 24, 2022, were identified from claims data in the MHS Data",
    "entities": [
      {
        "text": "9, 2020",
        "label": "DATE"
      },
      {
        "text": "January 24, 2022",
        "label": "DATE"
      },
      {
        "text": "MHS Data",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Repository (MDR). Analyses comprised descriptive statistics on demographics and",
    "entities": []
  },
  {
    "text": "frequency of COVID-19 mAb treatment for all eligible beneficiaries and by sex,",
    "entities": [
      {
        "text": "COVID-19 mAb",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "race, sponsor rank, and risk status. Unadjusted and adjusted odds ratios (OR)",
    "entities": []
  },
  {
    "text": "for likelihood of receiving mAb treatment were obtained using multivariable",
    "entities": []
  },
  {
    "text": "logistic regression models for all beneficiaries as well as only those",
    "entities": []
  },
  {
    "text": "classified as \"high risk.\"",
    "entities": []
  },
  {
    "text": "RESULTS: Of 221,036 COVID-19 patients receiving outpatient care, 9907 (4.5%)",
    "entities": [
      {
        "text": "221,036",
        "label": "CARDINAL"
      },
      {
        "text": "9907",
        "label": "DATE"
      },
      {
        "text": "4.5%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "received mAb treatment. Beneficiaries who received treatment were predominately",
    "entities": []
  },
  {
    "text": "White (53%), female (57%), ages 45-64 (64%), dependents (56%), associated with",
    "entities": [
      {
        "text": "53%",
        "label": "PERCENT"
      },
      {
        "text": "57%",
        "label": "PERCENT"
      },
      {
        "text": "45-64",
        "label": "DATE"
      },
      {
        "text": "64%",
        "label": "PERCENT"
      },
      {
        "text": "56%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "enlisted rank (77%), and not at high risk of developing severe COVID-19 and/or",
    "entities": [
      {
        "text": "77%",
        "label": "PERCENT"
      },
      {
        "text": "COVID-19 and/or\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "hospitalization (86%). Greater uptake of mAbs by American Indian/Alaska Native",
    "entities": [
      {
        "text": "86%",
        "label": "PERCENT"
      },
      {
        "text": "mAbs",
        "label": "ORG"
      },
      {
        "text": "American",
        "label": "NORP"
      },
      {
        "text": "Indian",
        "label": "NORP"
      },
      {
        "text": "Alaska Native",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "and lesser uptake by Black and Asian compared to White patients, and by female",
    "entities": [
      {
        "text": "Black",
        "label": "NORP"
      },
      {
        "text": "Asian",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "compared to male patients, concurs with published results in the greater US",
    "entities": [
      {
        "text": "US",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "CONCLUSIONS: Despite universal insurance, significant differences were observed",
    "entities": []
  },
  {
    "text": "in receipt of mAbs by race, rank (proxy for socioeconomic status), and sex.",
    "entities": [
      {
        "text": "mAbs",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "These results suggest that factors beyond insurance play roles in determining",
    "entities": []
  },
  {
    "text": "who receives mAbs. The provision of mAbs to non-high-risk patients also suggests",
    "entities": [
      {
        "text": "mAbs",
        "label": "ORG"
      },
      {
        "text": "mAbs",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "a role for either patient- or provider-induced demand. Further research is",
    "entities": []
  },
  {
    "text": "needed to determine the scope of factors affecting mAb uptake in the MHS, and in",
    "entities": [
      {
        "text": "mAb uptake",
        "label": "ORG"
      },
      {
        "text": "MHS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "other large health systems.",
    "entities": []
  },
  {
    "text": "\u00a9 2025. This is a U.S. Government work and not under copyright protection in the",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "a U.S. Government",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "US; foreign copyright protection may apply.",
    "entities": [
      {
        "text": "US",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Declarations. Conflict of Interest: The authors",
    "entities": []
  },
  {
    "text": "declare no conflicts of interest. Human Ethics and Consent to Participate",
    "entities": [
      {
        "text": "Ethics",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Declarations: NA. Disclaimer: The contents of this publication are the sole",
    "entities": [
      {
        "text": "NA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "responsibility of the authors and do not necessarily reflect the views,",
    "entities": []
  },
  {
    "text": "assertions, opinions, or policies of the Uniformed Services University of the",
    "entities": [
      {
        "text": "the Uniformed Services University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Health Sciences (USUHS); the Henry M. Jackson Foundation for the Advancement of",
    "entities": [
      {
        "text": "Health Sciences",
        "label": "ORG"
      },
      {
        "text": "USUHS",
        "label": "ORG"
      },
      {
        "text": "the Henry M. Jackson Foundation",
        "label": "FAC"
      },
      {
        "text": "the Advancement of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Military Medicine, Inc. (HJF); the Department of Defense (DoD); the Departments",
    "entities": [
      {
        "text": "Military Medicine, Inc.",
        "label": "ORG"
      },
      {
        "text": "HJF",
        "label": "ORG"
      },
      {
        "text": "the Department of Defense",
        "label": "ORG"
      },
      {
        "text": "Departments",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of the Army, Navy, or Air Force; or SeaStar Medical. Mention of trade names,",
    "entities": [
      {
        "text": "Army",
        "label": "ORG"
      },
      {
        "text": "Navy",
        "label": "ORG"
      },
      {
        "text": "Air Force",
        "label": "ORG"
      },
      {
        "text": "SeaStar Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "commercial products, or organizations does not imply endorsement by the US",
    "entities": [
      {
        "text": "US",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Government.",
    "entities": []
  },
  {
    "text": "Emotional state in patients after COVID-19 in relation to comprehensive",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "rehabilitation, Brain-Derived neurotrophic factor, Irisin levels, and selected",
    "entities": [
      {
        "text": "Brain",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "clinical factors.",
    "entities": []
  },
  {
    "text": "(1)Department of Medical Rehabilitation and Clinical Physiotherapy, Pomeranian",
    "entities": [
      {
        "text": "Medical Rehabilitation and Clinical Physiotherapy",
        "label": "ORG"
      },
      {
        "text": "Pomeranian",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Medical University, Szczecin, 71-210, Poland. alicja.minko287@gmail.com.",
    "entities": [
      {
        "text": "Medical University",
        "label": "ORG"
      },
      {
        "text": "Szczecin",
        "label": "GPE"
      },
      {
        "text": "71",
        "label": "CARDINAL"
      },
      {
        "text": "Poland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Medical Rehabilitation and Clinical Physiotherapy, Pomeranian",
    "entities": [
      {
        "text": "Pomeranian",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Medical University, Szczecin, 71-210, Poland.",
    "entities": [
      {
        "text": "Medical University",
        "label": "ORG"
      },
      {
        "text": "Szczecin",
        "label": "GPE"
      },
      {
        "text": "71",
        "label": "CARDINAL"
      },
      {
        "text": "Poland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "The outbreak of the COVID-19 epidemic is a breach of health protection",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "worldwide. Complications in people who limit the risk of COVID-19 can be",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "associated with physical and mental health. Identification of states associated",
    "entities": []
  },
  {
    "text": "with anxiety and depression and threats that may occur in patients after",
    "entities": []
  },
  {
    "text": "COVID-19 is a very important aspect that occurs on the selection of therapeutic",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "methods, and thus recovery occurs. The aim of the study was to assess the",
    "entities": []
  },
  {
    "text": "penalty in the treatment of anxiety symptoms and depressiveness in a patient",
    "entities": []
  },
  {
    "text": "after COVID-19. The study includes the effects resulting from brain-derived",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "neurotrophic factor, irisin and other problems related to problems and",
    "entities": []
  },
  {
    "text": "depressive symptoms in patients after COVID-19. included in the study",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "participation in the rehabilitation education program in stationary conditions.",
    "entities": []
  },
  {
    "text": "The Generalized Anxiety Disorder Questionnaire was used to solve anxiety",
    "entities": [
      {
        "text": "Questionnaire",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "problems. The Beck Depression Inventory was used to assess the effects of",
    "entities": [
      {
        "text": "The Beck Depression Inventory",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "depression. To assess the update of the irisin (ng/mL) and brain-derived",
    "entities": []
  },
  {
    "text": "neurotrophic factor (ng/mL) configuration on the day of treatment initiation",
    "entities": [
      {
        "text": "ng/mL",
        "label": "ORG"
      },
      {
        "text": "the day",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "from each patient's blood was collected from a female venous sample. After",
    "entities": []
  },
  {
    "text": "rehabilitation, patients scored lower in both depression and anxiety",
    "entities": []
  },
  {
    "text": "assessments. Women had higher scores in the assessment of anxiety disorders and",
    "entities": []
  },
  {
    "text": "depression. The longer the period from the end of COVID-19 treatment to the",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "start of rehabilitation, the higher the Generalized Anxiety Disorder",
    "entities": []
  },
  {
    "text": "Questionnaire and The Beck Depression Inventory scores. The higher the",
    "entities": [
      {
        "text": "The Beck Depression Inventory",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Generalized Anxiety Disorder Questionnaire and The Beck Depression Inventory",
    "entities": [
      {
        "text": "Generalized Anxiety",
        "label": "ORG"
      },
      {
        "text": "Questionnaire",
        "label": "PERSON"
      },
      {
        "text": "The Beck Depression Inventory",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "scores, the lower the handgrip strength values. With increasing irisin",
    "entities": []
  },
  {
    "text": "concentration, The Beck Depression Inventory values also increased.",
    "entities": [
      {
        "text": "The Beck Depression Inventory",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Comprehensive rehabilitation may be associated with a reduction in the severity",
    "entities": []
  },
  {
    "text": "of anxiety and depressive symptoms in patients after COVID-19. Earlier",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "initiation of rehabilitation may be associated with better emotional well-being",
    "entities": []
  },
  {
    "text": "in patients after COVID-19. The severity of anxiety and depressive symptoms may",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "be associated with gender, age, and hospitalization during COVID-19 treatment.",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Increased irisin levels in patients after COVID-19 may be associated with",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "inflammatory and metabolic complications after infection. However,",
    "entities": []
  },
  {
    "text": "interpretation of these relationships requires further studies taking into",
    "entities": []
  },
  {
    "text": "account additional biological variables and prospective analyses.",
    "entities": []
  },
  {
    "text": "PMID: 40665009 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40665009",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Declarations. Competing interests: The authors",
    "entities": []
  },
  {
    "text": "declare no competing interests. Institutional review board statement: The study",
    "entities": []
  },
  {
    "text": "was conducted in accordance with the Declaration of Helsinki and approved by the",
    "entities": [
      {
        "text": "the Declaration of Helsinki",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "Bioethics Committee of the Pomeranian Medical University (protocol code",
    "entities": [
      {
        "text": "Bioethics Committee",
        "label": "ORG"
      },
      {
        "text": "the Pomeranian Medical University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "KB-0012/15/2021 of 28 June 2023). Informed consent Statement: Informed consent",
    "entities": [
      {
        "text": "28 June 2023",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "was obtained from all subjects involved in the study.",
    "entities": []
  },
  {
    "text": "70. Commun Med (Lond). 2025 Jul 15;5(1):294. doi: 10.1038/s43856-025-00998-1.",
    "entities": [
      {
        "text": "70",
        "label": "CARDINAL"
      },
      {
        "text": "Commun Med (Lond",
        "label": "PERSON"
      },
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "15;5(1):294",
        "label": "CARDINAL"
      },
      {
        "text": "10.1038",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(1)College of Computer Science and Artificial Intelligence, Fudan University,",
    "entities": [
      {
        "text": "Computer Science and Artificial Intelligence",
        "label": "ORG"
      },
      {
        "text": "Fudan University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)College of Computer Science and Artificial Intelligence, Fudan University,",
    "entities": [
      {
        "text": "2)College",
        "label": "CARDINAL"
      },
      {
        "text": "Fudan University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Institute of Digestive Disease, School of Medicine, Tongji University,",
    "entities": [
      {
        "text": "Digestive Disease, School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Tongji University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)National Engineering Center for Biochip, Shanghai, 201203, China.",
    "entities": [
      {
        "text": "Engineering Center for Biochip",
        "label": "WORK_OF_ART"
      },
      {
        "text": "Shanghai",
        "label": "GPE"
      },
      {
        "text": "201203",
        "label": "DATE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Endoscopy Center of Zhongshan Hospital, Fudan University, Shanghai, 200032,",
    "entities": [
      {
        "text": "Center of Zhongshan Hospital",
        "label": "ORG"
      },
      {
        "text": "Fudan University",
        "label": "ORG"
      },
      {
        "text": "Shanghai",
        "label": "GPE"
      },
      {
        "text": "200032",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "BACKGROUND: The development of medical imaging techniques has made a significant",
    "entities": []
  },
  {
    "text": "contribution to clinical decision-making. However, the existence of suboptimal",
    "entities": []
  },
  {
    "text": "imaging quality, as indicated by irregular illumination or imbalanced intensity,",
    "entities": []
  },
  {
    "text": "presents significant obstacles in automating disease screening, analysis, and",
    "entities": []
  },
  {
    "text": "diagnosis. Existing approaches for natural image enhancement are mostly trained",
    "entities": []
  },
  {
    "text": "with numerous paired images, presenting challenges in data collection and",
    "entities": []
  },
  {
    "text": "training costs, all while lacking the ability to generalize effectively.",
    "entities": []
  },
  {
    "text": "METHODS: Here, we introduce a pioneering training-free Diffusion Model for",
    "entities": [
      {
        "text": "Diffusion Model",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "Universal Medical Image Enhancement, named UniMIE. UniMIE demonstrates its",
    "entities": [
      {
        "text": "Universal Medical Image Enhancement",
        "label": "ORG"
      },
      {
        "text": "UniMIE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "without the need for any fine-tuning. It accomplishes this by relying solely on",
    "entities": []
  },
  {
    "text": "a single pre-trained model from ImageNet.",
    "entities": [
      {
        "text": "ImageNet",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "RESULTS: We conduct a comprehensive evaluation on 13 imaging modalities and over",
    "entities": [
      {
        "text": "13",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "15 medical types, demonstrating better qualities, robustness, and accuracy than",
    "entities": [
      {
        "text": "15",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "other modality-specific and data-inefficient models. By delivering high-quality",
    "entities": []
  },
  {
    "text": "enhancement and corresponding accuracy downstream tasks across a wide range of",
    "entities": []
  },
  {
    "text": "tasks, UniMIE exhibits considerable potential to accelerate the advancement of",
    "entities": []
  },
  {
    "text": "diagnostic tools and customized treatment plans.",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: UniMIE represents a transformative approach to medical image",
    "entities": []
  },
  {
    "text": "enhancement, offering a versatile and robust solution that adapts to diverse",
    "entities": []
  },
  {
    "text": "imaging conditions. By improving image quality and facilitating better",
    "entities": []
  },
  {
    "text": "downstream analyses, UniMIE has the potential to revolutionize clinical",
    "entities": [
      {
        "text": "UniMIE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "workflows and enhance diagnostic accuracy across a wide range of medical",
    "entities": []
  },
  {
    "text": "applications.",
    "entities": []
  },
  {
    "text": "Plain Language Summary: Medical images, such as microscopy and X-rays, are",
    "entities": []
  },
  {
    "text": "important tools for diagnosing and treating illnesses. However, these images",
    "entities": []
  },
  {
    "text": "often have poor quality due to issues that include low contrast or noise, making",
    "entities": []
  },
  {
    "text": "it harder for doctors to use them effectively. To address this issue, we",
    "entities": []
  },
  {
    "text": "developed a method called UniMIE, which improves the quality of medical images",
    "entities": [
      {
        "text": "UniMIE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "without requiring computational training or inclusion of additional medical",
    "entities": []
  },
  {
    "text": "data. UniMIE enhances image clarity and brightness, enabling doctors to more",
    "entities": []
  },
  {
    "text": "easily analyze and diagnose conditions. Experimental results demonstrate that",
    "entities": []
  },
  {
    "text": "UniMIE outperforms existing enhancement methods across diverse applications,",
    "entities": []
  },
  {
    "text": "including COVID-19 detection, brain imaging and cardiac imaging. We hope that",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "this approach will contribute to improved diagnostic accuracy and, ultimately,",
    "entities": []
  },
  {
    "text": "DOI: 10.1038/s43856-025-00998-1",
    "entities": [
      {
        "text": "10.1038",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Competing interests: The authors declare no",
    "entities": []
  },
  {
    "text": "competing interests.",
    "entities": []
  },
  {
    "text": "Dysregulated type I/III interferon system in circulation from patients with",
    "entities": []
  },
  {
    "text": "(1)Department of Allergy and Rheumatology, Nippon Medical School Graduate School",
    "entities": [
      {
        "text": "Allergy and Rheumatology",
        "label": "ORG"
      },
      {
        "text": "Nippon Medical School Graduate School",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of Medicine, 1-1-5, Sendagi, Bunkyo-Ku, Tokyo, 113-8602, Japan.",
    "entities": [
      {
        "text": "1-1-5",
        "label": "CARDINAL"
      },
      {
        "text": "Sendagi",
        "label": "NORP"
      },
      {
        "text": "Bunkyo-Ku",
        "label": "GPE"
      },
      {
        "text": "Tokyo",
        "label": "GPE"
      },
      {
        "text": "113-8602",
        "label": "DATE"
      },
      {
        "text": "Japan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Scleroderma/Myositis Center of Excellence, Nippon Medical School Hospital,",
    "entities": [
      {
        "text": "Nippon Medical School Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Department of Microbiology and Immunology, Nippon Medical School Graduate",
    "entities": [
      {
        "text": "Microbiology and Immunology",
        "label": "ORG"
      },
      {
        "text": "Nippon Medical School Graduate",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "School of Medicine, Tokyo, 113-8602, Japan.",
    "entities": [
      {
        "text": "School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Tokyo",
        "label": "GPE"
      },
      {
        "text": "113-8602",
        "label": "DATE"
      },
      {
        "text": "Japan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Emergency and Critical Care Medicine, Nippon Medical School",
    "entities": [
      {
        "text": "Emergency and Critical Care Medicine",
        "label": "ORG"
      },
      {
        "text": "Nippon Medical School",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Graduate School of Medicine, Tokyo, 113-8602, Japan.",
    "entities": [
      {
        "text": "Graduate School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Tokyo",
        "label": "GPE"
      },
      {
        "text": "113-8602",
        "label": "DATE"
      },
      {
        "text": "Japan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Second Division, Department of Internal Medicine, Hamamatsu University School",
    "entities": [
      {
        "text": "Division, Department of Internal Medicine",
        "label": "ORG"
      },
      {
        "text": "Hamamatsu University School",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of Medicine, Hamamatsu, 431-3192, Japan.",
    "entities": [
      {
        "text": "Hamamatsu",
        "label": "ORG"
      },
      {
        "text": "431-3192",
        "label": "CARDINAL"
      },
      {
        "text": "Japan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Department of Allergy and Rheumatology, Nippon Medical School Graduate School",
    "entities": [
      {
        "text": "Allergy and Rheumatology",
        "label": "ORG"
      },
      {
        "text": "Nippon Medical School Graduate School",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(7)Scleroderma/Myositis Center of Excellence, Nippon Medical School Hospital,",
    "entities": [
      {
        "text": "7)Scleroderma/Myositis Center of Excellence",
        "label": "ORG"
      },
      {
        "text": "Nippon Medical School Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(DM) is often complicated by rapidly progressive interstitial lung disease",
    "entities": []
  },
  {
    "text": "(RP-ILD), leading to early mortality. Previous studies on the pathogenesis of",
    "entities": []
  },
  {
    "text": "anti-MDA5-positive DM highlighted type I interferons (IFNs), while recent",
    "entities": [
      {
        "text": "DM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "investigations reported the significance of a type III IFN, IFN-\u03bb3. We",
    "entities": [
      {
        "text": "III IFN",
        "label": "ORG"
      },
      {
        "text": "IFN",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "investigated a range of cytokines, including type I/II/III IFNs, in serum",
    "entities": [
      {
        "text": "I/II/III",
        "label": "EVENT"
      }
    ]
  },
  {
    "text": "samples from anti-MDA5-positive DM patients collected at diagnosis before",
    "entities": [
      {
        "text": "DM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "treatment introduction. Elevations of IFN-\u03b2 and \u03bb3 were identified as the",
    "entities": [
      {
        "text": "IFN",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "hallmark of anti-MDA5-positive DM, in comparison with other myositis subtypes,",
    "entities": [
      {
        "text": "myositis",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "systemic lupus erythematosus, and COVID-19 pneumonia. The elevation of IFN-\u03bb3",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      },
      {
        "text": "IFN",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "was associated with decreased CD56dimCD16pos NK cells in circulation. The unique",
    "entities": []
  },
  {
    "text": "cytokine profile with type I/III IFN upregulation in anti-MDA5-positive DM was",
    "entities": [
      {
        "text": "DM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "replicated in independent validation cohorts. A cluster analysis using serum",
    "entities": []
  },
  {
    "text": "type I/III IFN levels identified three subgroups in anti-MDA5-positive DM: mild",
    "entities": [
      {
        "text": "I/III IFN",
        "label": "ORG"
      },
      {
        "text": "three",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "elevations of IFN-\u03b1/\u03b2 and \u03bb3; a marked increase in IFN-\u03bb3 alone; and pronounced",
    "entities": [
      {
        "text": "IFN",
        "label": "ORG"
      },
      {
        "text": "IFN",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "elevations of IFN-\u03b1/\u03b2 with mild to moderate increase in IFN-\u03bb3. Patients in the",
    "entities": [
      {
        "text": "IFN",
        "label": "ORG"
      },
      {
        "text": "IFN",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "cluster with a marked elevation of IFN-\u03bb3 alone tended to present with RP-ILD",
    "entities": [
      {
        "text": "IFN",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and decreased survival. The combination of serum type I/III IFN levels could",
    "entities": []
  },
  {
    "text": "serve as a prognostic biomarker in anti-MDA5-positive DM.",
    "entities": [
      {
        "text": "DM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "DOI: 10.1038/s41598-025-10895-1",
    "entities": [
      {
        "text": "10.1038",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40664875 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40664875",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Declarations. Competing interests: T.G. has",
    "entities": [
      {
        "text": "T.G.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "received speaking fees from Asahi Kasei Pharma, Astellas, Boehringer-Ingelheim,",
    "entities": [
      {
        "text": "Asahi Kasei Pharma",
        "label": "ORG"
      },
      {
        "text": "Astellas",
        "label": "PERSON"
      },
      {
        "text": "Boehringer-Ingelheim",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Bristol-Myers Squibb, Chugai, Eli Lily, Ono Pharmaceuticals, Pfizer, and",
    "entities": [
      {
        "text": "Bristol-Myers Squibb",
        "label": "ORG"
      },
      {
        "text": "Chugai",
        "label": "PERSON"
      },
      {
        "text": "Eli Lily, Ono Pharmaceuticals",
        "label": "ORG"
      },
      {
        "text": "Pfizer",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Tanabe-Mitsubishi; M.K. has received royalties from MBL; speaking honoraria from",
    "entities": [
      {
        "text": "Tanabe-Mitsubishi",
        "label": "PERSON"
      },
      {
        "text": "M.K.",
        "label": "PERSON"
      },
      {
        "text": "MBL",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Boehringer-Ingelheim; consulting honoraria from Argenx, AstraZeneca,",
    "entities": [
      {
        "text": "Boehringer-Ingelheim",
        "label": "ORG"
      },
      {
        "text": "Argenx",
        "label": "LOC"
      },
      {
        "text": "AstraZeneca",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Boehringer-Ingelheim, GSK, and Novartis; and research grants from",
    "entities": [
      {
        "text": "Boehringer-Ingelheim",
        "label": "ORG"
      },
      {
        "text": "GSK",
        "label": "ORG"
      },
      {
        "text": "Novartis",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Boehringer-Ingelheim and MBL. The other authors have no conflicts of interest.",
    "entities": [
      {
        "text": "Boehringer-Ingelheim",
        "label": "ORG"
      },
      {
        "text": "MBL",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "COLA-GLM: collaborative one-shot and lossless algorithms of generalized linear",
    "entities": [
      {
        "text": "one",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "models for decentralized observational healthcare data.",
    "entities": []
  },
  {
    "text": "(1)Department of Biostatistics and Health Data Science, University of",
    "entities": [
      {
        "text": "Biostatistics and Health Data Science, University of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Department of Biostatistics, Epidemiology, and Informatics, University of",
    "entities": [
      {
        "text": "2)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Biostatistics, Epidemiology",
        "label": "ORG"
      },
      {
        "text": "Informatics, University of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.",
    "entities": [
      {
        "text": "Pennsylvania Perelman School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Philadelphia",
        "label": "GPE"
      },
      {
        "text": "PA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)The Center for Health AI and Synthesis of Evidence (CHASE), University of",
    "entities": [
      {
        "text": "3)The Center for Health AI",
        "label": "ORG"
      },
      {
        "text": "University of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Observational Health Data Sciences and Informatics, New York, NY, USA.",
    "entities": [
      {
        "text": "Health Data Sciences",
        "label": "ORG"
      },
      {
        "text": "Informatics",
        "label": "ORG"
      },
      {
        "text": "New York",
        "label": "GPE"
      },
      {
        "text": "NY",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Janssen Research & Development, Titusville, NJ, USA.",
    "entities": [
      {
        "text": "Research & Development",
        "label": "ORG"
      },
      {
        "text": "Titusville",
        "label": "GPE"
      },
      {
        "text": "NJ",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Department of Medical Informatics, Erasmus University Medical Center,",
    "entities": [
      {
        "text": "Medical Informatics, Erasmus University Medical Center",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Rotterdam, The Netherlands.",
    "entities": [
      {
        "text": "Rotterdam",
        "label": "GPE"
      },
      {
        "text": "The Netherlands",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)The Graduate Group in Applied Mathematics and Computational Science, School",
    "entities": [
      {
        "text": "7)The Graduate Group",
        "label": "ORG"
      },
      {
        "text": "Applied Mathematics",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of Arts and Sciences, University of Pennsylvania, Philadelphia, PA, USA.",
    "entities": [
      {
        "text": "Arts and Sciences, University of Pennsylvania",
        "label": "ORG"
      },
      {
        "text": "Philadelphia",
        "label": "GPE"
      },
      {
        "text": "PA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(8)Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health,",
    "entities": [
      {
        "text": "Biostatistics",
        "label": "NORP"
      },
      {
        "text": "Johns Hopkins Bloomberg School of Public Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(9)Department of Statistics, Faculty of Science, University of Auckland,",
    "entities": [
      {
        "text": "Statistics, Faculty of Science, University of Auckland",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(10)Real World Solutions, IQVIA, Durham, NC, USA.",
    "entities": [
      {
        "text": "World Solutions",
        "label": "ORG"
      },
      {
        "text": "Durham",
        "label": "GPE"
      },
      {
        "text": "NC",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(11)Department of Biomedical Informatics, Columbia University Irving Medical",
    "entities": [
      {
        "text": "11)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Biomedical Informatics",
        "label": "ORG"
      },
      {
        "text": "Columbia University Irving Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Center, New York, NY, USA.",
    "entities": [
      {
        "text": "New York",
        "label": "GPE"
      },
      {
        "text": "NY",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(12)Department of Biostatistics and Health Data Science, Indiana University,",
    "entities": [
      {
        "text": "12)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Biostatistics and Health Data Science",
        "label": "ORG"
      },
      {
        "text": "Indiana University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(13)Center for Biomedical Informatics, Regenstrief Institute, Indianapolis, IN,",
    "entities": [
      {
        "text": "13)Center",
        "label": "CARDINAL"
      },
      {
        "text": "Biomedical Informatics",
        "label": "ORG"
      },
      {
        "text": "Regenstrief Institute",
        "label": "PERSON"
      },
      {
        "text": "Indianapolis",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(14)Department of Population Health Sciences, Weill Cornell Medicine, New York,",
    "entities": [
      {
        "text": "Population Health Sciences",
        "label": "ORG"
      },
      {
        "text": "Weill Cornell Medicine",
        "label": "ORG"
      },
      {
        "text": "New York",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(15)Department of Biomedical Informatics, Vanderbilt University Medical Center,",
    "entities": [
      {
        "text": "15)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Biomedical Informatics",
        "label": "ORG"
      },
      {
        "text": "Vanderbilt University Medical Center",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(16)Department of Electrical and Software Engineering, University of Calgary,",
    "entities": [
      {
        "text": "University of Calgary",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(17)Clinical and Translational Science Institute, Tufts Medical Center, Boston,",
    "entities": [
      {
        "text": "Translational Science Institute",
        "label": "ORG"
      },
      {
        "text": "Tufts Medical Center",
        "label": "ORG"
      },
      {
        "text": "Boston",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(18)Institute for Clinical Research and Health Policy Studies, Tufts Medical",
    "entities": [
      {
        "text": "18)Institute for Clinical Research",
        "label": "ORG"
      },
      {
        "text": "Tufts Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Center, Boston, MA, USA.",
    "entities": [
      {
        "text": "Center",
        "label": "GPE"
      },
      {
        "text": "Boston",
        "label": "GPE"
      },
      {
        "text": "MA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(19)Department of Biostatistics, Vanderbilt University Medical Center,",
    "entities": [
      {
        "text": "19)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Vanderbilt University Medical Center",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(20)Department of Computer Science, Vanderbilt University, Nashville, TN, USA.",
    "entities": [
      {
        "text": "20)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Nashville",
        "label": "GPE"
      },
      {
        "text": "TN",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(21)Department of Biostatistics, University of California, Los Angeles, CA, USA.",
    "entities": [
      {
        "text": "21)Department",
        "label": "CARDINAL"
      },
      {
        "text": "University of California",
        "label": "ORG"
      },
      {
        "text": "Los Angeles",
        "label": "GPE"
      },
      {
        "text": "CA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(22)Center for Biologics Evaluation and Research, Food and Drug Administration,",
    "entities": [
      {
        "text": "22)Center",
        "label": "CARDINAL"
      },
      {
        "text": "Biologics Evaluation and Research, Food and Drug Administration",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(23)School of Information, University of Michigan, Ann Arbor, MI, USA.",
    "entities": [
      {
        "text": "23)School of Information, University of Michigan",
        "label": "ORG"
      },
      {
        "text": "Ann Arbor",
        "label": "GPE"
      },
      {
        "text": "MI",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(24)Leonard Davis Institute of Health Economics, University of Pennsylvania,",
    "entities": [
      {
        "text": "24)Leonard",
        "label": "CARDINAL"
      },
      {
        "text": "Davis Institute of Health Economics",
        "label": "ORG"
      },
      {
        "text": "University of Pennsylvania",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(25)Division of General Internal Medicine, University of Pennsylvania Perelman",
    "entities": [
      {
        "text": "25)Division",
        "label": "CARDINAL"
      },
      {
        "text": "General Internal Medicine",
        "label": "ORG"
      },
      {
        "text": "University of Pennsylvania Perelman",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "School of Medicine, Philadelphia, PA, USA.",
    "entities": [
      {
        "text": "School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Philadelphia",
        "label": "GPE"
      },
      {
        "text": "PA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(26)Department of Biostatistics, Epidemiology, and Informatics, University of",
    "entities": [
      {
        "text": "26)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Biostatistics, Epidemiology",
        "label": "ORG"
      },
      {
        "text": "Informatics, University of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(27)The Center for Health AI and Synthesis of Evidence (CHASE), University of",
    "entities": [
      {
        "text": "27)The Center for Health AI",
        "label": "ORG"
      },
      {
        "text": "University of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(28)Leonard Davis Institute of Health Economics, University of Pennsylvania,",
    "entities": [
      {
        "text": "28)Leonard",
        "label": "CARDINAL"
      },
      {
        "text": "Davis Institute of Health Economics",
        "label": "ORG"
      },
      {
        "text": "University of Pennsylvania",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(29)Penn Medicine Center for Evidence-based Practice (CEP), Philadelphia, PA,",
    "entities": [
      {
        "text": "Practice",
        "label": "ORG"
      },
      {
        "text": "Philadelphia",
        "label": "GPE"
      },
      {
        "text": "PA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(30)Penn Institute for Biomedical Informatics (IBI), Philadelphia, PA, USA.",
    "entities": [
      {
        "text": "Institute for Biomedical Informatics",
        "label": "ORG"
      },
      {
        "text": "IBI",
        "label": "ORG"
      },
      {
        "text": "Philadelphia",
        "label": "GPE"
      },
      {
        "text": "PA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Clinical insights from real-world data often require aggregating information",
    "entities": []
  },
  {
    "text": "from institutions to ensure sufficient sample sizes and generalizability.",
    "entities": []
  },
  {
    "text": "However, patient privacy concerns only limit the sharing of patient-level data,",
    "entities": []
  },
  {
    "text": "and traditional federated learning algorithms, relying on extensive",
    "entities": []
  },
  {
    "text": "back-and-forth communications, can be inefficient to implement. We introduce the",
    "entities": []
  },
  {
    "text": "Collaborative One-shot Lossless Algorithm for Generalized Linear Models",
    "entities": [
      {
        "text": "One",
        "label": "CARDINAL"
      },
      {
        "text": "Lossless Algorithm",
        "label": "FAC"
      }
    ]
  },
  {
    "text": "(COLA-GLM), a novel federated learning algorithm that supports diverse outcome",
    "entities": []
  },
  {
    "text": "types via generalized linear models and achieves results identical to a pooled",
    "entities": [
      {
        "text": "linear",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "patient-level data analysis (lossless) with only a single round of aggregated",
    "entities": []
  },
  {
    "text": "data exchange (one-shot). To further protect aggregated institutional data, we",
    "entities": [
      {
        "text": "one",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "developed a secure extension, secure-COLA-GLM, utilizing homomorphic encryption.",
    "entities": []
  },
  {
    "text": "We demonstrated the effectiveness and lossless property of COLA-GLM through",
    "entities": [
      {
        "text": "COLA-GLM",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "applications to an international influenza cohort and a decentralized U.S.",
    "entities": [
      {
        "text": "U.S.",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "COVID-19 mortality study. COLA-GLM and secure-COLA-GLM offer a scalable,",
    "entities": []
  },
  {
    "text": "efficient solution for decentralized collaborative learning involving multiple",
    "entities": []
  },
  {
    "text": "data partners and diverse security requirements.",
    "entities": []
  },
  {
    "text": "DOI: 10.1038/s41746-025-01781-1",
    "entities": [
      {
        "text": "10.1038",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "COVID-19 susceptibility, severity, and vaccine effectiveness in patients with",
    "entities": []
  },
  {
    "text": "psoriasis: a nationwide cohort study in South Korea.",
    "entities": [
      {
        "text": "South Korea",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(1)Department of Dermatology, Konkuk University School of Medicine, 120-1",
    "entities": [
      {
        "text": "Dermatology, Konkuk University School of Medicine",
        "label": "ORG"
      },
      {
        "text": "120",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Neungdong-ro, Gwangjin-gu, Seoul, 05030, Republic of Korea.",
    "entities": [
      {
        "text": "Neungdong",
        "label": "GPE"
      },
      {
        "text": "Gwangjin",
        "label": "GPE"
      },
      {
        "text": "Seoul",
        "label": "GPE"
      },
      {
        "text": "05030",
        "label": "DATE"
      },
      {
        "text": "Republic of Korea",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Public Health Sciences, Seoul National University, 1 Gwanak-ro,",
    "entities": [
      {
        "text": "Public Health Sciences",
        "label": "ORG"
      },
      {
        "text": "Seoul National University",
        "label": "ORG"
      },
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Gwanak-gu, Seoul, 08826, Republic of Korea.",
    "entities": [
      {
        "text": "Seoul",
        "label": "GPE"
      },
      {
        "text": "08826",
        "label": "DATE"
      },
      {
        "text": "Republic of Korea",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Institute of Health and Environment, Seoul National University, 1 Gwanak-ro,",
    "entities": [
      {
        "text": "Health and Environment",
        "label": "ORG"
      },
      {
        "text": "Seoul National University",
        "label": "ORG"
      },
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(4)RexSoft Inc, 542 Yeoksam-ro, Gangnam-gu, Seoul, 06187, Republic of Korea.",
    "entities": [
      {
        "text": "4)RexSoft Inc",
        "label": "ORG"
      },
      {
        "text": "542",
        "label": "CARDINAL"
      },
      {
        "text": "Gangnam",
        "label": "GPE"
      },
      {
        "text": "Seoul",
        "label": "GPE"
      },
      {
        "text": "06187",
        "label": "DATE"
      },
      {
        "text": "Republic of Korea",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Research Institute of Medical Science, Konkuk University School of Medicine,",
    "entities": [
      {
        "text": "5)Research Institute of Medical Science, Konkuk University School of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "120-1 Neungdong-ro, Gwangjin-gu, Seoul, 05030, Republic of Korea.",
    "entities": [
      {
        "text": "120",
        "label": "CARDINAL"
      },
      {
        "text": "Neungdong",
        "label": "GPE"
      },
      {
        "text": "Gwangjin",
        "label": "GPE"
      },
      {
        "text": "Seoul",
        "label": "GPE"
      },
      {
        "text": "05030",
        "label": "DATE"
      },
      {
        "text": "Republic of Korea",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Department of Dermatology, Konkuk University School of Medicine, 120-1",
    "entities": [
      {
        "text": "Dermatology, Konkuk University School of Medicine",
        "label": "ORG"
      },
      {
        "text": "120",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Neungdong-ro, Gwangjin-gu, Seoul, 05030, Republic of Korea. cyb@kuh.ac.kr.",
    "entities": [
      {
        "text": "Neungdong",
        "label": "GPE"
      },
      {
        "text": "Gwangjin",
        "label": "GPE"
      },
      {
        "text": "Seoul",
        "label": "GPE"
      },
      {
        "text": "05030",
        "label": "DATE"
      },
      {
        "text": "Republic of Korea",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Research Institute of Medical Science, Konkuk University School of Medicine,",
    "entities": [
      {
        "text": "Institute of Medical Science, Konkuk University School of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "120-1 Neungdong-ro, Gwangjin-gu, Seoul, 05030, Republic of Korea. cyb@kuh.ac.kr.",
    "entities": [
      {
        "text": "120",
        "label": "CARDINAL"
      },
      {
        "text": "Neungdong",
        "label": "GPE"
      },
      {
        "text": "Gwangjin",
        "label": "GPE"
      },
      {
        "text": "Seoul",
        "label": "GPE"
      },
      {
        "text": "05030",
        "label": "DATE"
      },
      {
        "text": "Republic of Korea",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Patients with psoriasis are vulnerable to infections due to dysregulated",
    "entities": []
  },
  {
    "text": "immunity, use of immunosuppressive drugs, and comorbid conditions. Despite",
    "entities": []
  },
  {
    "text": "ongoing concerns regarding coronavirus disease 2019 (COVID-19) vulnerability in",
    "entities": [
      {
        "text": "2019",
        "label": "DATE"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "patients with psoriasis, evidence remains limited. This nationwide,",
    "entities": []
  },
  {
    "text": "population-based, retrospective cohort study aimed to assess the risk and",
    "entities": []
  },
  {
    "text": "severity of COVID-19 and vaccine effectiveness in patients with psoriasis,",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "including those receiving immunomodulatory therapy, using Korean National Health",
    "entities": [
      {
        "text": "Korean National Health\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Insurance Service claims data from 2018 to 2021. The primary analysis included",
    "entities": [
      {
        "text": "Insurance Service",
        "label": "ORG"
      },
      {
        "text": "2018",
        "label": "DATE"
      },
      {
        "text": "2021",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "167,746 patients with psoriasis and 866,582 controls, revealing no significant",
    "entities": [
      {
        "text": "167,746",
        "label": "CARDINAL"
      },
      {
        "text": "866,582",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "associations between psoriasis and COVID-19 (adjusted hazard ratio [aHR]: 0.99,",
    "entities": [
      {
        "text": "COVID-19",
        "label": "PERSON"
      },
      {
        "text": "0.99",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "95% confidence interval [CI]: 0.95-1.04). Conversely, the secondary analysis of",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "PERSON"
      },
      {
        "text": "0.95-1.04",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "3,131 patients with psoriasis and 265,475 controls revealed significantly higher",
    "entities": [
      {
        "text": "3,131",
        "label": "CARDINAL"
      },
      {
        "text": "265,475",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "rates of severe COVID-19 in patients with psoriasis (aHR: 1.33, 95% CI:",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      },
      {
        "text": "1.33",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "1.08-1.64). While some treatment subgroups - such as the cyclosporine and",
    "entities": [
      {
        "text": "1.08-1.64",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "methotrexate subgroups - demonstrated higher incidences of COVID-19 than the",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "reference (nonsystemic) subgroup, these differences were not statistically",
    "entities": []
  },
  {
    "text": "significant. Furthermore, vaccine interaction effects between the duration of",
    "entities": []
  },
  {
    "text": "immunity and psoriasis or each treatment were insignificant (all P > 0.05).",
    "entities": [
      {
        "text": "0.05",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Patients with psoriasis exhibited a higher risk of severe COVID-19; however,",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "their COVID-19 susceptibility and vaccine effectiveness resembled those of the",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "control group. Additionally, the use of immunomodulatory agents did not impact",
    "entities": [
      {
        "text": "control group",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "COVID-19 risk or vaccine effectiveness. These findings highlight the need for",
    "entities": []
  },
  {
    "text": "dermatologists to implement pre- and postinfection strategies tailored for",
    "entities": []
  },
  {
    "text": "patients with psoriasis.",
    "entities": []
  },
  {
    "text": "DOI: 10.1038/s41598-025-06495-8",
    "entities": [
      {
        "text": "10.1038",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40664730 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40664730",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Declarations. Ethical approval: This study was",
    "entities": []
  },
  {
    "text": "reviewed and approved by the Konkuk University Medical Center IRB; approval",
    "entities": [
      {
        "text": "the Konkuk University Medical Center IRB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "number: 36 #KUMC 2021-12-033. Written consent was waived since this study used",
    "entities": [
      {
        "text": "36",
        "label": "CARDINAL"
      },
      {
        "text": "2021-12-033",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "de-identified data. Competing interests: Y.B.C. has received research grants",
    "entities": [
      {
        "text": "Y.B.C.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "from the the Konkuk University. The remaining authors have no conflict of",
    "entities": [
      {
        "text": "the the Konkuk University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Development and validation of a RP-HPLC method for simultaneous determination of",
    "entities": []
  },
  {
    "text": "five COVID-19 antiviral drugs in pharmaceutical formulations.",
    "entities": [
      {
        "text": "five",
        "label": "CARDINAL"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Al-",
    "entities": [
      {
        "text": "Analytical Chemistry Department",
        "label": "ORG"
      },
      {
        "text": "Faculty of Pharmacy",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Azhar University, Nasr City, 11751, Cairo, Egypt.",
    "entities": [
      {
        "text": "Azhar University",
        "label": "ORG"
      },
      {
        "text": "Nasr City",
        "label": "GPE"
      },
      {
        "text": "11751",
        "label": "DATE"
      },
      {
        "text": "Cairo",
        "label": "GPE"
      },
      {
        "text": "Egypt",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Al-",
    "entities": [
      {
        "text": "Analytical Chemistry Department",
        "label": "ORG"
      },
      {
        "text": "Faculty of Pharmacy",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Azhar University, Nasr City, 11751, Cairo, Egypt. Ahmedserag777@azhar.edu.eg.",
    "entities": [
      {
        "text": "Azhar University",
        "label": "ORG"
      },
      {
        "text": "Nasr City",
        "label": "GPE"
      },
      {
        "text": "11751",
        "label": "DATE"
      },
      {
        "text": "Cairo",
        "label": "GPE"
      },
      {
        "text": "Egypt",
        "label": "GPE"
      },
      {
        "text": "Ahmedserag777@azhar.edu.eg",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "A rapid, sensitive, and selective reversed-phase high-performance liquid",
    "entities": []
  },
  {
    "text": "chromatography (RP-HPLC) method was developed and validated for the simultaneous",
    "entities": []
  },
  {
    "text": "determination of five COVID-19 antiviral drugs: favipiravir, molnupiravir,",
    "entities": [
      {
        "text": "five",
        "label": "CARDINAL"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "nirmatrelvir, remdesivir, and ritonavir. The chromatographic separation was",
    "entities": []
  },
  {
    "text": "achieved on a Hypersil BDS C18 column (4.5 \u00d7 150 mm, 5 \u03bcm particle size) using",
    "entities": [
      {
        "text": "Hypersil BDS C18",
        "label": "ORG"
      },
      {
        "text": "4.5",
        "label": "CARDINAL"
      },
      {
        "text": "5 \u03bcm",
        "label": "QUANTITY"
      }
    ]
  },
  {
    "text": "an isocratic mobile phase consisting of water and methanol (30:70 v/v, pH 3.0",
    "entities": [
      {
        "text": "30:70 v/v",
        "label": "QUANTITY"
      },
      {
        "text": "3.0",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "adjusted with 0.1% ortho-phosphoric acid) at a flow rate of 1 mL/min with UV",
    "entities": [
      {
        "text": "0.1%",
        "label": "PERCENT"
      },
      {
        "text": "1 mL/min",
        "label": "QUANTITY"
      }
    ]
  },
  {
    "text": "detection at 230 nm. The optimized method demonstrated good chromatographic",
    "entities": [
      {
        "text": "230",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "resolution with retention times of 1.23, 1.79, 2.47, 2.86, and 4.34 min for",
    "entities": [
      {
        "text": "1.23",
        "label": "CARDINAL"
      },
      {
        "text": "1.79",
        "label": "CARDINAL"
      },
      {
        "text": "2.47",
        "label": "CARDINAL"
      },
      {
        "text": "2.86",
        "label": "CARDINAL"
      },
      {
        "text": "4.34",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "respectively. The method was validated according to ICH guidelines, showing",
    "entities": []
  },
  {
    "text": "linearity in the concentration range of 10-50 \u00b5g/mL with correlation",
    "entities": [
      {
        "text": "10-50",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "coefficients (r\u00b2) \u2265 0.9997 for all analytes. The limits of detection were",
    "entities": [
      {
        "text": "\u2265 0.9997",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "0.415-0.946 \u00b5g/mL, while the limits of quantification were 1.260-2.868 \u00b5g/mL.",
    "entities": [
      {
        "text": "0.415-0.946",
        "label": "CARDINAL"
      },
      {
        "text": "1.260",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "The method demonstrated high trueness (99.59-100.08%) and precision",
    "entities": [
      {
        "text": "99.59-100.08%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "(RSD < 1.1%). The validated method was successfully applied to the determination",
    "entities": [
      {
        "text": "RSD",
        "label": "ORG"
      },
      {
        "text": "1.1%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "of these drugs in their pharmaceutical formulations, with recovery values",
    "entities": []
  },
  {
    "text": "ranging from 99.98 to 100.7% and no significant interference from excipients.",
    "entities": [
      {
        "text": "99.98",
        "label": "CARDINAL"
      },
      {
        "text": "100.7%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "Comprehensive greenness and practicality evaluations using five assessment tools",
    "entities": [
      {
        "text": "five",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "yielded favorable scores: AGREE (0.70), AGREEprep (0.59), MoGAPI (70%), BAGI",
    "entities": [
      {
        "text": "AGREE",
        "label": "ORG"
      },
      {
        "text": "0.70",
        "label": "CARDINAL"
      },
      {
        "text": "AGREEprep",
        "label": "GPE"
      },
      {
        "text": "0.59",
        "label": "CARDINAL"
      },
      {
        "text": "MoGAPI",
        "label": "GPE"
      },
      {
        "text": "70%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "(82.5), and CACI (79), indicating good environmental performance and excellent",
    "entities": [
      {
        "text": "82.5",
        "label": "CARDINAL"
      },
      {
        "text": "CACI",
        "label": "ORG"
      },
      {
        "text": "79",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "practical applicability for routine pharmaceutical quality control analysis. The",
    "entities": []
  },
  {
    "text": "multi-tool assessment confirmed the method's environmental friendliness through",
    "entities": []
  },
  {
    "text": "strategic solvent selection and minimal sample preparation requirements, while",
    "entities": []
  },
  {
    "text": "demonstrating superior practical implementation characteristics including",
    "entities": []
  },
  {
    "text": "cost-effectiveness and accessibility in standard analytical laboratories.",
    "entities": []
  },
  {
    "text": "DOI: 10.1038/s41598-025-09904-0",
    "entities": [
      {
        "text": "10.1038",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40664729 [Indexed for MEDLINE]",
    "entities": []
  },
  {
    "text": "applicable to this study. Consent for publication: Not applicable to this study.",
    "entities": []
  },
  {
    "text": "Pleural mesothelioma incidence and use of systemic treatment decreased during",
    "entities": [
      {
        "text": "Pleural",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "the COVID-19 pandemic in The Netherlands.",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      },
      {
        "text": "The Netherlands",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(1)Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, The",
    "entities": [
      {
        "text": "Thoracic Oncology",
        "label": "ORG"
      },
      {
        "text": "Netherlands Cancer Institute",
        "label": "ORG"
      },
      {
        "text": "Amsterdam",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Pulmonary Medicine, Leiden University Medical Center, Leiden,",
    "entities": [
      {
        "text": "Pulmonary Medicine",
        "label": "PERSON"
      },
      {
        "text": "Leiden University Medical Center",
        "label": "ORG"
      },
      {
        "text": "Leiden",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "The Netherlands. i.smesseim@nki.nl.",
    "entities": [
      {
        "text": "Netherlands",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, The",
    "entities": [
      {
        "text": "Thoracic Oncology",
        "label": "ORG"
      },
      {
        "text": "Netherlands Cancer Institute",
        "label": "ORG"
      },
      {
        "text": "Amsterdam",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Research and Development, Association of Comprehensive Cancer",
    "entities": [
      {
        "text": "Research and Development, Association of Comprehensive Cancer",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Centres, Utrecht, The Netherlands.",
    "entities": [
      {
        "text": "Utrecht",
        "label": "GPE"
      },
      {
        "text": "The Netherlands",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Pleural mesothelioma (PM) is a lethal cancer often linked to asbestos exposure.",
    "entities": [
      {
        "text": "Pleural",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "The COVID-19 pandemic caused a global health crisis, raising concerns about its",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "impact on cancer diagnoses and treatments. In response to the immense pressures",
    "entities": []
  },
  {
    "text": "on the healthcare system caused by the COVID-19 pandemic, many countries advised",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "prioritizing essential healthcare services while postponing or suspending care",
    "entities": []
  },
  {
    "text": "considered non-emergent to prevent overburdening healthcare systems. This study",
    "entities": []
  },
  {
    "text": "assesses the impact of COVID-19 on the incidence, treatment, and overall",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "survival of PM patients in the Netherlands between 2018 and 2022. Data were",
    "entities": [
      {
        "text": "Netherlands",
        "label": "GPE"
      },
      {
        "text": "between 2018 and 2022",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "collected from the Netherlands Cancer Registry for 2,629 PM patients. Incidence,",
    "entities": [
      {
        "text": "the Netherlands Cancer Registry",
        "label": "ORG"
      },
      {
        "text": "2,629 PM",
        "label": "TIME"
      }
    ]
  },
  {
    "text": "treatment patterns, and survival rates were analyzed using statistical methods,",
    "entities": []
  },
  {
    "text": "including Kruskal-Wallis and log-rank tests. PM incidence dropped 13.2% in 2020",
    "entities": [
      {
        "text": "Kruskal-Wallis",
        "label": "PERSON"
      },
      {
        "text": "PM",
        "label": "ORG"
      },
      {
        "text": "13.2%",
        "label": "PERCENT"
      },
      {
        "text": "2020",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "during the pandemic, with a 58.8% increase in patients receiving best supportive",
    "entities": [
      {
        "text": "58.8%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "care and a decline in chemotherapy use (from 39.4% to 32.0%). In 2021, diagnoses",
    "entities": [
      {
        "text": "39.4%",
        "label": "PERCENT"
      },
      {
        "text": "32.0%",
        "label": "PERCENT"
      },
      {
        "text": "2021",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "rebounded (+ 15.2%), and immunotherapy use rose following its approval. However,",
    "entities": [
      {
        "text": "+ 15.2%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "no significant difference in overall survival was found between 2018 and 2022.",
    "entities": [
      {
        "text": "between 2018 and 2022",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "COVID-19 led to a temporary decline in PM diagnoses and systemic treatments in",
    "entities": []
  },
  {
    "text": "2020, followed by recovery in 2021. Despite these changes, overall survival",
    "entities": [
      {
        "text": "2020",
        "label": "DATE"
      },
      {
        "text": "2021",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "rates remained stable.",
    "entities": []
  },
  {
    "text": "DOI: 10.1038/s41598-025-10054-6",
    "entities": [
      {
        "text": "10.1038",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40664720 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40664720",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "competing interests. Ethical approval: This study was approved by the Ethics",
    "entities": [
      {
        "text": "Ethics",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Review Committee of the Netherlands Cancer Registry, under approval number",
    "entities": [
      {
        "text": "Review Committee",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Structural stabilization of the intrinsically disordered SARS-CoV-2 N by binding",
    "entities": [
      {
        "text": "SARS-CoV-2 N",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "to RNA sequences engineered from the viral genome fragment.",
    "entities": [
      {
        "text": "RNA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Olmedillas E(3), Miller R(3), Shresta S(3), Wysocki VH(4), Saphire EO(5)(6).",
    "entities": [
      {
        "text": "Miller",
        "label": "PERSON"
      },
      {
        "text": "Shresta S(3",
        "label": "PERSON"
      },
      {
        "text": "Wysocki",
        "label": "PERSON"
      },
      {
        "text": "Saphire EO(5)(6",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(4)Department of Chemistry and Biochemistry, The Ohio State University,",
    "entities": [
      {
        "text": "Chemistry and Biochemistry",
        "label": "ORG"
      },
      {
        "text": "The Ohio State University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Columbus, OH, USA.",
    "entities": [
      {
        "text": "Columbus",
        "label": "GPE"
      },
      {
        "text": "OH",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Department of Medicine, University of California, La Jolla, CA, USA.",
    "entities": [
      {
        "text": "Medicine, University of California",
        "label": "ORG"
      },
      {
        "text": "La Jolla",
        "label": "GPE"
      },
      {
        "text": "CA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "The nucleocapsid N is one of four structural proteins of the coronaviruses. Its",
    "entities": [
      {
        "text": "N",
        "label": "ORG"
      },
      {
        "text": "one",
        "label": "CARDINAL"
      },
      {
        "text": "four",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "essential role in genome encapsidation makes it a critical therapeutic target",
    "entities": []
  },
  {
    "text": "for COVID-19 and related diseases. However, the inherent disorder of full-length",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "N hampers its structural analysis. Here, we describe a stepwise method using",
    "entities": []
  },
  {
    "text": "viral-derived RNAs to stabilize SARS-CoV-2 N for EM analysis. We identify pieces",
    "entities": [
      {
        "text": "SARS-CoV-2 N",
        "label": "ORG"
      },
      {
        "text": "EM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of RNA from the SARS-CoV-2 genome that promote the formation of structurally",
    "entities": [
      {
        "text": "RNA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "homogeneous N dimers, intermediates of assembly, and filamentous capsid-like",
    "entities": []
  },
  {
    "text": "structures. Building on these results, we engineer a symmetric RNA to stabilize",
    "entities": [
      {
        "text": "RNA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "N protein dimers, the building block of high-order assemblies, for EM studies.",
    "entities": [
      {
        "text": "EM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "We combine domain-specific monoclonal antibodies against N with chemical",
    "entities": [
      {
        "text": "N",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "cross-linking mass spectrometry to validate the spatial arrangement of the N",
    "entities": [
      {
        "text": "N",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "domains within the dimer. Additionally, our cryo-EM analysis reveals novel",
    "entities": []
  },
  {
    "text": "antigenic sites on the N protein. Our findings provide insights into N protein\u00b4s",
    "entities": [
      {
        "text": "N",
        "label": "ORG"
      },
      {
        "text": "N",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "architectural and antigenic principles, which can guide design of",
    "entities": []
  },
  {
    "text": "pan-coronavirus therapeutics.",
    "entities": [
      {
        "text": "pan-coronavirus",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "DOI: 10.1038/s41467-025-61861-4",
    "entities": [
      {
        "text": "10.1038",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40664703 [Indexed for MEDLINE]",
    "entities": []
  },
  {
    "text": "Mortality among inpatients with systemic lupus erythematosus in a tertiary care",
    "entities": [
      {
        "text": "tertiary",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "(1)Department of Internal Medicine, Post Graduate Institute of Medical Education",
    "entities": [
      {
        "text": "Internal Medicine",
        "label": "ORG"
      },
      {
        "text": "Post Graduate Institute of Medical Education",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and Research, Chandigarh, India.",
    "entities": [
      {
        "text": "Research, Chandigarh",
        "label": "ORG"
      },
      {
        "text": "India",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Internal Medicine, Indira Gandhi Medical College, Shimla,",
    "entities": [
      {
        "text": "Internal Medicine",
        "label": "ORG"
      },
      {
        "text": "Indira Gandhi Medical College",
        "label": "ORG"
      },
      {
        "text": "Shimla",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(3)Department of Pulmonary Medicine, Post Graduate Institute of Medical",
    "entities": [
      {
        "text": "Pulmonary Medicine",
        "label": "ORG"
      },
      {
        "text": "Post Graduate Institute of Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Education and Research, Chandigarh, India.",
    "entities": [
      {
        "text": "Research, Chandigarh",
        "label": "ORG"
      },
      {
        "text": "India",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Gastroenterology, Post Graduate Institute of Medical Education",
    "entities": [
      {
        "text": "Gastroenterology, Post Graduate Institute of Medical Education",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)Department of Nephrology, Post Graduate Institute of Medical Education and",
    "entities": [
      {
        "text": "Nephrology, Post Graduate Institute of Medical Education",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Research, Chandigarh, India.",
    "entities": [
      {
        "text": "Chandigarh",
        "label": "GPE"
      },
      {
        "text": "India",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BackgroundSystemic lupus erythematosus (SLE) is associated with significant",
    "entities": [
      {
        "text": "SLE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "morbidity and mortality, particularly during hospitalisation. Differentiating",
    "entities": []
  },
  {
    "text": "between infection and disease activity is crucial but challenging. Regional",
    "entities": []
  },
  {
    "text": "variations in infection rates and disease manifestations necessitate",
    "entities": []
  },
  {
    "text": "region-specific studies.ObjectivesTo evaluate whether infections at or during",
    "entities": [
      {
        "text": "ObjectivesTo",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "hospitalisation are associated with increased mortality among SLE patients and",
    "entities": [
      {
        "text": "SLE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "identify additional predictors of adverse outcomes.MethodsThis retrospective",
    "entities": []
  },
  {
    "text": "case-control study included SLE patients hospitalised between January 2012 and",
    "entities": [
      {
        "text": "SLE",
        "label": "ORG"
      },
      {
        "text": "January 2012",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "December 2021. Cases (n = 111) were patients who expired during hospitalisation,",
    "entities": [
      {
        "text": "December 2021",
        "label": "DATE"
      },
      {
        "text": "111",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "matched 1:2 with controls (n = 222) discharged alive, based on age (\u00b13 years)",
    "entities": [
      {
        "text": "1:2",
        "label": "CARDINAL"
      },
      {
        "text": "222",
        "label": "CARDINAL"
      },
      {
        "text": "age (\u00b13 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "and sex, stratified annually. SLE diagnosis was based on ACR 1997 or SLICC 2012",
    "entities": [
      {
        "text": "annually",
        "label": "DATE"
      },
      {
        "text": "1997",
        "label": "DATE"
      },
      {
        "text": "2012",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "criteria. COVID-19 cases were excluded. Patients were categorised by admission",
    "entities": []
  },
  {
    "text": "cause as 'Infection', 'Disease-associated', or 'Mixed'. Data on demographics,",
    "entities": []
  },
  {
    "text": "clinical features, laboratory parameters, and treatments were extracted, and",
    "entities": []
  },
  {
    "text": "multivariable logistic regression identified independent predictors of",
    "entities": []
  },
  {
    "text": "mortality.ResultsThe hospital mortality rate was 8.9%. Infection (with or",
    "entities": [
      {
        "text": "ResultsThe",
        "label": "ORG"
      },
      {
        "text": "8.9%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "without disease activity) significantly contributed to hospital admissions among",
    "entities": []
  },
  {
    "text": "non-survivors (57%) compared to survivors (25%; p < 0.001). Acinetobacter",
    "entities": [
      {
        "text": "57%",
        "label": "PERCENT"
      },
      {
        "text": "25%",
        "label": "PERCENT"
      },
      {
        "text": "p < 0.001",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "baumannii was the most frequent pathogen. Multivariable analysis showed",
    "entities": [
      {
        "text": "baumannii",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "infection at hospitalisation (OR 3.37, 95% CI 1.85-6.13), pulmonary involvement",
    "entities": [
      {
        "text": "3.37",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.85-6.13",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "and serum creatinine levels as independent predictors of mortality. Higher serum",
    "entities": []
  },
  {
    "text": "albumin was protective (OR 0.53, 95% CI 0.35-0.79). Juvenile lupus subgroup",
    "entities": [
      {
        "text": "albumin",
        "label": "ORG"
      },
      {
        "text": "0.53",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.35-0.79",
        "label": "CARDINAL"
      },
      {
        "text": "Juvenile",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "analysis (n = 38) revealed similar infection-related mortality",
    "entities": [
      {
        "text": "38",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "patterns.ConclusionsOur study highlights the significant impact of infections,",
    "entities": [
      {
        "text": "ConclusionsOur",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "particularly hospital-acquired infections, on mortality among hospitalised SLE",
    "entities": [
      {
        "text": "SLE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "patients. Enhanced clinical vigilance, early interventions, and rigorous",
    "entities": []
  },
  {
    "text": "infection control measures are needed to improve outcomes in hospitalised SLE",
    "entities": [
      {
        "text": "SLE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Multilayer networks describing urban interactions for building the digital twins",
    "entities": [
      {
        "text": "Multilayer",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of five cities in Spain.",
    "entities": [
      {
        "text": "five",
        "label": "CARDINAL"
      },
      {
        "text": "Spain",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)CA UNED Illes Balears, Palma, Spain. jorgeprodriguezg@gmail.com.",
    "entities": [
      {
        "text": "2)CA",
        "label": "CARDINAL"
      },
      {
        "text": "Illes Balears",
        "label": "PERSON"
      },
      {
        "text": "Palma",
        "label": "GPE"
      },
      {
        "text": "Spain",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Institute for Biocomputation and Physics of Complex Systems (BIFI),",
    "entities": [
      {
        "text": "Biocomputation and Physics of Complex Systems",
        "label": "ORG"
      },
      {
        "text": "BIFI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University of Zaragoza, Zaragoza, Spain.",
    "entities": [
      {
        "text": "University of Zaragoza",
        "label": "ORG"
      },
      {
        "text": "Zaragoza",
        "label": "GPE"
      },
      {
        "text": "Spain",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Theoretical Physics, University of Zaragoza, Zaragoza, Spain.",
    "entities": [
      {
        "text": "Theoretical Physics",
        "label": "ORG"
      },
      {
        "text": "University of Zaragoza",
        "label": "ORG"
      },
      {
        "text": "Zaragoza",
        "label": "GPE"
      },
      {
        "text": "Spain",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Networks specifying who interacts with whom are crucial for mathematical models",
    "entities": []
  },
  {
    "text": "of epidemic spreading. In the context of emerging diseases, these networks have",
    "entities": []
  },
  {
    "text": "the potential to encode multiple interaction contexts where non-pharmaceutical",
    "entities": []
  },
  {
    "text": "interventions can be introduced, allowing for proper comparisons among different",
    "entities": []
  },
  {
    "text": "intervention strategies in a plethora of contexts. Consequently, a multilayer",
    "entities": []
  },
  {
    "text": "network describing interactions in a population and detailing their contexts in",
    "entities": []
  },
  {
    "text": "different layers constitutes an appropriate tool for such descriptions. These",
    "entities": []
  },
  {
    "text": "approaches however become challenging in large-scale systems such as cities,",
    "entities": []
  },
  {
    "text": "particularly in a framework where data protection policies are enhanced. In this",
    "entities": []
  },
  {
    "text": "work, we present a methodology to build such multilayer networks and make those",
    "entities": []
  },
  {
    "text": "corresponding to five Spanish cities available. Our work uses approaches",
    "entities": [
      {
        "text": "five",
        "label": "CARDINAL"
      },
      {
        "text": "Spanish",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "informed by multiple available datasets to create realistic digital twins of the",
    "entities": []
  },
  {
    "text": "citizens and their interactions and provides a playground to explore different",
    "entities": []
  },
  {
    "text": "pandemic scenario in realistic settings for better preparedness.",
    "entities": []
  },
  {
    "text": "DOI: 10.1038/s41597-025-05551-2",
    "entities": [
      {
        "text": "10.1038",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40664652 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40664652",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Competing interests: Authors declare no",
    "entities": []
  },
  {
    "text": "Evaluating the safety of XBB.1.5-containing COVID-19 mRNA vaccines using a",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "self-controlled case series study.",
    "entities": []
  },
  {
    "text": "Collaborators: Chute CG.",
    "entities": [
      {
        "text": "Chute CG",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Department of Radiology, People's Hospital of Guizhou Province, Guiyang,",
    "entities": [
      {
        "text": "People's Hospital",
        "label": "ORG"
      },
      {
        "text": "Guizhou Province",
        "label": "GPE"
      },
      {
        "text": "Guiyang",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Guizhou Province, China.",
    "entities": [
      {
        "text": "Guizhou Province",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Unit for Laboratory Animal Medicine, University of Michigan Medical School,",
    "entities": [
      {
        "text": "Laboratory Animal Medicine,",
        "label": "ORG"
      },
      {
        "text": "University of Michigan Medical School",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Guizhou University Medical College, Guiyang, Guizhou Province, China.",
    "entities": [
      {
        "text": "University Medical College",
        "label": "ORG"
      },
      {
        "text": "Guiyang",
        "label": "GPE"
      },
      {
        "text": "Guizhou Province",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Internal Medicine, Division of Nephrology, University of",
    "entities": [
      {
        "text": "Internal Medicine, Division of Nephrology, University of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Michigan, Medical School, Ann Arbor, MI, USA.",
    "entities": [
      {
        "text": "Michigan",
        "label": "GPE"
      },
      {
        "text": "Medical School",
        "label": "ORG"
      },
      {
        "text": "Ann Arbor",
        "label": "GPE"
      },
      {
        "text": "MI",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Radiology, University of Michigan, Medical School, Ann Arbor,",
    "entities": [
      {
        "text": "Radiology, University of Michigan,",
        "label": "ORG"
      },
      {
        "text": "Medical School",
        "label": "ORG"
      },
      {
        "text": "Ann Arbor",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Department of Preventive Medicine (Biostatistics Division), Northwestern",
    "entities": [
      {
        "text": "Preventive Medicine (Biostatistics Division",
        "label": "ORG"
      },
      {
        "text": "Northwestern\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University, Evanston, IL, USA.",
    "entities": [
      {
        "text": "Evanston",
        "label": "ORG"
      },
      {
        "text": "IL",
        "label": "ORG"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Guizhou University Medical College, Guiyang, Guizhou Province, China.",
    "entities": [
      {
        "text": "7)Guizhou University Medical College",
        "label": "ORG"
      },
      {
        "text": "Guiyang",
        "label": "GPE"
      },
      {
        "text": "Guizhou Province",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(8)Department of Respiratory and Critical Care Medicine and NHC Key Laboratory",
    "entities": [
      {
        "text": "Respiratory and Critical Care Medicine",
        "label": "ORG"
      },
      {
        "text": "NHC Key Laboratory",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of Immunological Diseases, People's Hospital of Guizhou Province, Guiyang,",
    "entities": [
      {
        "text": "Immunological Diseases",
        "label": "ORG"
      },
      {
        "text": "People's Hospital",
        "label": "ORG"
      },
      {
        "text": "Guizhou Province",
        "label": "GPE"
      },
      {
        "text": "Guiyang",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Guizhou Province, China. yxw1205@163.com.",
    "entities": [
      {
        "text": "Guizhou Province",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(9)Unit for Laboratory Animal Medicine, University of Michigan Medical School,",
    "entities": [
      {
        "text": "Laboratory Animal Medicine,",
        "label": "ORG"
      },
      {
        "text": "University of Michigan Medical School",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(10)Department of Learning Health Sciences, University of Michigan Medical",
    "entities": [
      {
        "text": "10)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Learning Health Sciences",
        "label": "ORG"
      },
      {
        "text": "University of Michigan Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "School, Ann Arbor, MI, USA. yongqunh@med.umich.edu.",
    "entities": [
      {
        "text": "Ann Arbor",
        "label": "GPE"
      },
      {
        "text": "MI",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      },
      {
        "text": "yongqunh@med.umich.edu",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(11)Center for Computational Medicine and Bioinformatics, University of Michigan",
    "entities": [
      {
        "text": "11)Center",
        "label": "CARDINAL"
      },
      {
        "text": "Bioinformatics, University of Michigan",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medical School, Ann Arbor, MI, USA. yongqunh@med.umich.edu.",
    "entities": [
      {
        "text": "Medical School",
        "label": "ORG"
      },
      {
        "text": "Ann Arbor",
        "label": "GPE"
      },
      {
        "text": "MI",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      },
      {
        "text": "yongqunh@med.umich.edu",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "The safety of XBB.1.5-containing COVID-19 mRNA vaccines warrants investigation.",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "We assessed the relative risk of 15 adverse events following the XBB.1.5",
    "entities": [
      {
        "text": "15",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "vaccination using a self-controlled case series study design with data from the",
    "entities": []
  },
  {
    "text": "National COVID Cohort Collaborative (N3C) from September 11, 2023, to June 1,",
    "entities": [
      {
        "text": "National COVID Cohort Collaborative",
        "label": "ORG"
      },
      {
        "text": "September 11, 2023",
        "label": "DATE"
      },
      {
        "text": "June 1",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "2024 in the USA. Based on a baseline population of 244,494 patients, adverse",
    "entities": [
      {
        "text": "2024",
        "label": "DATE"
      },
      {
        "text": "USA",
        "label": "GPE"
      },
      {
        "text": "244,494",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "events included Guillain-Barr\u00e9 syndrome, seizure, non-hemorrhagic stroke and",
    "entities": []
  },
  {
    "text": "transient ischemic attack, hemorrhagic stroke, narcolepsy or cataplexy,",
    "entities": [
      {
        "text": "hemorrhagic",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "anaphylaxis, acute myocardial infarction, myo/pericarditis, coagulopathy,",
    "entities": []
  },
  {
    "text": "multisystem inflammatory syndrome, Bell's palsy, transverse myelitis,",
    "entities": [
      {
        "text": "Bell",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "appendicitis, pulmonary embolism, and encephalitis. We found an association",
    "entities": [
      {
        "text": "appendicitis",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "between vaccination and anaphylaxis (IRR [95% CI]: day 0-17.35 [9.32-30.03], day",
    "entities": [
      {
        "text": "IRR",
        "label": "ORG"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0-17.35",
        "label": "CARDINAL"
      },
      {
        "text": "9.32",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "1-9.35 [5.12-15.95], day 2-6.20 [3.40-10.57], <20 patients in each risk period).",
    "entities": [
      {
        "text": "1-9.35",
        "label": "PERCENT"
      },
      {
        "text": "5.12-15.95",
        "label": "CARDINAL"
      },
      {
        "text": "2-6.20",
        "label": "DATE"
      },
      {
        "text": "3.40",
        "label": "CARDINAL"
      },
      {
        "text": "20",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "No other outcomes showed significantly increased risk following vaccination. Our",
    "entities": []
  },
  {
    "text": "results contribute to the safety profile evaluation for XBB.1.5-containing",
    "entities": []
  },
  {
    "text": "DOI: 10.1038/s41467-025-61613-4",
    "entities": [
      {
        "text": "10.1038",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40664645 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40664645",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Exploring COVID-19 vaccination behavior: A cross-country study among pregnant",
    "entities": []
  },
  {
    "text": "Temmerman M(13), Torpey K(14), Cecatti JG(15), Brizuela V(16), Schue JL(17).",
    "entities": [
      {
        "text": "Temmerman",
        "label": "PERSON"
      },
      {
        "text": "Torpey K(14",
        "label": "NORP"
      },
      {
        "text": "Cecatti JG(15",
        "label": "PRODUCT"
      },
      {
        "text": "Brizuela V(16",
        "label": "PERSON"
      },
      {
        "text": "Schue JL(17",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Department of International Health, Johns Hopkins Bloomberg School of Public",
    "entities": [
      {
        "text": "International Health",
        "label": "ORG"
      },
      {
        "text": "Johns Hopkins Bloomberg School of Public",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Health, 615 N Wolfe Street, Baltimore, MD 21205, USA. Electronic address:",
    "entities": [
      {
        "text": "615",
        "label": "CARDINAL"
      },
      {
        "text": "N Wolfe Street",
        "label": "ORG"
      },
      {
        "text": "Baltimore",
        "label": "GPE"
      },
      {
        "text": "MD",
        "label": "GPE"
      },
      {
        "text": "21205",
        "label": "DATE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of International Health, Johns Hopkins Bloomberg School of Public",
    "entities": [
      {
        "text": "International Health",
        "label": "ORG"
      },
      {
        "text": "Johns Hopkins Bloomberg School of Public",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Department of International Health, Johns Hopkins Bloomberg School of Public",
    "entities": [
      {
        "text": "International Health",
        "label": "ORG"
      },
      {
        "text": "Johns Hopkins Bloomberg School of Public",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Department of International Health, Johns Hopkins Bloomberg School of Public",
    "entities": [
      {
        "text": "International Health",
        "label": "ORG"
      },
      {
        "text": "Johns Hopkins Bloomberg School of Public",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)Department of Community Health Sciences, Aga Khan University, Stadium Road,",
    "entities": [
      {
        "text": "Community Health Sciences",
        "label": "ORG"
      },
      {
        "text": "Aga Khan University",
        "label": "ORG"
      },
      {
        "text": "Stadium Road",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "PO Box 3500, Karachi 74800, Pakistan. Electronic address:",
    "entities": [
      {
        "text": "PO Box 3500",
        "label": "PERSON"
      },
      {
        "text": "Pakistan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Department of Community Health Sciences, Aga Khan University, Stadium Road,",
    "entities": [
      {
        "text": "Community Health Sciences",
        "label": "ORG"
      },
      {
        "text": "Aga Khan University",
        "label": "ORG"
      },
      {
        "text": "Stadium Road",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "PO Box 3500, Karachi 74800, Pakistan. Electronic address: asim.muhammad@aku.edu.",
    "entities": [
      {
        "text": "PO Box 3500",
        "label": "PERSON"
      },
      {
        "text": "Pakistan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Aga Khan University Centre of Excellence in Women and Child Health, P.O. Box",
    "entities": [
      {
        "text": "Khan University Centre of Excellence in Women and Child Health",
        "label": "ORG"
      },
      {
        "text": "P.O. Box",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(8)University of Ghana School of Nursing and Midwifery, P.O. Box LG 43, Legon,",
    "entities": [
      {
        "text": "Ghana School of Nursing and Midwifery",
        "label": "ORG"
      },
      {
        "text": "Legon",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(9)University of Ghana School of Public Health, P.O. Box LG 13, Legon, Accra,",
    "entities": [
      {
        "text": "9)University",
        "label": "CARDINAL"
      },
      {
        "text": "Ghana School of Public Health",
        "label": "ORG"
      },
      {
        "text": "P.O. Box LG 13",
        "label": "PERSON"
      },
      {
        "text": "Legon",
        "label": "PERSON"
      },
      {
        "text": "Accra",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(10)Department of Obstetrics and Gynecology, University of Campinas 101",
    "entities": [
      {
        "text": "10)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Obstetrics and Gynecology",
        "label": "ORG"
      },
      {
        "text": "University of Campinas",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(11)Department of Obstetrics and Gynecology, University of Campinas 101",
    "entities": [
      {
        "text": "Obstetrics and Gynecology",
        "label": "ORG"
      },
      {
        "text": "University of Campinas",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Alexander Fleming Street, Campinas, Sao Paulo, Brazil. Electronic address:",
    "entities": [
      {
        "text": "Alexander Fleming Street",
        "label": "PERSON"
      },
      {
        "text": "Campinas",
        "label": "GPE"
      },
      {
        "text": "Sao Paulo",
        "label": "GPE"
      },
      {
        "text": "Brazil",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(12)Department of Community Health Sciences, Aga Khan University, Stadium Road,",
    "entities": [
      {
        "text": "12)Department of",
        "label": "MONEY"
      },
      {
        "text": "Community Health Sciences",
        "label": "ORG"
      },
      {
        "text": "Aga Khan University",
        "label": "ORG"
      },
      {
        "text": "Stadium Road",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "PO Box 3500, Karachi 74800, Pakistan. Electronic address: sarah.saleem@aku.edu.",
    "entities": [
      {
        "text": "PO Box 3500",
        "label": "PERSON"
      },
      {
        "text": "Pakistan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(13)Aga Khan University Centre of Excellence in Women and Child Health, P.O. Box",
    "entities": [
      {
        "text": "13)Aga",
        "label": "CARDINAL"
      },
      {
        "text": "Khan University Centre of Excellence in Women and Child Health",
        "label": "ORG"
      },
      {
        "text": "P.O. Box",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(14)University of Ghana School of Public Health, P.O. Box LG 13, Legon, Accra,",
    "entities": [
      {
        "text": "14)University",
        "label": "CARDINAL"
      },
      {
        "text": "Ghana School of Public Health",
        "label": "ORG"
      },
      {
        "text": "P.O. Box LG 13",
        "label": "PERSON"
      },
      {
        "text": "Legon",
        "label": "PERSON"
      },
      {
        "text": "Accra",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(15)Department of Obstetrics and Gynecology, University of Campinas 101",
    "entities": [
      {
        "text": "15)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Obstetrics and Gynecology",
        "label": "ORG"
      },
      {
        "text": "University of Campinas",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(16)UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research,Development",
    "entities": []
  },
  {
    "text": "and Research Training in Human Reproduction, Department of Sexual and",
    "entities": [
      {
        "text": "Research Training in Human Reproduction",
        "label": "ORG"
      },
      {
        "text": "Department of Sexual",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Reproductive Health and Research, World Health Organization, Geneva 1211,",
    "entities": [
      {
        "text": "Reproductive Health and Research, World Health Organization",
        "label": "ORG"
      },
      {
        "text": "1211",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Switzerland. Electronic address: brizuelav@who.int.",
    "entities": [
      {
        "text": "Switzerland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(17)Department of International Health, Johns Hopkins Bloomberg School of Public",
    "entities": [
      {
        "text": "17)Department",
        "label": "CARDINAL"
      },
      {
        "text": "International Health",
        "label": "ORG"
      },
      {
        "text": "Johns Hopkins Bloomberg School of Public",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Pregnant women infected with SARS-CoV2 are more likely to be hospitalized and",
    "entities": []
  },
  {
    "text": "require ventilation, compared to non-pregnant women. Although the development of",
    "entities": []
  },
  {
    "text": "the COVID-19 vaccine was regarded as a scientific breakthrough among many, the",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "pace of development in combination with delayed and unclear recommendations for",
    "entities": []
  },
  {
    "text": "maternal vaccination led to slower vaccine uptake among this population. We",
    "entities": []
  },
  {
    "text": "explored the decision-making process for COVID-19 vaccination among pregnant and",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "postpartum women in four countries: Brazil, Ghana, Kenya, and Pakistan through",
    "entities": [
      {
        "text": "four",
        "label": "CARDINAL"
      },
      {
        "text": "Brazil",
        "label": "GPE"
      },
      {
        "text": "Ghana",
        "label": "GPE"
      },
      {
        "text": "Kenya",
        "label": "GPE"
      },
      {
        "text": "Pakistan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "201 in-depth interviews. A grounded theory approach was used for analysis, and a",
    "entities": [
      {
        "text": "201",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "socio-ecological framework was used to synthesize emerging themes. Four levels",
    "entities": [
      {
        "text": "Four",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "of influence on vaccine-related attitudes and behaviors were identified:",
    "entities": []
  },
  {
    "text": "individual, interpersonal, community, and policy. Risk perception and beliefs",
    "entities": []
  },
  {
    "text": "about vaccines safety were the primary individual-level factors identified. Risk",
    "entities": []
  },
  {
    "text": "perception of the disease was a common reason for vaccine acceptance, whereas",
    "entities": []
  },
  {
    "text": "lower risk perception emerged as a reason to not vaccinate. Vaccine safety",
    "entities": []
  },
  {
    "text": "concerns, for the pregnant woman herself, her pregnancy, and her baby were",
    "entities": []
  },
  {
    "text": "common across all countries. At the interpersonal level, the influence of the",
    "entities": []
  },
  {
    "text": "male partner and peers emerged across all countries. While participants",
    "entities": []
  },
  {
    "text": "identified the partner or spouse was most influential, they also discussed the",
    "entities": []
  },
  {
    "text": "limited impact the male partner had on decision-making, particularly in Ghana,",
    "entities": [
      {
        "text": "Ghana",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Kenya, and Pakistan. At the community-level, healthcare providers helped in",
    "entities": [
      {
        "text": "Kenya",
        "label": "GPE"
      },
      {
        "text": "Pakistan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "allaying vaccine safety concerns, and women looked to them for their health",
    "entities": []
  },
  {
    "text": "expertise and recommendations. At the policy-level, the requirement - real or",
    "entities": []
  },
  {
    "text": "perceived - of vaccination to access services, travel, work, and education was",
    "entities": []
  },
  {
    "text": "an important factor in all countries. Vaccine decision-making is complex,",
    "entities": [
      {
        "text": "Vaccine",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "multi-faceted, and context-specific. When promoting vaccination among pregnant",
    "entities": []
  },
  {
    "text": "and postpartum women, engaging influential individuals can support the",
    "entities": []
  },
  {
    "text": "successful uptake of maternal vaccination.",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025 The Author(s). Published by Elsevier Ltd.. All rights reserved.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Elsevier Ltd",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Declaration of competing interest The authors",
    "entities": []
  },
  {
    "text": "declare the following financial interests/personal relationships which may be",
    "entities": []
  },
  {
    "text": "considered as potential competing interests: Rupali J. Limaye reports financial",
    "entities": [
      {
        "text": "Rupali J. Limaye",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "support was provided by Bill & Melinda Gates Foundation. If there are other",
    "entities": [
      {
        "text": "Bill & Melinda Gates Foundation",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "authors, they declare that they have no known competing financial interests or",
    "entities": []
  },
  {
    "text": "personal relationships that could have appeared to influence the work reported",
    "entities": []
  },
  {
    "text": "in this paper.",
    "entities": []
  },
  {
    "text": "Incidence and characteristics of self-harm during the 3-year period of",
    "entities": [
      {
        "text": "3-year",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "COVID-19-related social distancing in the Republic of Korea.",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      },
      {
        "text": "the Republic of Korea",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(1)Department of Emergency Medicine Medicine, Chung-Ang University College of",
    "entities": [
      {
        "text": "Emergency Medicine Medicine",
        "label": "ORG"
      },
      {
        "text": "Chung-Ang University College",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medicine, Seoul, The Republic of Korea.",
    "entities": [
      {
        "text": "Seoul",
        "label": "GPE"
      },
      {
        "text": "The Republic of Korea",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Emergency Medicine, Sungkyunkwan University School of Medicine,",
    "entities": [
      {
        "text": "Emergency Medicine",
        "label": "ORG"
      },
      {
        "text": "Sungkyunkwan University School of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Suwon, The Republic of Korea.",
    "entities": [
      {
        "text": "Suwon",
        "label": "GPE"
      },
      {
        "text": "The Republic of Korea",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Emergency Medicine, Sungkyunkwan University School of Medicine,",
    "entities": [
      {
        "text": "Emergency Medicine",
        "label": "ORG"
      },
      {
        "text": "Sungkyunkwan University School of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Suwon, The Republic of Korea wc.cha@samsung.com.",
    "entities": [
      {
        "text": "Suwon",
        "label": "GPE"
      },
      {
        "text": "The Republic of Korea wc.cha@samsung.com",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: Suicide is a leading cause of mortality worldwide, and self-harm is",
    "entities": [
      {
        "text": "Suicide",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "a key risk factor. Continuous monitoring of self-harm trends facilitates",
    "entities": []
  },
  {
    "text": "effective prevention. During the coronavirus disease pandemic, social distancing",
    "entities": []
  },
  {
    "text": "significantly influenced self-harm incidence. This study aimed to compare",
    "entities": []
  },
  {
    "text": "self-harm rates and patient characteristics in 3-year prepandemic and pandemic",
    "entities": [
      {
        "text": "3-year",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "periods (2017-2019 and 2020-2022, respectively).",
    "entities": [
      {
        "text": "2017-2019",
        "label": "DATE"
      },
      {
        "text": "2020-2022",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "METHODS: We retrospectively analysed and subdivided the data over 6 years into",
    "entities": [
      {
        "text": "6 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "3-month intervals, obtained from the Emergency Department (ED)-based Injury",
    "entities": [
      {
        "text": "3-month",
        "label": "DATE"
      },
      {
        "text": "the Emergency Department",
        "label": "ORG"
      },
      {
        "text": "Injury",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "In-depth Surveillance database, South Korea, to examine changes in the incidence",
    "entities": [
      {
        "text": "South Korea",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "of self-harm in patients visiting the ED from the prepandemic to pandemic period",
    "entities": []
  },
  {
    "text": "and compared the characteristics of patients who attempted self-harm and risk",
    "entities": []
  },
  {
    "text": "factors for in-hospital mortality.",
    "entities": []
  },
  {
    "text": "RESULTS: Among 8 02 032 patients (age: 18-64 years), we identified 45 535",
    "entities": [
      {
        "text": "8 02",
        "label": "CARDINAL"
      },
      {
        "text": "18-64 years",
        "label": "DATE"
      },
      {
        "text": "45 535",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "patients with self-harm injuries (overall rate: 5.68%), which significantly",
    "entities": [
      {
        "text": "5.68%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "increased during the pandemic (4.6% (21 852) in 2017-2019 to 7.2% (n=23 683) in",
    "entities": [
      {
        "text": "4.6%",
        "label": "PERCENT"
      },
      {
        "text": "21 852",
        "label": "CARDINAL"
      },
      {
        "text": "2017-2019",
        "label": "DATE"
      },
      {
        "text": "7.2%",
        "label": "PERCENT"
      },
      {
        "text": "n=23",
        "label": "ORG"
      },
      {
        "text": "683",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "2020-2022). Age-group-stratified comparisons showed increased self-harm",
    "entities": [
      {
        "text": "2020-2022",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "incidence across all age groups, especially among women younger than 30 years,",
    "entities": [
      {
        "text": "30 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "during the pandemic period. The proportion of self-harm attributed to",
    "entities": []
  },
  {
    "text": "psychological problems increased markedly. However, the two periods showed no",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "significant difference in the in-hospital mortality.",
    "entities": []
  },
  {
    "text": "DISCUSSION AND CONCLUSION: The incidence of self-harm significantly increased",
    "entities": []
  },
  {
    "text": "and remained consistently higher in patients visiting EDs throughout the",
    "entities": []
  },
  {
    "text": "pandemic period than during the 3 years prepandemic, even after the relaxation",
    "entities": [
      {
        "text": "the 3 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "of social distancing measures. Young women primarily drove this increase, and",
    "entities": []
  },
  {
    "text": "psychological problems constituted a major risk factor.",
    "entities": []
  },
  {
    "text": "\u00a9 Author(s) (or their employer(s)) 2025. No commercial re-use. See rights and",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "permissions. Published by BMJ Group.",
    "entities": [
      {
        "text": "BMJ Group",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Competing interests: None declared.",
    "entities": []
  },
  {
    "text": "Impact of a community-based asynchronous review clinic on appointment attendance",
    "entities": []
  },
  {
    "text": "delays across an eye hospital network in London, UK: an interrupted time series",
    "entities": [
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "S(6), Alarc\u00f3n Garavito GA(6), Elphinstone H(6), Mills G(8), Scully P(9), Symons",
    "entities": [
      {
        "text": "Alarc\u00f3n Garavito GA(6",
        "label": "PERSON"
      },
      {
        "text": "Elphinstone",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Foster PJ(2), Clarke CS(4); HERCULES Research Consortium.",
    "entities": [
      {
        "text": "Foster",
        "label": "PERSON"
      },
      {
        "text": "Clarke CS(4",
        "label": "GPE"
      },
      {
        "text": "HERCULES Research Consortium",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Research Department of Primary Care and Population Health, University College",
    "entities": [
      {
        "text": "Department of Primary Care and Population Health, University College",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)National Institute for Health and Care Research (NIHR) Biomedical Research",
    "entities": [
      {
        "text": "Institute for Health and Care Research",
        "label": "ORG"
      },
      {
        "text": "NIHR",
        "label": "ORG"
      },
      {
        "text": "Biomedical Research",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Centre (BRC) at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute",
    "entities": [
      {
        "text": "BRC",
        "label": "ORG"
      },
      {
        "text": "Moorfields Eye Hospital NHS Foundation Trust",
        "label": "ORG"
      },
      {
        "text": "UCL Institute",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of Ophthalmology, London, UK.",
    "entities": [
      {
        "text": "Ophthalmology",
        "label": "ORG"
      },
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Moorfields Eye Hospital NHS Foundation Trust, London, UK.",
    "entities": [
      {
        "text": "Eye Hospital NHS Foundation Trust",
        "label": "ORG"
      },
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Research Department of Primary Care and Population Health, University College",
    "entities": [
      {
        "text": "Department of Primary Care and Population Health, University College",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(6)Research Department of Behavioural Science and Health, University College",
    "entities": [
      {
        "text": "6)Research Department of Behavioural Science and Health, University College",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(7)Institute of Epidemiology and Health Care, University College London, London,",
    "entities": [
      {
        "text": "Epidemiology and Health Care, University College London",
        "label": "ORG"
      },
      {
        "text": "London",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(8)University College London The Bartlett School of Sustainable Construction,",
    "entities": [
      {
        "text": "College London",
        "label": "ORG"
      },
      {
        "text": "The Bartlett School of Sustainable Construction",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "London, UK.",
    "entities": [
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(9)University College London The Bartlett School of Architecture, London, UK.",
    "entities": [
      {
        "text": "College London",
        "label": "ORG"
      },
      {
        "text": "The Bartlett School of Architecture",
        "label": "ORG"
      },
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "OBJECTIVE: To assess the impact of opening a large community-based asynchronous",
    "entities": []
  },
  {
    "text": "review ophthalmic clinic on attendance delays among patients with stable chronic",
    "entities": []
  },
  {
    "text": "eye disease attending a London teaching eye hospital network.",
    "entities": [
      {
        "text": "London",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "DESIGN: Interrupted time-series analysis of routine electronic health records of",
    "entities": []
  },
  {
    "text": "SETTING: A large eye hospital network with facilities across London, UK, between",
    "entities": [
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "June 2018 and April 2023.",
    "entities": [
      {
        "text": "June 2018",
        "label": "DATE"
      },
      {
        "text": "April 2023",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "PARTICIPANTS: We analysed 69 257 attendances from 39 357 patients, with glaucoma",
    "entities": [
      {
        "text": "69",
        "label": "CARDINAL"
      },
      {
        "text": "257",
        "label": "CARDINAL"
      },
      {
        "text": "39 357",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "and medical retina accounting for 62% (n=42 982) and 38% (n=26 275) of visits,",
    "entities": [
      {
        "text": "62%",
        "label": "PERCENT"
      },
      {
        "text": "982",
        "label": "CARDINAL"
      },
      {
        "text": "38%",
        "label": "PERCENT"
      },
      {
        "text": "275",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "respectively. Patients over 65 made up 54% (n=37 824) of attendances, while 53%",
    "entities": [
      {
        "text": "54%",
        "label": "PERCENT"
      },
      {
        "text": "824",
        "label": "CARDINAL"
      },
      {
        "text": "53%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "(n=37 014) were from the more deprived half of the population, and 51%",
    "entities": [
      {
        "text": "014",
        "label": "CARDINAL"
      },
      {
        "text": "half",
        "label": "CARDINAL"
      },
      {
        "text": "51%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "INTERVENTION: An asynchronous review clinic opened in a shopping centre in",
    "entities": []
  },
  {
    "text": "London, in autumn 2021, following the COVID-19 lockdown in spring 2020.",
    "entities": [
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "autumn 2021",
        "label": "DATE"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      },
      {
        "text": "spring 2020",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "MAIN OUTCOME MEASURES: Average attendance delays (days), calculated as the",
    "entities": [
      {
        "text": "MAIN",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "difference between follow-up attendance date and the latest clinically",
    "entities": []
  },
  {
    "text": "appropriate date determined at the preceding attendance.",
    "entities": []
  },
  {
    "text": "RESULTS: Pre-COVID-19, attendance delays for chronic eye disease monitoring were",
    "entities": []
  },
  {
    "text": "increasing by 0.9 days per week (95% CI, 0.8 to 0.9) on average, worsening to",
    "entities": [
      {
        "text": "0.9 days per week",
        "label": "DATE"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.8",
        "label": "DATE"
      },
      {
        "text": "0.9",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "2.0 days per week (95% CI, 2.0 to 2.0) after the first COVID-19 national",
    "entities": [
      {
        "text": "2.0 days per week",
        "label": "DATE"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "2.0",
        "label": "CARDINAL"
      },
      {
        "text": "2.0",
        "label": "CARDINAL"
      },
      {
        "text": "first",
        "label": "ORDINAL"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "lockdown, mid-March 2020. Opening the asynchronous review clinic increased",
    "entities": [
      {
        "text": "mid-March 2020",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "appointment capacity, with delays decreasing on average by 8.1 days per week",
    "entities": [
      {
        "text": "8.1 days",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "(95% CI, 8.1 to 8.2) shortly after opening. The rate of decrease slowed to 0.3",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "8.1",
        "label": "CARDINAL"
      },
      {
        "text": "8.2",
        "label": "CARDINAL"
      },
      {
        "text": "0.3",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "days per week (95% CI, 0.3 to 0.3) after 5 months. We found no significant",
    "entities": [
      {
        "text": "days per week",
        "label": "DATE"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.3",
        "label": "CARDINAL"
      },
      {
        "text": "0.3",
        "label": "CARDINAL"
      },
      {
        "text": "5 months",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "CONCLUSION: The asynchronous review clinic significantly reduced attendance",
    "entities": []
  },
  {
    "text": "delays across the hospital network, addressing pre-existing backlog for stable",
    "entities": []
  },
  {
    "text": "chronic eye diseases. The reduction appeared to be maintained after the initial",
    "entities": []
  },
  {
    "text": "backlog had been cleared.",
    "entities": []
  },
  {
    "text": "\u00a9 Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY. Published",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "CC BY",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "by BMJ Group.",
    "entities": [
      {
        "text": "BMJ Group",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "PMID: 40664400 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40664400",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Competing interests: HB, JC, PJF, HJ and PTK",
    "entities": [
      {
        "text": "HB",
        "label": "ORG"
      },
      {
        "text": "JC",
        "label": "GPE"
      },
      {
        "text": "PJF",
        "label": "ORG"
      },
      {
        "text": "PTK",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "acknowledge salary support from the National Institute for Health and Care",
    "entities": [
      {
        "text": "the National Institute for Health and Care\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Research (NIHR) through a grant for a Biomedical Research Centre (BRC) at",
    "entities": [
      {
        "text": "NIHR",
        "label": "ORG"
      },
      {
        "text": "Biomedical Research Centre",
        "label": "ORG"
      },
      {
        "text": "BRC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology.",
    "entities": [
      {
        "text": "Moorfields Eye Hospital NHS Foundation Trust",
        "label": "ORG"
      },
      {
        "text": "UCL Institute of Ophthalmology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Additionally, PJF reports personal fees from Abbvie, Allergan, AlphaSights, Carl",
    "entities": [
      {
        "text": "PJF",
        "label": "ORG"
      },
      {
        "text": "Abbvie",
        "label": "GPE"
      },
      {
        "text": "Allergan",
        "label": "GPE"
      },
      {
        "text": "AlphaSights",
        "label": "ORG"
      },
      {
        "text": "Carl\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Zeiss, DeepMind, Google Health, GLG, Guidepoint, PwC and Santen, as well as a",
    "entities": [
      {
        "text": "Zeiss",
        "label": "ORG"
      },
      {
        "text": "DeepMind",
        "label": "PERSON"
      },
      {
        "text": "Google Health",
        "label": "ORG"
      },
      {
        "text": "GLG",
        "label": "GPE"
      },
      {
        "text": "Guidepoint",
        "label": "GPE"
      },
      {
        "text": "PwC",
        "label": "WORK_OF_ART"
      },
      {
        "text": "Santen",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "grant from Alcon, all outside the submitted work. HJ has consulted for Allergan,",
    "entities": [
      {
        "text": "Alcon",
        "label": "GPE"
      },
      {
        "text": "Allergan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Ivantis, Scope Ophthalmics and Rebio; received honoraria for lectures and",
    "entities": [
      {
        "text": "Scope Ophthalmics",
        "label": "ORG"
      },
      {
        "text": "Rebio",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "educational events from Allergan, Laboratoires Th\u00e9a, and Santen; received",
    "entities": [
      {
        "text": "Allergan",
        "label": "GPE"
      },
      {
        "text": "Laboratoires Th\u00e9a",
        "label": "PERSON"
      },
      {
        "text": "Santen",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "support to attend meetings from Allergan; participated on an Advisory Board for",
    "entities": [
      {
        "text": "Allergan",
        "label": "GPE"
      },
      {
        "text": "Advisory Board",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Allergan. SS reports receiving research grants from Novartis, Bayer, Allergan,",
    "entities": [
      {
        "text": "Allergan",
        "label": "GPE"
      },
      {
        "text": "SS",
        "label": "ORG"
      },
      {
        "text": "Novartis",
        "label": "ORG"
      },
      {
        "text": "Bayer",
        "label": "GPE"
      },
      {
        "text": "Allergan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Roche, Boehringer, Ingelheim and Optos plc, travel grants from Novartis, Bayer,",
    "entities": [
      {
        "text": "Roche",
        "label": "ORG"
      },
      {
        "text": "Boehringer,",
        "label": "ORG"
      },
      {
        "text": "Ingelheim",
        "label": "GPE"
      },
      {
        "text": "Optos plc",
        "label": "ORG"
      },
      {
        "text": "Novartis",
        "label": "ORG"
      },
      {
        "text": "Bayer",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "speaker fees from Novartis, Bayer and Optos plc, and attending advisory board",
    "entities": [
      {
        "text": "Novartis",
        "label": "ORG"
      },
      {
        "text": "Bayer",
        "label": "ORG"
      },
      {
        "text": "Optos plc",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Apellis, Oculis and Eyebiotech. Sir Peng T Khaw is also supported by the Helen",
    "entities": [
      {
        "text": "Apellis",
        "label": "PERSON"
      },
      {
        "text": "Oculis",
        "label": "GPE"
      },
      {
        "text": "Eyebiotech",
        "label": "GPE"
      },
      {
        "text": "Peng T Khaw",
        "label": "PERSON"
      },
      {
        "text": "Helen",
        "label": "FAC"
      }
    ]
  },
  {
    "text": "Hamlyn Trust, the Nolan Family, the Katz Foundation and reports consulting and",
    "entities": [
      {
        "text": "Hamlyn Trust",
        "label": "PERSON"
      },
      {
        "text": "the Nolan Family",
        "label": "ORG"
      },
      {
        "text": "the Katz Foundation",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "lecturing at Aerie Pharmaceuticals and consulting for Novartis, Thea, Glaukos,",
    "entities": [
      {
        "text": "Aerie Pharmaceuticals",
        "label": "ORG"
      },
      {
        "text": "Novartis, Thea, Glaukos",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Santen, Genentech, CMER Hospital Group, Hong Kong Alcon, ISA RNA Therapeutics",
    "entities": [
      {
        "text": "Genentech",
        "label": "ORG"
      },
      {
        "text": "CMER Hospital Group",
        "label": "ORG"
      },
      {
        "text": "Hong Kong",
        "label": "GPE"
      },
      {
        "text": "Alcon",
        "label": "GPE"
      },
      {
        "text": "ISA RNA Therapeutics",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "GmbH; he is also on the Advisory Board of Novartis, DrugTech, Santen, CRICK",
    "entities": [
      {
        "text": "the Advisory Board of Novartis",
        "label": "ORG"
      },
      {
        "text": "DrugTech",
        "label": "ORG"
      },
      {
        "text": "Santen",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Institute Translational Advisory Group, and Decisions on health Care to",
    "entities": [
      {
        "text": "Institute Translational Advisory Group",
        "label": "ORG"
      },
      {
        "text": "Decisions on health Care",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Introduce or Diffuse innovations using Evidence (DECIDE). NJF is an NIHR Senior",
    "entities": [
      {
        "text": "NJF",
        "label": "ORG"
      },
      {
        "text": "NIHR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Investigator. SN and CSC hold honorary research contracts from Moorfields Eye",
    "entities": [
      {
        "text": "SN",
        "label": "ORG"
      },
      {
        "text": "CSC",
        "label": "ORG"
      },
      {
        "text": "Moorfields Eye",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Hospital to perform this work. PW reports receiving support from Ubisense",
    "entities": [
      {
        "text": "PW",
        "label": "GPE"
      },
      {
        "text": "Ubisense",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Limited in the form of equipment used for tracking participants as part of the",
    "entities": []
  },
  {
    "text": "HERCULES project. This equipment was loaned at a subsidised rate, primarily",
    "entities": [
      {
        "text": "HERCULES",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "covering initial installation and customisation costs. AIGR is a trustee at",
    "entities": [
      {
        "text": "AIGR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Health Services Research UK. NJF is an NIHR Senior Investigator and",
    "entities": [
      {
        "text": "Health Services Research",
        "label": "ORG"
      },
      {
        "text": "UK",
        "label": "GPE"
      },
      {
        "text": "NJF",
        "label": "ORG"
      },
      {
        "text": "NIHR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Non-Executive Director at Covid-19 Bereaved Families for Justice UK. She was a",
    "entities": [
      {
        "text": "Non-Executive",
        "label": "ORG"
      },
      {
        "text": "Covid-19 Bereaved Families for",
        "label": "ORG"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Non-Executive Director at Whittington Health NHS Trust until October 2024 and a",
    "entities": [
      {
        "text": "Non-Executive",
        "label": "ORG"
      },
      {
        "text": "Whittington Health NHS Trust",
        "label": "ORG"
      },
      {
        "text": "October 2024",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "trustee at Health Services Research UK until 2022; she was a member of the UKRI",
    "entities": [
      {
        "text": "Health Services Research",
        "label": "ORG"
      },
      {
        "text": "UK",
        "label": "GPE"
      },
      {
        "text": "2022",
        "label": "DATE"
      },
      {
        "text": "UKRI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and NIHR College of Experts for Covid-19 Research Funding (2020), the NIHR",
    "entities": [
      {
        "text": "NIHR College of Experts",
        "label": "ORG"
      },
      {
        "text": "2020",
        "label": "DATE"
      },
      {
        "text": "NIHR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Health Services and Delivery Research (HS&DR) Programme Funding Committee",
    "entities": [
      {
        "text": "Health Services and",
        "label": "ORG"
      },
      {
        "text": "Delivery Research",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2013-2018), and the HS&DR Evidence Synthesis Sub Board (2016). NJF and AIGR are",
    "entities": [
      {
        "text": "2013-2018",
        "label": "DATE"
      },
      {
        "text": "the HS&DR Evidence Synthesis Sub Board",
        "label": "ORG"
      },
      {
        "text": "2016",
        "label": "DATE"
      },
      {
        "text": "NJF",
        "label": "ORG"
      },
      {
        "text": "AIGR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "supported by the NIHR Central London Patient Safety Research Collaboration. All",
    "entities": [
      {
        "text": "the NIHR Central London Patient Safety Research Collaboration",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "other authors have no competing interests to declare.",
    "entities": []
  },
  {
    "text": "83. Clin Infect Dis. 2025 Jul 16:ciaf318. doi: 10.1093/cid/ciaf318. Online ahead",
    "entities": [
      {
        "text": "83",
        "label": "CARDINAL"
      },
      {
        "text": "Clin Infect Dis",
        "label": "PERSON"
      },
      {
        "text": "16",
        "label": "CARDINAL"
      },
      {
        "text": "10.1093",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Antibody Response in Healthcare Workers During the Severe Acute Respiratory",
    "entities": [
      {
        "text": "the Severe Acute Respiratory",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Syndrome Coronavirus 2 Gamma Variant Outbreak in Manaus, Brazil.",
    "entities": [
      {
        "text": "Manaus",
        "label": "GPE"
      },
      {
        "text": "Brazil",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(1)COVID-19 Response - International Task Force, Centers for Diseases Control",
    "entities": [
      {
        "text": "1)COVID-19",
        "label": "CARDINAL"
      },
      {
        "text": "Response - International Task Force",
        "label": "ORG"
      },
      {
        "text": "Centers for Diseases Control",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and Prevention (CDC), Atlanta, Georgia, USA.",
    "entities": [
      {
        "text": "CDC",
        "label": "ORG"
      },
      {
        "text": "Atlanta",
        "label": "GPE"
      },
      {
        "text": "Georgia",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Division of Healthcare Quality Promotion, Centers for Disease Control and",
    "entities": [
      {
        "text": "Healthcare Quality Promotion",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Prevention, Atlanta, Georgia, USA.",
    "entities": [
      {
        "text": "Atlanta",
        "label": "GPE"
      },
      {
        "text": "Georgia",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(8)South America Regional Office, Centers for Disease Control and Prevention",
    "entities": [
      {
        "text": "America Regional Office",
        "label": "ORG"
      },
      {
        "text": "Centers for Disease Control and Prevention",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(11)Laboratory of Infectious Diseases and Immunology (IDI), ILMD-FIOCRUZ",
    "entities": [
      {
        "text": "11)Laboratory",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "BACKGROUND: This study aimed to evaluate severe acute respiratory syndrome",
    "entities": []
  },
  {
    "text": "coronavirus 2 (SARS-CoV-2)-specific binding and neutralizing antibody responses",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "in healthcare workers (HCWs) who received coronavirus disease 2019 (COVID-19)",
    "entities": [
      {
        "text": "2019",
        "label": "DATE"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "vaccines, with or without postvaccination infections.",
    "entities": []
  },
  {
    "text": "METHODS: We conducted a prospective, observational cohort study of HCW in 2",
    "entities": [
      {
        "text": "HCW",
        "label": "ORG"
      },
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "hospitals in Manaus, Brazil. From 31 March through 31 May 2021, HCWs had nasal",
    "entities": [
      {
        "text": "Manaus",
        "label": "GPE"
      },
      {
        "text": "Brazil",
        "label": "GPE"
      },
      {
        "text": "31 March",
        "label": "DATE"
      },
      {
        "text": "May 2021",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "swabs collected and questionnaires administered weekly for 4 visits. Nasal swabs",
    "entities": [
      {
        "text": "weekly",
        "label": "DATE"
      },
      {
        "text": "4",
        "label": "CARDINAL"
      },
      {
        "text": "Nasal",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "were tested for SARS-CoV-2 by real-time reverse transcription polymerase chain",
    "entities": [
      {
        "text": "transcription",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "reaction (rRT-PCR). Blood specimens were obtained at visits 1 and 4 unless the",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      },
      {
        "text": "4",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "HCW was found to be infected. If infected, a blood specimen was collected on",
    "entities": []
  },
  {
    "text": "days 14 and 28 after symptom onset or date of positive specimen, if",
    "entities": [
      {
        "text": "days 14 and 28",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "asymptomatic. COVID-19 vaccination cards, state immunization records, and",
    "entities": []
  },
  {
    "text": "self-reported history of previous SARS-CoV-2 infection were obtained. Fully",
    "entities": []
  },
  {
    "text": "vaccinated HCWs who tested SARS-CoV-2 rRT-PCR positive were classified as",
    "entities": []
  },
  {
    "text": "postvaccination infections.",
    "entities": []
  },
  {
    "text": "RESULTS: A total of 771 HCWs were enrolled, with 73.7% (568/771) fully",
    "entities": [
      {
        "text": "771",
        "label": "CARDINAL"
      },
      {
        "text": "73.7%",
        "label": "PERCENT"
      },
      {
        "text": "568/771",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "vaccinated. Anti-SARS-CoV-2 S1 immunoglobulin G and neutralizing antibody levels",
    "entities": [
      {
        "text": "S1",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "showed steep decay within the first 50 days after COVID-19 vaccination. HCWs",
    "entities": [
      {
        "text": "the first 50 days",
        "label": "DATE"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "with prior SARS-CoV-2 infection had slower visible decay after 50 days compared",
    "entities": [
      {
        "text": "50 days",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "with those without prior infection. We identified 12 postvaccination infections",
    "entities": [
      {
        "text": "12",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "of 16 HCWs who were SARS-CoV-2 rRT-PCR+, including 4 who also reported previous",
    "entities": [
      {
        "text": "16",
        "label": "CARDINAL"
      },
      {
        "text": "4",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "infection. Those positive for SARS-CoV-2 had lower baseline neutralizing",
    "entities": []
  },
  {
    "text": "antibody levels against Gamma and Delta variants preinfection (median log10",
    "entities": [
      {
        "text": "Gamma",
        "label": "PERSON"
      },
      {
        "text": "Delta",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "titers [interquartile range]: Gamma, 1.5 [3]; Delta: 0 [0.25]) compared to those",
    "entities": [
      {
        "text": "Gamma",
        "label": "PERSON"
      },
      {
        "text": "1.5",
        "label": "CARDINAL"
      },
      {
        "text": "3",
        "label": "CARDINAL"
      },
      {
        "text": "Delta",
        "label": "ORG"
      },
      {
        "text": "0",
        "label": "CARDINAL"
      },
      {
        "text": "0.25",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "who remained rRT-PCR negative (median log10 titers [interquartile range]: Gamma,",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: Our findings highlight the importance of routine antibody",
    "entities": []
  },
  {
    "text": "surveillance, targeted boosters, and hybrid immunity in low and middle income",
    "entities": []
  },
  {
    "text": "countries. Timely booster doses for HCWs and the development of new vaccines",
    "entities": []
  },
  {
    "text": "against emerging variants can help sustain immunity and prevent workforce",
    "entities": []
  },
  {
    "text": "shortages, strengthening healthcare resilience in resource-limited settings.",
    "entities": []
  },
  {
    "text": "\u00a9 The Author(s) 2025. Published by Oxford University Press on behalf of",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Oxford University Press",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Infectious Diseases Society of America.",
    "entities": []
  },
  {
    "text": "Conflict of interest statement: Potential conflicts of interest. The authors: No",
    "entities": []
  },
  {
    "text": "reported conflicts of interest. All authors have submitted the ICMJE Form for",
    "entities": []
  },
  {
    "text": "Disclosure of Potential Conflicts of Interest.",
    "entities": []
  },
  {
    "text": "84. J Adv Nurs. 2025 Jul 15. doi: 10.1111/jan.70079. Online ahead of print.",
    "entities": [
      {
        "text": "84",
        "label": "CARDINAL"
      },
      {
        "text": "J Adv Nurs",
        "label": "WORK_OF_ART"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "15",
        "label": "CARDINAL"
      },
      {
        "text": "10.1111",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Exploring Nurses' Work Resumption Behaviour and Its Related Factors Under",
    "entities": []
  },
  {
    "text": "Emerging Infectious Diseases Pandemic: A Cross-Sectional Study.",
    "entities": []
  },
  {
    "text": "(1)Department of Neurosurgery, West China Hospital, Sichuan University/West",
    "entities": [
      {
        "text": "Neurosurgery",
        "label": "GPE"
      },
      {
        "text": "West China Hospital",
        "label": "ORG"
      },
      {
        "text": "Sichuan University/West",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "China School of Nursing, Sichuan University, Chengdu, Sichuan, China.",
    "entities": [
      {
        "text": "China School of Nursing,",
        "label": "ORG"
      },
      {
        "text": "Sichuan University",
        "label": "ORG"
      },
      {
        "text": "Chengdu",
        "label": "GPE"
      },
      {
        "text": "Sichuan",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Evidence-Based Nursing Center, West China Hospital, Sichuan University,",
    "entities": [
      {
        "text": "Based Nursing Center",
        "label": "ORG"
      },
      {
        "text": "Sichuan University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Department of Critical Care Medicine, West China Hospital, Sichuan",
    "entities": [
      {
        "text": "Critical Care Medicine",
        "label": "ORG"
      },
      {
        "text": "West China Hospital",
        "label": "ORG"
      },
      {
        "text": "Sichuan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "University/West China School of Nursing, Sichuan University, Chengdu, Sichuan,",
    "entities": [
      {
        "text": "University/West China School of Nursing, Sichuan University",
        "label": "ORG"
      },
      {
        "text": "Chengdu",
        "label": "GPE"
      },
      {
        "text": "Sichuan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Mental Health Center, West China Hospital, Sichuan University/West China",
    "entities": [
      {
        "text": "Health Center",
        "label": "ORG"
      },
      {
        "text": "Sichuan University/West China",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "School of Nursing, Sichuan University, Chengdu, Sichuan, China.",
    "entities": [
      {
        "text": "School of Nursing,",
        "label": "ORG"
      },
      {
        "text": "Sichuan University",
        "label": "ORG"
      },
      {
        "text": "Chengdu",
        "label": "GPE"
      },
      {
        "text": "Sichuan",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Nursing, West China Hospital, Sichuan University/West China",
    "entities": [
      {
        "text": "Nursing",
        "label": "GPE"
      },
      {
        "text": "West China Hospital",
        "label": "ORG"
      },
      {
        "text": "Sichuan University/West China",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "AIM: In December 2022, a large population infected with COVID-19 emerged in",
    "entities": [
      {
        "text": "AIM",
        "label": "ORG"
      },
      {
        "text": "December 2022",
        "label": "DATE"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "China, including frontline nurses. To maintain the medical system's function,",
    "entities": [
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "many infected nurses returned to work before full recovery. This study aims to",
    "entities": []
  },
  {
    "text": "examine the characteristics of work resumption behaviour among the infected",
    "entities": []
  },
  {
    "text": "nurses and its influencing factors.",
    "entities": []
  },
  {
    "text": "METHODS: An indicator was developed to assess the work resumption behaviour:",
    "entities": []
  },
  {
    "text": "work resumption type (autonomous work resumption, constrained work resumption).",
    "entities": []
  },
  {
    "text": "As the possible influencing factors of work resumption type, professional",
    "entities": []
  },
  {
    "text": "commitment, organisational commitment and psychological capital were included",
    "entities": []
  },
  {
    "text": "and measured by the Professional Commitment Scale (PCS), Organizational",
    "entities": [
      {
        "text": "the Professional Commitment Scale",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "The logistic regression models were applied to estimate the association between",
    "entities": []
  },
  {
    "text": "the score of the PCS, OCQ, PCQ, and work resumption type.",
    "entities": [
      {
        "text": "PCS",
        "label": "ORG"
      },
      {
        "text": "OCQ",
        "label": "ORG"
      },
      {
        "text": "PCQ",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "RESULTS: A total of 30,062 nurses were included. The mean time of nurses",
    "entities": [
      {
        "text": "30,062",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "returning to work after infection was 1.8 days, with 88.6% exhibiting autonomous",
    "entities": [
      {
        "text": "1.8 days",
        "label": "DATE"
      },
      {
        "text": "88.6%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "work resumption behaviour. One standard deviation increment in the score of the",
    "entities": [
      {
        "text": "One",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PCS, OCQ, and PCQ was associated with a 41% (OR = 1.41), 29% (OR = 1.29) and 42%",
    "entities": [
      {
        "text": "PCS",
        "label": "ORG"
      },
      {
        "text": "OCQ",
        "label": "ORG"
      },
      {
        "text": "PCQ",
        "label": "ORG"
      },
      {
        "text": "41%",
        "label": "PERCENT"
      },
      {
        "text": "1.41",
        "label": "CARDINAL"
      },
      {
        "text": "29%",
        "label": "PERCENT"
      },
      {
        "text": "1.29",
        "label": "CARDINAL"
      },
      {
        "text": "42%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "(OR = 1.42) average increase in the odds of having an autonomous work",
    "entities": [
      {
        "text": "1.42",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "resumption, respectively.",
    "entities": []
  },
  {
    "text": "CONCLUSION: The majority of nurses returned to work before full recovery during",
    "entities": []
  },
  {
    "text": "the pandemic. Elevated professional commitment, organisational commitment and",
    "entities": []
  },
  {
    "text": "psychological capital were associated with autonomous work resumption behaviour.",
    "entities": []
  },
  {
    "text": "IMPACT: The large-scale work resumption in this emerging infectious disease",
    "entities": []
  },
  {
    "text": "outbreak demonstrated that the healthcare system should reevaluate nursing",
    "entities": []
  },
  {
    "text": "workforce growth targets for pandemics. It is still warranted for future",
    "entities": []
  },
  {
    "text": "research to explore the long-term effects of work resumption on individual and",
    "entities": []
  },
  {
    "text": "TRIAL REGISTRATION: Chinese clinical trial registry: ChiCTR2300067706 (January",
    "entities": [
      {
        "text": "Chinese",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Online ahead of print.",
    "entities": []
  },
  {
    "text": "A dual-tag strategy with superfolder green fluorescent protein (sfGFP) and small",
    "entities": []
  },
  {
    "text": "ubiquitin-like modifier (SUMO) for soluble expression of SARS-CoV-2 RNA",
    "entities": [
      {
        "text": "ubiquitin-like",
        "label": "PERSON"
      },
      {
        "text": "SUMO",
        "label": "ORG"
      },
      {
        "text": "SARS-CoV-2 RNA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "polymerase visibly in Escherichia coli.",
    "entities": [
      {
        "text": "Escherichia",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)State Key Laboratory of Biocatalysis and Enzyme Engineering, and School of",
    "entities": [
      {
        "text": "Key Laboratory",
        "label": "ORG"
      },
      {
        "text": "Enzyme Engineering",
        "label": "ORG"
      },
      {
        "text": "School of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Life Sciences, Hubei University, Wuhan 430062, China. Electronic address:",
    "entities": [
      {
        "text": "Life Sciences",
        "label": "ORG"
      },
      {
        "text": "Hubei University",
        "label": "ORG"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)State Key Laboratory of Biocatalysis and Enzyme Engineering, and School of",
    "entities": [
      {
        "text": "Key Laboratory",
        "label": "ORG"
      },
      {
        "text": "Enzyme Engineering",
        "label": "ORG"
      },
      {
        "text": "School of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)State Key Laboratory of Biocatalysis and Enzyme Engineering, and School of",
    "entities": [
      {
        "text": "Key Laboratory",
        "label": "ORG"
      },
      {
        "text": "Enzyme Engineering",
        "label": "ORG"
      },
      {
        "text": "School of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)State Key Laboratory of Biocatalysis and Enzyme Engineering, and School of",
    "entities": [
      {
        "text": "Key Laboratory",
        "label": "ORG"
      },
      {
        "text": "Enzyme Engineering",
        "label": "ORG"
      },
      {
        "text": "School of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)State Key Laboratory of Biocatalysis and Enzyme Engineering, and School of",
    "entities": [
      {
        "text": "Key Laboratory",
        "label": "ORG"
      },
      {
        "text": "Enzyme Engineering",
        "label": "ORG"
      },
      {
        "text": "School of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Life Sciences, Hubei University, Wuhan 430062, China.",
    "entities": [
      {
        "text": "Life Sciences",
        "label": "ORG"
      },
      {
        "text": "Hubei University",
        "label": "ORG"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)State Key Laboratory of Biocatalysis and Enzyme Engineering, and School of",
    "entities": [
      {
        "text": "Key Laboratory",
        "label": "ORG"
      },
      {
        "text": "Enzyme Engineering",
        "label": "ORG"
      },
      {
        "text": "School of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(7)State Key Laboratory of Biocatalysis and Enzyme Engineering, and School of",
    "entities": [
      {
        "text": "Key Laboratory",
        "label": "ORG"
      },
      {
        "text": "Enzyme Engineering",
        "label": "ORG"
      },
      {
        "text": "School of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(8)State Key Laboratory of Biocatalysis and Enzyme Engineering, and School of",
    "entities": [
      {
        "text": "8)State",
        "label": "CARDINAL"
      },
      {
        "text": "Key Laboratory",
        "label": "ORG"
      },
      {
        "text": "Enzyme Engineering",
        "label": "ORG"
      },
      {
        "text": "School of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(9)State Key Laboratory of Biocatalysis and Enzyme Engineering, and School of",
    "entities": [
      {
        "text": "Key Laboratory",
        "label": "ORG"
      },
      {
        "text": "Enzyme Engineering",
        "label": "ORG"
      },
      {
        "text": "School of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "RNA-dependent RNA polymerase (RdRp) of SARS-CoV-2 composed of three",
    "entities": [
      {
        "text": "RNA",
        "label": "ORG"
      },
      {
        "text": "RdRp",
        "label": "ORG"
      },
      {
        "text": "three",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "non-structural proteins NSP12, NSP8, and NSP7, which is responsible for",
    "entities": [
      {
        "text": "NSP12",
        "label": "PERSON"
      },
      {
        "text": "NSP8",
        "label": "GPE"
      },
      {
        "text": "NSP7",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "replication and transcription, making it a promising target for antiviral drug",
    "entities": []
  },
  {
    "text": "development. However, the limited solubility presents a significant challenge in",
    "entities": []
  },
  {
    "text": "the expression of NSP12, restricting in-depth research in both scientific and",
    "entities": [
      {
        "text": "NSP12",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "clinical fields. To address the challenge of soluble expression of NSP12 using",
    "entities": []
  },
  {
    "text": "the bacterial expression system, we developed a strategy integrating the",
    "entities": []
  },
  {
    "text": "super-folder GFP (sfGFP) tag to overcome the low solubility of NSP12 in this",
    "entities": [
      {
        "text": "GFP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "study. By engineering an sfGFP-mediated auto-secretion platform that eliminates",
    "entities": []
  },
  {
    "text": "signal peptides while enabling real-time visualization, we achieved soluble",
    "entities": []
  },
  {
    "text": "production of all RdRp subunits (NSP12/8/7) using a two-step nickel-affinity",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "purification strategy in E. coli. Furthermore, the tandem sfGFP-SUMO fusion",
    "entities": []
  },
  {
    "text": "strategy and optimized expression conditions (18 \u00b0C, 0.5 mM IPTG) were used to",
    "entities": [
      {
        "text": "18",
        "label": "CARDINAL"
      },
      {
        "text": "0.5 mM",
        "label": "QUANTITY"
      }
    ]
  },
  {
    "text": "enhance the efficient expression of NSP12, further boosting the yield of NSP12",
    "entities": [
      {
        "text": "NSP12",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "to 1.73 mg/L. This produced all soluble RdRp subunits (NSP12/8/7), with",
    "entities": [
      {
        "text": "1.73",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "size-exclusion chromatography confirming complex assembly, offering a universal",
    "entities": []
  },
  {
    "text": "framework for other important insoluble viral protein production. The",
    "entities": []
  },
  {
    "text": "integration of real-time visualization with hyper-solubility of this system",
    "entities": []
  },
  {
    "text": "addresses both the technical barrier in viral protein expression and the urgent",
    "entities": []
  },
  {
    "text": "need for scalable antiviral drug development platforms.",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025. Published by Elsevier B.V.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Elsevier B.V.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "declare no competing interests.",
    "entities": []
  },
  {
    "text": "The association between perinatal maternal mental health during the COVID-19",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "pandemic and offspring neurodevelopment at 24 months of age.",
    "entities": [
      {
        "text": "24 months of age",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Huddleston R(6), Julian-Kwong M(7), Corley J(8), Hoskin E(9), Lindquist KJ(10).",
    "entities": [
      {
        "text": "Huddleston",
        "label": "ORG"
      },
      {
        "text": "Julian-Kwong",
        "label": "NORP"
      },
      {
        "text": "Corley J(8",
        "label": "PERSON"
      },
      {
        "text": "Lindquist",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Center for Reproductive Health, 499 Illinois Street, 6th Floor, University of",
    "entities": [
      {
        "text": "Reproductive Health",
        "label": "ORG"
      },
      {
        "text": "499",
        "label": "CARDINAL"
      },
      {
        "text": "Illinois Street",
        "label": "ORG"
      },
      {
        "text": "6th Floor, University of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)School of Public Health, 2121 Berkeley Way, University of California,",
    "entities": [
      {
        "text": "2121",
        "label": "DATE"
      },
      {
        "text": "Berkeley Way",
        "label": "ORG"
      },
      {
        "text": "University of California",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Berkeley, Berkeley, CA 94704, USA. Electronic address: kgeisler@berkeley.edu.",
    "entities": [
      {
        "text": "Berkeley",
        "label": "GPE"
      },
      {
        "text": "Berkeley",
        "label": "GPE"
      },
      {
        "text": "CA 94704",
        "label": "ORG"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Center for Reproductive Health, 499 Illinois Street, 6th Floor, University of",
    "entities": [
      {
        "text": "Reproductive Health",
        "label": "ORG"
      },
      {
        "text": "499",
        "label": "CARDINAL"
      },
      {
        "text": "Illinois Street",
        "label": "ORG"
      },
      {
        "text": "6th Floor, University of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Center for Reproductive Health, 499 Illinois Street, 6th Floor, University of",
    "entities": [
      {
        "text": "Reproductive Health",
        "label": "ORG"
      },
      {
        "text": "499",
        "label": "CARDINAL"
      },
      {
        "text": "Illinois Street",
        "label": "ORG"
      },
      {
        "text": "6th Floor, University of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)Center for Reproductive Health, 499 Illinois Street, 6th Floor, University of",
    "entities": [
      {
        "text": "Reproductive Health",
        "label": "ORG"
      },
      {
        "text": "499",
        "label": "CARDINAL"
      },
      {
        "text": "Illinois Street",
        "label": "ORG"
      },
      {
        "text": "6th Floor, University of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(6)Depertment of Integrative Biology, 45 Noland Hall, 250 N Mills St, University",
    "entities": [
      {
        "text": "Integrative Biology",
        "label": "ORG"
      },
      {
        "text": "45",
        "label": "DATE"
      },
      {
        "text": "Noland Hall",
        "label": "PERSON"
      },
      {
        "text": "250",
        "label": "CARDINAL"
      },
      {
        "text": "N Mills St",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of Wisconsin-Madison, Madison, WI 53706, USA. Electronic address:",
    "entities": [
      {
        "text": "Wisconsin",
        "label": "GPE"
      },
      {
        "text": "Madison",
        "label": "PERSON"
      },
      {
        "text": "WI 53706",
        "label": "ORG"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Department of Neuroscience, Box G-LN, Brown University, Providence, RI 02912,",
    "entities": [
      {
        "text": "Neuroscience",
        "label": "ORG"
      },
      {
        "text": "Box G-LN",
        "label": "PERSON"
      },
      {
        "text": "Brown University",
        "label": "ORG"
      },
      {
        "text": "Providence",
        "label": "GPE"
      },
      {
        "text": "RI 02912",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(8)Center for Reproductive Health, 499 Illinois Street, 6th Floor, University of",
    "entities": [
      {
        "text": "8)Center",
        "label": "CARDINAL"
      },
      {
        "text": "Reproductive Health",
        "label": "ORG"
      },
      {
        "text": "499",
        "label": "CARDINAL"
      },
      {
        "text": "Illinois Street",
        "label": "ORG"
      },
      {
        "text": "6th Floor, University of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(9)Center for Reproductive Health, 499 Illinois Street, 6th Floor, University of",
    "entities": [
      {
        "text": "Reproductive Health",
        "label": "ORG"
      },
      {
        "text": "499",
        "label": "CARDINAL"
      },
      {
        "text": "Illinois Street",
        "label": "ORG"
      },
      {
        "text": "6th Floor, University of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(10)Center for Reproductive Health, 499 Illinois Street, 6th Floor, University",
    "entities": [
      {
        "text": "10)Center",
        "label": "CARDINAL"
      },
      {
        "text": "Reproductive Health",
        "label": "ORG"
      },
      {
        "text": "499",
        "label": "CARDINAL"
      },
      {
        "text": "Illinois Street",
        "label": "ORG"
      },
      {
        "text": "6th Floor, University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of California, San Francisco, San Francisco, CA 94158, USA. Electronic address:",
    "entities": [
      {
        "text": "California",
        "label": "GPE"
      },
      {
        "text": "San Francisco",
        "label": "GPE"
      },
      {
        "text": "San Francisco",
        "label": "GPE"
      },
      {
        "text": "CA 94158",
        "label": "ORG"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: Prenatal anxiety and depression have been linked to adverse",
    "entities": []
  },
  {
    "text": "childhood neurodevelopment, potentially through cortisol-induced epigenetic",
    "entities": []
  },
  {
    "text": "changes. Postpartum depression is also associated with neurodevelopmental",
    "entities": []
  },
  {
    "text": "delays, possibly via altered parental attachment. While prenatal and postpartum",
    "entities": []
  },
  {
    "text": "mental health may be correlated, their relative and independent impacts on",
    "entities": []
  },
  {
    "text": "offspring neurodevelopment remain unclear. This study examines the effects of",
    "entities": []
  },
  {
    "text": "prenatal and postpartum anxiety and/or depression on neurodevelopmental delay at",
    "entities": []
  },
  {
    "text": "24 months.",
    "entities": [
      {
        "text": "24 months",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "METHODS: In a nationwide prospective cohort from the \"Assessing the Safety of",
    "entities": [
      {
        "text": "Assessing the Safety of\n",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "Pregnancy in the Coronavirus Pandemic\" study, prenatal anxiety (GAD-7), prenatal",
    "entities": [
      {
        "text": "GAD-7",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "depression (PHQ-9), and six-week postpartum depression (EPDS) were assessed.",
    "entities": [
      {
        "text": "six-week",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Childhood neurodevelopment was measured using the Ages and Stages Questionnaire,",
    "entities": [
      {
        "text": "Childhood",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "3rd edition (ASQ-3). Logistic regression tested associations between",
    "entities": [
      {
        "text": "3rd",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "moderate-to-severe maternal anxiety/depression and neurodevelopmental delay,",
    "entities": []
  },
  {
    "text": "adjusting for participant age, education, household income, and residential",
    "entities": []
  },
  {
    "text": "density. Alcohol, nicotine, anxiety/depression medication use during pregnancy,",
    "entities": []
  },
  {
    "text": "and preterm birth were considered as moderators/mediators.",
    "entities": []
  },
  {
    "text": "RESULTS: Offspring of participants experiencing both prenatal and postpartum",
    "entities": []
  },
  {
    "text": "moderate-to-severe anxiety or depression (N = 62) had a higher risk of",
    "entities": [
      {
        "text": "62",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "neurodevelopmental delay at 24 months compared to those who experienced neither",
    "entities": [
      {
        "text": "24 months",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "(N = 1060) with an adjusted risk ratio of 1.88 (p < 0.001). While delay risk was",
    "entities": [
      {
        "text": "1060",
        "label": "DATE"
      },
      {
        "text": "1.88",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "higher in offspring of those with only prenatal (N = 218) or postpartum (N = 45)",
    "entities": [
      {
        "text": "218",
        "label": "CARDINAL"
      },
      {
        "text": "45",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "anxiety/depression, these were not statistically significant.",
    "entities": []
  },
  {
    "text": "CONCLUSION: Having both moderate-to-severe prenatal and postpartum anxiety or",
    "entities": []
  },
  {
    "text": "depression independently increased the risk of developmental delay at 24 months,",
    "entities": [
      {
        "text": "24 months",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "even after adjusting for confounders. Further research is needed to explore",
    "entities": []
  },
  {
    "text": "underlying mechanisms linking maternal mental health and fetal neurodevelopment.",
    "entities": []
  },
  {
    "text": "considered as potential competing interests: Marcelle I. Cedars reports",
    "entities": [
      {
        "text": "Marcelle I. Cedars",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "financial support was provided by Start Smal Foundation. Marcelle I. Cedars",
    "entities": [
      {
        "text": "Start Smal Foundation",
        "label": "ORG"
      },
      {
        "text": "Marcelle I. Cedars",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "reports financial support was provided by California Breast Cancer Research",
    "entities": [
      {
        "text": "California Breast Cancer Research",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Program. Marcelle I. Cedars reports financial support was provided by COVID",
    "entities": [
      {
        "text": "Marcelle I. Cedars",
        "label": "PERSON"
      },
      {
        "text": "COVID",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Catalyst Award. Marcelle I. Cedars reports financial support was provided by",
    "entities": [
      {
        "text": "Marcelle I. Cedars",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "AbbVie Inc. Marcelle I. Cedars reports financial support was provided by Ferring",
    "entities": [
      {
        "text": "AbbVie Inc.",
        "label": "ORG"
      },
      {
        "text": "Marcelle I. Cedars",
        "label": "PERSON"
      },
      {
        "text": "Ferring\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Pharmaceuticals. Marcelle I. Cedars reports administrative support was provided",
    "entities": [
      {
        "text": "Marcelle I. Cedars",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "by The Society for Assisted Reproductive Technology. Heather G. Huddleston",
    "entities": [
      {
        "text": "The Society for Assisted Reproductive Technology",
        "label": "ORG"
      },
      {
        "text": "G. Huddleston",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "reports a relationship with Allara Health that includes: consulting or advisory.",
    "entities": [
      {
        "text": "Allara Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Heather G. Huddleston reports a relationship with May Health that includes:",
    "entities": [
      {
        "text": "G. Huddleston",
        "label": "PERSON"
      },
      {
        "text": "May Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "funding grants. Heather G. Huddleston reports a relationship with Rejoni that",
    "entities": [
      {
        "text": "G. Huddleston",
        "label": "PERSON"
      },
      {
        "text": "Rejoni",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "includes: funding grants. Marcelle I. Cedars reports a relationship with",
    "entities": [
      {
        "text": "Marcelle I. Cedars",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "American Society for Reproductive Medicine that includes: board membership.",
    "entities": [
      {
        "text": "American Society for Reproductive Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Marcelle I. Cedars reports a relationship with American Gynecological &",
    "entities": [
      {
        "text": "Marcelle I. Cedars",
        "label": "PERSON"
      },
      {
        "text": "American Gynecological &\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Obstetrical Society that includes: board membership. Marcelle I. Cedars reports",
    "entities": [
      {
        "text": "Marcelle I. Cedars",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "a relationship with UptoDate Inc. that includes: consulting or advisory. Eleni",
    "entities": [
      {
        "text": "UptoDate Inc.",
        "label": "ORG"
      },
      {
        "text": "Eleni\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "G. Jaswa reports a relationship with Oura Health that includes: consulting or",
    "entities": [
      {
        "text": "G. Jaswa",
        "label": "PERSON"
      },
      {
        "text": "Oura Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "advisory. If there are other authors, they declare that they have no known",
    "entities": []
  },
  {
    "text": "competing financial interests or personal relationships that could have appeared",
    "entities": []
  },
  {
    "text": "to influence the work reported in this paper.",
    "entities": []
  },
  {
    "text": "10.1016/j.neuroscience.2025.07.005. Online ahead of print.",
    "entities": [
      {
        "text": "10.1016",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Repeated low doses of lipopolysaccharide exacerbate behavioral changes induced",
    "entities": []
  },
  {
    "text": "by social isolation.",
    "entities": []
  },
  {
    "text": "(1)Center of Health Sciences, Department of Physiology and Pharmacology, Federal",
    "entities": [
      {
        "text": "Health Sciences",
        "label": "ORG"
      },
      {
        "text": "Department of Physiology and Pharmacology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University of Santa Maria, Santa Maria, RS, Brazil; Center of Health Sciences,",
    "entities": [
      {
        "text": "University of Santa Maria",
        "label": "ORG"
      },
      {
        "text": "Santa Maria",
        "label": "PERSON"
      },
      {
        "text": "RS",
        "label": "ORG"
      },
      {
        "text": "Brazil",
        "label": "GPE"
      },
      {
        "text": "Center of Health Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Postgraduate Program in Pharmacology, Federal University of Santa Maria, Santa",
    "entities": [
      {
        "text": "Postgraduate Program",
        "label": "ORG"
      },
      {
        "text": "Federal University of",
        "label": "ORG"
      },
      {
        "text": "Santa",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Center of Rural Sciences, Postgraduate Program in Veterinary Medicine,",
    "entities": [
      {
        "text": "2)Center",
        "label": "CARDINAL"
      },
      {
        "text": "Rural Sciences",
        "label": "ORG"
      },
      {
        "text": "Postgraduate Program",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Federal University of Santa Maria (UFSM), Santa Maria, RS, Brazil.",
    "entities": [
      {
        "text": "Federal University of Santa Maria",
        "label": "ORG"
      },
      {
        "text": "Santa Maria",
        "label": "PERSON"
      },
      {
        "text": "RS",
        "label": "ORG"
      },
      {
        "text": "Brazil",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Laboratory of Biotechnology and Animal Reproduction (BioRep), Veterinary",
    "entities": [
      {
        "text": "Biotechnology and Animal Reproduction",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Center of Health Sciences, Department of Physiology and Pharmacology, Federal",
    "entities": [
      {
        "text": "Health Sciences",
        "label": "ORG"
      },
      {
        "text": "Department of Physiology and Pharmacology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Social isolation (SI) due to Coronavirus disease 2019 had a substantial impact",
    "entities": [
      {
        "text": "Coronavirus",
        "label": "GPE"
      },
      {
        "text": "2019",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "on mental health, increasing cases of major depressive disorder (MDD) and",
    "entities": [
      {
        "text": "MDD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "anxiety. Young individuals are notably affected, as research indicates that",
    "entities": []
  },
  {
    "text": "inflammatory responses can trigger mental health disorders, with chronic stress",
    "entities": []
  },
  {
    "text": "worsening this effect. Thus, the primary objective of this study was to",
    "entities": []
  },
  {
    "text": "investigate the combination of SI with repeated low doses of an inflammation",
    "entities": [
      {
        "text": "SI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "inducer in young mice on behavioral and molecular changes in adulthood. For",
    "entities": []
  },
  {
    "text": "this, young Swiss male mice were housed in groups or isolated and administered",
    "entities": [
      {
        "text": "Swiss",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "intraperitoneally either low doses of lipopolysaccharide (LPS) or saline for",
    "entities": [
      {
        "text": "LPS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "6 weeks. In the seventh week, behavioral tests were carried out. Another cohort",
    "entities": [
      {
        "text": "6 weeks",
        "label": "DATE"
      },
      {
        "text": "the seventh week",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "of animals, at the end of the 6-week experimental protocol, was subjected to the",
    "entities": [
      {
        "text": "the end of the",
        "label": "DATE"
      },
      {
        "text": "6-week",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "restraint stress challenge (RSC) before behavioral tests. Our results suggest",
    "entities": [
      {
        "text": "RSC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "that the SI disrupts the animal's self-grooming and memory, in addition to",
    "entities": [
      {
        "text": "SI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "inducing an anxiety-related behavioral phenotype and increasing the expression",
    "entities": []
  },
  {
    "text": "of transient receptor potential ankyrin 1 (TRPA1) in the hippocampus. On the",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "other hand, the LPS administration triggered despair-like behavior accompanied",
    "entities": [
      {
        "text": "LPS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "by an increase in hippocampal microglial activation. When SI and LPS were",
    "entities": [
      {
        "text": "SI",
        "label": "ORG"
      },
      {
        "text": "LPS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "combined, the behavioral changes were added. Concerning RSC, in general, it",
    "entities": [
      {
        "text": "RSC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "reversed most of the changes induced by the protocols. In this way, it can be",
    "entities": []
  },
  {
    "text": "concluded that repeated administration of low doses of LPS in young mice housed",
    "entities": [
      {
        "text": "LPS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "alone induced behavioral changes in different features observed in MDD.",
    "entities": [
      {
        "text": "MDD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Copyright \u00a9 2025 International Brain Research Organization (IBRO). Published by",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "International Brain Research Organization",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Elsevier Inc. All rights reserved.",
    "entities": [
      {
        "text": "Elsevier Inc.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "declare that they have no known competing financial interests or personal",
    "entities": []
  },
  {
    "text": "relationships that could have appeared to influence the work reported in this",
    "entities": []
  },
  {
    "text": "Binding of an N protein peptide to M protein of a bat coronavirus.",
    "entities": [
      {
        "text": "N",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(1)Department of Integrated Traditional Chinese and Western Medicine, State Key",
    "entities": [
      {
        "text": "Integrated Traditional Chinese and Western Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu,",
    "entities": [
      {
        "text": "Sichuan University",
        "label": "ORG"
      },
      {
        "text": "Chengdu",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Integrated Traditional Chinese and Western Medicine, State Key",
    "entities": [
      {
        "text": "Integrated",
        "label": "NORP"
      },
      {
        "text": "Chinese",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Sichuan 610041, China. Electronic address: x.zhou@scu.edu.cn.",
    "entities": [
      {
        "text": "Sichuan 610041",
        "label": "DATE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "The interaction between the membrane (M) protein and the nucleocapsid (N)",
    "entities": []
  },
  {
    "text": "protein of coronaviruses plays a crucial role in virus assembly and",
    "entities": []
  },
  {
    "text": "morphogenesis. Previous studies indicate that one M-N interaction occurs between",
    "entities": [
      {
        "text": "one",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "M protein and the carboxy-terminus of N protein. However, the mechanistic",
    "entities": [
      {
        "text": "N",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "details of M-N interactions remain unclear. Here, we present a complex structure",
    "entities": [
      {
        "text": "M-N",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of an N protein carboxy-terminal peptide bound to M protein from Pipistrellus",
    "entities": [
      {
        "text": "N",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "bat coronavirus HKU5. The structure shows that the M-N peptide binding site",
    "entities": [
      {
        "text": "the M-N",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "includes a \"horizontal\" groove located between the carboxy-terminal domain and",
    "entities": []
  },
  {
    "text": "the transmembrane domain of M protein. Combined with molecular docking and",
    "entities": []
  },
  {
    "text": "binding analysis, our results provide structural insight into the binding",
    "entities": []
  },
  {
    "text": "mechanism between M and N proteins of a coronavirus.",
    "entities": [
      {
        "text": "N",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Copyright \u00a9 2025 Elsevier Inc. All rights reserved.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Establishment of an indirect ELISA for Feline Coronavirus Antibody Detection and",
    "entities": [
      {
        "text": "ELISA",
        "label": "ORG"
      },
      {
        "text": "Feline Coronavirus Antibody Detection",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Serotype Discrimination.",
    "entities": []
  },
  {
    "text": "(1)State Key Laboratory for Animal Disease Control and Prevention, Center for",
    "entities": [
      {
        "text": "Key Laboratory",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Emerging and Zoonotic Diseases, College of Veterinary Medicine, South China",
    "entities": [
      {
        "text": "Zoonotic Diseases",
        "label": "ORG"
      },
      {
        "text": "College of Veterinary Medicine",
        "label": "ORG"
      },
      {
        "text": "South China",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "Agricultural University, Guangzhou, 510642, China.",
    "entities": [
      {
        "text": "Agricultural University",
        "label": "ORG"
      },
      {
        "text": "Guangzhou",
        "label": "GPE"
      },
      {
        "text": "510642",
        "label": "DATE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)State Key Laboratory for Animal Disease Control and Prevention, Center for",
    "entities": [
      {
        "text": "Key Laboratory",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Agricultural University, Guangzhou, 510642, China; School of Agriculture and",
    "entities": [
      {
        "text": "Agricultural University",
        "label": "ORG"
      },
      {
        "text": "Guangzhou",
        "label": "GPE"
      },
      {
        "text": "510642",
        "label": "DATE"
      },
      {
        "text": "China",
        "label": "GPE"
      },
      {
        "text": "School of Agriculture",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Biology, Shanghai Jiao Tong University, Shanghai 200240, China. Electronic",
    "entities": [
      {
        "text": "Shanghai",
        "label": "GPE"
      },
      {
        "text": "Tong University",
        "label": "ORG"
      },
      {
        "text": "Shanghai 200240",
        "label": "ORG"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Feline coronavirus (FCoV) is a highly contagious pathogen that is endemic to",
    "entities": [
      {
        "text": "FCoV",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "feline populations and is classified into two serotypes, I and II. Current",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "diagnostic techniques are insufficient for distinguishing between these",
    "entities": []
  },
  {
    "text": "serotypes, which impedes effective surveillance and prevention efforts. In",
    "entities": []
  },
  {
    "text": "response to this limitation, we have developed an indirect enzyme-linked",
    "entities": []
  },
  {
    "text": "the broad detection of FCoV, alongside receptor-binding domain (RBD) proteins",
    "entities": [
      {
        "text": "FCoV",
        "label": "PRODUCT"
      },
      {
        "text": "RBD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "specific to serotypes I (I-RBD) and II (II-RBD) for the purpose of serotype",
    "entities": [
      {
        "text": "II",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "differentiation. The assay underwent systematic optimization, achieving high",
    "entities": []
  },
  {
    "text": "sensitivity (with detection limits of 1:64,000 dilution for N and I-RBD, and",
    "entities": [
      {
        "text": "1:64,000",
        "label": "CARDINAL"
      },
      {
        "text": "N",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "1:32,000 for II-RBD) and specificity, exhibiting no cross-reactivity with feline",
    "entities": [
      {
        "text": "1:32,000",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "calicivirus (FCV), feline herpesvirus (FHV), or feline parvovirus (FPV). The",
    "entities": [
      {
        "text": "FCV",
        "label": "ORG"
      },
      {
        "text": "FPV",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "reproducibility of the assay was validated, with intra- and inter-assay",
    "entities": []
  },
  {
    "text": "coefficients of variation remaining below 10%. Clinical validation conducted on",
    "entities": [
      {
        "text": "below 10%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "123 feline serum samples indicated a seroprevalence of 73.17%, with the serotype",
    "entities": [
      {
        "text": "123",
        "label": "CARDINAL"
      },
      {
        "text": "73.17%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "distribution comprising 91.11% serotype I, 1.11% serotype II, 2.22% mixed",
    "entities": [
      {
        "text": "91.11%",
        "label": "PERCENT"
      },
      {
        "text": "1.11%",
        "label": "PERCENT"
      },
      {
        "text": "II",
        "label": "CARDINAL"
      },
      {
        "text": "2.22%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "infections, and 5.56% cases that could not be typed. This ELISA represents a",
    "entities": [
      {
        "text": "5.56%",
        "label": "PERCENT"
      },
      {
        "text": "ELISA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "rapid, cost-effective, and field-deployable method for large-scale FCoV",
    "entities": [
      {
        "text": "FCoV",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "surveillance and serotyping, thereby contributing to enhanced feline health",
    "entities": []
  },
  {
    "text": "management and epidemiological research.",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025 Elsevier B.V. All rights reserved.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Declaration of Competing Interest The authors",
    "entities": []
  },
  {
    "text": "90. Biomed Pharmacother. 2025 Jul 14;189:118346. doi:",
    "entities": [
      {
        "text": "90",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "10.1016/j.biopha.2025.118346. Online ahead of print.",
    "entities": [
      {
        "text": "10.1016",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Do vitamins halt the COVID-19-evoked pro-inflammatory cytokines involved in the",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "development of neuropathic pain?",
    "entities": []
  },
  {
    "text": "(1)Department of Pharmacology and Pharmacotherapy, Faculty of Medicine,",
    "entities": [
      {
        "text": "Pharmacology and Pharmacotherapy, Faculty of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Semmelweis University, Nagyv\u00e1rad t\u00e9r 4, Budapest H-1085, Hungary; Center for",
    "entities": [
      {
        "text": "Semmelweis University",
        "label": "ORG"
      },
      {
        "text": "Nagyv\u00e1rad t\u00e9r",
        "label": "ORG"
      },
      {
        "text": "4",
        "label": "CARDINAL"
      },
      {
        "text": "Budapest H-1085",
        "label": "GPE"
      },
      {
        "text": "Hungary",
        "label": "GPE"
      },
      {
        "text": "Center",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Pharmacology and Drug Research & Development, Semmelweis University, \u00dcll\u0151i \u00fat",
    "entities": [
      {
        "text": "Pharmacology and Drug Research & Development",
        "label": "ORG"
      },
      {
        "text": "\u00dcll\u0151i",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "26., Budapest H-1085, Hungary. Electronic address:",
    "entities": [
      {
        "text": "26",
        "label": "CARDINAL"
      },
      {
        "text": "Budapest H-1085",
        "label": "GPE"
      },
      {
        "text": "Hungary",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Pharmacology and Pharmacotherapy, Faculty of Medicine,",
    "entities": [
      {
        "text": "Pharmacology and Pharmacotherapy, Faculty of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Department of Pharmacology and Pharmacotherapy, Faculty of Medicine,",
    "entities": [
      {
        "text": "Pharmacology and Pharmacotherapy, Faculty of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Semmelweis University, Nagyv\u00e1rad t\u00e9r 4, Budapest H-1085, Hungary.",
    "entities": [
      {
        "text": "Semmelweis University",
        "label": "ORG"
      },
      {
        "text": "Nagyv\u00e1rad t\u00e9r",
        "label": "ORG"
      },
      {
        "text": "4",
        "label": "CARDINAL"
      },
      {
        "text": "Budapest H-1085",
        "label": "GPE"
      },
      {
        "text": "Hungary",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Drug and Health Sciences, University of Catania, Viale A. Doria",
    "entities": [
      {
        "text": "Drug and Health Sciences",
        "label": "ORG"
      },
      {
        "text": "University of Catania",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)Department of Pharmacology and Pharmacotherapy, Faculty of Medicine,",
    "entities": [
      {
        "text": "Pharmacology and Pharmacotherapy, Faculty of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(6)Department of Pharmacology and Pharmacotherapy, Faculty of Medicine,",
    "entities": [
      {
        "text": "Pharmacology and Pharmacotherapy, Faculty of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Semmelweis University, Nagyv\u00e1rad t\u00e9r 4, Budapest H-1085, Hungary; Institute of",
    "entities": [
      {
        "text": "Semmelweis University",
        "label": "ORG"
      },
      {
        "text": "Nagyv\u00e1rad t\u00e9r",
        "label": "ORG"
      },
      {
        "text": "4",
        "label": "CARDINAL"
      },
      {
        "text": "Budapest H-1085",
        "label": "GPE"
      },
      {
        "text": "Hungary",
        "label": "GPE"
      },
      {
        "text": "Institute of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Experimental Medicine, E\u00f6tv\u00f6s L\u00f3r\u00e1nd Research Network, Szigony utca 43.,",
    "entities": [
      {
        "text": "Experimental Medicine",
        "label": "ORG"
      },
      {
        "text": "Szigony",
        "label": "PERSON"
      },
      {
        "text": "43",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Neuropathic pain (NP), a disease affecting the somatosensory nervous system,",
    "entities": [
      {
        "text": "Neuropathic",
        "label": "PERSON"
      },
      {
        "text": "NP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "causes a high socioeconomic burden on healthcare systems and society; yet, its",
    "entities": []
  },
  {
    "text": "management has not been fully solved. Post COVID-19, with sequelae of the",
    "entities": []
  },
  {
    "text": "somatosensory system, further increases the number of individuals with chronic",
    "entities": []
  },
  {
    "text": "pain, thus further exacerbating the social burden related to NP. The",
    "entities": [
      {
        "text": "NP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "pro-inflammatory mediators, such as TNF-\u03b1, IL-1\u03b2, and IL-6, are massively",
    "entities": [
      {
        "text": "TNF",
        "label": "ORG"
      },
      {
        "text": "IL-1\u03b2",
        "label": "ORG"
      },
      {
        "text": "IL-6",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "released in patients with COVID-19 and are known to be involved in the",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "pathomechanisms of NP, particularly in relation to neuronal sensitization.",
    "entities": [
      {
        "text": "NP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Specifically, the release of large amounts of these pro-inflammatory cytokines",
    "entities": []
  },
  {
    "text": "from immune and non-immune effector cells during the acute and post COVID-19",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "phases prone to have substantial involvement in the development of post COVID-19",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "NP. Several preclinical and clinical studies have shown that vitamins'",
    "entities": [
      {
        "text": "NP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "supplementation, namely vitamins A, B1, B2, B3, B5, B6, B7, B9, B12, C, D, E,",
    "entities": [
      {
        "text": "B1",
        "label": "CARDINAL"
      },
      {
        "text": "B3",
        "label": "NORP"
      },
      {
        "text": "B5",
        "label": "PRODUCT"
      },
      {
        "text": "B6",
        "label": "PRODUCT"
      },
      {
        "text": "B7",
        "label": "CARDINAL"
      },
      {
        "text": "B9",
        "label": "GPE"
      },
      {
        "text": "B12, C",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and K can attenuate the enhanced release of TNF-\u03b1, IL-1\u03b2, and IL-6. The early",
    "entities": [
      {
        "text": "TNF",
        "label": "ORG"
      },
      {
        "text": "IL-1\u03b2",
        "label": "ORG"
      },
      {
        "text": "IL-6",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "supplementation of these vitamins may mitigate the neuronal sensitization evoked",
    "entities": []
  },
  {
    "text": "by cytokine storm due to COVID-19 or other viruses. This strategy may provide a",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "novel approach to prevent the development of post COVID-19 NP. This review",
    "entities": [
      {
        "text": "COVID-19 NP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "highlights the mechanisms by which COVID-19 can induce NP and how vitamins may",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      },
      {
        "text": "NP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "help to alleviate these post COVID-19 sequelae.",
    "entities": [
      {
        "text": "COVID-19 sequelae",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Copyright \u00a9 2025 The Authors. Published by Elsevier Masson SAS.. All rights",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Masson SAS",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Declaration of Competing Interest P\u00e9ter",
    "entities": []
  },
  {
    "text": "Ferdinandya is the founder and CEO of Pharmahungary Group, a group of R&D",
    "entities": [
      {
        "text": "Pharmahungary Group",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "companies. Other authors affirm that they have no known competing financial",
    "entities": []
  },
  {
    "text": "interests or personal relationships that could be perceived as influencing the",
    "entities": []
  },
  {
    "text": "work reported in this paper.",
    "entities": []
  },
  {
    "text": "Intraventricular mould infection suggestive of Aspergillosis in a 2-year-old",
    "entities": [
      {
        "text": "Aspergillosis",
        "label": "ORG"
      },
      {
        "text": "2-year-old",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "child with successful clinical outcomes.",
    "entities": []
  },
  {
    "text": "(1)Department of Neurosurgery, Postgraduate Institute of Medical Education &",
    "entities": [
      {
        "text": "Neurosurgery, Postgraduate Institute of Medical Education &\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Research (PGIMER), Chandigarh, India.",
    "entities": [
      {
        "text": "Chandigarh",
        "label": "GPE"
      },
      {
        "text": "India",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Neurosurgery, Postgraduate Institute of Medical Education &",
    "entities": [
      {
        "text": "Neurosurgery, Postgraduate Institute of Medical Education &\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Research (PGIMER), Chandigarh, India. Electronic address:",
    "entities": [
      {
        "text": "Chandigarh",
        "label": "GPE"
      },
      {
        "text": "India",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Histopathology, PGIMER, Chandigarh, India.",
    "entities": [
      {
        "text": "Histopathology",
        "label": "GPE"
      },
      {
        "text": "PGIMER",
        "label": "GPE"
      },
      {
        "text": "Chandigarh",
        "label": "GPE"
      },
      {
        "text": "India",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Medical Microbiology, Mycology Division, Center of Advanced",
    "entities": [
      {
        "text": "Medical Microbiology, Mycology Division",
        "label": "ORG"
      },
      {
        "text": "Center of Advanced",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Research in Medical Mycology & WHO Collaborating Center, PGIMER, Chandigarh,",
    "entities": [
      {
        "text": "Medical Mycology & WHO Collaborating Center",
        "label": "ORG"
      },
      {
        "text": "PGIMER",
        "label": "GPE"
      },
      {
        "text": "Chandigarh",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Pediatric isolated central nervous system (CNS) mould infections are uncommon",
    "entities": [
      {
        "text": "CNS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "but potentially fatal if not promptly diagnosed and treated. Such invasive",
    "entities": []
  },
  {
    "text": "lesions usually present as abscesses in parenchymal locations. Although the",
    "entities": []
  },
  {
    "text": "newer azole antifungals have shown improved outcomes, treatment data are limited",
    "entities": []
  },
  {
    "text": "in the pediatric age group, especially in young children. We report a case of a",
    "entities": []
  },
  {
    "text": "very young child with an unusual location of mould infection, in the temporal",
    "entities": []
  },
  {
    "text": "horn of the lateral ventricle, managed successfully. The 2-year-old-male child",
    "entities": [
      {
        "text": "2-year-old",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "with prior COVID-19 infection and no other apparent immune dysfunction presented",
    "entities": [
      {
        "text": "COVID-19",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "with features of raised intracranial pressure. CT/MRI imaging demonstrated a",
    "entities": []
  },
  {
    "text": "left temporal horn cystic lesion. Following an initial non-diagnostic aspiration",
    "entities": []
  },
  {
    "text": "of the cyst contents, the child underwent excision of the lesion. The potassium",
    "entities": []
  },
  {
    "text": "hydroxide stain of the content revealed hyaline septate hyphae, but the fungal",
    "entities": []
  },
  {
    "text": "culture was sterile. Histopathology of the specimen was highly suggestive of",
    "entities": []
  },
  {
    "text": "aspergillosis. The child was adequately treated with voriconazole, and had",
    "entities": []
  },
  {
    "text": "excellent clinical outcome at 22-month follow up. Rarely, CNS mould infection",
    "entities": [
      {
        "text": "22-month",
        "label": "DATE"
      },
      {
        "text": "CNS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "can manifest as an intraventricular space occupying lesion in children. Such a",
    "entities": []
  },
  {
    "text": "differential must be borne in mind. In our case, the infection was possibly a",
    "entities": []
  },
  {
    "text": "COVID-19 sequelae. The case also highlights the potential for successful",
    "entities": [
      {
        "text": "COVID-19 sequelae",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "clinical outcomes with an early and aggressive voriconazole treatment in",
    "entities": []
  },
  {
    "text": "pediatric intracranial mould infections, most likely aspergillosis.",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025 SFMM. Published by Elsevier Masson SAS. All rights reserved.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Elsevier Masson SAS",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Critical exposure windows of PM2.5-Meteorological interactions triggering",
    "entities": []
  },
  {
    "text": "pediatric mycoplasma pneumoniae epidemics: An age-stratified distributed lag",
    "entities": []
  },
  {
    "text": "nonlinear modeling approach.",
    "entities": []
  },
  {
    "text": "(1)Department of Pediatrics, Shengjing Hospital of China Medical University,",
    "entities": [
      {
        "text": "Pediatrics",
        "label": "ORG"
      },
      {
        "text": "Shengjing Hospital of China Medical University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Department of Health Management, Shengjing Hospital of China Medical",
    "entities": [
      {
        "text": "Health Management",
        "label": "ORG"
      },
      {
        "text": "Shengjing Hospital of China Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University, Shenyang, Liaoning, 110000, China.",
    "entities": [
      {
        "text": "University",
        "label": "ORG"
      },
      {
        "text": "Shenyang",
        "label": "GPE"
      },
      {
        "text": "Liaoning",
        "label": "GPE"
      },
      {
        "text": "110000",
        "label": "DATE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Institute of Atmospheric Environment, China Meteorological Administration,",
    "entities": [
      {
        "text": "China Meteorological Administration",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Department of Laboratory Medicine, Shengjing Hospital of China Medical",
    "entities": [
      {
        "text": "Laboratory Medicine",
        "label": "ORG"
      },
      {
        "text": "Shengjing Hospital of China Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University, Liaoning Clinical Research Center for Laboratory Medicine, Shenyang,",
    "entities": [
      {
        "text": "University, Liaoning Clinical Research Center for Laboratory Medicine",
        "label": "ORG"
      },
      {
        "text": "Shenyang",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Pediatrics, Shengjing Hospital of China Medical University,",
    "entities": [
      {
        "text": "Pediatrics",
        "label": "ORG"
      },
      {
        "text": "Shengjing Hospital of China Medical University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Shenyang, Liaoning, 110000, China. Electronic address: tomxu.123@163.com.",
    "entities": [
      {
        "text": "Shenyang",
        "label": "GPE"
      },
      {
        "text": "Liaoning",
        "label": "GPE"
      },
      {
        "text": "110000",
        "label": "DATE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Department of Pediatrics, Shengjing Hospital of China Medical University,",
    "entities": [
      {
        "text": "Pediatrics",
        "label": "ORG"
      },
      {
        "text": "Shengjing Hospital of China Medical University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Shenyang, Liaoning, 110000, China. Electronic address: qcheng@cmu.edu.cn.",
    "entities": [
      {
        "text": "Shenyang",
        "label": "GPE"
      },
      {
        "text": "Liaoning",
        "label": "GPE"
      },
      {
        "text": "110000",
        "label": "DATE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: The rising prevalence of Mycoplasma pneumoniae infection (MPI) in",
    "entities": [
      {
        "text": "Mycoplasma",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "children, a leading cause of severe pneumonia and mortality, highlights the need",
    "entities": []
  },
  {
    "text": "to clarify impacts of air pollution and meteorological factors.",
    "entities": []
  },
  {
    "text": "METHODS: This study analyzed associations of PM2.5, temperature, and humidity",
    "entities": []
  },
  {
    "text": "with outpatient MPI, inpatient MPP, and severe MPP (SMPP). Data on 391,559",
    "entities": [
      {
        "text": "MPP",
        "label": "ORG"
      },
      {
        "text": "MPP",
        "label": "PERSON"
      },
      {
        "text": "SMPP",
        "label": "ORG"
      },
      {
        "text": "391,559",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "children from 15 Northeast China hospitals (2017-2023) were analyzed using a",
    "entities": [
      {
        "text": "15",
        "label": "CARDINAL"
      },
      {
        "text": "Northeast China",
        "label": "LOC"
      },
      {
        "text": "2017-2023",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "distributed lag nonlinear model, with sensitivity analysis after 2020 (COVID-19",
    "entities": [
      {
        "text": "2020",
        "label": "DATE"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "RESULTS: PM2.5 (60-100 \u03bcg/m3) showed nonlinear associations with outpatient MPI",
    "entities": [
      {
        "text": "60-100",
        "label": "CARDINAL"
      },
      {
        "text": "MPI\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(7-15-day lag, RR = 2.28 at 100 \u03bcg/m3, 10-day lag), especially in preschoolers.",
    "entities": [
      {
        "text": "7-15-day",
        "label": "DATE"
      },
      {
        "text": "2.28",
        "label": "CARDINAL"
      },
      {
        "text": "100",
        "label": "CARDINAL"
      },
      {
        "text": "10-day",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Temperature correlated positively with outpatient MPI (peaks at 20 \u00b0C/30 \u00b0C,",
    "entities": [
      {
        "text": "MPI",
        "label": "ORG"
      },
      {
        "text": "20",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "7-10-day lag; RR = 1.82 at 30 \u00b0C, 10-day lag), with high temperatures increasing",
    "entities": [
      {
        "text": "7-10-day",
        "label": "DATE"
      },
      {
        "text": "1.82",
        "label": "CARDINAL"
      },
      {
        "text": "30",
        "label": "CARDINAL"
      },
      {
        "text": "10-day",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "female MPP/SMPP risk. Humidity had a U-shaped association with outpatient MPI",
    "entities": [
      {
        "text": "MPP",
        "label": "ORG"
      },
      {
        "text": "MPI\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(20 %/100 % humidity increased risk 2.75/2.18-fold at 15-day lag), with high",
    "entities": [
      {
        "text": "20 %",
        "label": "PERCENT"
      },
      {
        "text": "2.75/2.18-fold",
        "label": "CARDINAL"
      },
      {
        "text": "15-day",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "humidity elevating female/school-age SMPP risk (RR = 5.32). Trends were",
    "entities": [
      {
        "text": "SMPP",
        "label": "ORG"
      },
      {
        "text": "5.32",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "CONCLUSION: High PM2.5, high temperature, and extreme humidity correlate with",
    "entities": []
  },
  {
    "text": "increased childhood MPI cases and severity, emphasizing targeted strategies for",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025 Elsevier Ltd. All rights reserved.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "93. Water Res. 2025 Jul 7;286:124176. doi: 10.1016/j.watres.2025.124176. Online",
    "entities": [
      {
        "text": "93",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "10.1016",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Using a hybrid modelling approach for high time-resolution prediction of",
    "entities": []
  },
  {
    "text": "influent orthophosphate load in a water resource recovery facility.",
    "entities": []
  },
  {
    "text": "(1)Division of Industrial Electrical Engineering and Automation (IEA),",
    "entities": [
      {
        "text": "Industrial Electrical Engineering and Automation",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Department of Biomedical Engineering, Lund University, P.O. Box 118, SE-22100,",
    "entities": [
      {
        "text": "Department of Biomedical Engineering",
        "label": "ORG"
      },
      {
        "text": "Lund University",
        "label": "ORG"
      },
      {
        "text": "P.O. Box",
        "label": "ORG"
      },
      {
        "text": "118",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Lund, Sweden; RISE Research Institutes of Sweden AB, Gibraltargatan 35,",
    "entities": [
      {
        "text": "Sweden",
        "label": "GPE"
      },
      {
        "text": "RISE Research Institutes of Sweden AB",
        "label": "ORG"
      },
      {
        "text": "Gibraltargatan",
        "label": "GPE"
      },
      {
        "text": "35",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "SE-41279, Gothenburg, Sweden. Electronic address: christoffer.warff@iea.lth.se.",
    "entities": [
      {
        "text": "Gothenburg",
        "label": "GPE"
      },
      {
        "text": "Sweden",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Division of Systems and Control, Department of Information Technology,",
    "entities": [
      {
        "text": "Systems",
        "label": "GPE"
      },
      {
        "text": "Control, Department of Information Technology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Uppsala University, PO Box 337, SE-75105, Uppsala, Sweden. Electronic address:",
    "entities": [
      {
        "text": "Uppsala University",
        "label": "ORG"
      },
      {
        "text": "PO Box 337",
        "label": "PERSON"
      },
      {
        "text": "Uppsala",
        "label": "GPE"
      },
      {
        "text": "Sweden",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Division of Industrial Electrical Engineering and Automation (IEA),",
    "entities": [
      {
        "text": "Industrial Electrical Engineering and Automation",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "SE-41279, Gothenburg, Sweden. Electronic address: magnus.arnell@iea.lth.se.",
    "entities": [
      {
        "text": "Gothenburg",
        "label": "GPE"
      },
      {
        "text": "Sweden",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Sweden. Electronic address: federico.micolucci@nsva.se.",
    "entities": [
      {
        "text": "Sweden",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)IVL Swedish Environmental Research Institute, Valhallav\u00e4gen 81, Stockholm,",
    "entities": [
      {
        "text": "Swedish Environmental Research Institute",
        "label": "ORG"
      },
      {
        "text": "Valhallav\u00e4gen 81",
        "label": "ORG"
      },
      {
        "text": "Stockholm",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "114 28, Sweden. Electronic address: oscar.samuelsson@ivl.se.",
    "entities": [
      {
        "text": "114 28",
        "label": "CARDINAL"
      },
      {
        "text": "Sweden",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Division of Industrial Electrical Engineering and Automation (IEA),",
    "entities": [
      {
        "text": "Industrial Electrical Engineering and Automation",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Lund, Sweden. Electronic address: ulf.jeppsson@iea.lth.se.",
    "entities": [
      {
        "text": "Sweden",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Water resource recovery facilities face challenges with increasingly stringent",
    "entities": []
  },
  {
    "text": "effluent demands, complexity and demand for capacity increasing investments.",
    "entities": []
  },
  {
    "text": "Emerging technologies such as digital twins could alleviate these problems but",
    "entities": []
  },
  {
    "text": "require high frequency influent data. This work presents a method for utilising",
    "entities": []
  },
  {
    "text": "measurements in the primary clarifier effluent with a model of the processes",
    "entities": []
  },
  {
    "text": "between the influent and primary clarifier effluent to predict influent",
    "entities": []
  },
  {
    "text": "orthophosphate load for a plant with considerable internal load. Five functions",
    "entities": [
      {
        "text": "Five",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "for describing daily load variations were tested and compared for accuracy and",
    "entities": [
      {
        "text": "daily",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "computational time. All functions were shown to reproduce the measured primary",
    "entities": []
  },
  {
    "text": "effluent orthophosphate concentration with high accuracy, although the function",
    "entities": []
  },
  {
    "text": "based on four normal distributions was deemed the most suitable due to its short",
    "entities": [
      {
        "text": "four",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "computational time, realistic influent concentration variations and accurate",
    "entities": []
  },
  {
    "text": "estimated primary effluent orthophosphate concentration. Validation of the",
    "entities": []
  },
  {
    "text": "optimised influent concentrations shows that it follows similar patterns but",
    "entities": []
  },
  {
    "text": "might overpredict the afternoon load, which could be due to deviating daily",
    "entities": [
      {
        "text": "afternoon",
        "label": "TIME"
      },
      {
        "text": "daily",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "patterns by inhabitants during the COVID-19 pandemic (although this requires",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "further investigation). The presented methodology can be extended also to",
    "entities": []
  },
  {
    "text": "performance.",
    "entities": []
  },
  {
    "text": "10.1016/j.intimp.2025.115226. Online ahead of print.",
    "entities": [
      {
        "text": "10.1016",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "The role of ELK4 up-regulation in macrophage polarization and its mechanism in",
    "entities": []
  },
  {
    "text": "connective tissue disease-associated interstitial lung disease.",
    "entities": []
  },
  {
    "text": "(1)Department of Rheumatology, The First Affiliated Hospital of China Medical",
    "entities": [
      {
        "text": "The First Affiliated Hospital of China Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Department of Pathology,Shengjing Hospital Affiliated to China Medical",
    "entities": [
      {
        "text": "2)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Pathology",
        "label": "ORG"
      },
      {
        "text": "Shengjing Hospital Affiliated",
        "label": "ORG"
      },
      {
        "text": "China Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University,China.",
    "entities": [
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Rheumatology, The First Affiliated Hospital of China Medical",
    "entities": [
      {
        "text": "The First Affiliated Hospital of China Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University,Shenyang 110001,Liaoning,China. Electronic address:",
    "entities": [
      {
        "text": "University",
        "label": "ORG"
      },
      {
        "text": "Shenyang 110001,Liaoning",
        "label": "PERSON"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "OBJECTIVE: To examine the role of ETS domain containing protein ELK4 in",
    "entities": [
      {
        "text": "ELK4",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "macrophage polarization and pulmonary fibrosis in connective tissue",
    "entities": []
  },
  {
    "text": "disease-related interstitial lung disease(CTD-ILD).",
    "entities": []
  },
  {
    "text": "METHODS: This study analyzed gene expression datasets (SSc-ILD, ALI, COVID-19)",
    "entities": [
      {
        "text": "ALI",
        "label": "ORG"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "to identify target genes in CTD-ILD. We performed RT-qPCR, Western blot, and",
    "entities": [
      {
        "text": "CTD-ILD",
        "label": "ORG"
      },
      {
        "text": "RT-qPCR",
        "label": "ORG"
      },
      {
        "text": "Western",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "immunohistochemistry to assess macrophage polarization and",
    "entities": []
  },
  {
    "text": "epithelial-mesenchymal transition (EMT) both in vitro and in a mouse model of",
    "entities": [
      {
        "text": "EMT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "pulmonary fibrosis. Non-invasive lung function testing was also conducted.",
    "entities": []
  },
  {
    "text": "RESULTS: Bioinformatics analysis demonstrated that reduced ELK4 expression is",
    "entities": []
  },
  {
    "text": "associated with ILD. In CTD-ILD patients, lower ELK4 levels correlated with",
    "entities": [
      {
        "text": "ILD",
        "label": "ORG"
      },
      {
        "text": "CTD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "higher KL-6 and ferritin, and lower DLCO. In vitro, ELK4 down-regulation",
    "entities": [
      {
        "text": "KL-6",
        "label": "ORG"
      },
      {
        "text": "ferritin",
        "label": "ORG"
      },
      {
        "text": "DLCO",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "increased macrophage markers (CD86 and iNOS) and p38/JNK phosphorylation, while",
    "entities": []
  },
  {
    "text": "promoting mesenchymal markers (N-cadherin, Vimentin) and inhibiting E-cadherin.",
    "entities": [
      {
        "text": "Vimentin",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "In the bleomycin-induced fibrosis model, ELK4 overexpression reversed these",
    "entities": []
  },
  {
    "text": "changes, improved lung function, and reduced IL-6 and TNF-\u03b1 levels in",
    "entities": [
      {
        "text": "IL-6",
        "label": "ORG"
      },
      {
        "text": "TNF",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "CONCLUSION: The reduced expression of ELK4 activates the p38 and ERK signaling",
    "entities": [
      {
        "text": "ELK4",
        "label": "ORG"
      },
      {
        "text": "ERK",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "pathways in the MAPK signaling pathway, promoting macrophage polarization toward",
    "entities": [
      {
        "text": "MAPK",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "the M1 phenotype. These findings demonstrate that ELK4 plays a crucial role in",
    "entities": [
      {
        "text": "M1",
        "label": "PRODUCT"
      },
      {
        "text": "ELK4",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "the pathogenesis of CTD-ILD.",
    "entities": [
      {
        "text": "CTD-ILD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Correction: Association between long COVID and nonsteroidal anti-inflammatory",
    "entities": []
  },
  {
    "text": "drug use by patients with acute-phase COVID-19: A nationwide Korea National",
    "entities": [
      {
        "text": "Korea National",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Health Insurance Service cohort study.",
    "entities": [
      {
        "text": "Health Insurance Service",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "[This corrects the article DOI: 10.1371/journal.pone.0312530.].",
    "entities": [
      {
        "text": "10.1371/journal.pone.0312530",
        "label": "QUANTITY"
      }
    ]
  },
  {
    "text": "Copyright: \u00a9 2025 The PLOS One Staff. This is an open access article distributed",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "PLOS One Staff",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "under the terms of the Creative Commons Attribution License, which permits",
    "entities": [
      {
        "text": "the Creative Commons Attribution License",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "unrestricted use, distribution, and reproduction in any medium, provided the",
    "entities": []
  },
  {
    "text": "original author and source are credited.",
    "entities": []
  },
  {
    "text": "Genomic epidemiology of SARS-CoV-2 in Norfolk, UK, March 2020-December 2022.",
    "entities": [
      {
        "text": "Norfolk",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      },
      {
        "text": "March 2020-December 2022",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Hayles EH(1)(2)(3), Page AJ(1)(4), Kingsley RA(1)(3)(5), Guitian J(6), The",
    "entities": [
      {
        "text": "Page AJ(1)(4",
        "label": "FAC"
      },
      {
        "text": "Kingsley RA(1)(3)(5",
        "label": "PERSON"
      },
      {
        "text": "Guitian",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Covid-Genomics Uk Consortium, Langridge GC(1)(3).",
    "entities": [
      {
        "text": "Covid-Genomics Uk Consortium",
        "label": "PERSON"
      },
      {
        "text": "Langridge GC(1)(3",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Quadram Institute Bioscience, Norwich Research Park, Norwich, UK.",
    "entities": [
      {
        "text": "1)Quadram Institute Bioscience",
        "label": "ORG"
      },
      {
        "text": "Norwich Research Park",
        "label": "ORG"
      },
      {
        "text": "Norwich",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Norwich Medical School, University of East Anglia, Norwich Research Park,",
    "entities": [
      {
        "text": "Medical School, University of East Anglia",
        "label": "ORG"
      },
      {
        "text": "Norwich Research Park",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Centre for Microbial Interactions, Norwich Research Park, Norwich, UK.",
    "entities": [
      {
        "text": "3)Centre",
        "label": "CARDINAL"
      },
      {
        "text": "Microbial Interactions",
        "label": "ORG"
      },
      {
        "text": "Norwich Research Park",
        "label": "ORG"
      },
      {
        "text": "Norwich",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Theiagen Genomics, 1745 Shea Center Drive, Highlands Ranch, Co, USA.",
    "entities": [
      {
        "text": "1745",
        "label": "DATE"
      },
      {
        "text": "Highlands Ranch",
        "label": "ORG"
      },
      {
        "text": "Co, USA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)School of Biological Sciences, University of East Anglia, Norwich Research",
    "entities": [
      {
        "text": "5)School of",
        "label": "ORG"
      },
      {
        "text": "Biological Sciences",
        "label": "ORG"
      },
      {
        "text": "University of East Anglia",
        "label": "ORG"
      },
      {
        "text": "Norwich Research",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(6)Department of Pathobiology and Population Sciences, The Royal Veterinary",
    "entities": [
      {
        "text": "Pathobiology and Population Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "College, London, UK.",
    "entities": [
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "In the UK, the COVID-19 Genomics UK Consortium (COG-UK) established a real-time",
    "entities": [
      {
        "text": "UK",
        "label": "GPE"
      },
      {
        "text": "Genomics UK Consortium",
        "label": "ORG"
      },
      {
        "text": "COG-UK",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "national genomic surveillance system during the COVID-19 pandemic, producing",
    "entities": [
      {
        "text": "national genomic surveillance system",
        "label": "ORG"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "centralized data for monitoring severe acute respiratory syndrome coronavirus 2",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(SARS-CoV-2). As a COG-UK partner, Quadram Institute Bioscience in Norfolk",
    "entities": [
      {
        "text": "COG",
        "label": "ORG"
      },
      {
        "text": "UK",
        "label": "GPE"
      },
      {
        "text": "Quadram Institute Bioscience",
        "label": "ORG"
      },
      {
        "text": "Norfolk",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "sequenced over 87,000 SARS-CoV-2 genomes as part of the national effort,",
    "entities": [
      {
        "text": "over 87,000",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "contributing to the region becoming densely sequenced. Retrospective analysis of",
    "entities": []
  },
  {
    "text": "SARS-CoV-2 lineage dynamics in this region may contribute to preparedness for",
    "entities": []
  },
  {
    "text": "future pandemics. In total, 29,406 SARS-CoV-2 whole genome sequences and",
    "entities": [
      {
        "text": "29,406",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "corresponding metadata from Norfolk were extracted from the COG-UK dataset,",
    "entities": [
      {
        "text": "Norfolk",
        "label": "GPE"
      },
      {
        "text": "COG",
        "label": "ORG"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "sampled between March 2020 and December 2022, representing 9.9% of regional",
    "entities": [
      {
        "text": "between March 2020",
        "label": "DATE"
      },
      {
        "text": "December 2022",
        "label": "DATE"
      },
      {
        "text": "9.9%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "COVID-19 cases. Sequences were lineage typed using Pangolin, with subsequent",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      },
      {
        "text": "Pangolin",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "lineage analysis carried out in R using RStudio and related packages, including",
    "entities": [
      {
        "text": "RStudio",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "graphical analysis using ggplot2. In total, 401 global lineages were identified,",
    "entities": [
      {
        "text": "ggplot2",
        "label": "PERSON"
      },
      {
        "text": "401",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "with 69.8% appearing more than once and 31.2% over ten times. Temporal",
    "entities": [
      {
        "text": "69.8%",
        "label": "PERCENT"
      },
      {
        "text": "31.2%",
        "label": "PERCENT"
      },
      {
        "text": "ten",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "clustering identified six lineage communities based on first lineage emergence.",
    "entities": [
      {
        "text": "six",
        "label": "CARDINAL"
      },
      {
        "text": "first",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "Alpha, Delta and Omicron variants of concern (VOCs) accounted for 8.6, 34.9 and",
    "entities": [
      {
        "text": "Alpha",
        "label": "GPE"
      },
      {
        "text": "Delta",
        "label": "ORG"
      },
      {
        "text": "Omicron",
        "label": "ORG"
      },
      {
        "text": "8.6",
        "label": "CARDINAL"
      },
      {
        "text": "34.9",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "48.5% of sequences, respectively. These formed four regional epidemic waves",
    "entities": [
      {
        "text": "48.5%",
        "label": "PERCENT"
      },
      {
        "text": "four",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "alongside the remaining lineages which were observed in the early pandemic prior",
    "entities": []
  },
  {
    "text": "to VOC designation and were termed 'pre-VOC' lineages. Regional comparison",
    "entities": []
  },
  {
    "text": "highlighted variability in VOC epidemic wave dates dependent on location. This",
    "entities": [
      {
        "text": "VOC",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "study is the first to assess SARS-CoV-2 diversity in Norfolk across a large",
    "entities": [
      {
        "text": "first",
        "label": "ORDINAL"
      },
      {
        "text": "Norfolk",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "timescale within the COVID-19 pandemic. SARS-CoV-2 was both highly diverse and",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "dynamic throughout the Norfolk region between March 2020 and December 2022, with",
    "entities": [
      {
        "text": "Norfolk",
        "label": "GPE"
      },
      {
        "text": "March 2020",
        "label": "DATE"
      },
      {
        "text": "December 2022",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "a strong VOC presence within the latter two-thirds of the study period. The",
    "entities": [
      {
        "text": "two-thirds",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "study also displays the utility of incorporating genomic epidemiological methods",
    "entities": []
  },
  {
    "text": "PMID: 40663468 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40663468",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "'Vivaldi': an amplicon-based whole-genome sequencing method for the four",
    "entities": [
      {
        "text": "Vivaldi",
        "label": "PERSON"
      },
      {
        "text": "four",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "seasonal human coronaviruses, 229E, NL63, OC43 and HKU1, alongside SARS-CoV-2.",
    "entities": [
      {
        "text": "229E",
        "label": "CARDINAL"
      },
      {
        "text": "HKU1",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "McClure CP(1)(2)(3), Tsoleridis T(1)(2)(4), Hill JD(1)(2), Holmes N(2)(5),",
    "entities": [
      {
        "text": "Tsoleridis T(1)(2)(4",
        "label": "PERSON"
      },
      {
        "text": "Hill",
        "label": "PERSON"
      },
      {
        "text": "Holmes N(2)(5",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Clark G(6), Irving WL(1)(2)(3)(6), Tarr AW(1)(2)(3), Ball JK(1)(2)(3)(7),",
    "entities": [
      {
        "text": "Clark",
        "label": "PERSON"
      },
      {
        "text": "Irving WL(1)(2)(3)(6",
        "label": "PERSON"
      },
      {
        "text": "Tarr",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Astbury S(3)(8), Loose M(2)(5).",
    "entities": [
      {
        "text": "Astbury",
        "label": "GPE"
      },
      {
        "text": "Loose M(2)(5",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Wolfson Centre for Global Virus Research, University of Nottingham,",
    "entities": [
      {
        "text": "Centre for Global Virus Research,",
        "label": "WORK_OF_ART"
      },
      {
        "text": "University of Nottingham",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Nottingham, UK.",
    "entities": [
      {
        "text": "Nottingham",
        "label": "PERSON"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)School of Life Sciences, University of Nottingham, Nottingham, UK.",
    "entities": [
      {
        "text": "Life Sciences",
        "label": "ORG"
      },
      {
        "text": "University of Nottingham, Nottingham",
        "label": "ORG"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)National Institute for Health Research Nottingham Biomedical Research Centre,",
    "entities": [
      {
        "text": "3)National Institute for Health Research Nottingham Biomedical Research Centre",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University of Nottingham and Nottingham University Hospitals NHS Trust,",
    "entities": [
      {
        "text": "University of Nottingham and Nottingham University Hospitals NHS Trust",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)The Pirbright Institute, Ash Road, Pirbright, Woking, UK.",
    "entities": [
      {
        "text": "4)The Pirbright Institute",
        "label": "ORG"
      },
      {
        "text": "Woking",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Deep Seq, School of Life Sciences, University of Nottingham, Nottingham, UK.",
    "entities": [
      {
        "text": "Seq",
        "label": "PERSON"
      },
      {
        "text": "School of Life Sciences",
        "label": "ORG"
      },
      {
        "text": "University of Nottingham, Nottingham",
        "label": "ORG"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Clinical Microbiology, Nottingham University Hospitals NHS Trust, Nottingham,",
    "entities": [
      {
        "text": "6)Clinical Microbiology",
        "label": "ORG"
      },
      {
        "text": "Nottingham University Hospitals NHS Trust",
        "label": "ORG"
      },
      {
        "text": "Nottingham",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(7)Dept of Tropical Disease Biology, Liverpool School of Tropical Medicine,",
    "entities": [
      {
        "text": "Tropical Disease Biology",
        "label": "ORG"
      },
      {
        "text": "Liverpool School of Tropical Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Liverpool, UK.",
    "entities": [
      {
        "text": "Liverpool",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(8)Nottingham Digestive Diseases Centre, Translational Medical Sciences, School",
    "entities": [
      {
        "text": "8)Nottingham",
        "label": "CARDINAL"
      },
      {
        "text": "Translational Medical Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of Medicine, University of Nottingham, Nottingham, UK.",
    "entities": [
      {
        "text": "Medicine, University of Nottingham, Nottingham",
        "label": "ORG"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Prior to the emergence of SARS-CoV-2 in 2019, alphacoronaviruses 229E and NL63",
    "entities": [
      {
        "text": "2019",
        "label": "DATE"
      },
      {
        "text": "229E",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "and betacoronaviruses OC43 and HKU1 were already established endemic 'common",
    "entities": [
      {
        "text": "HKU1",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "cold' viral infections. Despite their collective contribution towards global",
    "entities": []
  },
  {
    "text": "respiratory morbidity and mortality and potential to inform the future",
    "entities": []
  },
  {
    "text": "trajectory of SARS-CoV-2 endemicity, they are infrequently sequenced. We",
    "entities": []
  },
  {
    "text": "therefore developed a 1,200 bp amplicon whole-genome sequencing scheme targeting",
    "entities": [
      {
        "text": "1,200",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "all four seasonal coronaviruses and SARS-CoV-2. The 'Vivaldi' method was applied",
    "entities": [
      {
        "text": "four",
        "label": "CARDINAL"
      },
      {
        "text": "Vivaldi",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "retrospectively and prospectively using Oxford Nanopore Technology to ~400",
    "entities": [
      {
        "text": "Oxford Nanopore Technology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "seasonal coronavirus infections diagnosed in Nottingham, UK, from February 2016",
    "entities": [
      {
        "text": "Nottingham",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      },
      {
        "text": "February 2016",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "to July 2023. We demonstrate that the amplicon multiplex strategy can be applied",
    "entities": [
      {
        "text": "July 2023",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "agnostically to determine the complete genomes of five different species from",
    "entities": [
      {
        "text": "five",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "two coronaviral genera. Three hundred and four unique seasonal coronavirus",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      },
      {
        "text": "Three hundred and four",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "genomes of greater than 95% coverage were achieved: 64 for 229E, 85 for NL63,",
    "entities": [
      {
        "text": "greater than",
        "label": "PERCENT"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "64",
        "label": "CARDINAL"
      },
      {
        "text": "229E",
        "label": "CARDINAL"
      },
      {
        "text": "85",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "128 for OC43 and 27 for HKU1. They collectively indicated a dynamic seasonal",
    "entities": [
      {
        "text": "128",
        "label": "CARDINAL"
      },
      {
        "text": "27",
        "label": "CARDINAL"
      },
      {
        "text": "HKU1",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "coronavirus genomic landscape, with co-circulation of multiple variants emerging",
    "entities": []
  },
  {
    "text": "and declining over the UK winter respiratory infection season, with further",
    "entities": [
      {
        "text": "UK",
        "label": "GPE"
      },
      {
        "text": "winter",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "geographical distinction when compared to a global dataset. Prolonged infection",
    "entities": []
  },
  {
    "text": "with concomitant intra-host evolution was also observed for both alpha- (NL63)",
    "entities": [
      {
        "text": "NL63",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and betacoronaviruses (OC43). This data represents the largest single cohort of",
    "entities": []
  },
  {
    "text": "seasonal coronavirus genomes to date and also a novel amplicon scheme for their",
    "entities": []
  },
  {
    "text": "future global surveillance suitable for widespread and easy adoption in the",
    "entities": []
  },
  {
    "text": "PMID: 40663464 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40663464",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: The authors declare that there are no conflicts",
    "entities": []
  },
  {
    "text": "of interest.",
    "entities": []
  },
  {
    "text": "Analysing risk factors for foetal growth outcomes - the influence of maternal",
    "entities": []
  },
  {
    "text": "conditions and congenital cytomegalovirus infection.",
    "entities": []
  },
  {
    "text": "[Article in English]",
    "entities": [
      {
        "text": "English",
        "label": "LANGUAGE"
      }
    ]
  },
  {
    "text": "OBJECTIVE: This study aimed to analyse the risk factors differentiating small",
    "entities": []
  },
  {
    "text": "for gestational age (SGA) and appropriate for gestational age (AGA) neonates.",
    "entities": [
      {
        "text": "AGA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "MATERIALS AND METHODS: A retrospective-prospective cohort study was conducted",
    "entities": []
  },
  {
    "text": "from 2019 to 2024 at the 2nd Department of Obstetrics and Gynaecology,",
    "entities": [
      {
        "text": "2019 to 2024",
        "label": "DATE"
      },
      {
        "text": "2nd",
        "label": "ORDINAL"
      },
      {
        "text": "Department of Obstetrics and Gynaecology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University Hospital Bratislava. The study involved 174 term neonates from",
    "entities": [
      {
        "text": "University Hospital Bratislava",
        "label": "ORG"
      },
      {
        "text": "174",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "singleton pregnancies, including 125 SGA and 49 AGA infants. Various maternal,",
    "entities": [
      {
        "text": "125",
        "label": "CARDINAL"
      },
      {
        "text": "49",
        "label": "CARDINAL"
      },
      {
        "text": "AGA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "foetal, and placental risk factors were analysed, with a particular focus on",
    "entities": []
  },
  {
    "text": "congenital cytomegalovirus infection (cCMV).",
    "entities": []
  },
  {
    "text": "RESULTS: Neonates' birth weights ranged from 1,480 to 4,470 grams. Of the risk",
    "entities": [
      {
        "text": "1,480",
        "label": "CARDINAL"
      },
      {
        "text": "4,470 grams",
        "label": "QUANTITY"
      }
    ]
  },
  {
    "text": "factors assessed, only maternal COVID-19 infection during pregnancy was",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "significantly associated with AGA outcomes (P = 0.009). No significant",
    "entities": [
      {
        "text": "AGA",
        "label": "ORG"
      },
      {
        "text": "0.009",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "associations were found between common risk factors (e. g. hypertension,",
    "entities": [
      {
        "text": "associations",
        "label": "ORG"
      },
      {
        "text": "e. g. hypertension",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "diabetes mellitus) and foetal growth restriction. Congenital CMV infection was",
    "entities": [
      {
        "text": "CMV",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "not significantly associated with SGA. Logistic regression analysis confirmed",
    "entities": [
      {
        "text": "SGA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "the association of COVID-19 infection with foetal weight, while no significant",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "effect was observed for CMV.",
    "entities": [
      {
        "text": "CMV",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "CONCLUSION: Maternal COVID-19 infection was associated with AGA outcomes,",
    "entities": [
      {
        "text": "AGA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "potentially due to enhanced medical surveillance and immune responses. However,",
    "entities": []
  },
  {
    "text": "the study's small sample size limits the interpretation of these findings, and",
    "entities": []
  },
  {
    "text": "further research is required to fully understand the impacts of COVID-19 on",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "pregnancy. No significant association between congenital CMV infection and",
    "entities": [
      {
        "text": "CMV",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "foetal growth restriction was found in this cohort, which was most likely due to",
    "entities": []
  },
  {
    "text": "the low prevalence of cCMV. Moreover, documented risk factors for foetal growth",
    "entities": []
  },
  {
    "text": "restriction, including hypertension and diabetes mellitus, were not",
    "entities": []
  },
  {
    "text": "statistically significant in our study population.",
    "entities": []
  },
  {
    "text": "PMID: 40663445 [Indexed for MEDLINE]",
    "entities": []
  },
  {
    "text": "Cases, Hospitalization, and Mortality in COVID-19 and Influenza Among Veterans",
    "entities": [
      {
        "text": "COVID-19",
        "label": "GPE"
      },
      {
        "text": "Influenza Among Veterans",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "in 2022-2025 Influenza Seasons.",
    "entities": [
      {
        "text": "2022-2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Xie Y(1), Wang N(1), Choi T(1), Al-Aly Z(1).",
    "entities": [
      {
        "text": "Xie Y(1",
        "label": "PRODUCT"
      },
      {
        "text": "Wang N(1",
        "label": "PERSON"
      },
      {
        "text": "Choi",
        "label": "ORG"
      },
      {
        "text": "T(1",
        "label": "PRODUCT"
      },
      {
        "text": "Al-Aly",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Clinical Epidemiology Center, VA Saint Louis Health Care System, Saint Louis,",
    "entities": [
      {
        "text": "1)Clinical",
        "label": "CARDINAL"
      },
      {
        "text": "Epidemiology Center",
        "label": "FAC"
      },
      {
        "text": "VA Saint Louis Health Care System",
        "label": "FAC"
      },
      {
        "text": "Saint Louis",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Plain Language Summary: This cohort study examines rates of positive tests,",
    "entities": []
  },
  {
    "text": "hospitalizations, and deaths for COVID-19 and influenza across the influenza",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "seasons of 2022 to 2023, 2023 to 2024, and 2024 to 2025 among US veterans.",
    "entities": [
      {
        "text": "2022",
        "label": "DATE"
      },
      {
        "text": "2023",
        "label": "DATE"
      },
      {
        "text": "2023 to 2024",
        "label": "DATE"
      },
      {
        "text": "2024 to 2025",
        "label": "DATE"
      },
      {
        "text": "US",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Pediatric COVID-19 Hospitalization Trends by Race and Ethnicity, 2020-2023.",
    "entities": [
      {
        "text": "Race and Ethnicity",
        "label": "WORK_OF_ART"
      },
      {
        "text": "2020-2023",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Anglin O(1), Patel K(1), Daily Kirley P(2), Sachdev D(3), Alden NB(4), Armistead",
    "entities": [
      {
        "text": "Daily Kirley",
        "label": "PERSON"
      },
      {
        "text": "Sachdev",
        "label": "PERSON"
      },
      {
        "text": "Alden",
        "label": "GPE"
      },
      {
        "text": "Armistead\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "I(4), Yousey-Hindes K(5), Meek J(5), Witt LS(6)(7), Openo KP(6)(7)(8), Monroe",
    "entities": [
      {
        "text": "Yousey-Hindes K(5",
        "label": "ORG"
      },
      {
        "text": "Meek",
        "label": "PERSON"
      },
      {
        "text": "Witt LS(6)(7",
        "label": "PERSON"
      },
      {
        "text": "Openo KP(6)(7)(8",
        "label": "PERSON"
      },
      {
        "text": "Monroe",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "ML(9), Kim S(10), Urlaub E(10), Como-Sabetti K(11), D'Heilly P(11), Ropp SL(12),",
    "entities": [
      {
        "text": "Kim S(10",
        "label": "PERSON"
      },
      {
        "text": "Urlaub",
        "label": "ORG"
      },
      {
        "text": "Como-Sabetti K(11",
        "label": "ORG"
      },
      {
        "text": "Ropp SL(12",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Sutton M(16), Abdullah N(16), Schaffner W(17), Talbot HK(17), Chatelain R(18),",
    "entities": [
      {
        "text": "Sutton",
        "label": "GPE"
      },
      {
        "text": "Abdullah N(16",
        "label": "PERSON"
      },
      {
        "text": "Schaffner W(17",
        "label": "ORG"
      },
      {
        "text": "Talbot",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Price A(18), King H(1), Taylor CA(1), Patton ME(1)(19), Havers FP(1)(19).",
    "entities": [
      {
        "text": "Taylor",
        "label": "PERSON"
      },
      {
        "text": "Patton ME(1)(19",
        "label": "PERSON"
      },
      {
        "text": "Havers FP(1)(19",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)National Center for Immunization and Respiratory Diseases, Centers for",
    "entities": [
      {
        "text": "Center for Immunization and Respiratory Diseases",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Disease Control and Prevention, Atlanta, Georgia.",
    "entities": [
      {
        "text": "Disease Control and Prevention",
        "label": "ORG"
      },
      {
        "text": "Atlanta",
        "label": "GPE"
      },
      {
        "text": "Georgia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)California Emerging Infections Program, Oakland.",
    "entities": [
      {
        "text": "Emerging Infections Program",
        "label": "ORG"
      },
      {
        "text": "Oakland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)California Department of Public Health, Richmond.",
    "entities": [
      {
        "text": "Department of Public Health",
        "label": "ORG"
      },
      {
        "text": "Richmond",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Colorado Department of Public Health & Environment, Denver.",
    "entities": [
      {
        "text": "4)Colorado Department of Public Health & Environment",
        "label": "ORG"
      },
      {
        "text": "Denver",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Connecticut Emerging Infections Program, Yale School of Public Health, New",
    "entities": [
      {
        "text": "Emerging Infections Program",
        "label": "ORG"
      },
      {
        "text": "Yale School of Public Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(6)Division of Infectious Diseases, Emory University School of Medicine,",
    "entities": [
      {
        "text": "Emory University School of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(7)Georgia Emerging Infections Program, Georgia Department of Public Health,",
    "entities": [
      {
        "text": "Emerging Infections Program",
        "label": "ORG"
      },
      {
        "text": "Georgia Department of Public Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(8)Research, Atlanta Veterans Affairs Medical Center, Decatur, Georgia.",
    "entities": [
      {
        "text": "Atlanta Veterans Affairs Medical Center",
        "label": "ORG"
      },
      {
        "text": "Decatur",
        "label": "GPE"
      },
      {
        "text": "Georgia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(9)Maryland Department of Health, Baltimore.",
    "entities": [
      {
        "text": "9)Maryland Department of Health",
        "label": "ORG"
      },
      {
        "text": "Baltimore",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(10)Michigan Department of Health and Human Services, Lansing.",
    "entities": [
      {
        "text": "10)Michigan Department of Health and Human Services",
        "label": "ORG"
      },
      {
        "text": "Lansing",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(11)Minnesota Department of Health, St Paul.",
    "entities": [
      {
        "text": "11)Minnesota",
        "label": "CARDINAL"
      },
      {
        "text": "Department of Health",
        "label": "ORG"
      },
      {
        "text": "St Paul",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(12)New Mexico Department of Health, Santa Fe.",
    "entities": [
      {
        "text": "12)New Mexico Department of Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(13)University of New Mexico Emerging Infections Program, Albuquerque.",
    "entities": [
      {
        "text": "13)University",
        "label": "CARDINAL"
      },
      {
        "text": "New Mexico Emerging Infections Program",
        "label": "ORG"
      },
      {
        "text": "Albuquerque",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(14)New York State Department of Health, Albany.",
    "entities": [
      {
        "text": "York State Department of Health",
        "label": "ORG"
      },
      {
        "text": "Albany",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(15)University of Rochester School of Medicine and Dentistry, Rochester, New",
    "entities": [
      {
        "text": "15)University",
        "label": "CARDINAL"
      },
      {
        "text": "Rochester School of Medicine and Dentistry",
        "label": "ORG"
      },
      {
        "text": "Rochester",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "York.",
    "entities": []
  },
  {
    "text": "(16)Public Health Division, Oregon Health Authority, Portland.",
    "entities": [
      {
        "text": "Health Division",
        "label": "ORG"
      },
      {
        "text": "Oregon Health Authority",
        "label": "ORG"
      },
      {
        "text": "Portland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(17)Vanderbilt University Medical Center, Nashville, Tennessee.",
    "entities": [
      {
        "text": "17)Vanderbilt",
        "label": "CARDINAL"
      },
      {
        "text": "University Medical Center",
        "label": "ORG"
      },
      {
        "text": "Nashville",
        "label": "GPE"
      },
      {
        "text": "Tennessee",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(18)Salt Lake County Health Department, Salt Lake City, Utah.",
    "entities": [
      {
        "text": "Lake County Health Department",
        "label": "ORG"
      },
      {
        "text": "Salt Lake City",
        "label": "GPE"
      },
      {
        "text": "Utah",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(19)United States Public Health Service, Rockville, Maryland.",
    "entities": [
      {
        "text": "19)United",
        "label": "CARDINAL"
      },
      {
        "text": "States Public Health Service",
        "label": "ORG"
      },
      {
        "text": "Rockville",
        "label": "GPE"
      },
      {
        "text": "Maryland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "IMPORTANCE: Examining racial and ethnic disparities in pediatric COVID-19",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "hospitalizations is critical to inform public health efforts to reduce those",
    "entities": []
  },
  {
    "text": "OBJECTIVE: To characterize trends in pediatric COVID-19 hospitalizations by race",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and ethnicity from March 2020 to September 2023, focusing on recent",
    "entities": [
      {
        "text": "March 2020 to September 2023",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "epidemiologic findings (October 2022 to September 2023).",
    "entities": [
      {
        "text": "October 2022 to September 2023",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study used data from the",
    "entities": []
  },
  {
    "text": "COVID-19 Hospitalization Surveillance Network (COVID-NET) including 13 555",
    "entities": [
      {
        "text": "COVID-19 Hospitalization Surveillance Network",
        "label": "ORG"
      },
      {
        "text": "13 555",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "hospitalizations among patients aged 17 years or younger with a",
    "entities": [
      {
        "text": "17 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "laboratory-confirmed SARS-CoV-2 infection who are residents of the COVID-NET",
    "entities": []
  },
  {
    "text": "catchment area in 12 states, covering approximately 10% of the US population.",
    "entities": [
      {
        "text": "12",
        "label": "CARDINAL"
      },
      {
        "text": "approximately 10%",
        "label": "PERCENT"
      },
      {
        "text": "US",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "EXPOSURE: Laboratory-confirmed SARS-CoV-2 infection within 14 days prior to or",
    "entities": [
      {
        "text": "14 days",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "during hospitalization.",
    "entities": []
  },
  {
    "text": "MAIN OUTCOMES AND MEASURES: Pediatric COVID-19-associated hospitalization rates",
    "entities": [
      {
        "text": "MAIN",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "by race and ethnicity and characteristics associated with COVID-19-associated",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "hospitalizations.",
    "entities": []
  },
  {
    "text": "RESULTS: Between March 2020 and September 2023, COVID-NET identified 13 555",
    "entities": [
      {
        "text": "Between March 2020 and September 2023",
        "label": "DATE"
      },
      {
        "text": "COVID-NET",
        "label": "ORG"
      },
      {
        "text": "13 555",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "pediatric hospitalizations (median patient age, 3.3 years [IQR, 0.6-12.5 years];",
    "entities": [
      {
        "text": "3.3 years",
        "label": "DATE"
      },
      {
        "text": "IQR",
        "label": "ORG"
      },
      {
        "text": "0.6-12.5 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "7110 boys [52.5%]; 780 non-Hispanic Asian or Pacific Islander children [5.8%],",
    "entities": [
      {
        "text": "7110",
        "label": "DATE"
      },
      {
        "text": "52.5%",
        "label": "PERCENT"
      },
      {
        "text": "780",
        "label": "CARDINAL"
      },
      {
        "text": "non-Hispanic",
        "label": "NORP"
      },
      {
        "text": "Asian",
        "label": "NORP"
      },
      {
        "text": "Pacific Islander",
        "label": "LOC"
      },
      {
        "text": "5.8%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "3837 non-Hispanic Black children [28.3%], 4131 Hispanic children [30.5%], and",
    "entities": [
      {
        "text": "3837",
        "label": "DATE"
      },
      {
        "text": "non-Hispanic",
        "label": "NORP"
      },
      {
        "text": "28.3%",
        "label": "PERCENT"
      },
      {
        "text": "4131",
        "label": "DATE"
      },
      {
        "text": "Hispanic",
        "label": "NORP"
      },
      {
        "text": "30.5%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "4807 non-Hispanic White children [35.5%]). Hospitalization rates were 2.15 (95%",
    "entities": [
      {
        "text": "4807",
        "label": "DATE"
      },
      {
        "text": "non-Hispanic",
        "label": "NORP"
      },
      {
        "text": "35.5%",
        "label": "PERCENT"
      },
      {
        "text": "2.15",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "CI, 2.01-2.34) times higher for Black children and 2.06 (95% CI, 1.91-2.23)",
    "entities": [
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "2.01",
        "label": "CARDINAL"
      },
      {
        "text": "2.06",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.91",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "times higher for Hispanic children compared with Asian or Pacific Islander",
    "entities": [
      {
        "text": "Hispanic",
        "label": "NORP"
      },
      {
        "text": "Asian",
        "label": "NORP"
      },
      {
        "text": "Pacific Islander",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "children, who had the lowest rates. Despite overall decreased pediatric",
    "entities": []
  },
  {
    "text": "hospitalization rates between October 2022 and September 2023, higher rates of",
    "entities": [
      {
        "text": "October 2022",
        "label": "DATE"
      },
      {
        "text": "September 2023",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "intensive care unit admissions among Black and Hispanic children persisted, at",
    "entities": [
      {
        "text": "Hispanic",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "1.88 (95% CI, 1.28-2.74) times higher for Black children and 2.13 (95% CI,",
    "entities": [
      {
        "text": "1.88",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.28-2.74",
        "label": "CARDINAL"
      },
      {
        "text": "2.13",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "1.47-3.10) times higher for Hispanic children compared with Asian or Pacific",
    "entities": [
      {
        "text": "1.47",
        "label": "CARDINAL"
      },
      {
        "text": "Hispanic",
        "label": "NORP"
      },
      {
        "text": "Asian",
        "label": "NORP"
      },
      {
        "text": "Pacific",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "Islander children. Among hospitalized children, 61.4% (95% CI, 57.0%-65.8%) of",
    "entities": [
      {
        "text": "61.4%",
        "label": "PERCENT"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "57.0%-65.8%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "Black patients and 45.5% (95% CI, 41.9%-49.3%) of Hispanic patients had 1 or",
    "entities": [
      {
        "text": "45.5%",
        "label": "PERCENT"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "GPE"
      },
      {
        "text": "41.9%-49.3%",
        "label": "PERCENT"
      },
      {
        "text": "Hispanic",
        "label": "NORP"
      },
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "more underlying medical condition compared with 45.6% (95% CI, 42.1%-49.1%) of",
    "entities": [
      {
        "text": "45.6%",
        "label": "PERCENT"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "42.1%-49.1%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "White children and 45.0% (95% CI, 41.9%-49.3%) of Asian or Pacific Islander",
    "entities": [
      {
        "text": "45.0%",
        "label": "PERCENT"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "GPE"
      },
      {
        "text": "41.9%-49.3%",
        "label": "PERCENT"
      },
      {
        "text": "Asian",
        "label": "NORP"
      },
      {
        "text": "Pacific Islander",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "children. Obesity (17.8%; 95% CI, 15.3%-20.5%) and neurologic disorders (15.2%;",
    "entities": [
      {
        "text": "17.8%",
        "label": "PERCENT"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "15.3%-20.5%",
        "label": "PERCENT"
      },
      {
        "text": "15.2%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "95% CI, 13.7%-16.8%) were the most common conditions overall; 11.9% (95% CI,",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "13.7%-16.8%",
        "label": "PERCENT"
      },
      {
        "text": "11.9%",
        "label": "PERCENT"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "9.1%-15.1%) of Black children had sickle cell disease, the fourth most common",
    "entities": [
      {
        "text": "9.1%-15.1%",
        "label": "PERCENT"
      },
      {
        "text": "fourth",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "condition in this group.",
    "entities": []
  },
  {
    "text": "CONCLUSIONS AND RELEVANCE: This study found that among pediatric patients",
    "entities": [
      {
        "text": "CONCLUSIONS",
        "label": "ORG"
      },
      {
        "text": "RELEVANCE",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "hospitalized with COVID-19, Black and Hispanic children were disproportionately",
    "entities": [
      {
        "text": "COVID-19, Black",
        "label": "ORG"
      },
      {
        "text": "Hispanic",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "more likely to be hospitalized for COVID-19 and experience severe disease",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "compared with White and Asian or Pacific Islander children. A higher proportion",
    "entities": [
      {
        "text": "Asian",
        "label": "NORP"
      },
      {
        "text": "Pacific Islander",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "of hospitalized Black children had underlying medical conditions. This study",
    "entities": []
  },
  {
    "text": "underlines the need for targeted interventions, particularly for children with",
    "entities": []
  },
  {
    "text": "underlying medical conditions, and the need for equitable access and use of",
    "entities": []
  },
  {
    "text": "vaccines and therapeutics for disproportionately affected populations.",
    "entities": []
  },
  {
    "text": "PMID: 40663351 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40663351",
        "label": "CARDINAL"
      }
    ]
  }
]